{"74f0134cf6adb7cdddac29129740da8736434ab2": [["IntroductionRapid diagnosis of influenza is useful for early administration of antiviral therapy, infection control and avoidance of unnecessary antibiotics use.", [["influenza", "DISEASE", 31, 40], ["infection", "DISEASE", 98, 107], ["influenza", "PROBLEM", 31, 40], ["antiviral therapy", "TREATMENT", 79, 96], ["infection control", "TREATMENT", 98, 115], ["unnecessary antibiotics", "TREATMENT", 133, 156], ["influenza", "OBSERVATION", 31, 40], ["antiviral therapy", "OBSERVATION", 79, 96]]], ["Multiplex RT-PCRs for the detection of respiratory pathogens are now commercially available and used in routine diagnostics of respiratory infections (Gharabaghi et al., 2011; Vallieres and Renaud, 2013) .", [["respiratory", "ANATOMY", 127, 138], ["respiratory pathogens", "DISEASE", 39, 60], ["respiratory infections", "DISEASE", 127, 149], ["Multiplex RT-PCRs", "TEST", 0, 17], ["respiratory pathogens", "PROBLEM", 39, 60], ["respiratory infections", "PROBLEM", 127, 149], ["respiratory", "ANATOMY", 39, 50], ["pathogens", "OBSERVATION", 51, 60], ["respiratory", "ANATOMY", 127, 138], ["infections", "OBSERVATION", 139, 149]]], ["They have the advantage of simultaneous detection of a panel of different respiratory pathogens.", [["respiratory pathogens", "DISEASE", 74, 95], ["simultaneous detection", "TEST", 27, 49], ["a panel", "TEST", 53, 60], ["different respiratory pathogens", "PROBLEM", 64, 95], ["respiratory pathogens", "OBSERVATION", 74, 95]]], ["However, they are time-consuming and usually performed in large series of specimens thereby prolonging the time until a result is available to the physician in charge of the patient.", [["specimens", "ANATOMY", 74, 83], ["specimens", "CANCER", 74, 83], ["patient", "ORGANISM", 174, 181], ["patient", "SPECIES", 174, 181]]], ["Rapid molecular diagnostic assays have been developed (Nie et al., 2014; Novak-Weekley et al., 2012) that can be performed upon demand for single specimens.", [["specimens", "ANATOMY", 146, 155], ["Rapid molecular diagnostic assays", "TEST", 0, 33], ["single specimens", "TEST", 139, 155]]], ["An example is the Xpert Flu test (Cepheid, France).ObjectivesUsing the Xpert Flu test (Cepheid, France) for urgent diagnostics of influenza, we became aware of apparently false-negative results.", [["influenza", "DISEASE", 130, 139], ["the Xpert Flu test", "TEST", 14, 32], ["the Xpert Flu test", "TEST", 67, 85], ["influenza", "PROBLEM", 130, 139]]], ["Therefore, we initiated the current study in order to systematically analyze the causes of these false-negative results.Clinical specimensFrom October 6th, 2014 to April 10th, 2016, 2108 specimens were sent to our laboratory for rapid influenza testing (Xpert Flu assay) and 3278 specimens were sent for multiplex RT-PCR detection of respiratory viruses.", [["specimens", "ANATOMY", 129, 138], ["specimens", "ANATOMY", 187, 196], ["specimens", "ANATOMY", 280, 289], ["respiratory viruses", "DISEASE", 334, 353], ["specimens", "CANCER", 187, 196], ["the current study", "TEST", 24, 41], ["these false", "TEST", 91, 102], ["Clinical specimens", "TEST", 120, 138], ["rapid influenza testing", "TEST", 229, 252], ["Xpert Flu assay", "TEST", 254, 269], ["specimens", "TEST", 280, 289], ["multiplex RT", "TEST", 304, 316], ["respiratory viruses", "PROBLEM", 334, 353], ["respiratory viruses", "OBSERVATION", 334, 353]]], ["Of these, 159 respiratory specimens were tested with both the Xpert Flu assay and a multiplex RT-PCR for respiratory viruses.", [["respiratory specimens", "ANATOMY", 14, 35], ["respiratory viruses", "DISEASE", 105, 124], ["respiratory specimens", "TEST", 14, 35], ["the Xpert Flu assay", "TEST", 58, 77], ["a multiplex RT-PCR", "TREATMENT", 82, 100], ["respiratory viruses", "PROBLEM", 105, 124], ["respiratory viruses", "OBSERVATION", 105, 124]]], ["The specimens were sent from intensive care units (n = 45), departments of pulmonary medicine (n = 30), pediatrics (n = 23), hematology (n = 20), infectious diseases (n = 9), geriatrics (n = 8), emergency medicine (n = 6) and less frequently from other departments (n = 18).", [["specimens", "ANATOMY", 4, 13], ["pulmonary", "ANATOMY", 75, 84], ["infectious diseases", "DISEASE", 146, 165], ["pulmonary", "ORGAN", 75, 84], ["The specimens", "TEST", 0, 13], ["pulmonary medicine", "TREATMENT", 75, 93], ["infectious diseases", "PROBLEM", 146, 165], ["pulmonary", "ANATOMY", 75, 84], ["infectious", "OBSERVATION", 146, 156]]], ["They were 151 nasopharyngeal swabs, 3 bronchoalveolar lavages, 1 nasopharyngeal aspiration, 2 expectorations, 1 bronchopulmonary secretion and 1 tracheal aspiration.", [["nasopharyngeal swabs", "ANATOMY", 14, 34], ["bronchoalveolar lavages", "ANATOMY", 38, 61], ["nasopharyngeal", "ANATOMY", 65, 79], ["bronchopulmonary", "ANATOMY", 112, 128], ["tracheal", "ANATOMY", 145, 153], ["bronchoalveolar lavages", "MULTI-TISSUE_STRUCTURE", 38, 61], ["tracheal", "ORGAN", 145, 153], ["nasopharyngeal swabs", "TEST", 14, 34], ["3 bronchoalveolar lavages", "TEST", 36, 61], ["1 nasopharyngeal aspiration", "PROBLEM", 63, 90], ["1 bronchopulmonary secretion", "PROBLEM", 110, 138], ["1 tracheal aspiration", "PROBLEM", 143, 164], ["bronchoalveolar lavages", "OBSERVATION", 38, 61], ["nasopharyngeal", "ANATOMY", 65, 79], ["aspiration", "OBSERVATION", 80, 90], ["bronchopulmonary", "ANATOMY", 112, 128], ["secretion", "OBSERVATION", 129, 138], ["tracheal", "ANATOMY", 145, 153], ["aspiration", "OBSERVATION", 154, 164]]], ["Remel Microtest M4RT Transport (Roche, France) was used as transport medium.Clinical specimensThe 159 specimens that were tested in both assays were analyzed in the current study.", [["specimens", "ANATOMY", 85, 94], ["specimens", "ANATOMY", 102, 111], ["Clinical specimens", "TEST", 76, 94], ["The 159 specimens", "TEST", 94, 111], ["the current study", "TEST", 161, 178]]], ["The Xpert Flu assay and a multiplex RT-PCR for respiratory viruses were prescribed simultaneously by the physician in charge of the patient in 150 of these specimens (cohort A).", [["specimens", "ANATOMY", 156, 165], ["respiratory viruses", "DISEASE", 47, 66], ["patient", "ORGANISM", 132, 139], ["patient", "SPECIES", 132, 139], ["The Xpert Flu assay", "TEST", 0, 19], ["a multiplex RT-PCR", "TREATMENT", 24, 42], ["respiratory viruses", "PROBLEM", 47, 66], ["respiratory", "ANATOMY", 47, 58], ["viruses", "OBSERVATION", 59, 66]]], ["In case of the other 9 specimens (cohort B), the laboratory physician additionally prescribed a multiplex RT-PCR for respiratory viruses because she/he doubted the Xpert Flu assay result (i.e. because a negative result was indicated by the automatic interpretation but an amplification curve was visible or an endpoint value was elevated).", [["specimens", "ANATOMY", 23, 32], ["respiratory viruses", "DISEASE", 117, 136], ["a multiplex RT-PCR", "TREATMENT", 94, 112], ["respiratory viruses", "PROBLEM", 117, 136], ["the Xpert Flu assay", "TEST", 160, 179], ["an amplification curve", "TEST", 269, 291], ["an endpoint value", "TEST", 307, 324]]], ["Nucleic acids extracts were submitted to a commercially available multiplex RT-PCR screening for a panel of respiratory viral pathogens including influenza virus A and B, respiratory syncytial virus A and B, human adenovirus (HAdV), human metapneumovirus, coronaviruses 229E, NL63 and OC43, parainfluenza virus 1-4, rhinovirus A/B/C, human enterovirus, and bocavirus 1-4 (Anyplex II RV16 Detection, Seegene, Seoul, Korea) from October 6th, 2014 to February 8th, 2016.", [["extracts", "ANATOMY", 14, 22], ["respiratory viral pathogens", "DISEASE", 108, 135], ["respiratory syncytial virus", "DISEASE", 171, 198], ["parainfluenza virus 1-4", "CHEMICAL", 291, 314], ["extracts", "ORGANISM_SUBSTANCE", 14, 22], ["influenza virus A", "ORGANISM", 146, 163], ["B,", "ORGANISM", 168, 170], ["respiratory syncytial virus A", "ORGANISM", 171, 200], ["B", "GENE_OR_GENE_PRODUCT", 205, 206], ["human adenovirus", "ORGANISM", 208, 224], ["HAdV", "ORGANISM", 226, 230], ["human", "ORGANISM", 233, 238], ["metapneumovirus", "ORGANISM", 239, 254], ["coronaviruses 229E", "ORGANISM", 256, 274], ["NL63", "GENE_OR_GENE_PRODUCT", 276, 280], ["OC43,", "ORGANISM", 285, 290], ["parainfluenza virus 1-4", "ORGANISM", 291, 314], ["rhinovirus A/B/C", "ORGANISM", 316, 332], ["human", "ORGANISM", 334, 339], ["enterovirus", "ORGANISM", 340, 351], ["bocavirus 1-4", "ORGANISM", 357, 370], ["influenza virus", "SPECIES", 146, 161], ["respiratory syncytial virus", "SPECIES", 171, 198], ["human", "SPECIES", 208, 213], ["human", "SPECIES", 233, 238], ["metapneumovirus", "SPECIES", 239, 254], ["parainfluenza virus 1", "SPECIES", 291, 312], ["human", "SPECIES", 334, 339], ["influenza virus A", "SPECIES", 146, 163], ["respiratory syncytial virus A", "SPECIES", 171, 200], ["human adenovirus", "SPECIES", 208, 224], ["HAdV", "SPECIES", 226, 230], ["human metapneumovirus", "SPECIES", 233, 254], ["human enterovirus", "SPECIES", 334, 351], ["Nucleic acids extracts", "TEST", 0, 22], ["multiplex RT", "TEST", 66, 78], ["PCR screening", "TEST", 79, 92], ["a panel", "TEST", 97, 104], ["respiratory viral pathogens", "PROBLEM", 108, 135], ["influenza virus A", "PROBLEM", 146, 163], ["respiratory syncytial virus", "PROBLEM", 171, 198], ["human adenovirus (HAdV", "PROBLEM", 208, 230], ["human metapneumovirus", "PROBLEM", 233, 254], ["coronaviruses", "TEST", 256, 269], ["NL63", "TEST", 276, 280], ["OC43", "TEST", 285, 289], ["parainfluenza virus", "PROBLEM", 291, 310], ["rhinovirus A/B/C", "PROBLEM", 316, 332], ["human enterovirus", "PROBLEM", 334, 351], ["bocavirus", "TEST", 357, 366], ["respiratory syncytial", "ANATOMY", 171, 192]]], ["The assay was performed according to the manufacturer's instructions.", [["The assay", "TEST", 0, 9]]], ["The assay contains an internal control.", [["The assay", "TEST", 0, 9], ["an internal control", "TREATMENT", 19, 38], ["internal control", "OBSERVATION", 22, 38]]], ["The result is indicated as \"invalid\", \"negative\" or \"positive\" with a semi-quantitative result: + for weakly positive, ++ for intermediate and +++ for strongly positive specimens.", [["specimens", "ANATOMY", 169, 178], ["weakly positive", "PROBLEM", 102, 117], ["strongly positive specimens", "PROBLEM", 151, 178]]], ["From February 9th to April 10th, 2016, Allplex Respiratory Panel 1 (Seegene, Seoul, Korea) was used according to the manufacturer's instructions.", [["Respiratory Panel", "TEST", 47, 64]]], ["This technique is a multiplex real-time one-step RT-PCR for the detection of influenza virus A and B, human respiratory syncytial virus A and B, and subtyping of influenza A virus (human influenza A virus subtypes H1, H3, and H1 2009) containing an internal control.", [["respiratory syncytial virus", "DISEASE", 108, 135], ["influenza A virus", "DISEASE", 162, 179], ["influenza virus A", "ORGANISM", 77, 94], ["B", "GENE_OR_GENE_PRODUCT", 99, 100], ["human respiratory syncytial virus A", "ORGANISM", 102, 137], ["B", "CANCER", 142, 143], ["influenza A virus", "ORGANISM", 162, 179], ["human influenza A virus subtypes H1", "ORGANISM", 181, 216], ["influenza virus", "SPECIES", 77, 92], ["human", "SPECIES", 102, 107], ["respiratory syncytial virus", "SPECIES", 108, 135], ["influenza A virus", "SPECIES", 162, 179], ["human", "SPECIES", 181, 186], ["influenza A virus", "SPECIES", 187, 204], ["influenza virus A", "SPECIES", 77, 94], ["human respiratory syncytial virus", "SPECIES", 102, 135], ["influenza A virus", "SPECIES", 162, 179], ["human influenza A virus", "SPECIES", 181, 204], ["the detection", "TEST", 60, 73], ["influenza virus A", "PROBLEM", 77, 94], ["human respiratory syncytial virus A", "PROBLEM", 102, 137], ["influenza A virus", "PROBLEM", 162, 179], ["human influenza A virus subtypes H1", "PROBLEM", 181, 216], ["H3", "PROBLEM", 218, 220], ["an internal control", "TREATMENT", 246, 265], ["influenza virus", "OBSERVATION", 77, 92], ["respiratory syncytial", "ANATOMY", 108, 129]]], ["Forty-five amplification cycles are performed.", [["five amplification cycles", "TREATMENT", 6, 31]]], ["Briefly, 300 \u03bcL of respiratory specimen was added to the cartridge.", [["respiratory specimen", "ANATOMY", 19, 39], ["respiratory specimen", "TREATMENT", 19, 39], ["the cartridge", "TREATMENT", 53, 66]]], ["Lysis of the specimen, purification and amplification of nucleic acids (40 cycles) as well as detection of the target sequence was fully automated on the above-mentioned instruments.", [["specimen", "ANATOMY", 13, 21], ["nucleic acids", "CHEMICAL", 57, 70], ["nucleic acids", "SIMPLE_CHEMICAL", 57, 70], ["the specimen", "TEST", 9, 21], ["nucleic acids", "TREATMENT", 57, 70], ["the target sequence", "TEST", 107, 126]]], ["The results were interpreted by the GeneXpert instrument and indicated as \"positive\", \"negative\" or \"invalid\".", [["the GeneXpert instrument", "TEST", 32, 56]]], ["In the case of positive results, a threshold cycle is specified.", [["a threshold cycle", "TREATMENT", 33, 50]]], ["Furthermore, amplification curves and endpoint values are displayed.", [["amplification curves and endpoint values", "TEST", 13, 53]]], ["This technique includes detection of influenza A, influenza A subtype H1N1 2009, and influenza B virus.", [["influenza A", "DISEASE", 37, 48], ["influenza B", "DISEASE", 85, 96], ["influenza A", "ORGANISM", 37, 48], ["influenza A subtype H1N1 2009", "ORGANISM", 50, 79], ["influenza B virus", "ORGANISM", 85, 102], ["influenza B virus", "SPECIES", 85, 102], ["influenza A", "SPECIES", 37, 48], ["influenza B virus", "SPECIES", 85, 102], ["influenza", "PROBLEM", 37, 46], ["influenza", "PROBLEM", 50, 59], ["influenza B virus", "PROBLEM", 85, 102], ["influenza", "OBSERVATION", 37, 46]]], ["The sensitivity is indicated by the manufacturer depending on the virus strain as at least 100 tissue culture infective dose (TCID)50/mL for influenza A and 25 TCID50/mL for influenza B.Influenza A/B r-Gene assayAll available nucleic acids extracts (stored at \u221280\u00b0C) of specimens that yielded discordant results between the two assays described above (n = 12) were submitted to the Influenza A/B r-gene assay (Argene, Biomerieux, France).", [["tissue", "ANATOMY", 95, 101], ["extracts", "ANATOMY", 240, 248], ["specimens", "ANATOMY", 270, 279], ["nucleic acids", "CHEMICAL", 226, 239], ["tissue", "TISSUE", 95, 101], ["specimens", "CANCER", 270, 279], ["The sensitivity", "TEST", 0, 15], ["the virus strain", "PROBLEM", 62, 78], ["influenza", "PROBLEM", 141, 150], ["influenza", "PROBLEM", 174, 183], ["All available nucleic acids extracts", "TEST", 212, 248], ["the two assays", "TEST", 320, 334]]], ["The assay was performed according to the manufacturer's instructions and was run on a 7500 Real-Time PCR System (Applied Biosystems, Thermofisher, France) (45 amplification cycles).", [["The assay", "TEST", 0, 9]]], ["The sensitivity is indicated by the manufacturer depending on the virus strain as at least 199.5 TCID50/ml for influenza A and 1.7 TCID50/ml for influenza B.Statistical analysisMedian and mean of quantitative variables were calculated.", [["The sensitivity", "TEST", 0, 15], ["the virus strain", "PROBLEM", 62, 78], ["influenza", "PROBLEM", 111, 120], ["influenza", "PROBLEM", 145, 154]]], ["Quantitative variables were compared by using Mann-Whitney U test with IBM SPSS statistics version 22 (IBM, USA).", [["Mann-Whitney U test", "TEST", 46, 65], ["IBM SPSS statistics version", "TEST", 71, 98]]], ["P b 0.05 was considered significant.ResultsDuring the study period, 258 of 2108 (12.2%) specimens yielded positive results for influenza A and 153 of 2108 (7.3%) for influenza B in the Xpert Flu assay; 1697 specimens yielded negative results for both influenza A and B.ResultsOf the 2108 specimens, 159 (7.5%) were also tested in a multiplex RT-PCR for respiratory viruses.", [["specimens", "ANATOMY", 88, 97], ["specimens", "ANATOMY", 207, 216], ["specimens", "ANATOMY", 288, 297], ["influenza A", "DISEASE", 127, 138], ["influenza B", "DISEASE", 166, 177], ["influenza A", "DISEASE", 251, 262], ["respiratory viruses", "DISEASE", 353, 372], ["specimens", "CANCER", 88, 97], ["specimens", "CANCER", 207, 216], ["influenza A", "SPECIES", 127, 138], ["the study", "TEST", 50, 59], ["specimens", "TEST", 88, 97], ["influenza A", "TEST", 127, 138], ["influenza B", "PROBLEM", 166, 177], ["specimens", "TEST", 207, 216], ["a multiplex RT", "TEST", 330, 344], ["respiratory viruses", "PROBLEM", 353, 372], ["respiratory viruses", "OBSERVATION", 353, 372]]], ["These 159 specimens are object of the current study.", [["specimens", "ANATOMY", 10, 19], ["specimens", "CANCER", 10, 19], ["the current study", "TEST", 34, 51]]], ["The Xpert Flu assay and a multiplex RT-PCR for respiratory viruses were prescribed simultaneously by the physician in charge of the patient in 150 of these specimens (cohort A).", [["specimens", "ANATOMY", 156, 165], ["respiratory viruses", "DISEASE", 47, 66], ["patient", "ORGANISM", 132, 139], ["patient", "SPECIES", 132, 139], ["The Xpert Flu assay", "TEST", 0, 19], ["a multiplex RT-PCR", "TREATMENT", 24, 42], ["respiratory viruses", "PROBLEM", 47, 66], ["respiratory", "ANATOMY", 47, 58], ["viruses", "OBSERVATION", 59, 66]]], ["In case of the other 9 specimens (cohort B), the laboratory physician additionally prescribed a multiplex RT-PCR for respiratory viruses because she/he doubted the Xpert Flu assay result.", [["specimens", "ANATOMY", 23, 32], ["respiratory viruses", "DISEASE", 117, 136], ["a multiplex RT-PCR", "TREATMENT", 94, 112], ["respiratory viruses", "PROBLEM", 117, 136]]], ["In cohort A, 7 specimens tested positive for influenza A and 6 specimens tested positive for influenza B, respectively, in both techniques.", [["specimens", "ANATOMY", 15, 24], ["specimens", "ANATOMY", 63, 72], ["influenza B", "DISEASE", 93, 104], ["specimens", "CANCER", 15, 24], ["influenza A", "SPECIES", 45, 56], ["7 specimens", "TEST", 13, 24], ["influenza", "PROBLEM", 45, 54], ["6 specimens", "TEST", 61, 72], ["influenza B", "PROBLEM", 93, 104]]], ["Five specimens gave a positive result for influenza A and 4 specimens gave a positive result for influenza B in a multiplex RT-PCR for respiratory viruses and a negative result in the Xpert Flu assay.", [["specimens", "ANATOMY", 5, 14], ["specimens", "ANATOMY", 60, 69], ["influenza B", "DISEASE", 97, 108], ["respiratory viruses", "DISEASE", 135, 154], ["influenza A", "SPECIES", 42, 53], ["Five specimens", "TEST", 0, 14], ["influenza", "PROBLEM", 42, 51], ["influenza B", "PROBLEM", 97, 108], ["a multiplex RT", "TEST", 112, 126], ["PCR", "TEST", 127, 130], ["respiratory viruses", "PROBLEM", 135, 154], ["respiratory", "ANATOMY", 135, 146], ["viruses", "OBSERVATION", 147, 154]]], ["In cohort B, 3 specimens tested concordantly negative in both assays whereas 2 and 4 specimens tested positive for influenza A and B, respectively, in the Allplex Respiratory Panel 1 and negative in the Flu Xpert assay.", [["specimens", "ANATOMY", 15, 24], ["specimens", "ANATOMY", 85, 94], ["B", "CELL", 131, 132], ["cohort B, 3 specimens", "TEST", 3, 24], ["4 specimens", "TEST", 83, 94], ["influenza", "PROBLEM", 115, 124], ["the Allplex Respiratory Panel", "TEST", 151, 180]]], ["The 15 discordant specimens were investigated in more detail ( Table 2 ).", [["specimens", "ANATOMY", 18, 27], ["specimens", "CANCER", 18, 27], ["The 15 discordant specimens", "TEST", 0, 27]]], ["Nucleic acids of 12 of these specimens were available and were tested in the Influenza A/B r-gene assay.", [["specimens", "ANATOMY", 29, 38], ["Nucleic acids", "AMINO_ACID", 0, 13], ["specimens", "CANCER", 29, 38], ["B r-", "GENE_OR_GENE_PRODUCT", 89, 93], ["Influenza A/B r-", "SPECIES", 77, 93], ["Nucleic acids", "TEST", 0, 13], ["these specimens", "TEST", 23, 38]]], ["All of these gave a positive result in the Influenza A/B r-gene assay thus confirming the result of the multiplex RT-PCR (Table 2) .", [["B r-", "GENE_OR_GENE_PRODUCT", 55, 59], ["Influenza A/B r-", "SPECIES", 43, 59], ["the multiplex RT-PCR", "TEST", 100, 120]]], ["Only four and three of the discordant specimens were weakly positive in the multiplex RT-PCR for respiratory viruses and in the Influenza A/B r-gene assay, respectively (defined as threshold cycle N38 or +) (Table 2) .", [["specimens", "ANATOMY", 38, 47], ["specimens", "CANCER", 38, 47], ["B r-", "GENE_OR_GENE_PRODUCT", 140, 144], ["Influenza A/B r-", "SPECIES", 128, 144], ["the discordant specimens", "TEST", 23, 47], ["respiratory viruses", "PROBLEM", 97, 116], ["the Influenza A/B r-gene assay", "TEST", 124, 154], ["threshold cycle", "TEST", 181, 196], ["respiratory", "ANATOMY", 97, 108], ["viruses", "OBSERVATION", 109, 116]]], ["However, when all Allplex Respiratory Panel 1 positive specimens (concordant and discordant) were analyzed, the median Ct value of discordant specimens was significantly higher than that of concordantly positive specimens (35.6 vs. 24.2, P = 0.001) (Supplementary Table 1 ).", [["specimens", "ANATOMY", 55, 64], ["specimens", "ANATOMY", 142, 151], ["specimens", "ANATOMY", 212, 221], ["specimens", "CANCER", 142, 151], ["all Allplex Respiratory Panel", "TEST", 14, 43], ["specimens", "TEST", 55, 64], ["Ct value of discordant specimens", "TEST", 119, 151], ["concordantly positive specimens", "PROBLEM", 190, 221], ["P", "TEST", 238, 239]]], ["The semiquantitative results between concordantly positive and discordant specimens for Anyplex II RV16 assay positive specimens were similar (Supplementary Table 1 ).ResultsInterestingly, in 10 of 15 discordant results, a typical amplification curve was visible in the amplification plot of the Xpert Flu assay.", [["specimens", "ANATOMY", 74, 83], ["specimens", "ANATOMY", 119, 128], ["The semiquantitative results", "TEST", 0, 28], ["discordant specimens", "TEST", 63, 83], ["Anyplex II RV16 assay", "TEST", 88, 109], ["a typical amplification curve", "PROBLEM", 221, 250]]], ["An example is shown for specimen 6 (influenza A, Fig. 1A and B) , and for specimen 11 (influenza B, Fig. 1C and D) .", [["B", "GENE_OR_GENE_PRODUCT", 61, 62], ["specimen", "TEST", 24, 32], ["specimen", "TEST", 74, 82], ["influenza B", "TEST", 87, 98]]], ["A doubtful curve was visible in 2/15 discordant results, as shown for specimen 2 (influenza A, Supplementary Fig. 1A and B) and specimen 10 (influenza B, Supplementary Fig. 1C and D) .ResultsThe Xpert Flu assay indicates endpoint values that correspond to the maximum of fluorescence in relative fluorescence units.", [["B", "CELL", 121, 122], ["A doubtful curve", "TEST", 0, 16], ["specimen", "TEST", 70, 78], ["Supplementary Fig", "TREATMENT", 95, 112], ["specimen", "TEST", 128, 136], ["influenza B", "TREATMENT", 141, 152], ["The Xpert Flu assay", "TEST", 191, 210], ["endpoint values", "TEST", 221, 236]]], ["In concordantly positive specimens, endpoint values ranged from 21 to 148 for influenza A (n = 7) and from 63 to 723 for influenza B (n = 6).", [["specimens", "ANATOMY", 25, 34], ["influenza", "DISEASE", 78, 87], ["influenza B", "DISEASE", 121, 132], ["endpoint values", "TEST", 36, 51], ["influenza A", "TEST", 78, 89], ["influenza B", "PROBLEM", 121, 132], ["positive specimens", "OBSERVATION_MODIFIER", 16, 34]]], ["4/7 (57%) influenza A discordant specimens had an endpoint value equal or higher than 10 for influenza A in the Xpert Flu assay and all had an endpoint value b10 for influenza B (Table 2) .", [["specimens", "ANATOMY", 33, 42], ["influenza B", "DISEASE", 166, 177], ["influenza A discordant specimens", "TEST", 10, 42], ["an endpoint value", "TEST", 47, 64], ["influenza", "PROBLEM", 93, 102], ["influenza", "PROBLEM", 166, 175]]], ["Six of 8 (75.0%) influenza B discordant specimens had an endpoint value equal or higher than 10 for influenza B and all had an endpoint value b10 for influenza A (Table 2) .", [["specimens", "ANATOMY", 40, 49], ["influenza B", "DISEASE", 100, 111], ["influenza", "DISEASE", 150, 159], ["influenza B discordant specimens", "TEST", 17, 49], ["an endpoint value", "TEST", 54, 71], ["influenza B", "PROBLEM", 100, 111], ["influenza", "PROBLEM", 150, 159]]], ["Specimens with endpoint values equal or higher than 10 all showed a typical curve in the amplification plot.", [["Specimens", "ANATOMY", 0, 9], ["Specimens with endpoint values", "TEST", 0, 30], ["the amplification plot", "TEST", 85, 107]]], ["When endpoint values of the Xpert Flu assay were compared between concordantly negative specimens (true-negative) and discordant results (false-negative), there was a statistically significant difference (P b 0.001) (Supplementary Table 2 ).ResultsIn contrast to the false-negative specimens, only 8 of 145 (5.5%) truenegative specimens had endpoint values equal or higher than 10.", [["specimens", "ANATOMY", 88, 97], ["specimens", "ANATOMY", 282, 291], ["specimens", "ANATOMY", 327, 336], ["specimens", "CANCER", 327, 336], ["endpoint values", "TEST", 5, 20], ["the Xpert Flu assay", "TEST", 24, 43], ["truenegative specimens", "TEST", 314, 336], ["endpoint values", "TEST", 341, 356], ["significant", "OBSERVATION_MODIFIER", 181, 192], ["difference", "OBSERVATION_MODIFIER", 193, 203], ["negative specimens", "OBSERVATION_MODIFIER", 273, 291]]], ["Three of these had endpoint values equal or higher than 10 both for influenza A and B suggesting a non-specific endpoint elevation (Supplementary Table 3 ).", [["endpoint values", "TEST", 19, 34], ["influenza A and B", "PROBLEM", 68, 85], ["a non-specific endpoint elevation", "PROBLEM", 97, 130], ["non-specific", "OBSERVATION_MODIFIER", 99, 111]]], ["Of the 5 other specimens with endpoint values equal or higher than 10 for influenza B, 3 had an endpoint value equal or higher than 10 for influenza A subtype H1N1 2009, also suggesting a non-specific endpoint elevation (Supplementary Table 3 ).", [["specimens", "ANATOMY", 15, 24], ["influenza B", "DISEASE", 74, 85], ["specimens", "CANCER", 15, 24], ["the 5 other specimens", "TEST", 3, 24], ["endpoint values", "TEST", 30, 45], ["influenza B", "PROBLEM", 74, 85], ["an endpoint value", "TEST", 93, 110], ["influenza", "PROBLEM", 139, 148], ["a non-specific endpoint elevation", "PROBLEM", 186, 219], ["non-specific", "OBSERVATION_MODIFIER", 188, 200]]], ["Only 2 of the 8 specimens with endpoint values equal or higher than 10 showed a doubtful amplification curve, whereas the other six showed no amplification curve (Supplementary Table 3 ).", [["specimens", "ANATOMY", 16, 25], ["specimens", "CANCER", 16, 25], ["the 8 specimens", "TEST", 10, 25], ["endpoint values", "TEST", 31, 46], ["a doubtful amplification curve", "TEST", 78, 108], ["amplification curve", "PROBLEM", 142, 161]]], ["Taken together, these data suggest that false-negative and true-negative specimens can be differentiated if both endpoint values and amplification curves are analyzed in detail.DiscussionThe current study was initiated to further investigate discordant results between different techniques used for the diagnosis of influenza.DiscussionAlthough the overall percentage of concordant results was high, there were 15 specimens (out of 159; 9.4%) that yielded negative results in the Xpert Flu assay and positive results in a multiplex RT-PCR for respiratory viruses.", [["specimens", "ANATOMY", 73, 82], ["specimens", "ANATOMY", 414, 423], ["influenza", "DISEASE", 316, 325], ["respiratory viruses", "DISEASE", 543, 562], ["specimens", "CANCER", 73, 82], ["these data", "TEST", 16, 26], ["false", "TEST", 40, 45], ["true-negative specimens", "TEST", 59, 82], ["amplification curves", "TEST", 133, 153], ["The current study", "TEST", 187, 204], ["different techniques", "TREATMENT", 269, 289], ["influenza", "PROBLEM", 316, 325], ["15 specimens", "TEST", 411, 423], ["the Xpert Flu assay", "TEST", 476, 495], ["a multiplex RT-PCR", "TEST", 520, 538], ["respiratory viruses", "PROBLEM", 543, 562], ["influenza", "OBSERVATION", 316, 325], ["respiratory viruses", "OBSERVATION", 543, 562]]], ["One of the specimens with discordant results (specimen 3, Table 2 ) was a tracheal aspiration.", [["specimens", "ANATOMY", 11, 20], ["tracheal", "ANATOMY", 74, 82], ["specimens", "CANCER", 11, 20], ["tracheal", "ORGAN", 74, 82], ["specimen", "TEST", 46, 54], ["a tracheal aspiration", "PROBLEM", 72, 93], ["tracheal", "ANATOMY", 74, 82], ["aspiration", "OBSERVATION", 83, 93]]], ["The package insert of the Xpert Flu assay indicates that nasal aspirates/washes and nasopharyngeal swab specimens can be used for the assay.", [["nasal aspirates", "ANATOMY", 57, 72], ["nasopharyngeal swab specimens", "ANATOMY", 84, 113], ["nasal aspirates", "MULTI-TISSUE_STRUCTURE", 57, 72], ["nasopharyngeal swab specimens", "ORGANISM_SUBSTANCE", 84, 113], ["The package insert", "TREATMENT", 0, 18], ["the Xpert Flu assay", "TEST", 22, 41], ["nasal aspirates", "TEST", 57, 72], ["washes", "TREATMENT", 73, 79], ["nasopharyngeal swab specimens", "TEST", 84, 113], ["the assay", "TEST", 130, 139], ["nasal", "ANATOMY", 57, 62], ["aspirates", "OBSERVATION", 63, 72]]], ["Therefore, the discordant result in case of specimen 3 might be because a tracheal aspiration is not an appropriate specimen type for testing in the Xpert Flu assay.", [["tracheal", "ANATOMY", 74, 82], ["specimen", "ANATOMY", 116, 124], ["tracheal", "ORGAN", 74, 82], ["specimen", "TEST", 44, 52], ["a tracheal aspiration", "PROBLEM", 72, 93], ["tracheal", "ANATOMY", 74, 82], ["aspiration", "OBSERVATION", 83, 93]]], ["The Influenza A/B r-gene assay was performed on all available discordant specimens (12/15, 80%) and confirmed the multiplex RT-PCR assay result in all cases.", [["specimens", "ANATOMY", 73, 82], ["Influenza A/B", "ORGANISM", 4, 17], ["Influenza A/B", "SPECIES", 4, 17], ["The Influenza A/B r-gene assay", "TEST", 0, 30], ["the multiplex RT-PCR assay", "TEST", 110, 136]]], ["Therefore, the results of the Xpert Flu assay were considered false-negative.", [["the Xpert Flu assay", "TEST", 26, 45], ["false", "TEST", 62, 67]]], ["The Xpert Flu assay contains an internal control (SPC; Fig. 1 and Supplementary Fig. 1 ) that was positive in all discordant specimens excluding PCR inhibition as the reason for false-negative results.", [["specimens", "ANATOMY", 125, 134], ["The Xpert Flu assay", "TEST", 0, 19], ["an internal control (SPC", "TREATMENT", 29, 53], ["PCR inhibition", "TEST", 145, 159], ["false", "TEST", 178, 183]]], ["A lack of sensitivity of the Xpert Flu assay could be the cause of false-negative results.", [["the Xpert Flu assay", "TEST", 25, 44]]], ["A finding that supports this hypothesis is that the median Ct value of false-negative specimens was significantly higher than that of concordantly positive specimens (Supplementary Table 1 ).", [["specimens", "ANATOMY", 86, 95], ["specimens", "ANATOMY", 156, 165], ["Ct value", "TEST", 59, 67]]], ["However, sensitivity of the Xpert Flu assay has previously been reported to be higher than 93% compared to another molecular assay (Dugas et al., 2014; Novak-Weekley et al., 2012) .", [["the Xpert Flu assay", "TEST", 24, 43]]], ["Most of the discordant results in our study were obtained in comparison with the Allplex Respiratory Panel 1 (Table 1) .", [["our study", "TEST", 34, 43], ["the Allplex Respiratory Panel", "TEST", 77, 106]]], ["A possible explanation might be that the Allplex Respiratory Panel 1 is more sensitive than the Anyplex RV16 assay and the assay used in these previously published studies.", [["the Allplex Respiratory Panel", "TEST", 37, 66], ["the Anyplex RV16 assay", "TEST", 92, 114], ["the assay", "TEST", 119, 128], ["possible explanation might be", "UNCERTAINTY", 2, 31]]], ["However, according to the package insert, the sensitivity of the Allplex Respiratory Panel 1 is not higher than that of the Anyplex RV16 assay.DiscussionData provided by the manufacturers in the package inserts of the Xpert Flu and the r-gene assays demonstrate that the sensitivity of the assays varies between different influenza virus types and strains.", [["influenza virus", "ORGANISM", 322, 337], ["RV16", "PROTEIN", 132, 136], ["the sensitivity", "TEST", 42, 57], ["the Allplex Respiratory Panel", "TEST", 61, 90], ["the r-gene assays", "TEST", 232, 249], ["the sensitivity", "TEST", 267, 282], ["the assays", "TEST", 286, 296], ["different influenza virus types", "PROBLEM", 312, 343], ["strains", "PROBLEM", 348, 355], ["influenza virus", "OBSERVATION", 322, 337]]], ["Although the package inserts of the Anyplex RV16 and Allplex Respiratory Panel 1 assays do not mention that the sensitivity of the assays varies between different virus types and strains, it probably is the case.", [["the Anyplex RV16", "TEST", 32, 48], ["Allplex Respiratory Panel", "TEST", 53, 78], ["the sensitivity", "TEST", 108, 123], ["the assays", "TEST", 127, 137], ["different virus types", "PROBLEM", 153, 174], ["strains", "PROBLEM", 179, 186]]], ["Therefore, differences in sensitivities of the assays to detect certain virus strains may partly explain the discordant results between the Xpert Flu assay and the other assays.", [["the assays", "TEST", 43, 53], ["certain virus strains", "PROBLEM", 64, 85], ["the Xpert Flu assay", "TEST", 136, 155], ["the other assays", "TEST", 160, 176]]], ["Interestingly, in 5 of the discordant specimens there was a difference of 2 Cts or more between the Influenza A/B r-gene assay and the Allplex Respiratory Panel 1.", [["specimens", "ANATOMY", 38, 47], ["specimens", "CANCER", 38, 47], ["B r-", "GENE_OR_GENE_PRODUCT", 112, 116], ["a difference of 2 Cts", "PROBLEM", 58, 79], ["the Influenza A", "TEST", 96, 111], ["the Allplex Respiratory Panel", "TEST", 131, 160]]], ["This might also be due to different sensitivities of the two assays for the detection of different influenza virus strains.", [["influenza virus", "ORGANISM", 99, 114], ["influenza virus", "SPECIES", 99, 114], ["the two assays", "TEST", 53, 67], ["the detection", "TEST", 72, 85], ["different influenza virus strains", "PROBLEM", 89, 122], ["influenza virus strains", "OBSERVATION", 99, 122]]], ["Failure of an assay to detect a specific virus strain due to mutations in the primer or probe regions has been previously reported (Binnicker et al., 2013) .", [["primer or probe regions", "DNA", 78, 101], ["an assay", "TEST", 11, 19], ["a specific virus strain", "PROBLEM", 30, 53], ["mutations in the primer", "PROBLEM", 61, 84]]], ["We cannot rule out that this was the reason for the false-negative results of the Xpert Flu assay because primer and probe sequences are not known to us.", [["primer and probe sequences", "DNA", 106, 132], ["the Xpert Flu assay", "TEST", 78, 97], ["primer and probe sequences", "TEST", 106, 132]]], ["However, in the current study, false-negative results were detected for both influenza A and B, therefore our findings do not support the hypothesis that the false-negative results were due to primer or probe mismatches.", [["B", "CANCER", 93, 94], ["the current study", "TEST", 12, 29], ["primer or probe mismatches", "PROBLEM", 193, 219]]], ["Furthermore, our analysis of the details of the Xpert Flu assay suggests Table 1 Results of the multiplex RT-PCRs for respiratory viruses and the Xpert Flu assay (cohort A). erroneous automatic interpretation as the main cause of false-negative results.", [["our analysis", "TEST", 13, 25], ["the Xpert Flu assay", "TEST", 44, 63], ["the multiplex RT-PCRs", "TEST", 92, 113], ["respiratory viruses", "PROBLEM", 118, 137], ["the Xpert Flu assay", "TEST", 142, 161], ["erroneous automatic interpretation", "TEST", 174, 208], ["respiratory", "ANATOMY", 118, 129], ["viruses", "OBSERVATION", 130, 137]]], ["In fact, the detailed analysis of endpoint values and amplification curves suggests that target amplification and detection had occurred in most of the specimens with false-negative results, although the automatic result interpretation indicated \"negative\".", [["specimens", "ANATOMY", 152, 161], ["specimens", "CANCER", 152, 161], ["endpoint values", "TEST", 34, 49], ["amplification curves", "TEST", 54, 74], ["target amplification", "TEST", 89, 109]]], ["Once we had become aware of this problem, we therefore carefully verified the amplification curves (after zooming) and endpoint values of each specimen and reported the specimens with a visible curve as \"weakly positive\" or \"indeterminate\".", [["specimen", "ANATOMY", 143, 151], ["specimens", "ANATOMY", 169, 178], ["the amplification curves", "TEST", 74, 98], ["endpoint values of each specimen", "TEST", 119, 151], ["the specimens", "TEST", 165, 178], ["a visible curve", "TEST", 184, 199], ["indeterminate", "OBSERVATION_MODIFIER", 225, 238]]], ["This approach allowed us to avoid reporting falsenegative results in 9 of the 15 discordant specimens described in the current study.", [["specimens", "ANATOMY", 92, 101], ["specimens", "CANCER", 92, 101], ["the current study", "TEST", 115, 132]]], ["Importantly, since February 2016, this approach was prospectively applied to specimens tested routinely in the Xpert Flu assay only.", [["specimens", "ANATOMY", 77, 86], ["this approach", "TREATMENT", 34, 47]]], ["In total, 16 of 2108 (0.8%) specimens (including the 9 specimens mentioned above) that were interpreted as negative by the automatic result interpretation of the Xpert Flu assay, were reported \"weakly positive\" (n = 7) or \"indeterminate\" (n = 9) by the laboratory physician.", [["specimens", "ANATOMY", 28, 37], ["specimens", "ANATOMY", 55, 64], ["specimens", "CANCER", 28, 37], ["specimens", "TEST", 28, 37], ["the 9 specimens", "TEST", 49, 64], ["the Xpert Flu assay", "TEST", 158, 177], ["indeterminate", "OBSERVATION_MODIFIER", 223, 236]]], ["However, we did not retrospectively review the amplification curves after zooming of all Xpert Flu assay results performed during the study period (n = 2108).", [["the amplification curves", "TEST", 43, 67], ["all Xpert Flu assay", "TEST", 85, 104], ["the study", "TEST", 130, 139]]], ["Taken together, our findings suggest that automatic result interpretation is not completely reliable and could represent a concern in case of use as point of care test.", [["care test", "TEST", 158, 167]]], ["We suggest that the automatic result interpretation should be changed to report \"indeterminate\" instead of \"negative\" in case of amplification curves of low amplitude or slightly elevated endpoints.", [["amplification curves", "TEST", 129, 149], ["low amplitude", "PROBLEM", 153, 166], ["slightly elevated endpoints", "PROBLEM", 170, 197], ["low amplitude", "OBSERVATION_MODIFIER", 153, 166], ["slightly", "OBSERVATION_MODIFIER", 170, 178], ["elevated", "OBSERVATION", 179, 187]]], ["This would alert the user who could come up with a personal interpretation after careful review of both amplification curves and endpoint data and then decide whether to report the assay result, to perform another assay or to recommend testing a second specimen.", [["specimen", "ANATOMY", 253, 261], ["both amplification curves", "TEST", 99, 124], ["a second specimen", "TEST", 244, 261]]], ["The study has the following limitations: testing of respiratory specimens by both techniques was done either if prescribed by the physician in charge of the patient (cohort A, 150/159, 94.3%) or if the laboratory physician in charge of result validation had a doubt about the result of the Xpert Flu assay (cohort B, 9/159, 5.7%).", [["respiratory specimens", "ANATOMY", 52, 73], ["patient", "ORGANISM", 157, 164], ["patient", "SPECIES", 157, 164], ["The study", "TEST", 0, 9], ["testing of respiratory specimens", "TEST", 41, 73], ["the Xpert Flu assay", "TEST", 286, 305]]], ["A doubt occurred when an amplification curve was visible or an endpoint value was elevated but the automatic result interpretation indicated \"negative\".", [["an amplification curve", "TEST", 22, 44], ["an endpoint value", "TEST", 60, 77], ["elevated", "PROBLEM", 82, 90]]], ["Furthermore, a doubt arose when the first specimen yielded a negative result and a second specimen from the same patient yielded a positive result in the Xpert Flu assay.", [["specimen", "ANATOMY", 42, 50], ["specimen", "ANATOMY", 90, 98], ["patient", "ORGANISM", 113, 120], ["patient", "SPECIES", 113, 120], ["a second specimen", "TEST", 81, 98]]], ["Nine of 22 (41%) and 6 of 9 (67%) multiplex RT-PCR positive specimens yielded negative results in the Xpert Flu assay in cohort A and cohort B, respectively.", [["specimens", "ANATOMY", 60, 69], ["multiplex RT-PCR", "TEST", 34, 50]]], ["There is enrichment in discordant results in cohort B. For this reason, results of cohort A and B were presented separately.Result of the multiplex RT-PCRs for respiratory virusesIn conclusion, we have analyzed specimens with false-negative results in the Xpert Flu Assay and show that these are mainly due to erroneous automatic interpretation.", [["specimens", "ANATOMY", 211, 220], ["respiratory viruses", "DISEASE", 160, 179], ["the multiplex RT-PCRs", "TEST", 134, 155], ["respiratory viruses", "PROBLEM", 160, 179], ["the Xpert Flu Assay", "TEST", 252, 271], ["erroneous automatic interpretation", "TEST", 310, 344], ["enrichment", "OBSERVATION_MODIFIER", 9, 19], ["respiratory", "ANATOMY", 160, 171], ["viruses", "OBSERVATION", 172, 179]]], ["Users of this technique should be aware of the problem and carefully interpret both amplification curves and endpoint data and not solely rely on the automatic result interpretation.Result of the multiplex RT-PCRs for respiratory virusesSupplementary data to this article can be found online at http://dx. doi.org/10.1016/j.diagmicrobio.2017.01.015.Compliance with ethical standardsFunding This work was supported by Minist\u00e8re de l'Education Nationale, de l'Enseignement Sup\u00e9rieur et de la Recherche, Universit\u00e9 Lille 2 (Equipe d'accueil 3610) and Centre Hospitalier R\u00e9gional et Universitaire de Lille.", [["this technique", "TREATMENT", 9, 23], ["amplification curves", "TEST", 84, 104], ["endpoint data", "TEST", 109, 122], ["the multiplex RT-PCRs", "TEST", 192, 213], ["respiratory viruses", "PROBLEM", 218, 237], ["ethical standards", "TREATMENT", 365, 382]]], ["The funding sources had no involvement in the study design, data collection and analysis nor in writing of the report.", [["the study", "TEST", 42, 51], ["data collection", "TEST", 60, 75], ["analysis", "TEST", 80, 88]]]], "540f2eaa6e1342ac0756d27fe772022931073484": [["and Maurice PensaertBiologically active interferon-a, tumor necrosis factor-a (TNF-a), and interleukin-1 (IL-1) were detected in bronchoalveolar lavage (BAL) fluids of 3-week-old cesarian-derived colostrum-deprived pigs inoculated with H1N1 influenza virus.", [["bronchoalveolar lavage (BAL) fluids", "ANATOMY", 129, 164], ["tumor", "DISEASE", 54, 59], ["necrosis", "DISEASE", 60, 68], ["influenza virus", "DISEASE", 241, 256], ["interferon-a", "GENE_OR_GENE_PRODUCT", 40, 52], ["tumor necrosis factor-a", "GENE_OR_GENE_PRODUCT", 54, 77], ["TNF-a", "GENE_OR_GENE_PRODUCT", 79, 84], ["interleukin-1", "GENE_OR_GENE_PRODUCT", 91, 104], ["IL-1", "GENE_OR_GENE_PRODUCT", 106, 110], ["bronchoalveolar lavage", "MULTI-TISSUE_STRUCTURE", 129, 151], ["cesarian", "ORGANISM", 179, 187], ["colostrum", "ORGANISM", 196, 205], ["pigs", "ORGANISM", 215, 219], ["H1N1 influenza virus", "ORGANISM", 236, 256], ["interferon", "PROTEIN", 40, 50], ["TNF", "PROTEIN", 79, 82], ["interleukin-1 (IL-1", "PROTEIN", 91, 110], ["pigs", "SPECIES", 215, 219], ["H1N1 influenza virus", "SPECIES", 236, 256], ["H1N1 influenza virus", "SPECIES", 236, 256], ["a, tumor necrosis factor", "PROBLEM", 51, 75], ["a (TNF", "TEST", 76, 82], ["interleukin", "TEST", 91, 102], ["bronchoalveolar lavage", "TEST", 129, 151], ["H1N1 influenza virus", "PROBLEM", 236, 256], ["active", "OBSERVATION_MODIFIER", 33, 39], ["interferon", "OBSERVATION", 40, 50], ["tumor", "OBSERVATION_MODIFIER", 54, 59], ["necrosis", "OBSERVATION", 60, 68], ["bronchoalveolar lavage", "OBSERVATION", 129, 151], ["influenza virus", "OBSERVATION", 241, 256]]], ["Cytokine titers and lung virus titers were significantly higher 18 -24 h after inoculation than at 48 -72 h after inoculation in all 4 litters of pigs examined.", [["lung", "ANATOMY", 20, 24], ["Cytokine", "GENE_OR_GENE_PRODUCT", 0, 8], ["lung", "ORGAN", 20, 24], ["pigs", "ORGANISM", 146, 150], ["Cytokine", "PROTEIN", 0, 8], ["pigs", "SPECIES", 146, 150], ["pigs", "SPECIES", 146, 150], ["Cytokine titers", "TEST", 0, 15], ["lung virus titers", "TEST", 20, 37], ["inoculation", "PROBLEM", 114, 125], ["lung", "ANATOMY", 20, 24], ["virus", "OBSERVATION", 25, 30]]], ["All three cytokines were positively correlated with a 3-to 4-fold increase in BAL cell numbers (P \u00f5 .036) and with a drastic neutrophil infiltration (24% -77% of BAL cells vs. 0 -1.5% in controls) (P \u00f5 .001).", [["BAL cell", "ANATOMY", 78, 86], ["neutrophil", "ANATOMY", 125, 135], ["BAL cells", "ANATOMY", 162, 171], ["BAL cell", "CELL", 78, 86], ["neutrophil", "CELL", 125, 135], ["BAL cells", "CELL", 162, 171], ["cytokines", "PROTEIN", 10, 19], ["BAL cells", "CELL_TYPE", 162, 171], ["BAL cell numbers", "TEST", 78, 94], ["P", "TEST", 96, 97], ["a drastic neutrophil infiltration", "PROBLEM", 115, 148], ["BAL cells", "TEST", 162, 171], ["BAL cell numbers", "OBSERVATION", 78, 94], ["drastic", "OBSERVATION_MODIFIER", 117, 124], ["neutrophil infiltration", "OBSERVATION", 125, 148]]], ["In addition, cytokine production coincided with the onset of general and respiratory symptoms of influenza and with the development of a necrotizing bronchopneumonia.", [["respiratory", "ANATOMY", 73, 84], ["influenza", "DISEASE", 97, 106], ["bronchopneumonia", "DISEASE", 149, 165], ["cytokine", "PROTEIN", 13, 21], ["cytokine production", "PROBLEM", 13, 32], ["general and respiratory symptoms", "PROBLEM", 61, 93], ["influenza", "PROBLEM", 97, 106], ["a necrotizing bronchopneumonia", "PROBLEM", 135, 165], ["influenza", "OBSERVATION", 97, 106], ["necrotizing", "OBSERVATION_MODIFIER", 137, 148], ["bronchopneumonia", "OBSERVATION", 149, 165]]], ["This study is the first demonstration of TNF-a and IL-1 in BAL fluids of a natural influenza virus host.", [["BAL fluids", "ANATOMY", 59, 69], ["TNF-a", "GENE_OR_GENE_PRODUCT", 41, 46], ["IL-1", "GENE_OR_GENE_PRODUCT", 51, 55], ["BAL", "ORGANISM_SUBSTANCE", 59, 62], ["influenza virus", "ORGANISM", 83, 98], ["TNF", "PROTEIN", 41, 44], ["IL-1", "PROTEIN", 51, 55], ["influenza virus", "SPECIES", 83, 98], ["This study", "TEST", 0, 10], ["TNF", "TEST", 41, 44], ["IL", "TEST", 51, 53], ["BAL fluids", "TREATMENT", 59, 69], ["a natural influenza virus host", "TREATMENT", 73, 103], ["influenza virus", "OBSERVATION", 83, 98]]], ["It documents that pigs may be a highly valuable experimental model in human influenza virus pneumonia.and Maurice PensaertSwine influenza (SI) is a highly important respiratory disease onset of fever, anorexia, tachypnea, dyspnea, and coughing. of pigs.", [["respiratory", "ANATOMY", 165, 176], ["influenza virus pneumonia", "DISEASE", 76, 101], ["influenza", "DISEASE", 128, 137], ["respiratory disease", "DISEASE", 165, 184], ["fever", "DISEASE", 194, 199], ["anorexia", "DISEASE", 201, 209], ["tachypnea", "DISEASE", 211, 220], ["dyspnea", "DISEASE", 222, 229], ["coughing", "DISEASE", 235, 243], ["pigs", "ORGANISM", 18, 22], ["human", "ORGANISM", 70, 75], ["influenza virus", "ORGANISM", 76, 91], ["Maurice PensaertSwine influenza", "ORGANISM", 106, 137], ["pigs", "ORGANISM", 248, 252], ["pigs", "SPECIES", 18, 22], ["human", "SPECIES", 70, 75], ["influenza virus", "SPECIES", 76, 91], ["pigs", "SPECIES", 248, 252], ["pigs", "SPECIES", 18, 22], ["human influenza virus", "SPECIES", 70, 91], ["a highly valuable experimental model in human influenza virus pneumonia", "PROBLEM", 30, 101], ["fever", "PROBLEM", 194, 199], ["anorexia", "PROBLEM", 201, 209], ["tachypnea", "PROBLEM", 211, 220], ["dyspnea", "PROBLEM", 222, 229], ["coughing", "PROBLEM", 235, 243], ["human", "OBSERVATION", 70, 75], ["influenza virus", "OBSERVATION", 76, 91], ["respiratory disease", "OBSERVATION", 165, 184], ["fever", "OBSERVATION", 194, 199], ["tachypnea", "OBSERVATION", 211, 220]]], ["The causative viruses are type A influenza viruses of Considerable economic losses result from growth retardation H1N1 and H3N2 subtype, which are antigenically related to or weight loss.", [["influenza viruses", "DISEASE", 33, 50], ["weight loss", "DISEASE", 175, 186], ["type A influenza", "ORGANISM", 26, 42], ["The causative viruses", "PROBLEM", 0, 21], ["type A influenza viruses", "PROBLEM", 26, 50], ["Considerable economic losses", "PROBLEM", 54, 82], ["growth retardation", "PROBLEM", 95, 113], ["H1N1", "PROBLEM", 114, 118], ["H3N2 subtype", "PROBLEM", 123, 135], ["weight loss", "PROBLEM", 175, 186], ["viruses", "OBSERVATION", 14, 21], ["growth", "OBSERVATION_MODIFIER", 95, 101], ["retardation", "OBSERVATION_MODIFIER", 102, 113], ["H1N1", "OBSERVATION", 114, 118]]], ["Experimental viral infections of pigs have docuhuman influenza viruses.", [["viral infections", "DISEASE", 13, 29], ["influenza viruses", "DISEASE", 53, 70], ["pigs", "ORGANISM", 33, 37], ["docuhuman influenza viruses", "ORGANISM", 43, 70], ["pigs", "SPECIES", 33, 37], ["pigs", "SPECIES", 33, 37], ["Experimental viral infections of pigs", "PROBLEM", 0, 37], ["docuhuman influenza viruses", "PROBLEM", 43, 70], ["viral", "OBSERVATION_MODIFIER", 13, 18], ["infections", "OBSERVATION", 19, 29], ["influenza viruses", "OBSERVATION", 53, 70]]], ["Typical outbreaks involve an abrupt mented massive viral replication in lung epithelial cells, accompanied by polymorphonuclear leukocyte infiltration and epithelial degeneration [1] .", [["lung epithelial cells", "ANATOMY", 72, 93], ["polymorphonuclear leukocyte", "ANATOMY", 110, 137], ["epithelial", "ANATOMY", 155, 165], ["lung epithelial cells", "CELL", 72, 93], ["polymorphonuclear leukocyte", "CELL", 110, 137], ["epithelial", "TISSUE", 155, 165], ["lung epithelial cells", "CELL_TYPE", 72, 93], ["Typical outbreaks", "PROBLEM", 0, 17], ["an abrupt mented massive viral replication in lung epithelial cells", "PROBLEM", 26, 93], ["polymorphonuclear leukocyte infiltration", "PROBLEM", 110, 150], ["epithelial degeneration", "PROBLEM", 155, 178], ["abrupt", "OBSERVATION_MODIFIER", 29, 35], ["massive", "OBSERVATION_MODIFIER", 43, 50], ["viral replication", "OBSERVATION", 51, 68], ["lung", "ANATOMY", 72, 76], ["epithelial cells", "OBSERVATION", 77, 93], ["polymorphonuclear leukocyte infiltration", "OBSERVATION", 110, 150], ["epithelial degeneration", "OBSERVATION", 155, 178]]], ["However, the exact mechanisms by which SI virus produces lung pathology and disease have not been studied.and Maurice Pensaertphragmatic lung were collected for standard histopathology, influorexia, and weight loss, particularly if produced at higher levels enza virus titrations, and fluorescent antibody stainings [7] .", [["lung", "ANATOMY", 57, 61], ["lung", "ANATOMY", 137, 141], ["influorexia", "DISEASE", 186, 197], ["weight loss", "DISEASE", 203, 214], ["SI virus", "ORGANISM", 39, 47], ["lung", "ORGAN", 57, 61], ["lung", "ORGAN", 137, 141], ["SI virus", "PROBLEM", 39, 47], ["lung pathology", "PROBLEM", 57, 71], ["disease", "PROBLEM", 76, 83], ["standard histopathology", "TEST", 161, 184], ["influorexia", "PROBLEM", 186, 197], ["weight loss", "PROBLEM", 203, 214], ["fluorescent antibody stainings", "TEST", 285, 315], ["lung", "ANATOMY", 57, 61], ["pathology", "OBSERVATION", 62, 71], ["lung", "ANATOMY", 137, 141]]], ["Evidence for a role of TNF-a and IL-1 in influenza virus right lung was lavaged with 60 mL of PBS.", [["right lung", "ANATOMY", 57, 67], ["TNF-a", "GENE_OR_GENE_PRODUCT", 23, 28], ["IL-1", "GENE_OR_GENE_PRODUCT", 33, 37], ["influenza virus", "ORGANISM", 41, 56], ["lung", "ORGAN", 63, 67], ["TNF", "PROTEIN", 23, 26], ["IL-1", "PROTEIN", 33, 37], ["influenza virus", "SPECIES", 41, 56], ["TNF", "TEST", 23, 26], ["a and IL", "TREATMENT", 27, 35], ["influenza virus right lung", "TREATMENT", 41, 67], ["PBS", "TREATMENT", 94, 97], ["right", "ANATOMY_MODIFIER", 57, 62], ["lung", "ANATOMY", 63, 67], ["lavaged", "OBSERVATION", 72, 79]]], ["Bronchoalveolar lavage pathogenesis and disease is growing [4, 6] .and Maurice Pensaert(BAL) cells were separated by centrifugation at 400 g and counted,and Maurice PensaertThe pathogenesis of human influenza has been studied aland cytospin preparations were stained with DiffQuik (Baxter, most exclusively in volunteers and in small laboratory animals.", [["Bronchoalveolar lavage", "ANATOMY", 0, 22], ["Pensaert(BAL) cells", "ANATOMY", 79, 98], ["influenza", "DISEASE", 199, 208], ["Bronchoalveolar lavage", "MULTI-TISSUE_STRUCTURE", 0, 22], ["BAL) cells", "CELL", 88, 98], ["human", "ORGANISM", 193, 198], ["volunteers", "ORGANISM", 310, 320], ["Maurice Pensaert(BAL) cells", "CELL_LINE", 71, 98], ["human", "SPECIES", 193, 198], ["human", "SPECIES", 193, 198], ["Bronchoalveolar lavage pathogenesis", "TEST", 0, 35], ["disease", "PROBLEM", 40, 47], ["human influenza", "PROBLEM", 193, 208], ["disease", "OBSERVATION", 40, 47]]], ["Here we studied the production of IFN-a, TNF-a, and IL-1 fluid samples in 96-well microtiter plates.", [["IFN-a", "GENE_OR_GENE_PRODUCT", 34, 39], ["TNF-a", "GENE_OR_GENE_PRODUCT", 41, 46], ["IL-1", "GENE_OR_GENE_PRODUCT", 52, 56], ["IFN", "PROTEIN", 34, 37], ["TNF", "PROTEIN", 41, 44], ["IFN", "TEST", 34, 37], ["TNF", "TEST", 41, 44], ["IL", "TEST", 52, 54], ["fluid samples", "TEST", 57, 70]]], ["IFN-a activity was dein the lungs of pigs and its relation with disease or inflammation termined in a cytopathic effect reduction assay by use of MDBK cells and vesicular stomatitis virus [8] . was defined as the reciprocal of the dilution producing 50% inhibition of cytopathic effect.", [["lungs", "ANATOMY", 28, 33], ["MDBK cells", "ANATOMY", 146, 156], ["IFN", "CHEMICAL", 0, 3], ["inflammation", "DISEASE", 75, 87], ["vesicular stomatitis", "DISEASE", 161, 181], ["IFN", "GENE_OR_GENE_PRODUCT", 0, 3], ["lungs", "ORGAN", 28, 33], ["pigs", "ORGANISM", 37, 41], ["MDBK cells", "CELL", 146, 156], ["vesicular stomatitis virus", "ORGANISM", 161, 187], ["IFN", "PROTEIN", 0, 3], ["MDBK cells", "CELL_LINE", 146, 156], ["pigs", "SPECIES", 37, 41], ["stomatitis virus", "SPECIES", 171, 187], ["pigs", "SPECIES", 37, 41], ["MDBK", "SPECIES", 146, 150], ["stomatitis virus", "SPECIES", 171, 187], ["disease", "PROBLEM", 64, 71], ["inflammation", "PROBLEM", 75, 87], ["a cytopathic effect reduction assay", "PROBLEM", 100, 135], ["MDBK cells", "PROBLEM", 146, 156], ["vesicular stomatitis virus", "PROBLEM", 161, 187], ["the dilution", "TEST", 227, 239], ["cytopathic effect", "PROBLEM", 268, 285], ["lungs", "ANATOMY", 28, 33], ["inflammation", "OBSERVATION", 75, 87], ["cytopathic", "OBSERVATION_MODIFIER", 102, 112], ["vesicular stomatitis", "OBSERVATION", 161, 181], ["cytopathic effect", "OBSERVATION", 268, 285]]], ["IFN-a specificity was demonstrated by neutralization of samples with rabbit antiserum against recombi-Materials and Methodsnant porcine IFN-a (gift from C. La Bonnardi\u00e8re, Jouy en Josas, France).", [["samples", "ANATOMY", 56, 63], ["IFN", "CHEMICAL", 0, 3], ["IFN", "GENE_OR_GENE_PRODUCT", 0, 3], ["rabbit", "ORGANISM", 69, 75], ["antiserum", "ORGANISM_SUBSTANCE", 76, 85], ["IFN", "PROTEIN", 0, 3], ["IFN", "PROTEIN", 136, 139], ["rabbit", "SPECIES", 69, 75], ["porcine", "SPECIES", 128, 135], ["rabbit", "SPECIES", 69, 75], ["a specificity", "TEST", 4, 17], ["rabbit antiserum", "TREATMENT", 69, 85], ["recombi-Materials", "TREATMENT", 94, 111], ["Methodsnant porcine IFN", "TREATMENT", 116, 139]]], ["TNF-a was assayed as cytotoxic activity in PK(15) sub-Experimental design, virologic examinations, and lung inflamclone 15 cells (gift from G. Bertoni, Bern, Switzerland) in the matory parameters.", [["lung inflamclone 15 cells", "ANATOMY", 103, 128], ["TNF", "GENE_OR_GENE_PRODUCT", 0, 3], ["lung inflamclone 15 cells", "CELL", 103, 128], ["TNF", "PROTEIN", 0, 3], ["lung inflamclone 15 cells", "CELL_LINE", 103, 128], ["TNF", "TEST", 0, 3], ["cytotoxic activity", "TEST", 21, 39], ["PK", "TEST", 43, 45], ["virologic examinations", "TEST", 75, 97], ["lung", "ANATOMY", 103, 107]]], ["Four litters (18 total) of 3-week-old cesarianpresence of actinomycin D [9] .", [["actinomycin D", "CHEMICAL", 58, 71], ["actinomycin D", "CHEMICAL", 58, 71], ["actinomycin D", "SIMPLE_CHEMICAL", 58, 71], ["actinomycin D", "TREATMENT", 58, 71]]], ["The plates were stained with crystal derived colostrum-deprived (CDCD) pigs were used.", [["colostrum", "ORGANISM", 45, 54], ["pigs", "ORGANISM", 71, 75], ["pigs", "SPECIES", 71, 75], ["The plates", "TREATMENT", 0, 10], ["crystal derived colostrum", "TREATMENT", 29, 54], ["CDCD) pigs", "TREATMENT", 65, 75], ["plates", "OBSERVATION_MODIFIER", 4, 10]]], ["The number of units of inoculated intratracheally with 10 7.0 EID 50 of influenza virus TNF-a per milliliter was defined as the reciprocal of the dilution (H1N1 A/Sw/Belgium/1/83), third passage in embryonated eggs.Materials and Methodsproducing 50% cytotoxicity.", [["intratracheally", "ANATOMY", 34, 49], ["eggs", "ANATOMY", 210, 214], ["influenza virus", "ORGANISM", 72, 87], ["TNF", "GENE_OR_GENE_PRODUCT", 88, 91], ["TNF", "PROTEIN", 88, 91], ["influenza virus", "SPECIES", 72, 87], ["H1N1 A/Sw/Belgium/1/83", "SPECIES", 156, 178], ["inoculated intratracheally", "TREATMENT", 23, 49], ["influenza virus TNF", "PROBLEM", 72, 91], ["the dilution", "TEST", 142, 154], ["third passage in embryonated eggs", "PROBLEM", 181, 214], ["Methodsproducing 50% cytotoxicity", "TREATMENT", 229, 262], ["embryonated eggs", "OBSERVATION", 198, 214]]], ["TNF-a specificity was established Control pigs were left either uninoculated or inoculated with PBS by neutralization with rabbit anti-human TNF-a (Innogenetics, or with sterile allantoic fluid ( in all groups.", [["allantoic fluid", "ANATOMY", 178, 193], ["TNF", "GENE_OR_GENE_PRODUCT", 0, 3], ["pigs", "ORGANISM", 42, 46], ["rabbit", "ORGANISM", 123, 129], ["TNF", "GENE_OR_GENE_PRODUCT", 141, 144], ["allantoic fluid", "MULTI-TISSUE_STRUCTURE", 178, 193], ["TNF", "PROTEIN", 0, 3], ["TNF", "PROTEIN", 141, 144], ["pigs", "SPECIES", 42, 46], ["rabbit", "SPECIES", 123, 129], ["pigs", "SPECIES", 42, 46], ["rabbit", "SPECIES", 123, 129], ["TNF", "TEST", 0, 3], ["a specificity", "TEST", 4, 17], ["PBS", "TREATMENT", 96, 99], ["rabbit anti-human TNF", "TREATMENT", 123, 144], ["a (Innogenetics", "TREATMENT", 145, 160], ["sterile allantoic fluid", "TREATMENT", 170, 193]]], ["Maximum IL-1 titers were 535, 245, 520, and 150 U/mL in the 4 respective groups.", [["IL-1", "GENE_OR_GENE_PRODUCT", 8, 12], ["IL", "PROTEIN", 8, 10], ["Maximum IL", "TEST", 0, 10]]], ["Only in group 1 pigs was IL-1 also found at 72 h after inoculation.ResultsLevels of the three cytokines were significantly higher 18 -24 h after inoculation than at 48 -72 h after inoculation (P \u00f5 Clinical responses, influenza virus titers, BAL cell numbers, percentage of neutrophils, and cytokine titers of individual pigs .016 for all three cytokines).", [["BAL cell", "ANATOMY", 241, 249], ["neutrophils", "ANATOMY", 273, 284], ["pigs", "ORGANISM", 16, 20], ["IL-1", "GENE_OR_GENE_PRODUCT", 25, 29], ["influenza virus", "ORGANISM", 217, 232], ["BAL cell", "CELL", 241, 249], ["neutrophils", "CELL", 273, 284], ["pigs", "ORGANISM", 320, 324], ["IL", "PROTEIN", 25, 27], ["cytokines", "PROTEIN", 94, 103], ["neutrophils", "CELL_TYPE", 273, 284], ["cytokine", "PROTEIN", 290, 298], ["cytokines", "PROTEIN", 344, 353], ["pigs", "SPECIES", 16, 20], ["pigs", "SPECIES", 320, 324], ["pigs", "SPECIES", 16, 20], ["the three cytokines", "TEST", 84, 103], ["inoculation", "PROBLEM", 145, 156], ["inoculation", "PROBLEM", 180, 191], ["Clinical responses", "TEST", 197, 215], ["influenza virus titers", "TEST", 217, 239], ["BAL cell numbers", "TEST", 241, 257], ["neutrophils", "TEST", 273, 284], ["cytokine titers", "TEST", 290, 305], ["individual pigs", "TREATMENT", 309, 324]]], ["Significant correlations were noted between production of all three cytokines and BAL cell num-are summarized in table 1.ResultsClinical symptoms.", [["BAL cell", "ANATOMY", 82, 90], ["BAL cell", "CELL", 82, 90], ["cytokines", "PROTEIN", 68, 77], ["BAL cell num", "TEST", 82, 94], ["ResultsClinical symptoms", "PROBLEM", 121, 145], ["BAL cell", "OBSERVATION", 82, 90]]], ["Control pigs remained healthy.", [["pigs", "ORGANISM", 8, 12], ["pigs", "SPECIES", 8, 12], ["pigs", "SPECIES", 8, 12]]], ["In in-bers (P \u00f5 .036 for each) and percentage of neutrophils (P \u00f5 .001 for each).", [["neutrophils", "ANATOMY", 49, 60], ["neutrophils", "CELL", 49, 60], ["neutrophils", "CELL_TYPE", 49, 60], ["neutrophils", "TEST", 49, 60]]], ["Cytokine production coincided with the onset fluenza virus -inoculated pigs, lethargy, shivering, anorexia, tachypnea, and labored abdominal respiration developed be-of clinical disease and development of bronchopneumonia. tween 18 and 24 h after inoculation.", [["abdominal", "ANATOMY", 131, 140], ["lethargy", "DISEASE", 77, 85], ["shivering", "DISEASE", 87, 96], ["anorexia", "DISEASE", 98, 106], ["tachypnea", "DISEASE", 108, 117], ["bronchopneumonia", "DISEASE", 205, 221], ["Cytokine", "GENE_OR_GENE_PRODUCT", 0, 8], ["fluenza virus", "ORGANISM", 45, 58], ["pigs", "ORGANISM", 71, 75], ["abdominal", "ORGANISM_SUBDIVISION", 131, 140], ["Cytokine", "PROTEIN", 0, 8], ["pigs", "SPECIES", 71, 75], ["pigs", "SPECIES", 71, 75], ["Cytokine production", "PROBLEM", 0, 19], ["the onset fluenza virus", "PROBLEM", 35, 58], ["lethargy", "PROBLEM", 77, 85], ["shivering", "PROBLEM", 87, 96], ["anorexia", "PROBLEM", 98, 106], ["tachypnea", "PROBLEM", 108, 117], ["labored abdominal respiration", "PROBLEM", 123, 152], ["clinical disease", "PROBLEM", 169, 185], ["bronchopneumonia", "PROBLEM", 205, 221], ["inoculation", "PROBLEM", 247, 258], ["anorexia", "OBSERVATION", 98, 106], ["tachypnea", "OBSERVATION", 108, 117], ["abdominal", "ANATOMY", 131, 140], ["bronchopneumonia", "OBSERVATION", 205, 221]]], ["Recovery started between 48 and 72 h after inoculation.", [["inoculation", "PROBLEM", 43, 54]]], ["Pigs in group 1 were most Discussion severely affected.ResultsInfluenza virus replication.", [["Pigs", "ORGANISM", 0, 4], ["Influenza virus", "ORGANISM", 62, 77], ["Pigs", "SPECIES", 0, 4], ["Influenza virus", "SPECIES", 62, 77], ["Influenza virus replication", "TREATMENT", 62, 89]]], ["Control pigs tested negative for At the start of this study, it was unknown whether the lungs of 3-week-old CDCD pigs are fully capable of TNF-a and virus.", [["lungs", "ANATOMY", 88, 93], ["pigs", "ORGANISM", 8, 12], ["lungs", "ORGAN", 88, 93], ["CDCD", "ORGANISM", 108, 112], ["pigs", "ORGANISM", 113, 117], ["TNF", "GENE_OR_GENE_PRODUCT", 139, 142], ["TNF", "PROTEIN", 139, 142], ["pigs", "SPECIES", 8, 12], ["pigs", "SPECIES", 113, 117], ["pigs", "SPECIES", 113, 117], ["this study", "TEST", 49, 59], ["old CDCD pigs", "PROBLEM", 104, 117], ["TNF", "TEST", 139, 142], ["virus", "PROBLEM", 149, 154], ["lungs", "ANATOMY", 88, 93]]], ["Virus titers and immunofluorescence scores were similar in the 4 influenza virus -inoculated groups (P \u00fa .577).", [["Virus", "ORGANISM", 0, 5], ["influenza virus", "ORGANISM", 65, 80], ["influenza virus", "SPECIES", 65, 80], ["Virus titers", "TEST", 0, 12], ["immunofluorescence scores", "TEST", 17, 42], ["the 4 influenza virus", "PROBLEM", 59, 80]]], ["Titers IL-1 production.", [["IL-1", "GENE_OR_GENE_PRODUCT", 7, 11], ["IL", "PROTEIN", 7, 9]]], ["Thus far, TNF-a and IL-1 have only been demonstrated in the lungs of pigs 6 -8 weeks old and older, in apical and diaphragmatic lung lobes were significantly higher 18 -24 h after inoculation than at 48 -72 h after inoculation (P either conventional [11] or gnotobiotic [12] .", [["lungs", "ANATOMY", 60, 65], ["apical", "ANATOMY", 103, 109], ["diaphragmatic lung lobes", "ANATOMY", 114, 138], ["TNF-a", "GENE_OR_GENE_PRODUCT", 10, 15], ["IL-1", "GENE_OR_GENE_PRODUCT", 20, 24], ["lungs", "ORGAN", 60, 65], ["pigs", "ORGANISM", 69, 73], ["apical", "MULTI-TISSUE_STRUCTURE", 103, 109], ["diaphragmatic lung lobes", "MULTI-TISSUE_STRUCTURE", 114, 138], ["TNF", "PROTEIN", 10, 13], ["IL-1", "PROTEIN", 20, 24], ["pigs", "SPECIES", 69, 73], ["pigs", "SPECIES", 69, 73], ["TNF", "TEST", 10, 13], ["apical and diaphragmatic lung lobes", "PROBLEM", 103, 138], ["lungs", "ANATOMY", 60, 65], ["apical", "ANATOMY_MODIFIER", 103, 109], ["diaphragmatic lung", "ANATOMY", 114, 132], ["lobes", "ANATOMY_MODIFIER", 133, 138], ["significantly", "OBSERVATION_MODIFIER", 144, 157], ["higher", "OBSERVATION_MODIFIER", 158, 164]]], ["In our study, the use of CDCD pigs was required, since we regularly detect \u00f5 .016 and .008, respectively).", [["pigs", "ORGANISM", 30, 34], ["pigs", "SPECIES", 30, 34], ["our study", "TEST", 3, 12], ["CDCD pigs", "TREATMENT", 25, 34]]], ["Fluorescence was evident in all sections examined.", [["sections", "ANATOMY", 32, 40], ["Fluorescence", "TEST", 0, 12], ["all sections", "TEST", 28, 40]]], ["Eighteen and 24 h after inoculation, TNF-a and/or IL-1 in BAL fluids from conventional pigs in the absence of experimental viral infections.", [["BAL fluids", "ANATOMY", 58, 68], ["viral infections", "DISEASE", 123, 139], ["TNF-a", "GENE_OR_GENE_PRODUCT", 37, 42], ["IL-1", "GENE_OR_GENE_PRODUCT", 50, 54], ["BAL", "ORGANISM_SUBSTANCE", 58, 61], ["pigs", "ORGANISM", 87, 91], ["TNF", "PROTEIN", 37, 40], ["IL", "PROTEIN", 50, 52], ["pigs", "SPECIES", 87, 91], ["pigs", "SPECIES", 87, 91], ["inoculation", "TREATMENT", 24, 35], ["TNF", "TEST", 37, 40], ["IL", "TREATMENT", 50, 52], ["BAL fluids", "TREATMENT", 58, 68], ["conventional pigs", "TREATMENT", 74, 91], ["experimental viral infections", "PROBLEM", 110, 139], ["experimental", "OBSERVATION_MODIFIER", 110, 122], ["viral infections", "OBSERVATION", 123, 139]]], ["The age of 3 weeks bronchi/bronchioli and alveoli had, respectively, 90% and 30% of their epithelial cells fluorescing.", [["bronchi", "ANATOMY", 19, 26], ["bronchioli", "ANATOMY", 27, 37], ["alveoli", "ANATOMY", 42, 49], ["epithelial cells", "ANATOMY", 90, 106], ["bronchi", "MULTI-TISSUE_STRUCTURE", 19, 26], ["alveoli", "MULTI-TISSUE_STRUCTURE", 42, 49], ["epithelial cells", "CELL", 90, 106], ["epithelial cells", "CELL_TYPE", 90, 106], ["bronchi/bronchioli", "TEST", 19, 37], ["alveoli", "PROBLEM", 42, 49], ["bronchi", "ANATOMY", 19, 26], ["bronchioli", "ANATOMY", 27, 37], ["alveoli", "ANATOMY_MODIFIER", 42, 49], ["epithelial cells", "OBSERVATION", 90, 106]]], ["Because sanitary status and age may influence cytokine production, we performed a prelim-alveolar tissue became involved.ResultsLung inflammatory changes.", [["alveolar tissue", "ANATOMY", 89, 104], ["alveolar tissue", "TISSUE", 89, 104], ["cytokine", "PROTEIN", 46, 54], ["a prelim", "TEST", 80, 88], ["ResultsLung inflammatory changes", "PROBLEM", 121, 153], ["alveolar tissue", "ANATOMY", 89, 104], ["inflammatory", "OBSERVATION", 133, 145]]], ["Control pigs did not have inary experiment in 3-week-old CDCD pigs.", [["pigs", "ORGANISM", 8, 12], ["CDCD", "ORGANISM", 57, 61], ["pigs", "ORGANISM", 62, 66], ["pigs", "SPECIES", 8, 12], ["pigs", "SPECIES", 62, 66]]], ["Two pigs were inoculated intratracheally with 17 mg of Escherichia coli O111: macroscopic or microscopic lung pathology.", [["intratracheally", "ANATOMY", 25, 40], ["lung", "ANATOMY", 105, 109], ["pigs", "ORGANISM", 4, 8], ["Escherichia coli", "ORGANISM", 55, 71], ["O111", "ORGANISM", 72, 76], ["lung", "ORGAN", 105, 109], ["pigs", "SPECIES", 4, 8], ["Escherichia coli", "SPECIES", 55, 71], ["pigs", "SPECIES", 4, 8], ["Escherichia coli", "SPECIES", 55, 71], ["Two pigs", "TREATMENT", 0, 8], ["Escherichia coli O111", "TREATMENT", 55, 76], ["macroscopic or microscopic lung pathology", "PROBLEM", 78, 119], ["lung", "ANATOMY", 105, 109], ["pathology", "OBSERVATION", 110, 119]]], ["BAL cell numbers were between 35 and 60 1 10 6 .", [["BAL cell", "ANATOMY", 0, 8], ["BAL cell", "CELL", 0, 8], ["BAL cell numbers", "TEST", 0, 16], ["cell numbers", "OBSERVATION", 4, 16]]], ["Fewer than 1.5% of cells were B4 lipopolysaccharide, a known potent TNF-a and IL-1 inducer.", [["cells", "ANATOMY", 19, 24], ["lipopolysaccharide", "CHEMICAL", 33, 51], ["cells", "CELL", 19, 24], ["B4 lipopolysaccharide", "SIMPLE_CHEMICAL", 30, 51], ["TNF-a", "GENE_OR_GENE_PRODUCT", 68, 73], ["IL-1", "GENE_OR_GENE_PRODUCT", 78, 82], ["TNF", "PROTEIN", 68, 71], ["B4 lipopolysaccharide", "TEST", 30, 51], ["a and IL-1 inducer", "TREATMENT", 72, 90], ["potent", "OBSERVATION_MODIFIER", 61, 67]]], ["BAL fluids collected 6 and 12 h after inoculation re-neutrophils; \u00fa95% had macrophage morphology.ResultsAfter influenza virus inoculation, gross lung lesions appeared vealed TNF titers of 184 and 128 U/mL and IL-1 titers of 564 and 596 U/mL in the respective bioassays.", [["BAL fluids", "ANATOMY", 0, 10], ["re-neutrophils", "ANATOMY", 50, 64], ["macrophage", "ANATOMY", 75, 85], ["lung lesions", "ANATOMY", 145, 157], ["macrophage", "CELL", 75, 85], ["ResultsAfter influenza virus", "ORGANISM", 97, 125], ["lung lesions", "PATHOLOGICAL_FORMATION", 145, 157], ["TNF", "GENE_OR_GENE_PRODUCT", 174, 177], ["IL-1", "GENE_OR_GENE_PRODUCT", 209, 213], ["TNF", "PROTEIN", 174, 177], ["influenza virus", "SPECIES", 110, 125], ["BAL fluids", "TEST", 0, 10], ["inoculation re-neutrophils", "TEST", 38, 64], ["\u00fa", "TEST", 66, 67], ["influenza virus inoculation", "PROBLEM", 110, 137], ["gross lung lesions", "PROBLEM", 139, 157], ["TNF titers", "TEST", 174, 184], ["U/mL", "TEST", 200, 204], ["IL", "TEST", 209, 211], ["macrophage morphology", "OBSERVATION", 75, 96], ["gross", "OBSERVATION_MODIFIER", 139, 144], ["lung", "ANATOMY", 145, 149], ["lesions", "OBSERVATION", 150, 157]]], ["Consequently, 3-between 48 and 72 h after inoculation.", [["inoculation", "PROBLEM", 42, 53]]], ["At that time, \u00c785%, 18%, 18%, and 8% of lung tissue was affected in groups 1, 2,Resultsweek-old CDCD pigs were found suitable for further influenza virus -cytokine studies.", [["lung tissue", "ANATOMY", 40, 51], ["lung tissue", "TISSUE", 40, 51], ["CDCD", "ORGANISM", 96, 100], ["pigs", "ORGANISM", 101, 105], ["cytokine", "PROTEIN", 155, 163], ["pigs", "SPECIES", 101, 105], ["pigs", "SPECIES", 101, 105], ["lung tissue", "TEST", 40, 51], ["Resultsweek", "TEST", 80, 91], ["old CDCD pigs", "PROBLEM", 92, 105], ["further influenza virus", "PROBLEM", 130, 153], ["cytokine studies", "TEST", 155, 171], ["lung tissue", "ANATOMY", 40, 51]]], ["On histopathology, bronchi/bronchioli and, to a lesser degree, alveoli showed epithelial necrosis and To our knowledge, this is the first demonstration of influenza virus -induced TNF-a and IL-1 in BAL fluids of a natural virus massive neutrophil infiltration at 18 -24 h after inoculation.", [["bronchi", "ANATOMY", 19, 26], ["bronchioli", "ANATOMY", 27, 37], ["alveoli", "ANATOMY", 63, 70], ["epithelial", "ANATOMY", 78, 88], ["BAL fluids", "ANATOMY", 198, 208], ["neutrophil", "ANATOMY", 236, 246], ["epithelial necrosis", "DISEASE", 78, 97], ["bronchi", "MULTI-TISSUE_STRUCTURE", 19, 26], ["alveoli", "MULTI-TISSUE_STRUCTURE", 63, 70], ["epithelial", "TISSUE", 78, 88], ["influenza virus", "ORGANISM", 155, 170], ["TNF-a", "GENE_OR_GENE_PRODUCT", 180, 185], ["IL-1", "GENE_OR_GENE_PRODUCT", 190, 194], ["BAL", "ORGANISM_SUBSTANCE", 198, 201], ["neutrophil", "CELL", 236, 246], ["TNF", "PROTEIN", 180, 183], ["IL-1", "PROTEIN", 190, 194], ["influenza virus", "SPECIES", 155, 170], ["histopathology", "TEST", 3, 17], ["bronchi/bronchioli", "PROBLEM", 19, 37], ["epithelial necrosis", "PROBLEM", 78, 97], ["influenza virus", "PROBLEM", 155, 170], ["TNF", "TEST", 180, 183], ["IL", "TEST", 190, 192], ["BAL fluids", "TREATMENT", 198, 208], ["a natural virus massive neutrophil infiltration", "PROBLEM", 212, 259], ["bronchi", "ANATOMY", 19, 26], ["bronchioli", "ANATOMY", 27, 37], ["lesser degree", "OBSERVATION_MODIFIER", 48, 61], ["alveoli", "ANATOMY", 63, 70], ["epithelial", "ANATOMY", 78, 88], ["necrosis", "OBSERVATION", 89, 97], ["influenza virus", "OBSERVATION", 155, 170], ["neutrophil infiltration", "OBSERVATION", 236, 259]]], ["Forty-eight and 72 h after inoculation, bronchioli and alveoli host.", [["bronchioli", "ANATOMY", 40, 50], ["alveoli", "ANATOMY", 55, 62], ["bronchioli", "CELL", 40, 50], ["alveoli", "MULTI-TISSUE_STRUCTURE", 55, 62], ["inoculation", "TREATMENT", 27, 38], ["alveoli host", "PROBLEM", 55, 67], ["alveoli host", "OBSERVATION", 55, 67]]], ["Interestingly, influenza virus was an equally effective inducer of TNF-a and IL-1 as was E. coli endotoxin.", [["influenza", "DISEASE", 15, 24], ["influenza virus", "ORGANISM", 15, 30], ["TNF-a", "GENE_OR_GENE_PRODUCT", 67, 72], ["IL-1", "GENE_OR_GENE_PRODUCT", 77, 81], ["E. coli", "ORGANISM", 89, 96], ["endotoxin", "SIMPLE_CHEMICAL", 97, 106], ["TNF", "PROTEIN", 67, 70], ["IL-1", "PROTEIN", 77, 81], ["E. coli endotoxin", "PROTEIN", 89, 106], ["E. coli", "SPECIES", 89, 96], ["influenza virus", "SPECIES", 15, 30], ["E. coli", "SPECIES", 89, 96], ["influenza virus", "PROBLEM", 15, 30], ["TNF", "TEST", 67, 70], ["E. coli endotoxin", "PROBLEM", 89, 106], ["influenza virus", "OBSERVATION", 15, 30], ["coli endotoxin", "OBSERVATION", 92, 106]]], ["TNF-a were filled with exudate containing necrotic debris and macrophages and only few neutrophils.", [["exudate", "ANATOMY", 23, 30], ["necrotic debris", "ANATOMY", 42, 57], ["macrophages", "ANATOMY", 62, 73], ["neutrophils", "ANATOMY", 87, 98], ["necrotic", "DISEASE", 42, 50], ["TNF", "GENE_OR_GENE_PRODUCT", 0, 3], ["exudate", "ORGANISM_SUBSTANCE", 23, 30], ["macrophages", "CELL", 62, 73], ["neutrophils", "CELL", 87, 98], ["TNF", "PROTEIN", 0, 3], ["macrophages", "CELL_TYPE", 62, 73], ["neutrophils", "CELL_TYPE", 87, 98], ["TNF", "TEST", 0, 3], ["exudate", "PROBLEM", 23, 30], ["necrotic debris", "PROBLEM", 42, 57], ["macrophages", "PROBLEM", 62, 73], ["exudate", "OBSERVATION_MODIFIER", 23, 30], ["necrotic", "OBSERVATION_MODIFIER", 42, 50], ["debris", "OBSERVATION", 51, 57], ["macrophages", "OBSERVATION_MODIFIER", 62, 73], ["few", "OBSERVATION_MODIFIER", 83, 86], ["neutrophils", "OBSERVATION", 87, 98]]], ["Histologic changes were most and IL-1 have remarkably overlapping and synergistic effects, several of which are consistent with clinicopathologic manifes-dramatic in group 1.", [["IL-1", "GENE_OR_GENE_PRODUCT", 33, 37], ["IL", "PROTEIN", 33, 35], ["Histologic changes", "PROBLEM", 0, 18], ["synergistic effects", "PROBLEM", 70, 89], ["clinicopathologic manifes", "PROBLEM", 128, 153], ["consistent with", "UNCERTAINTY", 112, 127]]], ["BAL cell numbers were between 112 and 160 1 10 6 at 18 -24 h after inoculation and consisted of a tations of influenza [5] .", [["BAL cell", "ANATOMY", 0, 8], ["influenza", "DISEASE", 109, 118], ["BAL cell", "CELL", 0, 8], ["BAL cell numbers", "TEST", 0, 16], ["influenza", "PROBLEM", 109, 118], ["cell numbers", "OBSERVATION", 4, 16]]], ["Our findings in pigs are in agreement with previous reports in mice [3, 4] and further substantiate the maximum of 56% -77% neutrophils in groups 1, 2, and 3.", [["neutrophils", "ANATOMY", 124, 135], ["pigs", "ORGANISM", 16, 20], ["mice", "ORGANISM", 63, 67], ["neutrophils", "CELL", 124, 135], ["neutrophils", "CELL_TYPE", 124, 135], ["pigs", "SPECIES", 16, 20], ["mice", "SPECIES", 63, 67], ["mice", "SPECIES", 63, 67], ["neutrophils", "TEST", 124, 135]]], ["In / 9d43$$ap48 03-04-98 19:03:33 jinfa UC: J Infect", [["J Infect", "PROBLEM", 44, 52], ["J Infect", "OBSERVATION_MODIFIER", 44, 52]]]], "PMC7468404": [["IntroductionHeavy metal contamination is a global environmental problem shown to cause both ecological and public health problems (Tchounwou et al., 2012).", [["Heavy metal contamination", "PROBLEM", 12, 37], ["a global environmental problem", "PROBLEM", 41, 71], ["Heavy", "OBSERVATION_MODIFIER", 12, 17], ["metal contamination", "OBSERVATION", 18, 37]]], ["However, ecosystems with pervasive and long-term heavy metal contamination, such as the Savannah River Site (SRS), located in Aiken, SC, United States, are known to harbor metal-resistant microorganisms, which have acquired genomic features to resist and circumvent metal toxicity (Ye, 2014; Agarwal et al., 2018; Pathak et al., 2019, 2020; Gendy et al., 2020a, b).", [["toxicity", "DISEASE", 272, 280], ["pervasive and long-term heavy metal contamination", "PROBLEM", 25, 74], ["resistant microorganisms", "PROBLEM", 178, 202], ["acquired genomic features", "PROBLEM", 215, 240], ["metal toxicity", "PROBLEM", 266, 280], ["long-term heavy", "OBSERVATION_MODIFIER", 39, 54], ["metal contamination", "OBSERVATION", 55, 74], ["SC", "ANATOMY", 133, 135]]], ["The two main heavy metal contaminants within the impacted SRS soils include mercury (Hg) and uranium (U) (Sowder et al., 2003).", [["mercury", "CHEMICAL", 76, 83], ["Hg", "CHEMICAL", 85, 87], ["uranium", "CHEMICAL", 93, 100], ["U", "CHEMICAL", 102, 103], ["mercury", "CHEMICAL", 76, 83], ["Hg", "CHEMICAL", 85, 87], ["uranium", "CHEMICAL", 93, 100], ["mercury", "SIMPLE_CHEMICAL", 76, 83], ["Hg", "SIMPLE_CHEMICAL", 85, 87], ["uranium", "SIMPLE_CHEMICAL", 93, 100], ["The two main heavy metal contaminants", "TREATMENT", 0, 37], ["two", "OBSERVATION_MODIFIER", 4, 7], ["main", "OBSERVATION_MODIFIER", 8, 12], ["heavy", "OBSERVATION_MODIFIER", 13, 18], ["metal contaminants", "OBSERVATION", 19, 37], ["impacted", "OBSERVATION_MODIFIER", 49, 57]]], ["Our ongoing culture-dependent and culture-independent work on the SRS metalliferous soils has demonstrated several different bacterial groups involved in metal cycling processes, such as Arthrobacter spp., Burkholderia spp., Bacillus spp., Bradyrhizobium spp., Pseudomonas spp., Lysinibacillus spp., Paenibacillus spp., Stenotrophomonas spp., and Serratia spp.", [["Arthrobacter spp.", "ORGANISM", 187, 204], ["Burkholderia spp.", "ORGANISM", 206, 223], ["Bacillus spp.", "ORGANISM", 225, 238], ["Bradyrhizobium spp.", "ORGANISM", 240, 259], ["Pseudomonas spp.", "ORGANISM", 261, 277], ["Lysinibacillus spp.", "ORGANISM", 279, 298], ["Paenibacillus spp.", "ORGANISM", 300, 318], ["Stenotrophomonas spp.", "ORGANISM", 320, 341], ["Serratia spp", "ORGANISM", 347, 359], ["Arthrobacter spp.", "SPECIES", 187, 204], ["Burkholderia spp.", "SPECIES", 206, 223], ["Bacillus spp.", "SPECIES", 225, 238], ["Bradyrhizobium spp.", "SPECIES", 240, 259], ["Pseudomonas spp.", "SPECIES", 261, 277], ["Lysinibacillus spp.", "SPECIES", 279, 298], ["Paenibacillus spp.", "SPECIES", 300, 318], ["Stenotrophomonas spp.", "SPECIES", 320, 341], ["Serratia spp", "SPECIES", 347, 359], ["Arthrobacter spp.", "SPECIES", 187, 204], ["Burkholderia spp.", "SPECIES", 206, 223], ["Bacillus spp.", "SPECIES", 225, 238], ["Bradyrhizobium spp.", "SPECIES", 240, 259], ["Pseudomonas spp.", "SPECIES", 261, 277], ["Lysinibacillus spp.", "SPECIES", 279, 298], ["Paenibacillus spp.", "SPECIES", 300, 318], ["Stenotrophomonas spp.", "SPECIES", 320, 341], ["Serratia spp", "SPECIES", 347, 359], ["Our ongoing culture", "TEST", 0, 19], ["culture", "TEST", 34, 41], ["the SRS metalliferous soils", "PROBLEM", 62, 89], ["several different bacterial groups", "PROBLEM", 107, 141], ["metal cycling processes", "PROBLEM", 154, 177], ["Arthrobacter spp.", "PROBLEM", 187, 204], ["Burkholderia spp.", "PROBLEM", 206, 223], ["Bacillus spp.", "PROBLEM", 225, 238], ["Bradyrhizobium spp.", "PROBLEM", 240, 259], ["Pseudomonas spp.", "PROBLEM", 261, 277], ["Paenibacillus spp.", "PROBLEM", 300, 318], ["Stenotrophomonas spp.", "PROBLEM", 320, 341], ["Serratia spp", "PROBLEM", 347, 359], ["bacterial groups", "OBSERVATION", 125, 141], ["Serratia spp", "OBSERVATION", 347, 359]]], ["Many of these groups have been demonstrated to cycle Hg by activity of their mer operon, which consists of regulatory proteins- MerR and MerD, transport proteins- MerP, T and E, as well as protein(s) with reductase activity- MerA (Agarwal et al., 2019; Pathak et al., 2020).", [["Hg", "CHEMICAL", 53, 55], ["Hg", "CHEMICAL", 53, 55], ["MerR", "GENE_OR_GENE_PRODUCT", 128, 132], ["MerD", "GENE_OR_GENE_PRODUCT", 137, 141], ["MerP", "GENE_OR_GENE_PRODUCT", 163, 167], ["T", "GENE_OR_GENE_PRODUCT", 169, 170], ["E", "GENE_OR_GENE_PRODUCT", 175, 176], ["mer operon", "DNA", 77, 87], ["regulatory proteins", "PROTEIN", 107, 126], ["MerR", "PROTEIN", 128, 132], ["MerD", "PROTEIN", 137, 141], ["transport proteins", "PROTEIN", 143, 161], ["MerP", "PROTEIN", 163, 167], ["T", "PROTEIN", 169, 170], ["E", "PROTEIN", 175, 176], ["reductase", "PROTEIN", 205, 214], ["their mer operon", "TREATMENT", 71, 87], ["transport proteins", "TEST", 143, 161]]], ["In reference to U cycling processes, several different genes have been shown to render U resistance and biomineralization, such as the gene encoding uranium binding complex (UBC), uranium response in Caulobacter (urcA), phosphatase genes (phoY; phoK; and phoN) and PIB-type ATPAse (Martinez et al., 2006; Hillson et al., 2007; Nilgiriwala et al., 2008; Nongkhlaw et al., 2012; Yung and Jiao, 2014; Kulkarni et al., 2016; Thorgersen et al., 2017).", [["uranium", "CHEMICAL", 149, 156], ["uranium", "CHEMICAL", 180, 187], ["uranium", "CHEMICAL", 149, 156], ["uranium", "CHEMICAL", 180, 187], ["U", "GENE_OR_GENE_PRODUCT", 87, 88], ["uranium binding complex", "GENE_OR_GENE_PRODUCT", 149, 172], ["UBC", "GENE_OR_GENE_PRODUCT", 174, 177], ["uranium", "SIMPLE_CHEMICAL", 180, 187], ["Caulobacter (urcA)", "GENE_OR_GENE_PRODUCT", 200, 218], ["phoY", "GENE_OR_GENE_PRODUCT", 239, 243], ["phoK", "GENE_OR_GENE_PRODUCT", 245, 249], ["phoN", "GENE_OR_GENE_PRODUCT", 255, 259], ["PIB-type ATPAse", "GENE_OR_GENE_PRODUCT", 265, 280], ["uranium binding complex", "PROTEIN", 149, 172], ["UBC", "PROTEIN", 174, 177], ["Caulobacter (urcA), phosphatase genes", "DNA", 200, 237], ["phoY", "DNA", 239, 243], ["phoK", "DNA", 245, 249], ["phoN", "DNA", 255, 259], ["PIB", "DNA", 265, 268], ["biomineralization", "PROBLEM", 104, 121], ["uranium response in Caulobacter (urcA)", "TEST", 180, 218], ["phosphatase genes", "TEST", 220, 237], ["phoK", "TEST", 245, 249], ["PIB", "TEST", 265, 268]]], ["However, no specific bacterial operon has been shown to be active under U stress to date.IntroductionDespite this advantage of microbially based heavy metal bioremediation, studies have also unequivocally shown that bacteria can acquire antibiotic resistance when exposed to long-term contamination, especially with Hg and U (Benyehuda et al., 2003), including our previous work (Agarwal et al., 2019, 2020a,b; Gendy et al., 2020a, b; Pathak et al., 2020).", [["Hg", "CHEMICAL", 316, 318], ["Hg", "CHEMICAL", 316, 318], ["bacterial operon", "DNA", 21, 37], ["specific bacterial operon", "PROBLEM", 12, 37], ["microbially based heavy metal bioremediation", "TREATMENT", 127, 171], ["bacteria", "PROBLEM", 216, 224], ["antibiotic resistance", "TREATMENT", 237, 258], ["long-term contamination", "PROBLEM", 275, 298], ["no", "UNCERTAINTY", 9, 11], ["long-term contamination", "OBSERVATION_MODIFIER", 275, 298]]], ["This builds upon significant evidence that exists on the SRS soils which unequivocally shows higher levels of antibiotic resistance in contaminated SRS soils relative to reference soils (Stepanauskas et al., 2006; Wright et al., 2006; Thomas et al., 2020).", [["SRS", "DISEASE", 148, 151], ["the SRS soils", "TEST", 53, 66], ["antibiotic resistance", "TREATMENT", 110, 131], ["significant", "OBSERVATION_MODIFIER", 17, 28], ["antibiotic resistance", "OBSERVATION", 110, 131]]], ["Furthermore, both, empirical and anecdotal evidence from SRS soils strongly suggest recruitment of antibiotic resistances in many human pathogens that are native to these soils [e.g., Burkholderia, Ralstonia, Massilia, Acinetobacter, and Pseudomonas (Stepanauskas et al., 2006)].", [["human", "ORGANISM", 130, 135], ["human", "SPECIES", 130, 135], ["human", "SPECIES", 130, 135], ["SRS soils", "PROBLEM", 57, 66], ["antibiotic resistances", "TREATMENT", 99, 121], ["many human pathogens", "PROBLEM", 125, 145], ["Burkholderia", "PROBLEM", 184, 196], ["Ralstonia", "PROBLEM", 198, 207], ["Massilia", "PROBLEM", 209, 217], ["Acinetobacter", "PROBLEM", 219, 232], ["Pseudomonas", "PROBLEM", 238, 249], ["antibiotic resistances", "OBSERVATION", 99, 121], ["Massilia", "ANATOMY", 209, 217], ["Pseudomonas", "OBSERVATION_MODIFIER", 238, 249]]], ["Despite the fact that many of these SRS native soil bacteria are bioremediative being armed with an arsenal of metal resistance genes (MRGs), but they can also pose public health risks by virtue of their acquired antibiotic resistance(s), via the activity of antibiotic resistant genes (ARGs), thus strongly negating their beneficial properties.", [["metal resistance genes", "DNA", 111, 133], ["MRGs", "DNA", 135, 139], ["antibiotic resistant genes", "DNA", 259, 285], ["ARGs", "DNA", 287, 291], ["these SRS native soil bacteria", "PROBLEM", 30, 60], ["their acquired antibiotic resistance", "TREATMENT", 198, 234], ["antibiotic resistant genes", "TREATMENT", 259, 285], ["metal resistance", "OBSERVATION", 111, 127]]], ["Thus, heavy-metal induced development and carriage of ARGs, or the \u2018resistome\u2019, within the native soil microbiota, can lead to the emergence and rapid spread of multidrug-resistant (MDR) bacteria, also referred to as \u201csuperbugs\u201d (Davies and Davies, 2010), leading to potential future pathogenic outbreaks.", [["multidrug-resistant (MDR) bacteria", "DISEASE", 161, 195], ["ARGs", "GENE_OR_GENE_PRODUCT", 54, 58], ["carriage of ARGs", "PROBLEM", 42, 58], ["the \u2018resistome\u2019", "TREATMENT", 63, 78], ["the emergence", "PROBLEM", 127, 140], ["multidrug-resistant (MDR) bacteria", "PROBLEM", 161, 195], ["heavy", "OBSERVATION_MODIFIER", 6, 11], ["metal induced", "OBSERVATION_MODIFIER", 12, 25], ["pathogenic", "OBSERVATION_MODIFIER", 284, 294], ["outbreaks", "OBSERVATION", 295, 304]]], ["In fact, antimicrobial resistance is projected to cause approximately 10 million deaths, annually by year 2050 (O\u2019Neill, 2014), outpacing cancer, which is the current leading cause of human mortality.", [["cancer", "ANATOMY", 138, 144], ["deaths", "DISEASE", 81, 87], ["cancer", "DISEASE", 138, 144], ["cancer", "CANCER", 138, 144], ["human", "ORGANISM", 184, 189], ["human", "SPECIES", 184, 189], ["human", "SPECIES", 184, 189], ["antimicrobial resistance", "TREATMENT", 9, 33], ["outpacing cancer", "PROBLEM", 128, 144], ["human mortality", "PROBLEM", 184, 199], ["antimicrobial resistance", "OBSERVATION", 9, 33], ["cancer", "OBSERVATION", 138, 144]]], ["It is also pertinent to mention here that secondary infections by nosocomial, or hospital acquired pathogens is on the rise; at least 50% of the deaths reported from the ongoing COVID-19 outbreak were caused from secondary infections (Antibiotic resistance: the hidden threat lurking behind COVID-191,2).", [["infections", "DISEASE", 52, 62], ["nosocomial", "DISEASE", 66, 76], ["deaths", "DISEASE", 145, 151], ["infections", "DISEASE", 223, 233], ["COVID-191,2", "CHEMICAL", 291, 302], ["secondary infections", "PROBLEM", 42, 62], ["nosocomial", "PROBLEM", 66, 76], ["hospital acquired pathogens", "PROBLEM", 81, 108], ["the deaths", "PROBLEM", 141, 151], ["the ongoing COVID", "TEST", 166, 183], ["secondary infections", "PROBLEM", 213, 233], ["Antibiotic resistance", "TREATMENT", 235, 256], ["secondary", "OBSERVATION_MODIFIER", 42, 51], ["infections", "OBSERVATION", 52, 62], ["secondary", "OBSERVATION_MODIFIER", 213, 222], ["infections", "OBSERVATION", 223, 233]]], ["Specifically, respiratory disease caused initially by the COVID-19 viral agent has been shown to rapidly ensue in pneumonia, thus predisposing patients to secondary bacterial infections, and exacerbating underlying cardiac and pulmonary conditions leading to death.", [["respiratory", "ANATOMY", 14, 25], ["cardiac", "ANATOMY", 215, 222], ["pulmonary", "ANATOMY", 227, 236], ["respiratory disease", "DISEASE", 14, 33], ["pneumonia", "DISEASE", 114, 123], ["bacterial infections", "DISEASE", 165, 185], ["cardiac and pulmonary conditions", "DISEASE", 215, 247], ["death", "DISEASE", 259, 264], ["patients", "ORGANISM", 143, 151], ["cardiac", "ORGAN", 215, 222], ["pulmonary", "ORGAN", 227, 236], ["patients", "SPECIES", 143, 151], ["respiratory disease", "PROBLEM", 14, 33], ["the COVID", "TEST", 54, 63], ["viral agent", "TREATMENT", 67, 78], ["pneumonia", "PROBLEM", 114, 123], ["secondary bacterial infections", "PROBLEM", 155, 185], ["underlying cardiac and pulmonary conditions", "PROBLEM", 204, 247], ["death", "PROBLEM", 259, 264], ["respiratory disease", "OBSERVATION", 14, 33], ["pneumonia", "OBSERVATION", 114, 123], ["secondary", "OBSERVATION_MODIFIER", 155, 164], ["bacterial", "OBSERVATION_MODIFIER", 165, 174], ["infections", "OBSERVATION", 175, 185], ["cardiac", "ANATOMY", 215, 222], ["pulmonary", "ANATOMY", 227, 236], ["conditions", "OBSERVATION", 237, 247]]], ["Therefore, it is critical to obtain a better understanding on the state of antimicrobial resistance prevalent in environmental representatives of bacterial pathogens, because the environment is a well-known reservoir of pathogens.", [["antimicrobial resistance", "TREATMENT", 75, 99], ["bacterial pathogens", "PROBLEM", 146, 165], ["pathogens", "PROBLEM", 220, 229], ["antimicrobial resistance", "OBSERVATION", 75, 99], ["bacterial pathogens", "OBSERVATION", 146, 165]]], ["A central question in our ongoing work is focused on assessing those genomic features that underpin antimicrobial resistances in opportunistic bacterial pathogens in the environment, so that appropriate mitigation strategies to combat these pathogens can be obtained.IntroductionAmong the bacteria genera that are listed above and relevant to the SRS ecosystem, one genus that deserves further study because of its double life strategy is Serratia species, from the Enterobacteria family.", [["opportunistic bacterial pathogens", "DISEASE", 129, 162], ["Serratia species", "ORGANISM", 439, 455], ["Enterobacteria", "GENE_OR_GENE_PRODUCT", 466, 480], ["antimicrobial resistances", "TREATMENT", 100, 125], ["opportunistic bacterial pathogens", "PROBLEM", 129, 162], ["appropriate mitigation strategies", "TREATMENT", 191, 224], ["these pathogens", "PROBLEM", 235, 250], ["the bacteria genera", "PROBLEM", 285, 304], ["further study", "TEST", 386, 399], ["its double life strategy", "TREATMENT", 411, 435], ["Serratia species", "PROBLEM", 439, 455], ["central", "OBSERVATION_MODIFIER", 2, 9], ["antimicrobial resistances", "OBSERVATION", 100, 125], ["Serratia species", "OBSERVATION", 439, 455]]], ["Notably, recent genomics analysis has resulted in the division of Serratia spp. into the following broad strain categories based on their functional activities: pathogenic, environmental and symbiotic strains (Sandner-Miranda et al., 2018).", [["Serratia spp", "ORGANISM", 66, 78], ["Serratia spp", "SPECIES", 66, 78], ["recent genomics analysis", "TEST", 9, 33], ["Serratia spp", "PROBLEM", 66, 78], ["broad strain categories", "TREATMENT", 99, 122], ["pathogenic", "PROBLEM", 161, 171], ["symbiotic strains", "PROBLEM", 191, 208], ["Serratia spp", "OBSERVATION", 66, 78]]], ["Furthermore, the environmental strains are divided into three sub-groups: environmental strains that are symbiotic and associated with soil and plants, environmental strains that have been isolated from water and environmental strains that were isolated from food sources.", [["the environmental strains", "PROBLEM", 13, 38], ["environmental strains", "PROBLEM", 74, 95], ["environmental strains", "PROBLEM", 152, 173], ["environmental strains", "PROBLEM", 213, 234]]], ["Overall, it was demonstrated that pathogenic and environmental Serratia isolates presented a high number of antibiotic resistant genes (ARGs); especially for efflux systems (Levy, 2002; Nelson et al., 2006; Armalyt\u0117 et al., 2019; Ben Maamar et al., 2020).", [["Serratia isolates", "ORGANISM", 63, 80], ["antibiotic resistant genes", "DNA", 108, 134], ["ARGs", "DNA", 136, 140], ["pathogenic and environmental Serratia isolates", "PROBLEM", 34, 80], ["antibiotic resistant genes", "TREATMENT", 108, 134]]], ["The nosocomial pathogenic Serratia strains possessed a higher degree of acquired resistance genes relative to environmental isolates.", [["Serratia strains", "ORGANISM", 26, 42], ["acquired resistance genes", "DNA", 72, 97], ["The nosocomial pathogenic Serratia strains", "PROBLEM", 0, 42], ["acquired resistance genes", "PROBLEM", 72, 97], ["nosocomial", "OBSERVATION_MODIFIER", 4, 14], ["pathogenic", "OBSERVATION_MODIFIER", 15, 25], ["Serratia strains", "OBSERVATION", 26, 42], ["higher degree", "OBSERVATION_MODIFIER", 55, 68], ["resistance genes", "OBSERVATION", 81, 97]]], ["However, stress posed by long-term heavy metal contamination is known to exacerbate recruitment and proliferation of ARGs in the native soil microbiota (Cyco\u0144 et al., 2019; Kraemer et al., 2019), leading to the main question for this study: are environmental Serratia species developing broad antimicrobial resistance activities?", [["ARGs", "GENE_OR_GENE_PRODUCT", 117, 121], ["Serratia species", "ORGANISM", 259, 275], ["long-term heavy metal contamination", "PROBLEM", 25, 60], ["proliferation of ARGs", "PROBLEM", 100, 121], ["this study", "TEST", 229, 239], ["environmental Serratia species", "PROBLEM", 245, 275], ["broad antimicrobial resistance activities", "PROBLEM", 287, 328], ["proliferation", "OBSERVATION_MODIFIER", 100, 113], ["antimicrobial resistance", "OBSERVATION", 293, 317]]], ["To address this overarching question, we performed this case study on environmental representatives of Serratia spp., specifically on a newly isolated representative strain (Gendy et al., 2020b), compared to a plethora of other Serratia spp., having originated from both environmental and clinical settings.IntroductionNote that the environmental Serratia species perform a variety of ecosystem services in the environment, including bioremediation of pentachlorophenol (Singh et al., 2009), dichlorodiphenyltrichloroethane (Bidlan and Manonmani, 2002), diesel (Rajasekar et al., 2007), chlorpyrifos (Cyco\u0144 et al., 2013), as well as heavy metals to include, nickel (Kannan and Ramteke, 2002), chromium (Mondaca et al., 2002; Campos et al., 2013), molybdate (Yunus et al., 2009; Shukor et al., 2010), lead, cadmium (Cristani et al., 2012), manganese (II) and Hg (Fran\u00e7ois et al., 2012).", [["pentachlorophenol", "CHEMICAL", 452, 469], ["dichlorodiphenyltrichloroethane", "CHEMICAL", 492, 523], ["diesel", "CHEMICAL", 554, 560], ["chlorpyrifos", "CHEMICAL", 587, 599], ["nickel", "CHEMICAL", 658, 664], ["chromium", "CHEMICAL", 693, 701], ["molybdate", "CHEMICAL", 747, 756], ["cadmium", "CHEMICAL", 806, 813], ["manganese", "CHEMICAL", 839, 848], ["Hg", "CHEMICAL", 858, 860], ["pentachlorophenol", "CHEMICAL", 452, 469], ["dichlorodiphenyltrichloroethane", "CHEMICAL", 492, 523], ["chlorpyrifos", "CHEMICAL", 587, 599], ["nickel", "CHEMICAL", 658, 664], ["chromium", "CHEMICAL", 693, 701], ["molybdate", "CHEMICAL", 747, 756], ["cadmium", "CHEMICAL", 806, 813], ["manganese (II)", "CHEMICAL", 839, 853], ["Hg", "CHEMICAL", 858, 860], ["Serratia spp.", "ORGANISM", 103, 116], ["Serratia spp.", "ORGANISM", 228, 241], ["Serratia species", "ORGANISM", 347, 363], ["pentachlorophenol", "SIMPLE_CHEMICAL", 452, 469], ["dichlorodiphenyltrichloroethane", "SIMPLE_CHEMICAL", 492, 523], ["Bidlan", "SIMPLE_CHEMICAL", 525, 531], ["chlorpyrifos", "SIMPLE_CHEMICAL", 587, 599], ["nickel", "SIMPLE_CHEMICAL", 658, 664], ["chromium", "SIMPLE_CHEMICAL", 693, 701], ["molybdate", "SIMPLE_CHEMICAL", 747, 756], ["cadmium", "SIMPLE_CHEMICAL", 806, 813], ["manganese (II)", "SIMPLE_CHEMICAL", 839, 853], ["Serratia spp.", "SPECIES", 103, 116], ["Serratia spp.", "SPECIES", 228, 241], ["Serratia spp.", "SPECIES", 103, 116], ["Serratia spp.", "SPECIES", 228, 241], ["this case study", "TEST", 51, 66], ["Serratia spp.", "PROBLEM", 103, 116], ["other Serratia spp.", "PROBLEM", 222, 241], ["the environmental Serratia species", "PROBLEM", 329, 363], ["dichlorodiphenyltrichloroethane (Bidlan and Manonmani", "TREATMENT", 492, 545], ["Serratia", "OBSERVATION", 228, 236]]], ["Some Serratia spp., are also well-known plant growth promoting bacteria (PGPB), exhibiting positive impacts by increasing nutrition to the plants, reducing stress and enhancing overall plant productivity (Singh and Jha, 2016).", [["Serratia spp.", "ORGANISM", 5, 18], ["Serratia spp.", "SPECIES", 5, 18], ["Serratia spp.", "SPECIES", 5, 18], ["Some Serratia spp.", "PROBLEM", 0, 18], ["reducing stress", "PROBLEM", 147, 162], ["Serratia", "OBSERVATION", 5, 13], ["growth", "OBSERVATION_MODIFIER", 46, 52], ["positive", "OBSERVATION_MODIFIER", 91, 99], ["impacts", "OBSERVATION_MODIFIER", 100, 107], ["enhancing", "OBSERVATION_MODIFIER", 167, 176], ["overall", "OBSERVATION_MODIFIER", 177, 184], ["plant productivity", "OBSERVATION", 185, 203]]], ["As stated above, despite these attractive environmental and agricultural traits of Serratia spp., they are also known to possess pathogenicity, accounting for nosocomial infections of the respiratory tract, urinary tract, surgical wounds and even meningitis (Khanna et al., 2013; Abreo and Altier, 2019; Cristina et al., 2019), specifically caused by Serratia marcescens.", [["respiratory tract", "ANATOMY", 188, 205], ["urinary tract", "ANATOMY", 207, 220], ["wounds", "ANATOMY", 231, 237], ["nosocomial infections of the respiratory tract", "DISEASE", 159, 205], ["urinary tract, surgical wounds", "DISEASE", 207, 237], ["meningitis", "DISEASE", 247, 257], ["Serratia spp.", "ORGANISM", 83, 96], ["respiratory tract", "ORGANISM_SUBDIVISION", 188, 205], ["urinary tract", "ORGANISM_SUBDIVISION", 207, 220], ["wounds", "PATHOLOGICAL_FORMATION", 231, 237], ["Serratia marcescens", "ORGANISM", 351, 370], ["Serratia spp.", "SPECIES", 83, 96], ["Serratia marcescens", "SPECIES", 351, 370], ["Serratia spp.", "SPECIES", 83, 96], ["Serratia marcescens", "SPECIES", 351, 370], ["Serratia spp.", "PROBLEM", 83, 96], ["pathogenicity", "PROBLEM", 129, 142], ["nosocomial infections of the respiratory tract", "PROBLEM", 159, 205], ["urinary tract, surgical wounds", "PROBLEM", 207, 237], ["meningitis", "PROBLEM", 247, 257], ["Abreo", "TEST", 280, 285], ["Serratia marcescens", "PROBLEM", 351, 370], ["respiratory tract", "ANATOMY", 188, 205], ["urinary tract", "ANATOMY", 207, 220], ["surgical wounds", "OBSERVATION", 222, 237], ["meningitis", "OBSERVATION", 247, 257], ["Serratia marcescens", "OBSERVATION", 351, 370]]], ["Therefore, this potential dual-life strategy of Serratia marcescens needs to be carefully assessed, specifically for the presence and activities of ARGs, in context to their environmental applications, such as for U and Hg bioremediation.IntroductionWith this backdrop, we pursued this study keeping in mind the following objectives which are summarized as follows: (1) obtain an environmental Serratia isolate resistant to Hg and U; (2) evaluate metabolic potential of the isolated strain and screen how metabolic activity is affected by stress posed by Hg; (3) evaluate the presence and functional activity of antimicrobial resistance using phenomics; and finally, (4) survey the genomic potential of the isolated strain in context to both, metal resistant genes (MRGs) and antibiotic resistant genes (ARGs).", [["U", "CHEMICAL", 214, 215], ["Hg", "CHEMICAL", 220, 222], ["Hg", "CHEMICAL", 424, 426], ["Hg", "CHEMICAL", 555, 557], ["metal", "CHEMICAL", 743, 748], ["Hg", "CHEMICAL", 220, 222], ["Hg", "CHEMICAL", 424, 426], ["Hg", "CHEMICAL", 555, 557], ["Serratia marcescens", "ORGANISM", 48, 67], ["ARGs", "SIMPLE_CHEMICAL", 148, 152], ["metal resistant genes", "DNA", 743, 764], ["MRGs", "DNA", 766, 770], ["antibiotic resistant genes", "DNA", 776, 802], ["ARGs", "DNA", 804, 808], ["Serratia marcescens", "SPECIES", 48, 67], ["Serratia marcescens", "SPECIES", 48, 67], ["Serratia marcescens", "PROBLEM", 48, 67], ["U and Hg bioremediation", "TREATMENT", 214, 237], ["this study", "TEST", 281, 291], ["an environmental Serratia isolate", "PROBLEM", 377, 410], ["the isolated strain", "PROBLEM", 470, 489], ["antimicrobial resistance", "TREATMENT", 612, 636], ["phenomics", "TREATMENT", 643, 652], ["the isolated strain", "PROBLEM", 703, 722], ["metal resistant genes (MRGs", "PROBLEM", 743, 770], ["antibiotic resistant genes", "TREATMENT", 776, 802], ["antimicrobial resistance", "OBSERVATION", 612, 636]]], ["Overall, this study provides a broader and comprehensive understanding on the myriad of evolutionary and adaptive traits possessed by an environmental isolate of Serratia species, which can be opportunistic pathogens, with special emphasis on carriage of heavy metal and antibiotic resistances.", [["opportunistic pathogens", "DISEASE", 193, 216], ["Serratia species", "ORGANISM", 162, 178], ["this study", "TEST", 9, 19], ["Serratia species", "PROBLEM", 162, 178], ["opportunistic pathogens", "PROBLEM", 193, 216], ["heavy metal", "TREATMENT", 255, 266], ["antibiotic resistances", "TREATMENT", 271, 293], ["Serratia species", "OBSERVATION", 162, 178]]], ["Acquired resistance to multiple antibiotics has been recognized as a global crisis, which needs urgent attention so that a major outbreak, similar to the ongoing global crisis brought about by COVID-19 pandemic, can be avoided.", [["Acquired resistance", "PROBLEM", 0, 19], ["multiple antibiotics", "TREATMENT", 23, 43], ["a global crisis", "PROBLEM", 67, 82], ["a major outbreak", "PROBLEM", 121, 137], ["the ongoing global crisis", "PROBLEM", 150, 175], ["multiple", "OBSERVATION_MODIFIER", 23, 31], ["antibiotics", "OBSERVATION", 32, 43], ["global", "OBSERVATION_MODIFIER", 69, 75], ["crisis", "OBSERVATION", 76, 82], ["global", "OBSERVATION_MODIFIER", 162, 168], ["crisis", "OBSERVATION", 169, 175]]], ["Studies such as this, suggests immediate remedial measures be adopted to obtain mitigation strategies against the development of multidrug resistant bacteria, such as the environmental Serratia species, and promulgate strategies in the event a bacterial pathogen outbreak occurs and causes large-scale human fatalities, akin to the COVID-19, which is ongoing, as of this writing.Isolation and Identification of Strain SRS-8-S-2018 ::: Experimental SectionAs part of an ongoing study, soil samples were obtained from the SRS Mills Branch (area 101) which is found co-contaminated with total Hg concentrations in the range of 300\u2013700 ng/g dry weight (Xu et al., 2019) as well as U. To isolate heavy metal resistant bacteria, soils were serially diluted and plated onto Lysogeny Broth agar (LBA) containing 5 \u03bcg/ml of mercuric chloride; the resulting colonies were picked and further isolated based on their distinct morphologies and pigmentation (Chauhan et al., 2018; Agarwal et al., 2019, 2020a).", [["samples", "ANATOMY", 489, 496], ["colonies", "ANATOMY", 848, 856], ["fatalities", "DISEASE", 308, 318], ["Hg", "CHEMICAL", 590, 592], ["metal", "CHEMICAL", 697, 702], ["mercuric chloride", "CHEMICAL", 815, 832], ["Hg", "CHEMICAL", 590, 592], ["mercuric chloride", "CHEMICAL", 815, 832], ["human", "ORGANISM", 302, 307], ["Hg", "SIMPLE_CHEMICAL", 590, 592], ["mercuric chloride", "SIMPLE_CHEMICAL", 815, 832], ["human", "SPECIES", 302, 307], ["human", "SPECIES", 302, 307], ["Studies", "TEST", 0, 7], ["mitigation strategies", "TREATMENT", 80, 101], ["multidrug resistant bacteria", "PROBLEM", 129, 157], ["the environmental Serratia species", "PROBLEM", 167, 201], ["promulgate strategies", "TREATMENT", 207, 228], ["a bacterial pathogen outbreak", "PROBLEM", 242, 271], ["large-scale human fatalities", "PROBLEM", 290, 318], ["the COVID", "TEST", 328, 337], ["Strain SRS", "TEST", 411, 421], ["an ongoing study", "TEST", 466, 482], ["soil samples", "TEST", 484, 496], ["total Hg concentrations", "TREATMENT", 584, 607], ["heavy metal resistant bacteria", "PROBLEM", 691, 721], ["Lysogeny Broth agar", "TREATMENT", 767, 786], ["mercuric chloride", "TREATMENT", 815, 832], ["the resulting colonies", "PROBLEM", 834, 856], ["multidrug resistant bacteria", "OBSERVATION", 129, 157], ["bacterial", "OBSERVATION_MODIFIER", 244, 253], ["pathogen", "OBSERVATION", 254, 262], ["large", "OBSERVATION_MODIFIER", 290, 295], ["-scale human", "OBSERVATION_MODIFIER", 295, 307]]], ["Plates were incubated aerobically at 30\u00b0C in the incubator, and resulting colonies were further isolated, yielding a robust Hg resistant (HgR) strain, labeled as SRS-8-S-2018.", [["colonies", "ANATOMY", 74, 82], ["Hg", "CHEMICAL", 124, 126], ["Hg", "CHEMICAL", 124, 126], ["resulting colonies", "PROBLEM", 64, 82], ["a robust Hg resistant (HgR) strain", "PROBLEM", 115, 149], ["SRS", "TEST", 162, 165]]], ["Strain identification was performed using 16S rRNA sequencing, as recently reported (Gendy et al., 2020b).Characterization of Strain SRS-8-S-2018 for Hg and U Resistance ::: Experimental SectionHg resistance of strain SRS-8-S-2018 was evaluated by dilution of overnight grown strain to OD600 of 0.2.", [["Hg", "CHEMICAL", 150, 152], ["SectionHg", "CHEMICAL", 187, 196], ["SRS-8-S-2018", "CHEMICAL", 218, 230], ["Hg", "CHEMICAL", 150, 152], ["Strain identification", "TEST", 0, 21], ["16S rRNA sequencing", "TEST", 42, 61], ["Strain SRS", "TEST", 126, 136], ["strain SRS", "TEST", 211, 221]]], ["This inoculum (30 \u03bcl) was then added to 270 \u03bcl of LB amended with incremental concentrations (0\u201330 \u03bcg/ml) of mercuric chloride.", [["LB", "CHEMICAL", 50, 52], ["mercuric chloride", "CHEMICAL", 109, 126], ["mercuric chloride", "CHEMICAL", 109, 126], ["mercuric chloride", "SIMPLE_CHEMICAL", 109, 126], ["This inoculum", "TREATMENT", 0, 13], ["incremental concentrations", "TREATMENT", 66, 92], ["mercuric chloride", "TREATMENT", 109, 126]]], ["OD600 was then evaluated every 3 h for up to 48 h at 30\u00b0C using the Bioscreen C microbial growth analysis system (Growth Curves USA, Piscataway, NJ, United States), as shown previously (Agarwal et al., 2019).", [["the Bioscreen C microbial growth analysis system", "TEST", 64, 112]]], ["This minimum inhibitory concentration (MIC) assay was performed three times, and the average values are reported.", [["This minimum inhibitory concentration (MIC) assay", "TEST", 0, 49], ["the average values", "TEST", 81, 99]]], ["Controls were also run on plates that did not contain Hg and compared under the same growth conditions.Characterization of Strain SRS-8-S-2018 for Hg and U Resistance ::: Experimental SectionTo evaluate resistance against uranium, our recently developed plate MIC method was used because U is known to cause precipitation in liquid media causing turbidity which interferes with monitoring of bacterial growth (Agarwal et al., 2020b).", [["Hg", "CHEMICAL", 54, 56], ["Hg", "CHEMICAL", 147, 149], ["uranium", "CHEMICAL", 222, 229], ["Hg", "CHEMICAL", 54, 56], ["Hg", "CHEMICAL", 147, 149], ["uranium", "CHEMICAL", 222, 229], ["uranium", "SIMPLE_CHEMICAL", 222, 229], ["Hg", "TEST", 54, 56], ["Strain SRS", "TEST", 123, 133], ["plate MIC method", "TREATMENT", 254, 270], ["liquid media", "TREATMENT", 325, 337], ["turbidity", "PROBLEM", 346, 355], ["bacterial growth", "PROBLEM", 392, 408]]], ["Briefly, strain SRS-8-S-2018 was prepared taking a single colony inoculated into LB broth overnight and then diluted to an OD600 of 0.1.", [["colony", "ANATOMY", 58, 64], ["SRS-8-S-2018", "CHEMICAL", 16, 28], ["SRS-8-S-2018", "CELL", 16, 28], ["strain SRS", "TEST", 9, 19]]], ["Further, a 10-fold dilution series was prepared up to 10\u20135 dilution range and plated onto LB plates containing U in concentrations of 2, 4, 5, and 6 mM, using Uranyl nitrate hexahydrate.", [["U", "CHEMICAL", 111, 112], ["Uranyl nitrate", "CHEMICAL", 159, 173], ["Uranyl nitrate hexahydrate", "CHEMICAL", 159, 185], ["Uranyl nitrate hexahydrate", "SIMPLE_CHEMICAL", 159, 185], ["a 10-fold dilution series", "TREATMENT", 9, 34], ["U in concentrations", "TEST", 111, 130], ["Uranyl nitrate hexahydrate", "TREATMENT", 159, 185]]], ["Plates were incubated at 30\u00b0C and photographs were taken after 48 hours of growth to identify MIC against U.Physiological Response of Strain SRS-8-S-2018 in the Presence of Hg ::: Experimental SectionInoculum was prepared in LB broth with a single colony of strain SRS-8-S-2018, incubated at 30\u00b0C until OD600 reached 0.4.", [["colony", "ANATOMY", 248, 254], ["Hg", "CHEMICAL", 173, 175], ["Plates", "TEST", 0, 6], ["photographs", "TEST", 34, 45], ["Strain SRS", "TEST", 134, 144], ["strain SRS", "TEST", 258, 268]]], ["Then the cells were washed five times with 0.9% NaCl to eliminate any nutrients originating from previous growth in LB broth.", [["cells", "ANATOMY", 9, 14], ["NaCl", "CHEMICAL", 48, 52], ["NaCl", "CHEMICAL", 48, 52], ["cells", "CELL", 9, 14], ["the cells", "TREATMENT", 5, 14], ["0.9% NaCl", "TREATMENT", 43, 52], ["growth", "OBSERVATION_MODIFIER", 106, 112]]], ["This cell suspension (120 \u03bcl) was used as inoculum for establishing Biolog\u00ae EcoPlates\u2122, as suggested by the manufacturer (Biolog Inc., Hayward, CA, United States), such that, each well contained a cell concentration of 10\u20135, which was checked by microscopic evaluation of cell density.", [["cell", "ANATOMY", 5, 9], ["cell", "ANATOMY", 197, 201], ["cell", "ANATOMY", 272, 276], ["cell", "CELL", 5, 9], ["cell", "CELL", 197, 201], ["cell", "CELL", 272, 276], ["This cell suspension", "TREATMENT", 0, 20], ["a cell concentration", "TEST", 195, 215], ["microscopic evaluation", "TEST", 246, 268], ["cell density", "PROBLEM", 272, 284], ["suspension", "OBSERVATION_MODIFIER", 10, 20], ["cell density", "OBSERVATION", 272, 284]]], ["The Biolog\u00ae EcoPlates\u2122 consists of 96-well microtiter plates with three replicates of 31 common substrates utilized by soil microbiota, thus are ecologically relevant for microbial physiological and metabolic activity assessment (Preston-Mafham et al., 2002).", [["The Biolog\u00ae EcoPlates\u2122", "TEST", 0, 22], ["microbial physiological", "TEST", 171, 194], ["metabolic activity assessment", "TEST", 199, 228]]], ["A separate set of EcoPlates was established, containing Hg at 3 different concentrations to assess the strain\u2019s physiological response; these concentrations were 1, 3, and 5 \u03bcg/ml mercuric chloride, respectively.", [["Hg", "CHEMICAL", 56, 58], ["mercuric chloride", "CHEMICAL", 180, 197], ["Hg", "CHEMICAL", 56, 58], ["mercuric chloride", "CHEMICAL", 180, 197], ["EcoPlates", "SIMPLE_CHEMICAL", 18, 27], ["mercuric chloride", "SIMPLE_CHEMICAL", 180, 197], ["EcoPlates", "TEST", 18, 27]]], ["The resulting absorbance was measured via plate reader at 590 nm (spectrophotometer-SpectraMax-M5), every 24 h over a 20-day period.", [["The resulting absorbance", "PROBLEM", 0, 24], ["spectrophotometer-SpectraMax-M5", "TREATMENT", 66, 97], ["absorbance", "OBSERVATION_MODIFIER", 14, 24]]], ["Obtained data was then plotted using Microsoft Excel and further analyzed.", [["Microsoft Excel", "TEST", 37, 52]]], ["Average well color development obtained from the Biolog\u00ae EcoPlates\u2122 was estimated as shown before (Gamo and Shoji, 1999; Deng et al., 2011; Gryta et al., 2014).Phenotype Microarray (PM) Analysis on Strain SRS-8-S-2018 ::: Experimental SectionPhenotype MicroPlate\u2122 (PM) from Biolog is an array of 96 well microtiter plate, where each set of 4 wells contain the same antibiotic in increasing increments along with the needed minimal medium components and specific dye.", [["MicroPlate\u2122", "CHEMICAL", 252, 263], ["Phenotype Microarray", "TEST", 160, 180], ["Strain SRS", "TEST", 198, 208], ["an array", "TEST", 284, 292], ["the same antibiotic", "TREATMENT", 356, 375], ["minimal medium components", "TREATMENT", 423, 448], ["medium components", "OBSERVATION_MODIFIER", 431, 448]]], ["The arrays can provide resistance patterns against 41 antibiotics belonging to 10 different chemical classes, e.g., aminoglycosides, \u03b2-lactams, lincosamides, synthetic antibiotics, glycopeptides, tetracyclines, amphenicols, macrolides, sulfonamides, and rifamycins.", [["aminoglycosides", "CHEMICAL", 116, 131], ["\u03b2-lactams", "CHEMICAL", 133, 142], ["lincosamides", "CHEMICAL", 144, 156], ["tetracyclines", "CHEMICAL", 196, 209], ["amphenicols", "CHEMICAL", 211, 222], ["macrolides", "CHEMICAL", 224, 234], ["sulfonamides", "CHEMICAL", 236, 248], ["rifamycins", "CHEMICAL", 254, 264], ["aminoglycosides", "CHEMICAL", 116, 131], ["\u03b2-lactams", "CHEMICAL", 133, 142], ["lincosamides", "CHEMICAL", 144, 156], ["tetracyclines", "CHEMICAL", 196, 209], ["amphenicols", "CHEMICAL", 211, 222], ["macrolides", "CHEMICAL", 224, 234], ["sulfonamides", "CHEMICAL", 236, 248], ["rifamycins", "CHEMICAL", 254, 264], ["aminoglycosides", "SIMPLE_CHEMICAL", 116, 131], ["\u03b2-lactams", "SIMPLE_CHEMICAL", 133, 142], ["lincosamides", "SIMPLE_CHEMICAL", 144, 156], ["glycopeptides", "SIMPLE_CHEMICAL", 181, 194], ["tetracyclines", "SIMPLE_CHEMICAL", 196, 209], ["amphenicols", "SIMPLE_CHEMICAL", 211, 222], ["macrolides", "SIMPLE_CHEMICAL", 224, 234], ["sulfonamides", "SIMPLE_CHEMICAL", 236, 248], ["rifamycins", "SIMPLE_CHEMICAL", 254, 264], ["41 antibiotics", "TREATMENT", 51, 65], ["aminoglycosides", "TREATMENT", 116, 131], ["\u03b2-lactams", "TREATMENT", 133, 142], ["lincosamides", "TREATMENT", 144, 156], ["synthetic antibiotics", "TREATMENT", 158, 179], ["glycopeptides", "TREATMENT", 181, 194], ["tetracyclines", "TREATMENT", 196, 209], ["amphenicols", "TREATMENT", 211, 222], ["macrolides", "TREATMENT", 224, 234], ["sulfonamides", "TREATMENT", 236, 248], ["rifamycins", "TREATMENT", 254, 264]]], ["The antibiotic resistance of bacteria was assessed using Biolog PM11C and PM12B MicroPlate\u2122 plate assays, as suggested by the manufacturer; layout of antibiotics is as detailed by the manufacturer for the Biolog\u00ae EcoPlates\u2122 (Biolog Inc., Hayward, CA, United States)3.", [["The antibiotic resistance of bacteria", "TREATMENT", 0, 37], ["Biolog PM11C", "TEST", 57, 69], ["PM12B MicroPlate\u2122 plate assays", "TEST", 74, 104], ["antibiotics", "TREATMENT", 150, 161]]], ["To initiate the PM assay, strain SRS-8-S-2018 was grown overnight at 30\u00b0C on an LB agar medium.", [["SRS-8-S-2018", "CHEMICAL", 33, 45], ["SRS-8-S-2018", "CELL", 33, 45], ["the PM assay", "TEST", 12, 24], ["strain SRS", "TEST", 26, 36]]], ["A single colony was then picked and inoculated into 20 ml of the inoculating fluid [IF-10a GN Base inoculating fluid (1.2\u00d7), Biolog Inc.].", [["colony", "ANATOMY", 9, 15], ["fluid", "ANATOMY", 77, 82], ["A single colony", "TREATMENT", 0, 15], ["the inoculating fluid", "TREATMENT", 61, 82], ["10a GN Base inoculating fluid", "TREATMENT", 87, 116], ["colony", "OBSERVATION", 9, 15]]], ["Resulting cell density was measured by a plate reader according to the Biolog protocol (Biolog Inc., Hayward, CA, United States), followed by inoculation of the cell suspension into plates (100 \u03bcl/well) and incubated at 30\u00b0C for 36 hours.", [["cell", "ANATOMY", 10, 14], ["cell", "ANATOMY", 161, 165], ["cell", "CELL", 10, 14], ["cell", "CELL", 161, 165], ["Resulting cell density", "PROBLEM", 0, 22], ["the Biolog protocol", "TEST", 67, 86], ["the cell suspension into plates", "TREATMENT", 157, 188], ["cell density", "OBSERVATION", 10, 22]]], ["OD590 was collected every 15 min to determine color shifts resulting from microbial growth in the wells reflected of phenotypic differences and sensitivity/resistance to different antibiotics.", [["OD590", "SIMPLE_CHEMICAL", 0, 5], ["OD590", "DNA", 0, 5], ["color shifts", "PROBLEM", 46, 58], ["microbial growth in the wells", "PROBLEM", 74, 103], ["phenotypic differences", "PROBLEM", 117, 139], ["different antibiotics", "TREATMENT", 170, 191], ["microbial growth", "OBSERVATION", 74, 90]]], ["Collected data was organized and plotted in Microsoft Excel.Statistical Analysis of BIOLOG Data ::: Experimental SectionData obtained from Biolog\u00ae EcoPlates\u2122 over the 7-day period was analyzed using PRIMER v6 (PRIMER-E Ltd.).", [["Collected data", "TEST", 0, 14], ["PRIMER v6 (PRIMER-E Ltd", "TREATMENT", 199, 222]]], ["Statistical relationships were evaluated by running non-metric multi-dimensional scaling (NMDS) analysis, where the different concentrations of substrates utilized in the presence and absence of Hg amendments were log transformed [(Log (X + 1)], Hg treatments were used as variables, as appropriate and scaled by maximum data point.Nucleotide Sequence Accession Number ::: Experimental SectionThe Whole Genome Shotgun project of Serratia sp.", [["Hg", "CHEMICAL", 195, 197], ["Hg", "CHEMICAL", 195, 197], ["Hg", "CHEMICAL", 246, 248], ["Serratia sp", "ORGANISM", 429, 440], ["Hg treatments", "TREATMENT", 246, 259], ["Experimental Section", "TREATMENT", 373, 393], ["Serratia sp", "PROBLEM", 429, 440], ["Serratia", "OBSERVATION", 429, 437]]], ["SRS-8-S-2018 reported in this study has been deposited at DDBJ/ENA/GenBank under the Accession VHNF000000004; BioProject: PRJNA5500975; BioSample: SAMN121077176.", [["SRS", "TEST", 0, 3], ["this study", "TEST", 25, 35]]], ["The version described in this research is version VHNF00000000.1.Genomic Analysis of Strain Serratia sp.", [["Strain Serratia sp", "ORGANISM", 85, 103], ["Genomic Analysis", "TEST", 65, 81], ["Strain Serratia sp", "PROBLEM", 85, 103], ["Strain Serratia", "OBSERVATION", 85, 100]]], ["SRS-8-S-2018 ::: Experimental SectionTo understand the genomic characteristics of strain SRS-8-S-2018 in reference to MRGs and ARGs, a single colony of the bacterium growing on LB plate, amended with Hg, was inoculated into liquid LB media and incubated overnight at 30\u00b0C in a shaker at 100 rpm.", [["colony", "ANATOMY", 142, 148], ["Hg", "CHEMICAL", 200, 202], ["Hg", "CHEMICAL", 200, 202], ["MRGs", "CELL", 118, 122], ["ARGs", "SIMPLE_CHEMICAL", 127, 131], ["MRGs", "DNA", 118, 122], ["SRS", "TEST", 0, 3], ["strain SRS", "TEST", 82, 92], ["MRGs", "TEST", 118, 122], ["ARGs", "PROBLEM", 127, 131], ["the bacterium", "PROBLEM", 152, 165]]], ["After overnight growth, the media was centrifuged at 7,500 rpm for 5 min to obtain a pellet, which was then used for DNA extraction with ZR fungal/bacterial DNA kit (Zymo Research, Irvine, CA, United States) and sequenced using an Illumina HiSeq2000 instrument.", [["DNA", "CELLULAR_COMPONENT", 117, 120], ["DNA extraction", "TREATMENT", 117, 131], ["ZR fungal/bacterial DNA kit", "TREATMENT", 137, 164], ["an Illumina HiSeq2000 instrument", "TREATMENT", 228, 260]]], ["Default settings were used in all the genomic analysis, unless otherwise stated.Genomic Analysis of Strain Serratia sp.", [["Strain Serratia sp", "ORGANISM", 100, 118], ["Default settings", "TREATMENT", 0, 16], ["the genomic analysis", "TEST", 34, 54], ["Genomic Analysis", "TEST", 80, 96], ["Strain Serratia sp", "PROBLEM", 100, 118], ["Strain Serratia", "OBSERVATION", 100, 115]]], ["SRS-8-S-2018 ::: Experimental SectionTaxonomic affiliation was conducted using the Onecodex workflow (Minot et al., 2015), which is based on the identification of typically 17\u201331 bp short sequences, that are found unique to a specific taxa within the inputted sequence reads.", [["17\u201331 bp short sequences", "DNA", 173, 197], ["inputted sequence reads", "DNA", 251, 274], ["SRS", "TEST", 0, 3], ["bp short sequences", "TEST", 179, 197]]], ["Based on the collection of k-mers found in a given read, the whole genome sequence is then assigned to a taxon.", [["whole genome sequence", "DNA", 61, 82]]], ["Phylogenomic analysis was run using the default value of k = 31 for the taxonomic assessment of strain SRS-8-S-2018 using the Onecodex database.", [["Onecodex database", "DNA", 126, 143], ["Phylogenomic analysis", "TEST", 0, 21], ["the default value", "TEST", 36, 53], ["k", "TEST", 57, 58], ["the taxonomic assessment", "TEST", 68, 92], ["strain SRS", "TEST", 96, 106]]], ["To obtain a physical map of the genome, CGView Comparison Tool was used with default settings (Grant et al., 2012).", [["CGView", "DNA", 40, 46]]], ["The genome, with a 106\u00d7 coverage was annotated and the genes were predicted using Rapid Annotations using Subsystems Technology-RAST (Aziz et al., 2008), Prokaryotic Genomes Automatic Annotation Pipeline (PGAAP), version 2.0 (Tatusova et al., 2016), the Pathosystems Resource Integration Center (PATRIC, version 3.6.5) (Wattam et al., 2017) or Integrated Microbial Genomes (IMG) system (Chen et al., 2019).", [["a 106\u00d7 coverage", "TREATMENT", 17, 32], ["Subsystems Technology", "TEST", 106, 127]]], ["Average nucleotide identity (ANI), and average amino acid identity (AAI) was also obtained via EDGAR (Blom et al., 2009) and EzBioCloud pipelines (Yoon et al., 2017).", [["nucleotide", "CHEMICAL", 8, 18], ["amino acid", "CHEMICAL", 47, 57], ["nucleotide", "CHEMICAL", 8, 18], ["amino acid", "CHEMICAL", 47, 57], ["amino acid", "AMINO_ACID", 47, 57], ["average amino acid identity", "TEST", 39, 66]]], ["ANI is a measure of the genomic resemblance of two different bacterial species and typically, ANI values between genomes of the same species are 95% or beyond (Goris et al., 2007).Genomic Analysis of Strain Serratia sp.", [["ANI", "CHEMICAL", 0, 3], ["Strain Serratia sp", "ORGANISM", 200, 218], ["two different bacterial species", "PROBLEM", 47, 78], ["ANI values", "TEST", 94, 104], ["Genomic Analysis", "TEST", 180, 196], ["Strain Serratia sp", "PROBLEM", 200, 218], ["two different", "OBSERVATION_MODIFIER", 47, 60], ["bacterial species", "OBSERVATION", 61, 78], ["Strain Serratia", "OBSERVATION", 200, 215]]], ["SRS-8-S-2018 ::: Experimental SectionThe merR gene taxonomy in strain SRS-8-S-2018 was evaluated using comparative functions embedded within the PATRIC pipeline.", [["merR", "GENE_OR_GENE_PRODUCT", 41, 45], ["merR gene taxonomy", "DNA", 41, 59], ["PATRIC pipeline", "DNA", 145, 160], ["SRS", "TEST", 0, 3], ["Experimental Section", "TREATMENT", 17, 37], ["The merR gene taxonomy", "TEST", 37, 59], ["strain SRS", "TEST", 63, 73]]], ["Venn diagram and phylogenomic comparisons were obtained using the EDGAR pipeline, version 2.0 (Blom et al., 2009).", [["Venn diagram", "TEST", 0, 12], ["phylogenomic comparisons", "TEST", 17, 41]]], ["After EDGAR analysis, the Newick phylogenomic tree file was downloaded and an amino acid based tree was constructed using MEGAX (Wattam et al., 2017; Kumar et al., 2018).", [["amino acid", "CHEMICAL", 78, 88], ["amino acid", "CHEMICAL", 78, 88], ["amino acid", "AMINO_ACID", 78, 88], ["EDGAR", "DNA", 6, 11], ["EDGAR analysis", "TEST", 6, 20], ["an amino acid", "TEST", 75, 88]]], ["Island Viewer (Bertelli et al., 2017) was used to identify genomic islands (GEIs) (Yung et al., 2015), within the genome of SRS-8-S-2018.", [["genomic islands", "DNA", 59, 74], ["GEIs", "DNA", 76, 80], ["SRS", "DNA", 124, 127], ["8-S-2018", "DNA", 128, 136]]], ["Remnants of phage DNA, also called prophage, present in the whole genome sequence of SRS-8-S-2018 were located using the prophage hunter (Song et al., 2019).Isolation, Identification and Characterization of Metal Resistance Potential of Strain SRS-8-S-2018 ::: Results and DiscussionOur recent studies suggest that the metalliferous SRS soils may be serving as a reservoir for the recruitment and proliferation of metal and antimicrobial resistances in the native microbial communities (Agarwal et al., 2019, 2020a, 2020b; Gendy et al., 2020a, b; Pathak et al., 2020), thus presenting risks to the ecological processes and public health.", [["DNA", "CELLULAR_COMPONENT", 18, 21], ["phage DNA", "DNA", 12, 21], ["prophage", "DNA", 35, 43], ["whole genome sequence", "DNA", 60, 81], ["SRS-8-S-2018", "DNA", 85, 97], ["phage DNA", "PROBLEM", 12, 21], ["SRS", "TEST", 85, 88], ["DiscussionOur recent studies", "TEST", 273, 301], ["the metalliferous SRS soils", "PROBLEM", 315, 342], ["a reservoir", "TREATMENT", 361, 372], ["the recruitment and proliferation of metal and antimicrobial resistances", "TREATMENT", 377, 449], ["phage DNA", "OBSERVATION_MODIFIER", 12, 21], ["antimicrobial resistances", "OBSERVATION", 424, 449]]], ["Overall, this study further builds upon evidence to show that the SRS contaminated soils inherently harbor higher antibiotic resistance, relative to the reference soils, and thus driving antimicrobial resistance to the native microbiota, including several known pathogens (e.g., Burkholderia, Ralstonia, Massilia, Acinetobacter, and Pseudomonas (Stepanauskas et al., 2006; Wright et al., 2006; Thomas et al., 2020).", [["this study", "TEST", 9, 19], ["the SRS contaminated soils inherently harbor higher antibiotic resistance", "PROBLEM", 62, 135], ["several known pathogens", "PROBLEM", 248, 271], ["Burkholderia", "PROBLEM", 279, 291], ["Ralstonia", "PROBLEM", 293, 302], ["Massilia", "PROBLEM", 304, 312], ["Acinetobacter", "PROBLEM", 314, 327], ["Pseudomonas", "PROBLEM", 333, 344], ["antibiotic resistance", "OBSERVATION", 114, 135], ["pathogens", "OBSERVATION", 262, 271], ["Massilia", "ANATOMY", 304, 312], ["Pseudomonas", "OBSERVATION_MODIFIER", 333, 344]]], ["To assess if carriage of metal resistant genes (MRGs), and antibiotic resistant genes (ARGS) is a rampantly widespread trait, especially within opportunistic bacteria native to the SRS soils, this study was conducted on soils collected from a different site (101), relative to that reported by our group recently (Pathak et al., 2020).", [["metal", "CHEMICAL", 25, 30], ["metal resistant genes", "DNA", 25, 46], ["MRGs", "DNA", 48, 52], ["antibiotic resistant genes", "DNA", 59, 85], ["ARGS", "DNA", 87, 91], ["metal resistant genes (MRGs)", "PROBLEM", 25, 53], ["antibiotic resistant genes", "PROBLEM", 59, 85], ["a rampantly widespread trait", "PROBLEM", 96, 124], ["opportunistic bacteria", "PROBLEM", 144, 166], ["this study", "TEST", 192, 202]]], ["Specifically, soils from a highly contaminated site- SRS 101 were serially diluted and spread plated onto LB agar plates supplemented with 5 \u03bcg/ml mercuric chloride.", [["mercuric chloride", "CHEMICAL", 147, 164], ["mercuric chloride", "CHEMICAL", 147, 164], ["mercuric chloride", "SIMPLE_CHEMICAL", 147, 164], ["SRS 101", "DNA", 53, 60], ["a highly contaminated site", "PROBLEM", 25, 51], ["SRS", "TEST", 53, 56], ["LB agar plates", "TREATMENT", 106, 120]]], ["Site 101 has been shown to be co-contaminated with a variety of different heavy metals, such as Hg and U (Edwards et al., 2014).", [["Hg", "CHEMICAL", 96, 98], ["Hg", "CHEMICAL", 96, 98]]], ["Plates were incubated at 30\u00b0C, for 48 hours and colonies that appeared on the plates were further purified resulting in a vigorous Hg-resistant (HgR) strain, labeled as SRS-8-S-2018.", [["colonies", "ANATOMY", 48, 56], ["Hg", "CHEMICAL", 131, 133], ["Hg", "CHEMICAL", 131, 133], ["Plates", "TEST", 0, 6], ["colonies", "PROBLEM", 48, 56], ["a vigorous Hg-resistant (HgR) strain", "PROBLEM", 120, 156], ["SRS", "TEST", 169, 172]]], ["Identification of the isolated strain using 16S rRNA gene sequencing revealed closest taxonomic affiliation with S. marcescens (Gendy et al., 2020b).", [["S. marcescens", "ORGANISM", 113, 126], ["16S rRNA gene", "DNA", 44, 57], ["S. marcescens", "SPECIES", 113, 126], ["S. marcescens", "SPECIES", 113, 126], ["the isolated strain", "PROBLEM", 18, 37], ["16S rRNA gene sequencing", "TEST", 44, 68], ["S. marcescens", "PROBLEM", 113, 126], ["taxonomic affiliation", "OBSERVATION", 86, 107]]], ["Specifically, phylogenomic analysis, as stated later in this study, revealed 71.62% of obtained genome reads affiliated with S. marcescens (Figure 1A); at the species level, 33% of the reads belonged to S. marcescens strain WW4, followed by 29% of S. marcescens strain EGD-HP20 (Figure 1B).Isolation, Identification and Characterization of Metal Resistance Potential of Strain SRS-8-S-2018 ::: Results and DiscussionTo determine the resistance potential of strain SRS-8-S-2018 against Hg, the bacteria was grown in LB broth, supplemented with different concentrations of Hg; these results were presented in our recent study (Gendy et al., 2020b).", [["SRS-8-S-2018", "CHEMICAL", 464, 476], ["Hg", "CHEMICAL", 485, 487], ["Hg", "CHEMICAL", 571, 573], ["Hg", "CHEMICAL", 485, 487], ["Hg", "CHEMICAL", 571, 573], ["S. marcescens", "ORGANISM", 125, 138], ["Figure 1A", "ORGANISM", 140, 149], ["S. marcescens strain", "ORGANISM", 203, 223], ["WW4", "ORGANISM", 224, 227], ["S. marcescens", "ORGANISM", 248, 261], ["strain", "ORGANISM", 262, 268], ["Hg", "SIMPLE_CHEMICAL", 485, 487], ["S. marcescens", "SPECIES", 125, 138], ["S. marcescens", "SPECIES", 203, 216], ["S. marcescens", "SPECIES", 248, 261], ["S. marcescens", "SPECIES", 125, 138], ["S. marcescens", "SPECIES", 203, 216], ["S. marcescens strain EGD-HP20", "SPECIES", 248, 277], ["phylogenomic analysis", "TEST", 14, 35], ["this study", "TEST", 56, 66], ["S. marcescens", "PROBLEM", 125, 138], ["the species level", "TEST", 155, 172], ["S. marcescens strain", "TEST", 203, 223], ["S. marcescens strain EGD", "TEST", 248, 272], ["HP20", "TEST", 273, 277], ["Strain SRS", "TEST", 370, 380], ["strain SRS", "TEST", 457, 467], ["Hg", "TEST", 485, 487], ["the bacteria", "PROBLEM", 489, 501]]], ["It was observed that strain SRS-8-S-2018 could resist up to 10 \u03bcg/ml Hg, which revealed a strong Hg resistance (HgR) phenotype of strain SRS-8-S-2018.", [["SRS-8-S-2018", "CHEMICAL", 28, 40], ["Hg", "CHEMICAL", 69, 71], ["Hg", "CHEMICAL", 97, 99], ["Hg", "CHEMICAL", 69, 71], ["Hg", "CHEMICAL", 97, 99], ["strain SRS", "TEST", 21, 31], ["Hg", "TEST", 69, 71], ["a strong Hg resistance", "PROBLEM", 88, 110], ["strain SRS", "TEST", 130, 140]]], ["To test for resistance against uranium (U), a plate MIC method was used, which showed resistance of strain SRS-8-S-2018 at 2, 4, and 5 mM but strain was sensitive at 6 mM U, respectively (Figure 2).", [["uranium", "CHEMICAL", 31, 38], ["U", "CHEMICAL", 40, 41], ["SRS-8-S-2018", "CHEMICAL", 107, 119], ["uranium", "CHEMICAL", 31, 38], ["uranium", "SIMPLE_CHEMICAL", 31, 38], ["U", "SIMPLE_CHEMICAL", 40, 41], ["a plate MIC method", "TEST", 44, 62], ["strain SRS", "TEST", 100, 110], ["strain", "PROBLEM", 142, 148]]], ["Note that S. marcescens has previously been shown to be resistant to U under both aerobic and anaerobic environments (Kumar et al., 2011; Choudhary et al., 2012; Nongkhlaw et al., 2012; Newsome et al., 2015).", [["U", "CHEMICAL", 69, 70], ["S. marcescens", "ORGANISM", 10, 23], ["S. marcescens", "SPECIES", 10, 23], ["S. marcescens", "SPECIES", 10, 23], ["S. marcescens", "PROBLEM", 10, 23]]], ["To further understand the Hg and U-resistant ability of this strain, physiological and genomic studies were then performed.Physiological Response of Serratia marcescens Strain SRS-8-S-2018 in the Absence and Presence of Hg Amendments ::: Results and DiscussionBiolog\u00ae EcoPlates\u2122, containing 31 distinct nutrient sources, was used to evaluate the metabolic and physiological response of strain SRS-8-S-2018 in the absence and presence of Hg amendments, as a representative heavy metal contaminant.", [["Hg", "CHEMICAL", 26, 28], ["U", "CHEMICAL", 33, 34], ["SRS-8-S-2018", "CHEMICAL", 393, 405], ["Hg", "CHEMICAL", 437, 439], ["Hg", "CHEMICAL", 26, 28], ["Hg", "CHEMICAL", 220, 222], ["Hg", "CHEMICAL", 437, 439], ["Serratia marcescens", "ORGANISM", 149, 168], ["Serratia marcescens", "SPECIES", 149, 168], ["Serratia marcescens", "SPECIES", 149, 168], ["this strain", "PROBLEM", 56, 67], ["genomic studies", "TEST", 87, 102], ["Serratia marcescens Strain SRS", "TEST", 149, 179], ["strain SRS", "TEST", 386, 396], ["Hg amendments", "PROBLEM", 437, 450], ["a representative heavy metal contaminant", "PROBLEM", 455, 495], ["Serratia marcescens", "OBSERVATION", 149, 168]]], ["The cellular response in this assay was monitored as a function of color change of the tetrazolium salt when substrates in each well are utilized by cellular respiration, resulting in the production of a purple formazan dye.", [["cellular", "ANATOMY", 4, 12], ["cellular", "ANATOMY", 149, 157], ["tetrazolium", "CHEMICAL", 87, 98], ["formazan", "CHEMICAL", 211, 219], ["tetrazolium", "CHEMICAL", 87, 98], ["formazan", "CHEMICAL", 211, 219], ["cellular", "CELL", 4, 12], ["tetrazolium salt", "SIMPLE_CHEMICAL", 87, 103], ["cellular", "CELL", 149, 157], ["formazan dye", "SIMPLE_CHEMICAL", 211, 223], ["this assay", "TEST", 25, 35], ["the tetrazolium salt", "TREATMENT", 83, 103], ["a purple formazan dye", "PROBLEM", 202, 223], ["cellular", "OBSERVATION_MODIFIER", 4, 12], ["response", "OBSERVATION_MODIFIER", 13, 21], ["cellular respiration", "OBSERVATION", 149, 169], ["purple", "OBSERVATION_MODIFIER", 204, 210], ["formazan dye", "OBSERVATION", 211, 223]]], ["Higher the substrate utilization, the more intense the color of the formazan produced and by inference, metabolic activity of the cell.", [["cell", "ANATOMY", 130, 134], ["formazan", "CHEMICAL", 68, 76], ["formazan", "CHEMICAL", 68, 76], ["formazan", "SIMPLE_CHEMICAL", 68, 76], ["cell", "CELL", 130, 134], ["intense", "OBSERVATION_MODIFIER", 43, 50], ["metabolic activity", "OBSERVATION", 104, 122], ["cell", "ANATOMY", 130, 134]]], ["Kinetic growth response curves were obtained for each growth substrate and plotted to assess cellular phenotype comparisons by calculation of the average well color development (AWCD), which revealed that Serratia sp.", [["cellular", "ANATOMY", 93, 101], ["cellular", "CELL", 93, 101], ["Serratia sp", "ORGANISM", 205, 216], ["Kinetic growth response curves", "TEST", 0, 30], ["each growth substrate", "TEST", 49, 70], ["Serratia sp", "PROBLEM", 205, 216], ["Serratia", "OBSERVATION", 205, 213]]], ["SRS-8-S-2018 utilized different sources of carbon in the following order carbohydrates > polymers > amino acids > carboxy acids > esters (Figure 3A), respectively.", [["SRS-8-S-2018", "CHEMICAL", 0, 12], ["carbon", "CHEMICAL", 43, 49], ["amino acids", "CHEMICAL", 100, 111], ["carboxy acids", "CHEMICAL", 114, 127], ["carbon", "CHEMICAL", 43, 49], ["carbohydrates", "CHEMICAL", 73, 86], ["amino acids", "CHEMICAL", 100, 111], ["carboxy acids", "CHEMICAL", 114, 127], ["esters", "CHEMICAL", 130, 136], ["carbon", "SIMPLE_CHEMICAL", 43, 49], ["carbohydrates", "SIMPLE_CHEMICAL", 73, 86], ["polymers > amino acids", "SIMPLE_CHEMICAL", 89, 111], ["carboxy acids > esters", "SIMPLE_CHEMICAL", 114, 136], ["SRS", "TEST", 0, 3], ["carbon", "TREATMENT", 43, 49], ["carbohydrates", "TEST", 73, 86], ["polymers", "TEST", 89, 97], ["amino acids", "TEST", 100, 111], ["carboxy acids", "TEST", 114, 127]]], ["Esters initially were preferred over carboxy acids and amino acids but after 3 days, the above stated trend held up until the experiment ended at 20 days.", [["carboxy acids", "CHEMICAL", 37, 50], ["amino acids", "CHEMICAL", 55, 66], ["carboxy acids", "CHEMICAL", 37, 50], ["amino acids", "CHEMICAL", 55, 66], ["Esters", "SIMPLE_CHEMICAL", 0, 6], ["carboxy acids", "SIMPLE_CHEMICAL", 37, 50], ["amino acids", "AMINO_ACID", 55, 66], ["carboxy acids", "TREATMENT", 37, 50], ["amino acids", "TREATMENT", 55, 66]]], ["Specific to different carbon sources, it was found that strain SRS-8-S-2018 preferred the following carbon substrates: Specific to different carbon sources, it was found that strain SRS-8-S-2018 preferred the following carbon substrates: D-Mannitol, i-Erythritol, \u03b3-Amino Butyric Acid, L-Asparagine, N-Acetyl-D-Glucosamine, and Tween 40 (data not shown).Physiological Response of Serratia marcescens Strain SRS-8-S-2018 in the Absence and Presence of Hg Amendments ::: Results and DiscussionTo understand how Hg stress may impact metabolic potential, growth of strain SRS-8-S-2018 was evaluated in the presence of increasing concentrations of Hg, which showed that at both, 1 and 3 \u03bcg/ml Hg concentrations, the strain\u2019s metabolic potential (AWCD) became inhibited; the strain started to use substrates after a lag of almost 12 days (Figure 3B).", [["SRS-8-S-2018", "CHEMICAL", 63, 75], ["SRS-8-S-2018", "CHEMICAL", 182, 194], ["D-Mannitol", "CHEMICAL", 238, 248], ["i-Erythritol", "CHEMICAL", 250, 262], ["\u03b3-Amino Butyric Acid", "CHEMICAL", 264, 284], ["L-Asparagine", "CHEMICAL", 286, 298], ["N-Acetyl-D-Glucosamine", "CHEMICAL", 300, 322], ["Hg", "CHEMICAL", 509, 511], ["SRS-8-S-2018", "CHEMICAL", 568, 580], ["Hg", "CHEMICAL", 643, 645], ["Hg", "CHEMICAL", 688, 690], ["carbon", "CHEMICAL", 22, 28], ["carbon", "CHEMICAL", 100, 106], ["carbon", "CHEMICAL", 141, 147], ["carbon", "CHEMICAL", 219, 225], ["D-Mannitol", "CHEMICAL", 238, 248], ["i-Erythritol", "CHEMICAL", 250, 262], ["\u03b3-Amino Butyric Acid", "CHEMICAL", 264, 284], ["L-Asparagine", "CHEMICAL", 286, 298], ["N-Acetyl-D-Glucosamine", "CHEMICAL", 300, 322], ["Tween 40", "CHEMICAL", 328, 336], ["Hg", "CHEMICAL", 451, 453], ["Hg", "CHEMICAL", 509, 511], ["Hg", "CHEMICAL", 643, 645], ["Hg", "CHEMICAL", 688, 690], ["D-Mannitol", "SIMPLE_CHEMICAL", 238, 248], ["i-Erythritol", "SIMPLE_CHEMICAL", 250, 262], ["\u03b3-Amino Butyric Acid", "SIMPLE_CHEMICAL", 264, 284], ["L-Asparagine", "SIMPLE_CHEMICAL", 286, 298], ["N-Acetyl-D-Glucosamine", "SIMPLE_CHEMICAL", 300, 322], ["Tween 40", "SIMPLE_CHEMICAL", 328, 336], ["Serratia marcescens", "ORGANISM", 380, 399], ["Hg", "SIMPLE_CHEMICAL", 509, 511], ["Hg", "SIMPLE_CHEMICAL", 643, 645], ["Serratia marcescens", "SPECIES", 380, 399], ["Serratia marcescens", "SPECIES", 380, 399], ["strain SRS", "TEST", 56, 66], ["strain SRS", "TEST", 175, 185], ["Mannitol", "TREATMENT", 240, 248], ["i-Erythritol", "TREATMENT", 250, 262], ["Amino Butyric Acid", "TREATMENT", 266, 284], ["L-Asparagine", "TREATMENT", 286, 298], ["Acetyl", "TREATMENT", 302, 308], ["Glucosamine", "TREATMENT", 311, 322], ["Serratia marcescens Strain SRS", "TEST", 380, 410], ["strain SRS", "TEST", 561, 571], ["increasing concentrations of Hg", "PROBLEM", 614, 645], ["the strain", "PROBLEM", 707, 717], ["the strain", "PROBLEM", 765, 775], ["carbon sources", "OBSERVATION", 22, 36], ["Serratia marcescens", "OBSERVATION", 380, 399]]], ["However, at an Hg concentration of 5 \u03bcg/ml, the strain was unable to utilize any of the carbon substrates, despite the strain\u2019s potential to resist up to 10 \u03bcg/ml Hg based on MIC values (Gendy et al., 2020b).", [["Hg", "CHEMICAL", 15, 17], ["Hg", "CHEMICAL", 163, 165], ["Hg", "CHEMICAL", 15, 17], ["carbon", "CHEMICAL", 88, 94], ["Hg", "CHEMICAL", 163, 165], ["an Hg concentration", "TREATMENT", 12, 31], ["the carbon substrates", "TREATMENT", 84, 105], ["MIC values", "TEST", 175, 185]]], ["This difference in the MIC and physiological activity response in the presence of Hg amendments can be explained on the basis that the higher MIC in LB broth, which is a richer nutrient source relative to those present in the Biolog\u00ae EcoPlates\u2122.", [["Hg", "CHEMICAL", 82, 84], ["MIC", "CHEMICAL", 142, 145], ["Hg", "CHEMICAL", 82, 84], ["the MIC", "TEST", 19, 26], ["Hg amendments", "TREATMENT", 82, 95], ["the higher MIC in LB broth", "PROBLEM", 131, 157], ["activity", "OBSERVATION_MODIFIER", 45, 53]]], ["Regardless, this extensive physiological characterization demonstrated that Serratia sp.", [["Serratia sp", "ORGANISM", 76, 87], ["this extensive physiological characterization", "TEST", 12, 57], ["Serratia sp", "PROBLEM", 76, 87], ["Serratia", "OBSERVATION", 76, 84]]], ["SRS-8-S-2018 used an average of 55.84% of the 31 different nutrient sources tested without Hg stress (Table 1); conversely, in the presence of 1 \u03bcg/ml Hg, this response became inhibited at 45.16% of total substrates; at 3 \u03bcg/ml Hg even fewer substrates were utilized- at an average of 32.25%, while at a concentration of 5 \u03bcg/ml Hg, total physiological activity of the Hg-resistant strain ceased (Figure 3B and Table 1), despite the robust Hg resistance ability of SRS-8-S-2018.", [["Hg", "CHEMICAL", 91, 93], ["Hg", "CHEMICAL", 151, 153], ["Hg", "CHEMICAL", 228, 230], ["Hg", "CHEMICAL", 329, 331], ["Hg", "CHEMICAL", 369, 371], ["Hg", "CHEMICAL", 440, 442], ["Hg", "CHEMICAL", 91, 93], ["Hg", "CHEMICAL", 151, 153], ["Hg", "CHEMICAL", 228, 230], ["Hg", "CHEMICAL", 329, 331], ["Hg", "CHEMICAL", 369, 371], ["Hg", "CHEMICAL", 440, 442], ["Hg", "SIMPLE_CHEMICAL", 369, 371], ["SRS-8-S-2018", "SIMPLE_CHEMICAL", 465, 477], ["SRS", "TEST", 0, 3], ["Hg stress", "PROBLEM", 91, 100], ["total substrates", "TREATMENT", 199, 215], ["the Hg", "TEST", 365, 371], ["resistant strain", "PROBLEM", 372, 388], ["SRS", "TEST", 465, 468]]], ["Interestingly, the utilization rates of amino acids, such as L-Asparagine, L-Alanine, and L-Serine, relative to other substrates significantly decreased upon exposure across all treatments (data not shown), most likely due to binding of Hg to amino acids which reduces their availability and hence physiological activity.", [["amino acids", "CHEMICAL", 40, 51], ["L-Asparagine", "CHEMICAL", 61, 73], ["L-Alanine", "CHEMICAL", 75, 84], ["L-Serine", "CHEMICAL", 90, 98], ["Hg", "CHEMICAL", 237, 239], ["amino acids", "CHEMICAL", 243, 254], ["amino acids", "CHEMICAL", 40, 51], ["L-Asparagine", "CHEMICAL", 61, 73], ["L-Alanine", "CHEMICAL", 75, 84], ["L-Serine", "CHEMICAL", 90, 98], ["Hg", "CHEMICAL", 237, 239], ["amino acids", "CHEMICAL", 243, 254], ["amino acids", "AMINO_ACID", 40, 51], ["L-Asparagine", "SIMPLE_CHEMICAL", 61, 73], ["L-Alanine", "SIMPLE_CHEMICAL", 75, 84], ["L-Serine", "SIMPLE_CHEMICAL", 90, 98], ["amino acids", "AMINO_ACID", 243, 254], ["amino acids", "TREATMENT", 40, 51], ["L-Asparagine", "TREATMENT", 61, 73], ["L-Alanine", "TREATMENT", 75, 84], ["L-Serine", "TREATMENT", 90, 98], ["all treatments", "TREATMENT", 174, 188], ["amino acids", "TREATMENT", 243, 254]]], ["It could also be that metabolic pathways for the utilization of these amino acids are hampered by Hg toxicity.", [["amino acids", "CHEMICAL", 70, 81], ["Hg", "CHEMICAL", 98, 100], ["toxicity", "DISEASE", 101, 109], ["amino acids", "CHEMICAL", 70, 81], ["Hg", "CHEMICAL", 98, 100], ["amino acids", "AMINO_ACID", 70, 81], ["Hg", "SIMPLE_CHEMICAL", 98, 100], ["these amino acids", "TREATMENT", 64, 81], ["Hg toxicity", "PROBLEM", 98, 109]]], ["It has been well-established that mercury, the most toxic heavy metal toxicity, is mainly owed to its high degree of affinity to the sulfhydryl ligands in amino acids, binding to which causes alteration in protein structure along with loss of protein function.", [["mercury", "CHEMICAL", 34, 41], ["toxicity", "DISEASE", 70, 78], ["sulfhydryl", "CHEMICAL", 133, 143], ["amino acids", "CHEMICAL", 155, 166], ["mercury", "CHEMICAL", 34, 41], ["sulfhydryl", "CHEMICAL", 133, 143], ["amino acids", "CHEMICAL", 155, 166], ["mercury", "SIMPLE_CHEMICAL", 34, 41], ["sulfhydryl", "SIMPLE_CHEMICAL", 133, 143], ["amino acids", "AMINO_ACID", 155, 166], ["the most toxic heavy metal toxicity", "PROBLEM", 43, 78], ["the sulfhydryl ligands", "TREATMENT", 129, 151], ["amino acids", "TEST", 155, 166], ["alteration in protein structure", "PROBLEM", 192, 223], ["loss of protein function", "PROBLEM", 235, 259], ["most", "OBSERVATION_MODIFIER", 47, 51], ["toxic", "OBSERVATION_MODIFIER", 52, 57], ["heavy", "OBSERVATION_MODIFIER", 58, 63], ["metal toxicity", "OBSERVATION", 64, 78], ["high degree", "OBSERVATION_MODIFIER", 102, 113], ["amino acids", "OBSERVATION", 155, 166], ["protein structure", "OBSERVATION", 206, 223], ["protein function", "OBSERVATION", 243, 259]]], ["Overall, this part of the study suggests that Hg can interfere with the bacterial physiological response, even on an organism that is resistant to Hg.", [["Hg", "CHEMICAL", 46, 48], ["Hg.", "CHEMICAL", 147, 150], ["Hg", "CHEMICAL", 46, 48], ["Hg", "SIMPLE_CHEMICAL", 46, 48], ["the study", "TEST", 22, 31], ["the bacterial physiological response", "PROBLEM", 68, 104], ["an organism", "PROBLEM", 114, 125]]], ["Therefore, continued addition of Hg can have detrimental impacts to microbially mediated ecosystem services, such as biogeochemical cycling of nutrients.", [["Hg", "CHEMICAL", 33, 35], ["Hg", "CHEMICAL", 33, 35], ["Hg", "SIMPLE_CHEMICAL", 33, 35], ["Hg", "TREATMENT", 33, 35], ["microbially mediated ecosystem services", "TREATMENT", 68, 107], ["biogeochemical cycling of nutrients", "TREATMENT", 117, 152]]], ["This is a significant finding from an environmental standpoint, which has not been demonstrated before, to our knowledge.Physiological Response of Serratia marcescens Strain SRS-8-S-2018 in the Absence and Presence of Hg Amendments ::: Results and DiscussionStatistical analysis of the strain\u2019s physiological response to Hg amendment was assessed using Primer v6, which is shown in Figure 3C.", [["Hg", "CHEMICAL", 321, 323], ["Hg", "CHEMICAL", 218, 220], ["Hg", "CHEMICAL", 321, 323], ["Serratia marcescens", "ORGANISM", 147, 166], ["Primer v6", "DNA", 353, 362], ["Serratia marcescens", "SPECIES", 147, 166], ["Serratia marcescens", "SPECIES", 147, 166], ["Serratia marcescens Strain SRS", "TEST", 147, 177], ["the strain", "PROBLEM", 282, 292], ["Hg amendment", "TEST", 321, 333], ["significant", "OBSERVATION_MODIFIER", 10, 21], ["Serratia marcescens", "OBSERVATION", 147, 166]]], ["Cluster analysis clearly showed that in the absence of Hg, the strain\u2019s metabolic activity was statistically different relative to Hg treatments.", [["Hg", "CHEMICAL", 55, 57], ["Hg", "CHEMICAL", 131, 133], ["Hg", "CHEMICAL", 55, 57], ["Hg", "CHEMICAL", 131, 133], ["Cluster analysis", "TEST", 0, 16], ["the strain", "PROBLEM", 59, 69], ["Hg treatments", "TREATMENT", 131, 144]]], ["Specifically, the metabolic activity profiles at 1 \u03bcg/ml Hg and 3 \u03bcg/ml Hg clustered together and away from the highest tested concentration of 5 \u03bcg/ml Hg, mirroring the trends shown in Figures 3A,B. This confirms the observation that Hg can interfere with the physiological and metabolic response, even in an organism that harbors Hg resistance.", [["Hg", "CHEMICAL", 57, 59], ["Hg", "CHEMICAL", 72, 74], ["Hg", "CHEMICAL", 235, 237], ["Hg", "CHEMICAL", 332, 334], ["Hg", "CHEMICAL", 57, 59], ["Hg", "CHEMICAL", 72, 74], ["Hg", "CHEMICAL", 152, 154], ["Hg", "CHEMICAL", 235, 237], ["Hg", "CHEMICAL", 332, 334], ["B", "GENE_OR_GENE_PRODUCT", 197, 198], ["Hg", "SIMPLE_CHEMICAL", 235, 237], ["the metabolic activity profiles", "TEST", 14, 45], ["Hg", "TEST", 57, 59], ["metabolic activity", "OBSERVATION", 18, 36], ["metabolic response", "OBSERVATION", 279, 297], ["Hg resistance", "OBSERVATION", 332, 345]]], ["Therefore, continued addition of Hg will likely have significant detrimental impacts to microbially mediated nutrient cycling processes; even to those microorganisms that have developed tolerance/resistance against heavy metals, such as Hg.", [["Hg", "CHEMICAL", 33, 35], ["Hg.", "CHEMICAL", 237, 240], ["Hg", "CHEMICAL", 33, 35], ["Hg", "SIMPLE_CHEMICAL", 33, 35], ["Hg", "TREATMENT", 33, 35], ["microbially mediated nutrient cycling processes", "PROBLEM", 88, 135]]], ["Arguably, microbiota that are unsuccessful in the recruitment of resistant gene determinants against heavy metals will have likely been removed from a contaminated soil habitat and ecosystem services rendered by the outcompeted bacteria are either lost, diminished or taken over by the surviving metal resistant bacteria.", [["heavy metals", "PROBLEM", 101, 113], ["a contaminated soil habitat", "TREATMENT", 149, 176], ["ecosystem services", "TREATMENT", 181, 199], ["the outcompeted bacteria", "PROBLEM", 212, 236], ["the surviving metal resistant bacteria", "PROBLEM", 282, 320], ["diminished", "OBSERVATION_MODIFIER", 254, 264]]], ["To further understand the gene determinants for heavy metal resistance, genomic studies were performed on strain SRS-8-S-2018.Genome-Centric Assessment of Serratia marcescens Strain SRS-8-S-2018 ::: Results and DiscussionGenomic sequences of strain SRS-8-S-2018, with a coverage of 106\u00d7 were obtained (Gendy et al., 2020b), and characterized by the following parameters: contig count (159); total length (5,323,630 bp); N50 (101301 bases); L50 (17); an average GC content of 59.48%; a coding sequence of 5,261 proteins (CDS) and 55 genes for transfer RNA (tRNA) and 3 genes for rRNA, respectively.", [["Serratia marcescens", "ORGANISM", 155, 174], ["N50", "DNA", 420, 423], ["L50", "DNA", 440, 443], ["5,261 proteins", "DNA", 504, 518], ["CDS", "DNA", 520, 523], ["transfer RNA", "RNA", 542, 554], ["tRNA", "RNA", 556, 560], ["Serratia marcescens", "SPECIES", 155, 174], ["Serratia marcescens", "SPECIES", 155, 174], ["heavy metal resistance", "PROBLEM", 48, 70], ["genomic studies", "TEST", 72, 87], ["strain SRS", "TEST", 106, 116], ["Serratia marcescens Strain SRS", "TEST", 155, 185], ["strain SRS", "TEST", 242, 252], ["a coverage", "TEST", 268, 278], ["contig count", "TEST", 371, 383], ["total length", "TEST", 391, 403], ["bp", "TEST", 415, 417], ["N50", "TEST", 420, 423], ["bases", "TEST", 432, 437], ["an average GC content", "TEST", 450, 471], ["a coding sequence", "TEST", 483, 500], ["CDS", "TEST", 520, 523], ["tRNA", "TEST", 556, 560]]], ["Figure 4 shows a circular genomic map of strain SRS-8-S-2018 constructed with CGView Comparison Tool.", [["Figure", "TEST", 0, 6], ["strain SRS", "TEST", 41, 51]]], ["Gene prediction performed using PATRIC, RAST and NCBI pipelines revealed that strain SRS-8-S-2018 harbored a total of 5095 protein coding genes; 80.29% of these genes were annotated as protein coding genes with predicted functions; 27.68% genes were annotated as protein coding genes with enzyme production and 31.14% genes were associated with KEGG pathways, respectively.", [["PATRIC, RAST and NCBI pipelines", "DNA", 32, 63], ["5095 protein coding genes", "DNA", 118, 143], ["protein coding genes", "DNA", 185, 205], ["27.68% genes", "DNA", 232, 244], ["protein coding genes", "DNA", 263, 283], ["Gene prediction", "TEST", 0, 15], ["NCBI pipelines", "TEST", 49, 63], ["strain SRS", "TEST", 78, 88], ["protein coding genes", "TEST", 263, 283], ["enzyme production", "TEST", 289, 306], ["KEGG pathways", "TEST", 345, 358]]], ["Moreover, 82.17% of the protein coding genes were annotated with COGs, i.e., clusters of orthologous groups of protein; COGs represent an ortholog or direct evolutionary counterpart among bacterial genomes as they evolve over time.Genome-Centric Assessment of Serratia marcescens Strain SRS-8-S-2018 ::: Results and DiscussionAs stated before, phylogenomic analysis of strain SRS-8-S-2018 relative to other sequenced Serratia species revealed closest taxonomic affiliation with Serratia species and other genera, such as Salmonella (Figure 1A).", [["Serratia marcescens", "ORGANISM", 260, 279], ["Serratia species", "ORGANISM", 417, 433], ["Serratia species", "ORGANISM", 478, 494], ["protein coding genes", "DNA", 24, 44], ["COGs", "DNA", 120, 124], ["bacterial genomes", "DNA", 188, 205], ["Serratia marcescens", "SPECIES", 260, 279], ["Serratia marcescens", "SPECIES", 260, 279], ["the protein coding genes", "TEST", 20, 44], ["COGs", "TEST", 65, 69], ["orthologous groups of protein", "PROBLEM", 89, 118], ["COGs", "PROBLEM", 120, 124], ["an ortholog", "PROBLEM", 135, 146], ["bacterial genomes", "PROBLEM", 188, 205], ["Serratia marcescens", "PROBLEM", 260, 279], ["phylogenomic analysis", "TEST", 344, 365], ["strain SRS", "TEST", 369, 379], ["Serratia species", "PROBLEM", 417, 433], ["Serratia species", "PROBLEM", 478, 494], ["other genera", "PROBLEM", 499, 511], ["Salmonella", "PROBLEM", 521, 531], ["bacterial genomes", "OBSERVATION", 188, 205], ["taxonomic affiliation", "OBSERVATION", 451, 472], ["Serratia species", "OBSERVATION", 478, 494]]], ["Specifically, onecodex analysis resulted in the assignment of 33% contigs from strain SRS-8-S-2018 to S. marcescens WW4, followed by 29% to S. marcescens EGD-HP20 and 14% with S. marcescens subsp.", [["S. marcescens WW4", "ORGANISM", 102, 119], ["S. marcescens", "ORGANISM", 140, 153], ["S. marcescens", "ORGANISM", 176, 189], ["subsp", "ORGANISM", 190, 195], ["S. marcescens", "SPECIES", 102, 115], ["S. marcescens EGD", "SPECIES", 140, 157], ["S. marcescens subsp", "SPECIES", 176, 195], ["S. marcescens", "SPECIES", 102, 115], ["S. marcescens EGD-HP20", "SPECIES", 140, 162], ["S. marcescens subsp", "SPECIES", 176, 195], ["onecodex analysis", "TEST", 14, 31], ["strain SRS", "TEST", 79, 89], ["marcescens EGD", "TEST", 143, 157], ["HP20", "TEST", 158, 162], ["S. marcescens subsp", "PROBLEM", 176, 195]]], ["Sakuensis, respectively (Figure 1B); these are all environmental strains not directly related to their hospital or nosocomial counterparts.", [["Sakuensis", "PROBLEM", 0, 9], ["all environmental strains", "PROBLEM", 47, 72]]], ["Similar result was demonstrated by EDGAR analysis (data not shown), in which a phylogenomic tree of strain SRS-8-S-2018 was built with 15 Serratia genome sequences, build out of a core of 1195 genes per genome, 17925 in total.", [["EDGAR", "PROTEIN", 35, 40], ["strain SRS-8-S-2018", "DNA", 100, 119], ["Serratia genome sequences", "DNA", 138, 163], ["1195 genes", "DNA", 188, 198], ["EDGAR analysis", "TEST", 35, 49], ["strain SRS", "TEST", 100, 110], ["15 Serratia genome sequences", "PROBLEM", 135, 163]]], ["The core had 321435 amino acid residues/bp per genome, 4821525 in total.", [["amino acid", "CHEMICAL", 20, 30], ["amino acid", "CHEMICAL", 20, 30], ["amino acid", "AMINO_ACID", 20, 30], ["amino acid residues", "TEST", 20, 39], ["bp", "TEST", 40, 42]]], ["Furthermore, average nucleotide identity (ANI) analysis mirrored the previous results such that S. marcescens sp.", [["nucleotide", "CHEMICAL", 21, 31], ["nucleotide", "CHEMICAL", 21, 31], ["S. marcescens sp", "ORGANISM", 96, 112], ["S. marcescens", "SPECIES", 96, 109], ["S. marcescens", "SPECIES", 96, 109]]], ["WW4 was the closest strain to Serratia sp.", [["WW4", "GENE_OR_GENE_PRODUCT", 0, 3], ["Serratia sp", "ORGANISM", 30, 41], ["Serratia sp", "PROBLEM", 30, 41]]], ["SRS-8-S-2018 with a 99.7% value followed by S. marcescens sp.", [["S. marcescens sp", "ORGANISM", 44, 60], ["S. marcescens", "SPECIES", 44, 57], ["S. marcescens", "SPECIES", 44, 57], ["SRS", "TEST", 0, 3]]], ["EGD HP20 (99.68%) and Serratia sp.", [["Serratia sp", "ORGANISM", 22, 33], ["EGD", "TEST", 0, 3], ["HP20", "TEST", 4, 8], ["Serratia sp", "PROBLEM", 22, 33], ["Serratia", "OBSERVATION", 22, 30]]], ["Note that the ANI calculator estimates the average nucleotide identity using both best hits (one-way ANI) and reciprocal best hits (two-way ANI) between two genomic datasets, as calculated by Goris et al. (2007).", [["nucleotide", "CHEMICAL", 51, 61], ["nucleotide", "CHEMICAL", 51, 61], ["ANI calculator", "DNA", 14, 28], ["the ANI calculator", "TEST", 10, 28]]], ["Typically, the ANI values between genomes of the same species are above 95% and therefore, strain SRS-8-S-2018 is assigned to S. marcescens.Genome-Centric Assessment of Serratia marcescens Strain SRS-8-S-2018 ::: Results and DiscussionAfter the taxonomic assessment of strain SRS-8-S-2018, further functional characterization was performed using RAST, which revealed the presence of 585 subsystems with the following top six categories, genes in parenthesis: amino acid metabolism (428); carbohydrate metabolism (391); vitamin and cofactor metabolism (197); protein metabolism (116); membrane transport (136) and fatty acids and lipids (136), respectively.", [["membrane", "ANATOMY", 584, 592], ["amino acid", "CHEMICAL", 459, 469], ["vitamin", "CHEMICAL", 519, 526], ["fatty acids", "CHEMICAL", 613, 624], ["amino acid", "CHEMICAL", 459, 469], ["carbohydrate", "CHEMICAL", 488, 500], ["vitamin", "CHEMICAL", 519, 526], ["fatty acids", "CHEMICAL", 613, 624], ["S. marcescens", "ORGANISM", 126, 139], ["Serratia marcescens", "ORGANISM", 169, 188], ["SRS-8-S-2018", "CELL", 276, 288], ["amino acid", "AMINO_ACID", 459, 469], ["carbohydrate", "SIMPLE_CHEMICAL", 488, 500], ["vitamin", "SIMPLE_CHEMICAL", 519, 526], ["membrane", "CELLULAR_COMPONENT", 584, 592], ["fatty acids", "SIMPLE_CHEMICAL", 613, 624], ["lipids", "SIMPLE_CHEMICAL", 629, 635], ["RAST", "PROTEIN", 346, 350], ["S. marcescens", "SPECIES", 126, 139], ["Serratia marcescens", "SPECIES", 169, 188], ["S. marcescens", "SPECIES", 126, 139], ["Serratia marcescens", "SPECIES", 169, 188], ["the ANI values", "TEST", 11, 25], ["strain SRS", "TEST", 91, 101], ["Serratia marcescens", "PROBLEM", 169, 188], ["the taxonomic assessment", "TEST", 241, 265], ["strain SRS", "TEST", 269, 279], ["further functional characterization", "TEST", 290, 325], ["RAST", "TEST", 346, 350], ["amino acid metabolism", "TEST", 459, 480], ["carbohydrate metabolism", "TEST", 488, 511], ["vitamin and cofactor metabolism", "TEST", 519, 550], ["protein metabolism", "TEST", 558, 576], ["membrane transport", "TEST", 584, 602], ["fatty acids", "TEST", 613, 624], ["lipids", "TEST", 629, 635], ["marcescens", "OBSERVATION", 129, 139]]], ["Similar results were shown by PATRIC based annotation also revealed the presence of genes (in parenthesis) for metabolism (967); energy production (310); protein processing (255); stress response/defense/virulence (207); membrane transport (174); cellular processes (157); DNA processing (109); 92 genes were also found for resistance to antibiotics and toxic compounds.", [["membrane", "ANATOMY", 221, 229], ["cellular", "ANATOMY", 247, 255], ["membrane", "CELLULAR_COMPONENT", 221, 229], ["cellular", "CELLULAR_COMPONENT", 247, 255], ["DNA", "CELLULAR_COMPONENT", 273, 276], ["PATRIC", "DNA", 30, 36], ["genes (in parenthesis", "PROBLEM", 84, 105], ["energy production", "TEST", 129, 146], ["protein processing", "TEST", 154, 172], ["stress response/defense/virulence", "PROBLEM", 180, 213], ["membrane transport", "TEST", 221, 239], ["cellular processes", "TEST", 247, 265], ["DNA processing", "TEST", 273, 287], ["antibiotics", "TREATMENT", 338, 349], ["toxic compounds", "PROBLEM", 354, 369]]], ["Also identified are 31 genes shown homologous with prophages, transposable elements and plasmids, indicating the receptivity or interactions of strain SRS-8-S-2018 with mobile genetic elements.Genome-Centric Assessment of Serratia marcescens Strain SRS-8-S-2018 ::: Results and DiscussionOf particular relevance are several gene homologs that have previously been shown to be involved in the resistance against heavy metals/radionuclides (genes in parenthesis), including efflux systems (48) and membrane transporters (121), which likely facilitates survival of strain SRS-8-S-2018 in a metalliferous soil habitat.", [["plasmids", "ANATOMY", 88, 96], ["membrane", "ANATOMY", 496, 504], ["metals", "CHEMICAL", 417, 423], ["Serratia marcescens", "ORGANISM", 222, 241], ["membrane", "CELLULAR_COMPONENT", 496, 504], ["prophages", "DNA", 51, 60], ["transposable elements", "DNA", 62, 83], ["plasmids", "DNA", 88, 96], ["strain SRS-8-S-2018", "DNA", 144, 163], ["mobile genetic elements", "DNA", 169, 192], ["membrane transporters", "PROTEIN", 496, 517], ["Serratia marcescens", "SPECIES", 222, 241], ["Serratia marcescens", "SPECIES", 222, 241], ["plasmids", "TREATMENT", 88, 96], ["strain SRS", "TEST", 144, 154], ["Serratia marcescens", "PROBLEM", 222, 241], ["efflux systems", "TEST", 472, 486], ["strain SRS", "TEST", 562, 572], ["a metalliferous soil habitat", "TREATMENT", 585, 613]]], ["These findings are similar to our previous genomic analysis of another Serratia species- strain S1B, isolated from the Savannah River Swamp System soils (Pathak et al., 2018).", [["Serratia species", "ORGANISM", 71, 87], ["strain S1B", "ORGANISM", 89, 99], ["Serratia species- strain S1B", "SPECIES", 71, 99], ["our previous genomic analysis", "TEST", 30, 59], ["another Serratia species", "PROBLEM", 63, 87], ["strain S1B", "PROBLEM", 89, 99], ["Serratia species", "OBSERVATION", 71, 87]]], ["Note that the SRSS site is located at the confluence of Four Mile Creek and the Savannah River, which received liquid Hg (Hg) effluents from a chloralkali facility near Augusta, GA, United States, until the 1980s.", [["SRSS site", "ANATOMY", 14, 23], ["Hg", "CHEMICAL", 118, 120], ["Hg", "CHEMICAL", 122, 124], ["Hg", "CHEMICAL", 118, 120], ["Hg", "CHEMICAL", 122, 124], ["chloralkali", "CHEMICAL", 143, 154], ["SRSS site", "DNA", 14, 23], ["the SRSS site", "PROBLEM", 10, 23], ["liquid Hg (Hg) effluents", "TREATMENT", 111, 135], ["confluence", "OBSERVATION_MODIFIER", 42, 52], ["Savannah River", "ANATOMY", 80, 94]]], ["Strain S1B, native to these Hg-contaminated soils, was found to harbor a genomic size of approximately 7,710,841 bases7 with 7,075 coding sequences and a GC content of 45.9%.", [["Hg", "CHEMICAL", 28, 30], ["Hg", "CHEMICAL", 28, 30], ["7,075 coding sequences", "DNA", 125, 147], ["Strain S1B", "PROBLEM", 0, 10], ["contaminated soils", "PROBLEM", 31, 49], ["coding sequences", "TEST", 131, 147], ["a GC content", "TEST", 152, 164], ["Hg", "OBSERVATION_MODIFIER", 28, 30], ["contaminated soils", "OBSERVATION", 31, 49], ["genomic", "OBSERVATION_MODIFIER", 73, 80], ["size", "OBSERVATION_MODIFIER", 81, 85]]], ["A total of 585 subsystems were annotated from strain S1B with genes (number in parentheses) for membrane transport (282), stress response (221), metabolism of aromatic compounds (173), motility and chemotaxis (9), among gene homologs shown to be involved in the resistance against heavy metals, similar to results presented here for strain SRS-8-S-2018.", [["membrane", "ANATOMY", 96, 104], ["S1B", "GENE_OR_GENE_PRODUCT", 53, 56], ["membrane", "CELLULAR_COMPONENT", 96, 104], ["membrane transport", "TEST", 96, 114], ["stress response", "TEST", 122, 137], ["aromatic compounds", "PROBLEM", 159, 177], ["chemotaxis", "TEST", 198, 208], ["strain SRS", "TEST", 333, 343], ["aromatic compounds", "OBSERVATION", 159, 177]]], ["Collectively, these analyses of Serratia species strain SRS-8-S-2018 revealed the presence of several genome-enabled metabolic and catabolic processes, which likely play a significant role in the colonization and strain\u2019s survival within the metalliferous SRS soil habitat; similar to previous studies that we have conducted on long-term contaminated sites (Olaniran et al., 2013; Ojuederie and Babalola, 2017; Chauhan et al., 2018).Genome-Centric Assessment of Serratia marcescens Strain SRS-8-S-2018 ::: Results and DiscussionFurther analysis was performed using comparative genomics to evaluate evolutionary and adaptive traits of strain SRS-8-S-2018 with the closest taxonomic strains- Serratia species WW4, EGD_HP20, VGH107, and FS14, as shown by EDGAR analysis (data not shown).", [["Serratia species", "ORGANISM", 32, 48], ["Serratia marcescens", "ORGANISM", 462, 481], ["SRS-8-S-2018", "CELL", 641, 653], ["Serratia species", "ORGANISM", 690, 706], ["WW4", "CELL", 707, 710], ["FS14", "GENE_OR_GENE_PRODUCT", 734, 738], ["Serratia marcescens", "SPECIES", 462, 481], ["Serratia marcescens", "SPECIES", 462, 481], ["Serratia species strain SRS", "TEST", 32, 59], ["several genome-enabled metabolic and catabolic processes", "PROBLEM", 94, 150], ["the colonization", "PROBLEM", 192, 208], ["previous studies", "TEST", 285, 301], ["Serratia marcescens", "PROBLEM", 462, 481], ["DiscussionFurther analysis", "TEST", 518, 544], ["comparative genomics", "TEST", 565, 585], ["strain SRS", "TEST", 634, 644], ["the closest taxonomic strains", "TEST", 659, 688], ["Serratia species", "PROBLEM", 690, 706], ["EGD_HP20", "TEST", 712, 720], ["VGH107", "TEST", 722, 728], ["FS14", "TEST", 734, 738], ["EDGAR analysis", "TEST", 752, 766], ["Serratia", "OBSERVATION_MODIFIER", 32, 40], ["several", "OBSERVATION_MODIFIER", 94, 101], ["genome", "OBSERVATION", 102, 108], ["catabolic processes", "OBSERVATION", 131, 150], ["significant", "OBSERVATION_MODIFIER", 172, 183], ["Serratia species", "OBSERVATION", 690, 706]]], ["This revealed the presence of 364 distinct genes present only in strain SRS-8-S-2018 relative to the other closely associated Serratia strains (Figure 5).", [["Serratia strains", "ORGANISM", 126, 142], ["strain SRS", "TEST", 65, 75], ["Serratia strains", "PROBLEM", 126, 142], ["Serratia", "OBSERVATION", 126, 134]]], ["Similarly, distinctive genes were also identified in the other four strains analyzed, shown in parenthesis: Serratia marcescens EGD_HP20 (52); S. marcescens VGH107 (347); S. marcescens WW4 (187), and S. species FS14 (215), respectively.", [["Serratia marcescens EGD_HP20", "ORGANISM", 108, 136], ["S. marcescens VGH107", "ORGANISM", 143, 163], ["S. marcescens WW4", "ORGANISM", 171, 188], ["Serratia marcescens", "SPECIES", 108, 127], ["S. marcescens VGH107", "SPECIES", 143, 163], ["S. marcescens", "SPECIES", 171, 184], ["S.", "SPECIES", 200, 202], ["Serratia marcescens", "SPECIES", 108, 127], ["S. marcescens", "SPECIES", 143, 156], ["S. marcescens", "SPECIES", 171, 184], ["S. species FS14", "SPECIES", 200, 215], ["Serratia marcescens EGD_HP20", "PROBLEM", 108, 136], ["S. marcescens VGH107", "TEST", 143, 163], ["S. marcescens", "TEST", 171, 184], ["S. species FS14", "TEST", 200, 215], ["distinctive genes", "OBSERVATION", 11, 28], ["Serratia", "OBSERVATION", 108, 116]]], ["Even though 364 genes present in SRS-8-S-2018 (#5 sector in Figure 5), made up only about 7% of the total genome size of the strain, but this set of genes are representative of \u201cdistinct\u201d determinants for efflux, metal resistance, universal stress proteins, cytochromes, drug resistance, transport proteins as well as transposases.", [["metal", "CHEMICAL", 213, 218], ["cytochromes", "GENE_OR_GENE_PRODUCT", 258, 269], ["universal stress proteins", "PROTEIN", 231, 256], ["cytochromes", "PROTEIN", 258, 269], ["transport proteins", "PROTEIN", 288, 306], ["SRS", "TEST", 33, 36], ["the strain", "PROBLEM", 121, 131], ["efflux", "PROBLEM", 205, 211], ["metal resistance", "PROBLEM", 213, 229], ["universal stress proteins", "PROBLEM", 231, 256], ["drug resistance", "PROBLEM", 271, 286], ["transport proteins", "TREATMENT", 288, 306], ["size", "OBSERVATION_MODIFIER", 113, 117], ["metal resistance", "OBSERVATION", 213, 229], ["drug resistance", "OBSERVATION", 271, 286]]], ["Moreover, many of the unique genes in SRS-8-S-2018 were classified as hypothetical proteins, functions of which are unknown at this time.Genome-Centric Assessment of Serratia marcescens Strain SRS-8-S-2018 ::: Results and DiscussionIt is also noteworthy that the strain harbored several genes that have been implicated in diverse roles pertaining to plant promoting activities, such as: phosphate metabolism (phoU, pstB, pstA, pstC, and pstS); spermidine synthase and N1-acetyltransferase genes (data not shown).", [["phosphate", "CHEMICAL", 387, 396], ["spermidine", "CHEMICAL", 444, 454], ["phosphate", "CHEMICAL", 387, 396], ["spermidine", "CHEMICAL", 444, 454], ["Serratia marcescens", "ORGANISM", 166, 185], ["phosphate", "SIMPLE_CHEMICAL", 387, 396], ["phoU", "GENE_OR_GENE_PRODUCT", 409, 413], ["pstB", "GENE_OR_GENE_PRODUCT", 415, 419], ["pstA", "GENE_OR_GENE_PRODUCT", 421, 425], ["pstC", "GENE_OR_GENE_PRODUCT", 427, 431], ["pstS", "GENE_OR_GENE_PRODUCT", 437, 441], ["spermidine synthase", "GENE_OR_GENE_PRODUCT", 444, 463], ["N1-acetyltransferase", "GENE_OR_GENE_PRODUCT", 468, 488], ["SRS", "DNA", 38, 41], ["S", "DNA", 44, 45], ["phoU", "PROTEIN", 409, 413], ["pstB", "PROTEIN", 415, 419], ["pstA", "PROTEIN", 421, 425], ["pstC", "PROTEIN", 427, 431], ["pstS", "PROTEIN", 437, 441], ["spermidine synthase", "PROTEIN", 444, 463], ["N1-acetyltransferase genes", "DNA", 468, 494], ["Serratia marcescens", "SPECIES", 166, 185], ["Serratia marcescens", "SPECIES", 166, 185], ["SRS", "TEST", 38, 41], ["hypothetical proteins", "PROBLEM", 70, 91], ["Serratia marcescens", "PROBLEM", 166, 185], ["phosphate metabolism", "TEST", 387, 407], ["pstB", "TEST", 415, 419], ["pstA", "TEST", 421, 425], ["pstC", "TEST", 427, 431], ["spermidine synthase", "TREATMENT", 444, 463], ["N1-acetyltransferase genes", "TREATMENT", 468, 494]]], ["These traits are similar to other Serratia species (Matteoli et al., 2018), and may render a plant growth promoting role of strain SRS-8-S-2018 in its native soil habitat, simultaneously reducing the metal toxicity.", [["SRS-8-S-2018", "CHEMICAL", 131, 143], ["toxicity", "DISEASE", 206, 214], ["Serratia species", "ORGANISM", 34, 50], ["other Serratia species", "PROBLEM", 28, 50], ["strain SRS", "TEST", 124, 134], ["the metal toxicity", "PROBLEM", 196, 214], ["metal toxicity", "OBSERVATION", 200, 214]]], ["Overall, this comparative genomic analysis confirmed a strong genome-enabled bioremediative as well as plant growth promoting potential of strain SRS-8-S-2018.Genomic Islands (GEIs) in Serratia marcescens Strain SRS-8-S-2018 ::: Results and DiscussionUsing the integrated prediction method to identify GEIs, strain SRS-8-S-2018 was shown to harbor 13 different GEIs, ranging in size from 125,063 to 5,237 bp (Figure 6), when S. marcescens WW4 was used as the reference genome.", [["Serratia marcescens", "ORGANISM", 185, 204], ["S. marcescens WW4", "ORGANISM", 425, 442], ["GEIs", "DNA", 302, 306], ["GEIs", "DNA", 361, 365], ["reference genome", "DNA", 459, 475], ["Serratia marcescens", "SPECIES", 185, 204], ["S. marcescens", "SPECIES", 425, 438], ["Serratia marcescens", "SPECIES", 185, 204], ["S. marcescens", "SPECIES", 425, 438], ["this comparative genomic analysis", "TEST", 9, 42], ["strain SRS", "TEST", 139, 149], ["Genomic Islands", "PROBLEM", 159, 174], ["GEIs", "TEST", 176, 180], ["Serratia marcescens Strain SRS", "TEST", 185, 215], ["GEIs", "TEST", 302, 306], ["strain SRS", "TEST", 308, 318], ["bp", "TEST", 405, 407], ["Figure", "TEST", 409, 415], ["S. marcescens", "PROBLEM", 425, 438], ["size", "OBSERVATION_MODIFIER", 378, 382]]], ["Note that genomic islands is a universal trait in many environmental isolates we have studied to date (Chauhan et al., 2018; Pathak et al., 2020); GEIs are beneficial gene segments recruited by host bacteria from their external environment via horizontal gene transfer (HGT) mechanisms (P\u00e9rez-Pantoja et al., 2013).", [["GEIs", "GENE_OR_GENE_PRODUCT", 147, 151], ["genomic islands", "PROBLEM", 10, 25], ["a universal trait", "PROBLEM", 29, 46], ["beneficial gene segments", "PROBLEM", 156, 180], ["horizontal gene transfer", "TREATMENT", 244, 268], ["genomic islands", "OBSERVATION", 10, 25]]], ["Typically, GEIs have been shown to be associated with host-beneficial adaptive traits such as bioremediation, virulence, antibiotic resistance and metabolism.", [["GEIs", "GENE_OR_GENE_PRODUCT", 11, 15], ["GEIs", "PROTEIN", 11, 15], ["bioremediation", "TREATMENT", 94, 108], ["virulence", "PROBLEM", 110, 119], ["antibiotic resistance", "TREATMENT", 121, 142]]], ["Overall, these GEI-encoded traits can be binned under the following four major categories (Bertelli et al., 2019): (1) metabolic islands (MIs), which are a set of genes for secondary metabolite biosynthesis; symbiotic islands (SIs), which are those set of genes that facilitate symbiotic associations with other micro and/or macroorganisms; pathogenicity islands (PAIs), coding for virulence or disease causing genes; and resistance islands (RIs), rendering resistance for antibiotics and other bacteriostatic/bactericidal agents.Genomic Islands (GEIs) in Serratia marcescens Strain SRS-8-S-2018 ::: Results and DiscussionOverall, this analysis led to the identification of several genomic islands in strain SRS-8-S-2018, with gene functions previously identified for metal resistance, efflux and transposons.", [["metal", "CHEMICAL", 768, 773], ["Serratia marcescens", "ORGANISM", 556, 575], ["S-2018", "CELL", 714, 720], ["GEI", "DNA", 15, 18], ["symbiotic islands", "DNA", 208, 225], ["SIs", "DNA", 227, 230], ["micro and/or macroorganisms; pathogenicity islands", "DNA", 312, 362], ["PAIs", "DNA", 364, 368], ["genomic islands", "DNA", 682, 697], ["strain SRS-8-S-2018", "DNA", 701, 720], ["transposons", "DNA", 797, 808], ["Serratia marcescens", "SPECIES", 556, 575], ["Serratia marcescens", "SPECIES", 556, 575], ["metabolic islands (MIs)", "PROBLEM", 119, 142], ["secondary metabolite biosynthesis", "PROBLEM", 173, 206], ["symbiotic islands (SIs)", "PROBLEM", 208, 231], ["other micro and/or macroorganisms", "PROBLEM", 306, 339], ["pathogenicity islands (PAIs)", "PROBLEM", 341, 369], ["virulence", "PROBLEM", 382, 391], ["disease", "PROBLEM", 395, 402], ["genes", "PROBLEM", 411, 416], ["resistance islands", "PROBLEM", 422, 440], ["antibiotics", "TREATMENT", 473, 484], ["other bacteriostatic/bactericidal agents", "TREATMENT", 489, 529], ["Genomic Islands", "PROBLEM", 530, 545], ["Serratia marcescens Strain SRS", "TEST", 556, 586], ["this analysis", "TEST", 631, 644], ["several genomic islands", "PROBLEM", 674, 697], ["strain SRS", "TEST", 701, 711], ["metal resistance", "PROBLEM", 768, 784], ["efflux and transposons", "PROBLEM", 786, 808], ["metabolite biosynthesis", "OBSERVATION", 183, 206], ["Islands", "OBSERVATION_MODIFIER", 538, 545], ["several", "OBSERVATION_MODIFIER", 674, 681], ["genomic islands", "OBSERVATION", 682, 697]]], ["This strongly indicates a likelihood that GEIs are probably recruited via HGT to promote survival in a heavy metal contaminated soil habitat (Bertelli et al., 2017).", [["GEIs", "GENE_OR_GENE_PRODUCT", 42, 46]]], ["These findings are similar to our previous reports from Serratia strain B1, which also revealed a repertoire of biodegradative genes, several occurring on genomic islands (Pathak et al., 2018).", [["Serratia strain B1", "ORGANISM", 56, 74], ["biodegradative genes", "DNA", 112, 132], ["Serratia strain B1", "SPECIES", 56, 74], ["Serratia strain B1", "TEST", 56, 74], ["biodegradative genes", "PROBLEM", 112, 132], ["repertoire", "OBSERVATION_MODIFIER", 98, 108], ["biodegradative genes", "OBSERVATION", 112, 132], ["several", "OBSERVATION_MODIFIER", 134, 141], ["islands", "OBSERVATION_MODIFIER", 163, 170]]], ["The presence of these GEIs in SRS-8-S-2018 also provides clues into the strain\u2019s genome plasticity, introduced by mobile genetic elements including integrases or transposases, which were also identified.Genomic Islands (GEIs) in Serratia marcescens Strain SRS-8-S-2018 ::: Results and DiscussionNotably, one mechanism for GEIs to be incorporated into bacterial genomes is through bacteriophage attack, which can leave phage remnant DNA, or prophage, integrated into the bacterial genome.", [["SRS-8-S-2018", "CHEMICAL", 30, 42], ["Serratia marcescens", "ORGANISM", 229, 248], ["GEIs", "GENE_OR_GENE_PRODUCT", 322, 326], ["DNA", "CELLULAR_COMPONENT", 432, 435], ["GEIs", "DNA", 22, 26], ["mobile genetic elements", "DNA", 114, 137], ["integrases", "DNA", 148, 158], ["transposases", "DNA", 162, 174], ["GEIs", "PROTEIN", 322, 326], ["phage remnant DNA", "DNA", 418, 435], ["bacterial genome", "DNA", 470, 486], ["Serratia marcescens", "SPECIES", 229, 248], ["Serratia marcescens", "SPECIES", 229, 248], ["these GEIs", "TEST", 16, 26], ["SRS", "TEST", 30, 33], ["Genomic Islands", "PROBLEM", 203, 218], ["GEIs", "TREATMENT", 322, 326], ["bacterial genomes", "PROBLEM", 351, 368], ["bacteriophage attack", "PROBLEM", 380, 400], ["phage remnant DNA", "TREATMENT", 418, 435], ["prophage", "TREATMENT", 440, 448], ["Islands", "OBSERVATION_MODIFIER", 211, 218], ["bacterial genome", "OBSERVATION", 470, 486]]], ["Thus, bacteriophage attacks is a major mechanism that influences bacterial evolution, resulting in the recruitment of genomic traits beneficial to the host species, such as virulence factors, antibiotic resistance mechanisms and bioremediative functions (Bernheim and Sorek, 2018).", [["virulence factors", "PROTEIN", 173, 190], ["bacteriophage attacks", "PROBLEM", 6, 27], ["bacterial evolution", "PROBLEM", 65, 84], ["genomic traits", "PROBLEM", 118, 132], ["the host species", "PROBLEM", 147, 163], ["virulence factors", "PROBLEM", 173, 190], ["antibiotic resistance mechanisms", "TREATMENT", 192, 224], ["bacteriophage attacks", "OBSERVATION", 6, 27]]], ["When presence of prophage was evaluated in strain SRS-8-S-2018, 156 candidate genes were identified in this category, as shown in Supplementary Table S1.", [["prophage", "DNA", 17, 25], ["strain SRS", "TEST", 43, 53]]], ["Specific details on the top 5 phage-associated genes are as follows (sizes in parenthesis): Salmonella phage FSL SP-004 (68,109 bp); Salmonella phage 29485 (52,465 bp); Nocardia phage NBR1 (47,541 bp); Edwardsiella phage PEi26 (47,062 bp) and Klebsiella phage 4 LV-2017 (38,728 bp), respectively.", [["top 5 phage-associated genes", "DNA", 24, 52], ["Salmonella phage 29485", "DNA", 133, 155], ["Nocardia phage NBR1", "DNA", 169, 188], ["Edwardsiella phage PEi26", "DNA", 202, 226], ["Klebsiella phage 4 LV-2017", "DNA", 243, 269], ["Salmonella phage", "SPECIES", 133, 149], ["Edwardsiella phage", "SPECIES", 202, 220], ["Salmonella phage FSL SP-004", "SPECIES", 92, 119], ["Salmonella phage 29485", "SPECIES", 133, 155], ["Edwardsiella phage PEi26", "SPECIES", 202, 226], ["Klebsiella phage 4 LV-2017", "SPECIES", 243, 269], ["bp", "TEST", 128, 130], ["Salmonella phage", "TEST", 133, 149], ["bp", "TEST", 164, 166], ["Nocardia phage NBR1", "TEST", 169, 188], ["bp", "TEST", 197, 199], ["Edwardsiella phage PEi26", "TEST", 202, 226], ["bp", "TEST", 235, 237], ["Klebsiella phage", "TEST", 243, 259], ["LV", "TEST", 262, 264], ["bp", "TEST", 278, 280]]], ["In fact, 12 different Salmonella-specific prophages were found associated in the genome of strain SRS-8-S-2018 followed by 5 from Klebsiella spp.", [["SRS-8-S-2018", "CHEMICAL", 98, 110], ["SRS-8-S-2018", "CELL", 98, 110], ["5", "ORGANISM", 123, 124], ["Klebsiella spp", "ORGANISM", 130, 144], ["Salmonella-specific prophages", "DNA", 22, 51], ["Klebsiella spp", "SPECIES", 130, 144], ["12 different Salmonella-specific prophages", "PROBLEM", 9, 51], ["strain SRS", "TEST", 91, 101], ["Klebsiella spp", "PROBLEM", 130, 144], ["12 different", "OBSERVATION_MODIFIER", 9, 21]]], ["Conversely, only 1 phage X20 was identified in the genome of strain SRS-8-S-2018 that was related to Serratia spp., which indicates strain SRS-8-S-2018 was more responsive to Salmonella-specific phage interactions relative to its own genus.", [["SRS-8-S-2018", "CHEMICAL", 68, 80], ["SRS-8-S-2018", "CHEMICAL", 139, 151], ["X20", "GENE_OR_GENE_PRODUCT", 25, 28], ["strain SRS-8-S-2018", "CELL", 61, 80], ["Serratia spp.", "ORGANISM", 101, 114], ["SRS-8", "ORGANISM", 139, 144], ["-S-2018", "CELL", 144, 151], ["1 phage X20", "DNA", 17, 28], ["Serratia spp.", "SPECIES", 101, 114], ["Serratia spp.", "SPECIES", 101, 114], ["strain SRS", "TEST", 61, 71], ["Serratia spp.", "PROBLEM", 101, 114], ["strain SRS", "TEST", 132, 142], ["Salmonella", "PROBLEM", 175, 185], ["specific phage interactions", "PROBLEM", 186, 213], ["Serratia", "OBSERVATION", 101, 109]]], ["Because Salmonella possess pathogenic traits, it is likely that pathogenicity of Serratia spp. are transmitted from Salmonella into Serratia via HGT mechanisms, but this observation is based only on genomic analysis with no rigorous functional proof available as of this writing.", [["Serratia spp.", "ORGANISM", 81, 94], ["Serratia spp.", "SPECIES", 81, 94], ["Salmonella", "SPECIES", 8, 18], ["Serratia spp.", "SPECIES", 81, 94], ["Salmonella", "SPECIES", 116, 126], ["Salmonella", "PROBLEM", 8, 18], ["pathogenic traits", "PROBLEM", 27, 44], ["Serratia spp.", "PROBLEM", 81, 94], ["Salmonella", "PROBLEM", 116, 126], ["Serratia", "PROBLEM", 132, 140], ["this observation", "TEST", 165, 181], ["genomic analysis", "TEST", 199, 215], ["is likely", "UNCERTAINTY", 49, 58], ["Serratia", "OBSERVATION", 81, 89]]], ["This observation, however, also goes well in line with the taxonomic similarity between the strain\u2019s genome with Salmonella spp., albeit at only 0.68% (data not shown).", [["Salmonella spp.", "ORGANISM", 113, 128], ["strain\u2019s genome", "DNA", 92, 107], ["Salmonella spp.", "SPECIES", 113, 128], ["Salmonella spp.", "SPECIES", 113, 128], ["This observation", "TEST", 0, 16], ["Salmonella spp.", "PROBLEM", 113, 128], ["Salmonella spp.", "OBSERVATION", 113, 128]]], ["In this context, genome-wide analysis of Serratia species have recently established that the environmental Serratia representatives have commonalities pertaining to the high number of antibiotic resistant genes relative to the hospital or nosocomial strains (Sandner-Miranda et al., 2018) and it appears that the environmental isolates are also equally potent in their antimicrobial activities.Metal Resistant Genes (MRGs) of Serratia marcescens Strain SRS-8-S-2018 ::: Results and DiscussionGenomic mining of Serratia sp.", [["nosocomial", "DISEASE", 239, 249], ["Metal", "CHEMICAL", 394, 399], ["Serratia species", "ORGANISM", 41, 57], ["Serratia marcescens", "ORGANISM", 426, 445], ["Serratia sp", "ORGANISM", 510, 521], ["antibiotic resistant genes", "DNA", 184, 210], ["Serratia marcescens", "SPECIES", 426, 445], ["Serratia marcescens", "SPECIES", 426, 445], ["Serratia species", "PROBLEM", 41, 57], ["the environmental Serratia", "PROBLEM", 89, 115], ["antibiotic resistant genes", "PROBLEM", 184, 210], ["nosocomial strains", "PROBLEM", 239, 257], ["the environmental isolates", "PROBLEM", 309, 335], ["Serratia marcescens Strain SRS", "TEST", 426, 456], ["Serratia sp", "PROBLEM", 510, 521], ["Serratia species", "OBSERVATION", 41, 57], ["Resistant Genes", "OBSERVATION", 400, 415], ["Serratia", "OBSERVATION", 510, 518]]], ["SRS-8-S-2018 also revealed several genes that likely enable bacterial adaptability and survival to survive in a contaminated environment.", [["SRS", "TEST", 0, 3], ["bacterial adaptability", "OBSERVATION", 60, 82]]], ["For example, it was found that the strain contained several gene homologs for heavy metal and biocide resistance such as efflux proteins [e.g., resistance, nodulation, and protein-family (RNDs); outer membrane channel TolC], and heavy metal-responding transcription regulators.", [["membrane", "ANATOMY", 201, 209], ["biocide", "CHEMICAL", 94, 101], ["biocide", "SIMPLE_CHEMICAL", 94, 101], ["outer membrane channel TolC", "GENE_OR_GENE_PRODUCT", 195, 222], ["efflux proteins", "PROTEIN", 121, 136], ["protein-family", "PROTEIN", 172, 186], ["RNDs", "PROTEIN", 188, 192], ["outer membrane channel", "PROTEIN", 195, 217], ["TolC", "PROTEIN", 218, 222], ["transcription regulators", "PROTEIN", 252, 276], ["the strain", "PROBLEM", 31, 41], ["heavy metal and biocide resistance", "TREATMENT", 78, 112], ["efflux proteins", "TEST", 121, 136], ["nodulation", "PROBLEM", 156, 166], ["outer membrane channel TolC", "TREATMENT", 195, 222], ["heavy metal-responding transcription regulators", "TREATMENT", 229, 276]]], ["Furthermore, the SRS-8-S-2018 strain genome had significant numbers of ABC-type transport and heavy metal detoxication proteins, which could maintain homeostasis of metals \u2013 all of these adaptations likely contribute for environmental and evolutionary response of strain SRS-8-S-2018 and survival in a metalliferous soil habitat.Metal Resistant Genes (MRGs) of Serratia marcescens Strain SRS-8-S-2018 ::: Results and DiscussionOne major mechanism underpinning microbial resistance against both heavy metals and antibiotics is by efflux of these compounds outside of the cellular environment, as soon as the cells sense their presence (Levy, 2002; Nies, 2003; Blanco et al., 2016; Buffet-Bataillon et al., 2016).", [["cellular", "ANATOMY", 570, 578], ["cells", "ANATOMY", 607, 612], ["metals", "CHEMICAL", 165, 171], ["SRS-8-S-2018", "CHEMICAL", 271, 283], ["Metal", "CHEMICAL", 329, 334], ["metals", "CHEMICAL", 500, 506], ["ABC", "GENE_OR_GENE_PRODUCT", 71, 74], ["Serratia marcescens", "ORGANISM", 361, 380], ["cellular", "CELL", 570, 578], ["cells", "CELL", 607, 612], ["SRS-8-S-2018 strain genome", "DNA", 17, 43], ["ABC", "PROTEIN", 71, 74], ["heavy metal detoxication proteins", "PROTEIN", 94, 127], ["Serratia marcescens", "SPECIES", 361, 380], ["Serratia marcescens Strain SRS-8-S-2018", "SPECIES", 361, 400], ["the SRS", "TEST", 13, 20], ["ABC", "TEST", 71, 74], ["type transport", "PROBLEM", 75, 89], ["heavy metal detoxication proteins", "PROBLEM", 94, 127], ["strain SRS", "TEST", 264, 274], ["a metalliferous soil habitat", "TREATMENT", 300, 328], ["Metal Resistant Genes", "PROBLEM", 329, 350], ["Serratia marcescens", "PROBLEM", 361, 380], ["antibiotics", "TREATMENT", 511, 522], ["Resistant Genes", "OBSERVATION", 335, 350]]], ["Strain SRS-8-S-2018 possessed at least 48 genes related to different efflux groups such as ABC-type efflux, multidrug efflux, RND efflux system etc. (data not shown).", [["SRS-8-S-2018", "CHEMICAL", 7, 19], ["ABC", "GENE_OR_GENE_PRODUCT", 91, 94], ["ABC", "PROTEIN", 91, 94], ["Strain SRS", "TEST", 0, 10], ["different efflux groups", "PROBLEM", 59, 82], ["type efflux", "PROBLEM", 95, 106], ["multidrug efflux", "PROBLEM", 108, 124], ["RND efflux system", "PROBLEM", 126, 143], ["multidrug efflux", "OBSERVATION", 108, 124]]], ["Therefore, efflux mechanisms may be one major response of strain SRS-8-S-2018 to survive in a highly metalliferous soil habitat.", [["SRS-8-S-2018", "CHEMICAL", 65, 77], ["efflux mechanisms", "PROBLEM", 11, 28], ["strain SRS", "TEST", 58, 68]]], ["Toward this end, Hg-resistance is also likely efflux based in the strain.", [["Hg", "CHEMICAL", 17, 19], ["Hg", "CHEMICAL", 17, 19], ["Hg", "SIMPLE_CHEMICAL", 17, 19], ["efflux", "PROBLEM", 46, 52], ["the strain", "PROBLEM", 62, 72], ["likely", "UNCERTAINTY", 39, 45], ["efflux", "OBSERVATION_MODIFIER", 46, 52]]], ["Genome mining revealed that the strain did not support a complete mer operon but only harbored the transcriptional regulator, MerR family (fig| 613.215.peg.349) (Supplementary Figure S2A), along with the heavy metal sensor histidine kinase (HMHK) and the DNA-binding heavy metal response regulator (HMRR).", [["histidine", "CHEMICAL", 223, 232], ["histidine", "CHEMICAL", 223, 232], ["MerR", "GENE_OR_GENE_PRODUCT", 126, 130], ["heavy metal sensor histidine kinase", "GENE_OR_GENE_PRODUCT", 204, 239], ["HMHK", "GENE_OR_GENE_PRODUCT", 241, 245], ["DNA", "CELLULAR_COMPONENT", 255, 258], ["mer operon", "DNA", 66, 76], ["transcriptional regulator", "PROTEIN", 99, 124], ["MerR family", "PROTEIN", 126, 137], ["fig| 613.215.peg.349", "PROTEIN", 139, 159], ["S2A", "PROTEIN", 183, 186], ["heavy metal sensor histidine kinase", "PROTEIN", 204, 239], ["HMHK", "PROTEIN", 241, 245], ["DNA-binding heavy metal response regulator", "PROTEIN", 255, 297], ["HMRR", "PROTEIN", 299, 303], ["the strain", "PROBLEM", 28, 38], ["a complete mer operon", "TREATMENT", 55, 76], ["the heavy metal sensor histidine kinase", "TREATMENT", 200, 239], ["the DNA", "PROBLEM", 251, 258]]], ["The merR gene in strain SRS-8-S-2018 was taxonomically closest to S. marcescens WW4 and S. marcescens EGD-HP20 (Supplementary Figure S2B); these strains were also identified closest relatives in the phylogenomic based analysis shown in Figures 1A,B. Therefore, one central question arises from the lack of a complete mer operon in strain SRS-8-S-2018- what mechanism(s) render Hg resistance to Serratia marcescens strain SRS-8-S-2018?Metal Resistant Genes (MRGs) of Serratia marcescens Strain SRS-8-S-2018 ::: Results and DiscussionTo this end, previous body of information revealed that not all HgR bacteria support a complete mer operon.", [["body", "ANATOMY", 554, 558], ["SRS-8-S-2018", "CHEMICAL", 24, 36], ["Hg", "CHEMICAL", 377, 379], ["Metal", "CHEMICAL", 434, 439], ["Hg", "CHEMICAL", 377, 379], ["merR", "GENE_OR_GENE_PRODUCT", 4, 8], ["strain SRS-8-S-2018", "CELL", 17, 36], ["S. marcescens WW4", "ORGANISM", 66, 83], ["S. marcescens", "ORGANISM", 88, 101], ["Serratia marcescens", "ORGANISM", 394, 413], ["Serratia marcescens", "ORGANISM", 466, 485], ["HgR", "GENE_OR_GENE_PRODUCT", 596, 599], ["merR gene", "DNA", 4, 13], ["mer operon", "DNA", 317, 327], ["mer operon", "DNA", 628, 638], ["S. marcescens", "SPECIES", 66, 79], ["S. marcescens", "SPECIES", 88, 101], ["Serratia marcescens", "SPECIES", 394, 413], ["Serratia marcescens", "SPECIES", 466, 485], ["S. marcescens", "SPECIES", 66, 79], ["S. marcescens EGD-HP20", "SPECIES", 88, 110], ["Serratia marcescens", "SPECIES", 394, 413], ["Serratia marcescens", "SPECIES", 466, 485], ["strain SRS", "TEST", 17, 27], ["S. marcescens", "TEST", 66, 79], ["S. marcescens EGD", "TEST", 88, 105], ["HP20", "TEST", 106, 110], ["Supplementary Figure S2B", "TREATMENT", 112, 136], ["these strains", "PROBLEM", 139, 152], ["a complete mer operon", "TREATMENT", 306, 327], ["strain SRS", "TEST", 331, 341], ["Hg resistance", "TEST", 377, 390], ["Serratia marcescens strain SRS", "TEST", 394, 424], ["Serratia marcescens Strain SRS", "TEST", 466, 496], ["all HgR bacteria", "PROBLEM", 592, 608], ["a complete mer operon", "TREATMENT", 617, 638], ["Resistant Genes", "OBSERVATION", 440, 455]]], ["The mer operon has origins in geothermal environments (Boyd and Barkay, 2012), and has evolved from being a constitutively expressed system made up of simple genetic elements to a highly regulated and complex operonic system- the complete mer operon.", [["mer operon", "DNA", 4, 14], ["mer operon", "DNA", 239, 249], ["the complete mer operon", "TREATMENT", 226, 249], ["geothermal environments", "OBSERVATION", 30, 53]]], ["We are tempted to speculate that Hg resistance in strain SRS-8-S-2018 is likely mediated via efflux mechanisms, as proposed elsewhere.", [["Hg", "CHEMICAL", 33, 35], ["SRS-8-S-2018", "CHEMICAL", 57, 69], ["Hg", "CHEMICAL", 33, 35], ["Hg", "SIMPLE_CHEMICAL", 33, 35], ["Hg resistance", "TEST", 33, 46], ["strain SRS", "TEST", 50, 60], ["efflux", "OBSERVATION", 93, 99]]], ["In fact, studies have found energy-dependent efflux systems to render resistance to many heavy metals, including cadmium, zinc, nickel, cobalt, and copper (Reyes et al., 1999).", [["cadmium", "CHEMICAL", 113, 120], ["zinc", "CHEMICAL", 122, 126], ["nickel", "CHEMICAL", 128, 134], ["cobalt", "CHEMICAL", 136, 142], ["copper", "CHEMICAL", 148, 154], ["cadmium", "CHEMICAL", 113, 120], ["zinc", "CHEMICAL", 122, 126], ["nickel", "CHEMICAL", 128, 134], ["cobalt", "CHEMICAL", 136, 142], ["copper", "CHEMICAL", 148, 154], ["cadmium", "SIMPLE_CHEMICAL", 113, 120], ["zinc", "SIMPLE_CHEMICAL", 122, 126], ["nickel", "SIMPLE_CHEMICAL", 128, 134], ["cobalt", "SIMPLE_CHEMICAL", 136, 142], ["copper", "SIMPLE_CHEMICAL", 148, 154], ["dependent efflux systems", "PROBLEM", 35, 59]]], ["In a seminal report, several mer negative but HgR bacteria exhibited decreased resistance to Hg when amended with the protonophore- carbonyl cyanide m-chlorophenylhydrazone (CCCP) (Reyes et al., 1999).", [["Hg", "CHEMICAL", 93, 95], ["protonophore- carbonyl cyanide m-chlorophenylhydrazone", "CHEMICAL", 118, 172], ["CCCP", "CHEMICAL", 174, 178], ["Hg", "CHEMICAL", 93, 95], ["protonophore- carbonyl cyanide m-chlorophenylhydrazone", "CHEMICAL", 118, 172], ["CCCP", "CHEMICAL", 174, 178], ["HgR", "GENE_OR_GENE_PRODUCT", 46, 49], ["Hg", "SIMPLE_CHEMICAL", 93, 95], ["protonophore- carbonyl cyanide m-chlorophenylhydrazone", "SIMPLE_CHEMICAL", 118, 172], ["CCCP", "SIMPLE_CHEMICAL", 174, 178], ["HgR bacteria", "PROBLEM", 46, 58], ["decreased resistance", "PROBLEM", 69, 89], ["the protonophore", "TREATMENT", 114, 130], ["carbonyl cyanide m-chlorophenylhydrazone", "TREATMENT", 132, 172], ["seminal", "ANATOMY", 5, 12], ["decreased resistance", "OBSERVATION", 69, 89]]], ["It may also be that strain SRS-8-S-2018 harbors genes which are not homologous to recognized mer genes and HgR is a mechanism driven by potentially novel genes; we are currently conducting more work to resolve these possibilities in strain SRS-8-S-2018 as it relates to Hg resistance.", [["Hg", "CHEMICAL", 270, 272], ["Hg", "CHEMICAL", 270, 272], ["HgR", "GENE_OR_GENE_PRODUCT", 107, 110], ["Hg", "SIMPLE_CHEMICAL", 270, 272], ["mer genes", "DNA", 93, 102], ["HgR", "DNA", 107, 110], ["strain SRS", "TEST", 20, 30], ["strain SRS", "TEST", 233, 243], ["Hg resistance", "PROBLEM", 270, 283], ["may also be", "UNCERTAINTY", 3, 14], ["Hg resistance", "OBSERVATION", 270, 283]]], ["Regardless of these possibilities, the presence of abundant MRGs in strain SRS-8-S-2018 provides for a deeper understanding on soil survival strategies.Antimicrobial Resistant Genes (ARGs) of Serratia marcescens Strain SRS-8-S-2018 ::: Results and DiscussionTo validate the phenomic response indicating carriage of broad antibiotic resistance in SRS-8-S-2018, a comprehensive survey of antibiotic resistance genes (ARGs) was performed employing PATRIC, CARD, and RAST pipelines.", [["MRGs", "GENE_OR_GENE_PRODUCT", 60, 64], ["Serratia marcescens", "ORGANISM", 192, 211], ["antibiotic resistance genes", "DNA", 386, 413], ["ARGs", "DNA", 415, 419], ["CARD", "PROTEIN", 453, 457], ["Serratia marcescens", "SPECIES", 192, 211], ["Serratia marcescens", "SPECIES", 192, 211], ["strain SRS", "TEST", 68, 78], ["soil survival strategies", "TREATMENT", 127, 151], ["Antimicrobial Resistant Genes", "PROBLEM", 152, 181], ["Serratia marcescens", "PROBLEM", 192, 211], ["broad antibiotic resistance", "TREATMENT", 315, 342], ["SRS", "TEST", 346, 349], ["antibiotic resistance genes", "TREATMENT", 386, 413], ["abundant", "OBSERVATION_MODIFIER", 51, 59], ["RAST pipelines", "OBSERVATION", 463, 477]]], ["This bioinformatic analysis revealed a plethora of 104 ARGs in Serratia sp.", [["Serratia sp", "ORGANISM", 63, 74], ["This bioinformatic analysis", "TEST", 0, 27], ["a plethora of 104 ARGs in Serratia sp", "PROBLEM", 37, 74], ["plethora", "OBSERVATION_MODIFIER", 39, 47], ["Serratia", "OBSERVATION_MODIFIER", 63, 71]]], ["SRS-8-S-2018.", [["SRS", "TEST", 0, 3]]], ["Specifically, PATRIC analysis revealed the presence of several genes classified under speciality category, that included 261 genes for transporters, 200 genes for drug targets, 173 genes for virulence factors, and 102 genes for antibiotic resistance, respectively (Figure 7A).", [["PATRIC", "DNA", 14, 20], ["drug targets", "DNA", 163, 175], ["virulence factors", "PROTEIN", 191, 208], ["PATRIC analysis", "TEST", 14, 29], ["drug targets", "TEST", 163, 175], ["virulence factors", "PROBLEM", 191, 208], ["antibiotic resistance", "TREATMENT", 228, 249]]], ["This points to the repertoire of speciality genes, many related to virulence and ARGs, that are recruited by this soil-borne isolate as its arsenal againts multiple antimicrobials, likely shaped by long-term exposure to heavy metals, such as uranium and mercury.", [["uranium", "CHEMICAL", 242, 249], ["mercury", "CHEMICAL", 254, 261], ["uranium", "CHEMICAL", 242, 249], ["mercury", "CHEMICAL", 254, 261], ["ARGs", "GENE_OR_GENE_PRODUCT", 81, 85], ["uranium", "SIMPLE_CHEMICAL", 242, 249], ["mercury", "SIMPLE_CHEMICAL", 254, 261], ["speciality genes", "DNA", 33, 49], ["virulence", "PROBLEM", 67, 76], ["ARGs", "PROBLEM", 81, 85], ["this soil-borne isolate", "TREATMENT", 109, 132], ["multiple antimicrobials", "TREATMENT", 156, 179], ["long-term exposure", "OBSERVATION_MODIFIER", 198, 216], ["heavy metals", "OBSERVATION_MODIFIER", 220, 232]]], ["Similar results were obtained by using CARD, which revealed resistomes for the following drugs (percent identity with the corresponding region is shown in parenthesis): fluoroquinolone (22.2%), tetracycline\u2019s (22.2%), cephalosporin (11%), penam (11%), carbapenem (5.6%), cephamycins (5.6%), fosfomycin (5.6%), macrolide (5.6%), monobactam (5.6%), and aminoglycoside (5.6%) (Jia et al., 2017), as shown in Figure 7B.", [["fluoroquinolone", "CHEMICAL", 169, 184], ["tetracycline", "CHEMICAL", 194, 206], ["cephalosporin", "CHEMICAL", 218, 231], ["penam", "CHEMICAL", 239, 244], ["carbapenem", "CHEMICAL", 252, 262], ["cephamycins", "CHEMICAL", 271, 282], ["fosfomycin", "CHEMICAL", 291, 301], ["macrolide", "CHEMICAL", 310, 319], ["monobactam", "CHEMICAL", 328, 338], ["aminoglycoside", "CHEMICAL", 351, 365], ["fluoroquinolone", "CHEMICAL", 169, 184], ["tetracycline", "CHEMICAL", 194, 206], ["cephalosporin", "CHEMICAL", 218, 231], ["penam", "CHEMICAL", 239, 244], ["carbapenem", "CHEMICAL", 252, 262], ["cephamycins", "CHEMICAL", 271, 282], ["fosfomycin", "CHEMICAL", 291, 301], ["macrolide", "CHEMICAL", 310, 319], ["monobactam", "CHEMICAL", 328, 338], ["aminoglycoside", "CHEMICAL", 351, 365], ["CARD", "GENE_OR_GENE_PRODUCT", 39, 43], ["fluoroquinolone", "SIMPLE_CHEMICAL", 169, 184], ["tetracycline\u2019s", "SIMPLE_CHEMICAL", 194, 208], ["cephalosporin", "SIMPLE_CHEMICAL", 218, 231], ["penam", "SIMPLE_CHEMICAL", 239, 244], ["carbapenem", "SIMPLE_CHEMICAL", 252, 262], ["cephamycins", "SIMPLE_CHEMICAL", 271, 282], ["fosfomycin", "SIMPLE_CHEMICAL", 291, 301], ["macrolide", "SIMPLE_CHEMICAL", 310, 319], ["monobactam", "SIMPLE_CHEMICAL", 328, 338], ["aminoglycoside", "SIMPLE_CHEMICAL", 351, 365], ["CARD", "PROTEIN", 39, 43], ["the following drugs", "TREATMENT", 75, 94], ["fluoroquinolone", "TREATMENT", 169, 184], ["tetracycline\u2019s", "TREATMENT", 194, 208], ["cephalosporin", "TREATMENT", 218, 231], ["penam", "TREATMENT", 239, 244], ["carbapenem", "TREATMENT", 252, 262], ["cephamycins", "TREATMENT", 271, 282], ["fosfomycin", "TREATMENT", 291, 301], ["macrolide", "TREATMENT", 310, 319], ["monobactam", "TREATMENT", 328, 338], ["aminoglycoside", "TREATMENT", 351, 365]]], ["Several other genes that possibly confer antibiotic resistance were also recognized, including antibiotic target protein (Penicillin-binding protein mutations), antibiotic target alteration, antibiotic self-resistance gene, resistance-nodulation-cell division (RND), major facilitator superfamily (MFS), efflux pump complex etc. This overall ARG evaluation of Serratia sp.", [["cell", "ANATOMY", 246, 250], ["Penicillin", "CHEMICAL", 122, 132], ["Penicillin", "CHEMICAL", 122, 132], ["Penicillin-binding protein", "GENE_OR_GENE_PRODUCT", 122, 148], ["cell", "CELL", 246, 250], ["Serratia sp", "ORGANISM", 360, 371], ["antibiotic target protein", "PROTEIN", 95, 120], ["Penicillin-binding protein", "PROTEIN", 122, 148], ["antibiotic self-resistance gene", "DNA", 191, 222], ["major facilitator superfamily", "PROTEIN", 267, 296], ["MFS", "PROTEIN", 298, 301], ["efflux pump complex etc", "PROTEIN", 304, 327], ["antibiotic resistance", "TREATMENT", 41, 62], ["antibiotic target protein", "TREATMENT", 95, 120], ["Penicillin-binding protein mutations", "TREATMENT", 122, 158], ["antibiotic target alteration", "TREATMENT", 161, 189], ["antibiotic self-resistance gene", "TREATMENT", 191, 222], ["This overall ARG evaluation", "TEST", 329, 356], ["Serratia sp", "PROBLEM", 360, 371], ["antibiotic resistance", "OBSERVATION", 41, 62], ["Serratia", "OBSERVATION", 360, 368]]], ["SRS-8-S-2018 indicates that the strain has acquired resistance to multiple antibiotics, most likely exacerbated by exposure to Hg, U and possibly other heavy metal contamination in the SRS soils.", [["Hg", "CHEMICAL", 127, 129], ["U", "CHEMICAL", 131, 132], ["Hg", "CHEMICAL", 127, 129], ["SRS", "TEST", 0, 3], ["the strain", "PROBLEM", 28, 38], ["multiple antibiotics", "TREATMENT", 66, 86], ["other heavy metal contamination in the SRS soils", "PROBLEM", 146, 194], ["most likely", "UNCERTAINTY", 88, 99], ["possibly", "UNCERTAINTY", 137, 145], ["heavy", "OBSERVATION_MODIFIER", 152, 157], ["metal contamination", "OBSERVATION", 158, 177]]], ["These findings are in line with previous body of information on SRS soils, which unequivocally show that the legacy contaminated SRS soils serve as a repository for acquisition of both metal and antibiotic resistances (Stepanauskas et al., 2006; Wright et al., 2006; Thomas et al., 2020).", [["SRS soils", "TEST", 64, 73], ["both metal and antibiotic resistances", "TREATMENT", 180, 217]]], ["However, this study is focused on Serratia spp., which are opportunistic pathogens and brings out the necessity for further focused studies on this aspect rather than a more generalized assessment of the proliferation and abundance of MRGs and ARGs within the SRS soil habitat, as has been the case with most previous studies.Phenomic Analysis of Serratia marcescens Strain SRS-8-S-2018 ::: Results and DiscussionTo validate the functional activity of ARGs in Serratia sp.", [["Serratia spp.", "ORGANISM", 34, 47], ["MRGs", "GENE_OR_GENE_PRODUCT", 235, 239], ["ARGs", "GENE_OR_GENE_PRODUCT", 244, 248], ["Serratia marcescens", "ORGANISM", 347, 366], ["ARGs", "SIMPLE_CHEMICAL", 452, 456], ["Serratia sp", "ORGANISM", 460, 471], ["Serratia spp.", "SPECIES", 34, 47], ["Serratia marcescens", "SPECIES", 347, 366], ["Serratia spp.", "SPECIES", 34, 47], ["Serratia marcescens", "SPECIES", 347, 366], ["this study", "TEST", 9, 19], ["Serratia spp.", "PROBLEM", 34, 47], ["opportunistic pathogens", "PROBLEM", 59, 82], ["further focused studies", "TEST", 116, 139], ["a more generalized assessment", "TEST", 167, 196], ["the proliferation", "PROBLEM", 200, 217], ["MRGs", "TEST", 235, 239], ["most previous studies", "TEST", 304, 325], ["Phenomic Analysis", "TEST", 326, 343], ["Serratia marcescens", "PROBLEM", 347, 366], ["Serratia sp", "PROBLEM", 460, 471], ["opportunistic", "OBSERVATION_MODIFIER", 59, 72], ["pathogens", "OBSERVATION", 73, 82], ["proliferation", "OBSERVATION", 204, 217], ["Serratia marcescens", "OBSERVATION", 347, 366]]], ["SRS-8-S-2018, phenotype microarray (PM) technique was used, which is a microtiter-plate-based substrate utilization assay (Bochner and Savageau, 1977; Bochner, 1989; Bochner et al., 2001), similar to the Biolog EcoPlates (Borglin et al., 2012).", [["SRS", "TEST", 0, 3], ["a microtiter", "TEST", 69, 81]]], ["Note that the PM technique, also referred to as phenomics, offers the ability to obtain cellular response of axenic microbiota or environmental communities, as well as screening antimicrobial resistances (Blanco et al., 2016).", [["cellular", "ANATOMY", 88, 96], ["communities", "ANATOMY", 144, 155], ["cellular", "CELL", 88, 96], ["the PM technique", "TEST", 10, 26], ["screening antimicrobial resistances", "TEST", 168, 203]]], ["The results obtained from the PM MicroPlate\u2122 analysis are shown in Figures 8A,B. This data is compared in Table 2, showing that only 9 out of 48 antibiotics tested, inhibited or ceased growth, indicating high antibiotic resistance.", [["the PM MicroPlate\u2122 analysis", "TEST", 26, 53], ["This data", "TEST", 81, 90], ["antibiotics", "TREATMENT", 145, 156], ["high antibiotic resistance", "PROBLEM", 204, 230], ["high antibiotic resistance", "OBSERVATION", 204, 230]]], ["In fact, 81.25% of the antibiotic/concentration tested did not affect growth, suggesting the broad ARG potential of this strain.", [["the antibiotic/concentration", "TEST", 19, 47], ["this strain", "PROBLEM", 116, 127]]], ["The antibiotics and concentrations (as provided by the manufacturer), that affected growth included the following: Cloxacillin (936 \u03bcg/ml), Lomefloxcin (0.42 \u03bcg/ml), Minocycline (20 \u03bcg/ml), Nafcillin (1060 \u03bcg/ml), Enoxacin (0.9 \u03bcg/ml), Nalidixic Acid (6 \u03bcg/ml), Potassium tellurite (0.3 \u03bcg/ml), F-12 Neomycin (1.5 \u03bcg/ml), Ofloxacin (0.17 \u03bcg/ml), Carbenicillin (13 \u03bcg/ml), Oxacillin (1,116 \u03bcg/ml), D,L-Serine hydroxamate (844 \u03bcg/ml), Novobiocin (363 \u03bcg/ml) D,L-Serine hydroxamate (103 \u03bcg/ml), Dodecyltrimethyl ammonium bromide (246 \u03bcg/ml), respectively.Phenomic Analysis of Serratia marcescens Strain SRS-8-S-2018 ::: Results and DiscussionAfter correlating the findings from the antimicrobial resistance genes (ARGs) analysis and phenotype microarray (PM) antibiotic profile of Serratia sp.", [["Cloxacillin", "CHEMICAL", 115, 126], ["Lomefloxcin", "CHEMICAL", 140, 151], ["Minocycline", "CHEMICAL", 166, 177], ["Nafcillin", "CHEMICAL", 190, 199], ["Enoxacin", "CHEMICAL", 214, 222], ["Nalidixic Acid", "CHEMICAL", 236, 250], ["Potassium", "CHEMICAL", 262, 271], ["tellurite", "CHEMICAL", 272, 281], ["F-12 Neomycin", "CHEMICAL", 295, 308], ["Ofloxacin", "CHEMICAL", 322, 331], ["Carbenicillin", "CHEMICAL", 346, 359], ["Oxacillin", "CHEMICAL", 372, 381], ["L-Serine hydroxamate", "CHEMICAL", 399, 419], ["Novobiocin", "CHEMICAL", 433, 443], ["L-Serine hydroxamate", "CHEMICAL", 458, 478], ["Dodecyltrimethyl ammonium bromide", "CHEMICAL", 492, 525], ["Cloxacillin", "CHEMICAL", 115, 126], ["Lomefloxcin", "CHEMICAL", 140, 151], ["Minocycline", "CHEMICAL", 166, 177], ["Nafcillin", "CHEMICAL", 190, 199], ["Enoxacin", "CHEMICAL", 214, 222], ["Nalidixic Acid", "CHEMICAL", 236, 250], ["Potassium tellurite", "CHEMICAL", 262, 281], ["Neomycin", "CHEMICAL", 300, 308], ["Ofloxacin", "CHEMICAL", 322, 331], ["Carbenicillin", "CHEMICAL", 346, 359], ["Oxacillin", "CHEMICAL", 372, 381], ["L-Serine hydroxamate", "CHEMICAL", 399, 419], ["Novobiocin", "CHEMICAL", 433, 443], ["L-Serine hydroxamate", "CHEMICAL", 458, 478], ["Dodecyltrimethyl ammonium bromide", "CHEMICAL", 492, 525], ["Cloxacillin", "SIMPLE_CHEMICAL", 115, 126], ["Lomefloxcin", "SIMPLE_CHEMICAL", 140, 151], ["Minocycline", "SIMPLE_CHEMICAL", 166, 177], ["Nafcillin", "SIMPLE_CHEMICAL", 190, 199], ["Enoxacin", "SIMPLE_CHEMICAL", 214, 222], ["Nalidixic Acid", "SIMPLE_CHEMICAL", 236, 250], ["Potassium tellurite", "SIMPLE_CHEMICAL", 262, 281], ["F-12 Neomycin", "SIMPLE_CHEMICAL", 295, 308], ["Ofloxacin", "SIMPLE_CHEMICAL", 322, 331], ["Carbenicillin", "SIMPLE_CHEMICAL", 346, 359], ["Oxacillin", "SIMPLE_CHEMICAL", 372, 381], ["D", "SIMPLE_CHEMICAL", 397, 398], ["L-Serine hydroxamate", "SIMPLE_CHEMICAL", 399, 419], ["Novobiocin", "SIMPLE_CHEMICAL", 433, 443], ["L-Serine hydroxamate", "SIMPLE_CHEMICAL", 458, 478], ["Dodecyltrimethyl ammonium bromide", "SIMPLE_CHEMICAL", 492, 525], ["Serratia marcescens", "ORGANISM", 573, 592], ["Serratia sp", "ORGANISM", 778, 789], ["antimicrobial resistance genes", "DNA", 679, 709], ["ARGs", "DNA", 711, 715], ["Serratia marcescens", "SPECIES", 573, 592], ["Serratia marcescens", "SPECIES", 573, 592], ["The antibiotics", "TREATMENT", 0, 15], ["concentrations", "TREATMENT", 20, 34], ["Cloxacillin", "TREATMENT", 115, 126], ["Lomefloxcin", "TREATMENT", 140, 151], ["Minocycline", "TREATMENT", 166, 177], ["Nafcillin", "TREATMENT", 190, 199], ["Enoxacin", "TREATMENT", 214, 222], ["Nalidixic Acid", "TREATMENT", 236, 250], ["Potassium tellurite", "TREATMENT", 262, 281], ["Neomycin", "TREATMENT", 300, 308], ["Ofloxacin", "TREATMENT", 322, 331], ["Carbenicillin", "TREATMENT", 346, 359], ["Oxacillin", "TREATMENT", 372, 381], ["L-Serine hydroxamate", "TREATMENT", 399, 419], ["Novobiocin", "TREATMENT", 433, 443], ["L-Serine hydroxamate", "TREATMENT", 458, 478], ["Dodecyltrimethyl ammonium bromide", "TREATMENT", 492, 525], ["Phenomic Analysis", "TEST", 552, 569], ["Serratia marcescens", "PROBLEM", 573, 592], ["the antimicrobial resistance genes", "TREATMENT", 675, 709], ["phenotype microarray", "TEST", 730, 750], ["antibiotic profile", "TEST", 756, 774], ["Serratia sp", "PROBLEM", 778, 789], ["Serratia marcescens", "OBSERVATION", 573, 592], ["Serratia", "OBSERVATION", 778, 786]]], ["SRS-8-S-2018, it can be concluded that the Serratia sp.", [["Serratia sp", "ORGANISM", 43, 54], ["SRS", "TEST", 0, 3], ["the Serratia sp", "PROBLEM", 39, 54], ["Serratia", "OBSERVATION", 43, 51]]], ["SRS-8-S-2018 harbors a suite of ARGs against many antibiotics as well as metal resistant genes (MRGs).", [["SRS-8-S-2018", "CHEMICAL", 0, 12], ["ARGs", "SIMPLE_CHEMICAL", 32, 36], ["metal resistant genes", "DNA", 73, 94], ["MRGs", "DNA", 96, 100], ["SRS", "TEST", 0, 3], ["many antibiotics", "TREATMENT", 45, 61], ["metal resistant genes", "PROBLEM", 73, 94]]], ["The antibiotic profile of Serratia sp.", [["Serratia sp", "ORGANISM", 26, 37], ["The antibiotic profile", "TEST", 0, 22], ["Serratia sp", "PROBLEM", 26, 37], ["Serratia", "OBSERVATION", 26, 34]]], ["SRS-8-S-2018 was also mirrored in the genomic analysis (Figures 7A,B).", [["SRS", "TEST", 0, 3]]], ["Biolog PM MicroPlate\u2122 array assay on Serratia sp.", [["Serratia sp", "ORGANISM", 37, 48], ["Biolog PM MicroPlate\u2122 array assay", "TEST", 0, 33], ["Serratia sp", "PROBLEM", 37, 48]]], ["SRS-8-S-2018 yielded an extensive resistance pattern to antibiotics.", [["SRS-8-S-2018", "CHEMICAL", 0, 12], ["SRS", "TEST", 0, 3], ["an extensive resistance pattern", "PROBLEM", 21, 52], ["antibiotics", "TREATMENT", 56, 67], ["extensive", "OBSERVATION_MODIFIER", 24, 33], ["resistance", "OBSERVATION", 34, 44]]], ["The development of a broad spectrum of ARGs in strain SRS-8-S-2018 are very likely due to the stress imposed by the long-term contamination of SRS soils with Hg and U, thus presenting with serious public health and ecological risks.", [["SRS", "DISEASE", 143, 146], ["Hg", "CHEMICAL", 158, 160], ["Hg", "CHEMICAL", 158, 160], ["strain SRS", "TEST", 47, 57], ["the stress", "PROBLEM", 90, 100], ["broad", "OBSERVATION_MODIFIER", 21, 26]]], ["Note that Hg resistance is almost invariably found to co-occur with antibiotic resistance, specifically for ampicillin, tetracycline, erythromycin, and penicillin (Ready et al., 2003).", [["Hg", "CHEMICAL", 10, 12], ["ampicillin", "CHEMICAL", 108, 118], ["tetracycline", "CHEMICAL", 120, 132], ["erythromycin", "CHEMICAL", 134, 146], ["penicillin", "CHEMICAL", 152, 162], ["Hg", "CHEMICAL", 10, 12], ["ampicillin", "CHEMICAL", 108, 118], ["tetracycline", "CHEMICAL", 120, 132], ["erythromycin", "CHEMICAL", 134, 146], ["penicillin", "CHEMICAL", 152, 162], ["Hg", "SIMPLE_CHEMICAL", 10, 12], ["ampicillin", "SIMPLE_CHEMICAL", 108, 118], ["tetracycline", "SIMPLE_CHEMICAL", 120, 132], ["erythromycin", "SIMPLE_CHEMICAL", 134, 146], ["penicillin", "SIMPLE_CHEMICAL", 152, 162], ["Hg resistance", "PROBLEM", 10, 23], ["antibiotic resistance", "TREATMENT", 68, 89], ["ampicillin", "TREATMENT", 108, 118], ["tetracycline", "TREATMENT", 120, 132], ["erythromycin", "TREATMENT", 134, 146], ["penicillin", "TREATMENT", 152, 162], ["Hg resistance", "OBSERVATION", 10, 23]]], ["Therefore, presence of Hg and U stressors present in the SRS soils pose public health and ecological concerns from the metal driven antibiotic resistome or vice versa.Genome-Wide Functional Comparisons Between Environmental and Medical Isolates of Serratia marcescens ::: Results and DiscussionSerratia marcescens represents a recently recognized pathogenic species and hence remains largely understudied.", [["Hg", "CHEMICAL", 23, 25], ["U", "CHEMICAL", 30, 31], ["Hg", "CHEMICAL", 23, 25], ["U", "GENE_OR_GENE_PRODUCT", 30, 31], ["Serratia marcescens", "ORGANISM", 248, 267], ["DiscussionSerratia marcescens", "ORGANISM", 284, 313], ["Serratia marcescens", "SPECIES", 248, 267], ["DiscussionSerratia marcescens", "SPECIES", 284, 313], ["Serratia marcescens", "SPECIES", 248, 267], ["DiscussionSerratia marcescens", "SPECIES", 284, 313], ["Hg and U stressors", "PROBLEM", 23, 41], ["the metal driven antibiotic resistome", "TREATMENT", 115, 152], ["Serratia marcescens", "PROBLEM", 248, 267], ["DiscussionSerratia marcescens", "PROBLEM", 284, 313], ["a recently recognized pathogenic species", "PROBLEM", 325, 365], ["pathogenic species", "OBSERVATION", 347, 365]]], ["Furthermore, whole genome sequence projects on this pathogen have also only recently become available to the scientific community (Abreo and Altier, 2019), thus limited understanding is available on the genome-wide adaptive traits of S. marcescens as a pathogenic agent.", [["S. marcescens", "ORGANISM", 234, 247], ["S. marcescens", "SPECIES", 234, 247], ["S. marcescens", "SPECIES", 234, 247], ["S. marcescens", "TREATMENT", 234, 247], ["a pathogenic agent", "TREATMENT", 251, 269]]], ["Toward this end, this study reveals evolutionary and adaptive traits possessed by an environmental Serratia species, and in particular, carriage of heavy metal and antibiotic resistance gene determinants.", [["antibiotic resistance gene determinants", "PROTEIN", 164, 203], ["this study", "TEST", 17, 27], ["evolutionary and adaptive traits", "PROBLEM", 36, 68], ["an environmental Serratia species", "PROBLEM", 82, 115], ["heavy metal", "TREATMENT", 148, 159], ["antibiotic resistance gene", "TREATMENT", 164, 190], ["Serratia species", "OBSERVATION", 99, 115], ["antibiotic resistance", "OBSERVATION", 164, 185]]], ["It is very likely that broad antibiotic resistances are being acquired by microbiomes, such as Serratia, in sites that remain historically contaminated with heavy metals, which is a major public health concern.", [["broad antibiotic resistances", "TREATMENT", 23, 51], ["Serratia", "PROBLEM", 95, 103], ["very likely", "UNCERTAINTY", 6, 17], ["broad", "OBSERVATION_MODIFIER", 23, 28], ["antibiotic resistances", "OBSERVATION", 29, 51], ["Serratia", "OBSERVATION", 95, 103]]], ["Note that resistance of opportunistic pathogens to one or more antibiotics has been recognized as a global crisis, which needs immediate attention such that a major pathogenic outbreak such as the COVID-19, can be avoided.", [["opportunistic pathogens", "DISEASE", 24, 47], ["opportunistic pathogens", "PROBLEM", 24, 47], ["antibiotics", "TREATMENT", 63, 74], ["a global crisis", "PROBLEM", 98, 113], ["a major pathogenic outbreak", "PROBLEM", 157, 184], ["the COVID", "TEST", 193, 202], ["global", "OBSERVATION_MODIFIER", 100, 106], ["crisis", "OBSERVATION", 107, 113]]], ["Even though COVID-19 is a viral disease but some preliminary estimates suggest that 50% of mortalities are occurring from nosocomial secondary infections.", [["viral disease", "DISEASE", 26, 39], ["nosocomial secondary infections", "DISEASE", 122, 153], ["COVID-19", "SPECIES", 12, 20], ["COVID", "TEST", 12, 17], ["a viral disease", "PROBLEM", 24, 39], ["nosocomial secondary infections", "PROBLEM", 122, 153], ["viral disease", "OBSERVATION", 26, 39], ["nosocomial", "OBSERVATION_MODIFIER", 122, 132], ["secondary", "OBSERVATION_MODIFIER", 133, 142], ["infections", "OBSERVATION", 143, 153]]], ["Therefore, one broader recommendation from this study is to take immediate action against development of multidrug resistant bacteria and develop strategies should a bacterial pathogen outbreak occur that is similar in magnitude to the ongoing COVID-19, as of this writing.Genome-Wide Functional Comparisons Between Environmental and Medical Isolates of Serratia marcescens ::: Results and DiscussionIt is noteworthy that outbreaks related to S. marcescens and other Serratia species have occurred sporadically since 1950s (Grohskopf et al., 2001; Mahlen, 2011; Yao et al., 2016), mainly in neonatal and cardiac ICUs, orthopedic clinics and dialysis centers.", [["cardiac", "ANATOMY", 604, 611], ["Serratia marcescens", "ORGANISM", 354, 373], ["S. marcescens", "ORGANISM", 443, 456], ["Serratia species", "ORGANISM", 467, 483], ["Serratia marcescens", "SPECIES", 354, 373], ["S. marcescens", "SPECIES", 443, 456], ["Serratia marcescens", "SPECIES", 354, 373], ["S. marcescens", "SPECIES", 443, 456], ["this study", "TEST", 43, 53], ["multidrug resistant bacteria", "PROBLEM", 105, 133], ["a bacterial pathogen outbreak", "PROBLEM", 164, 193], ["the ongoing COVID", "TEST", 232, 249], ["Serratia marcescens", "PROBLEM", 354, 373], ["S. marcescens", "PROBLEM", 443, 456], ["other Serratia species", "PROBLEM", 461, 483], ["dialysis centers", "TREATMENT", 641, 657], ["Serratia", "OBSERVATION", 467, 475], ["cardiac", "ANATOMY", 604, 611]]], ["There is a large body of information available on Serratia epidemiology and resistance patterns and S. marcescens strains are typically resistant to all penicillins and susceptible to all carbapenems; a recent study, however, was found resistant to all tested antibiotics (Bertrand and Dowzicky, 2012).", [["penicillins", "CHEMICAL", 153, 164], ["carbapenems", "CHEMICAL", 188, 199], ["penicillins", "CHEMICAL", 153, 164], ["carbapenems", "CHEMICAL", 188, 199], ["S. marcescens strains", "ORGANISM", 100, 121], ["penicillins", "SIMPLE_CHEMICAL", 153, 164], ["carbapenems", "SIMPLE_CHEMICAL", 188, 199], ["S. marcescens", "SPECIES", 100, 113], ["S. marcescens", "SPECIES", 100, 113], ["Serratia epidemiology", "TEST", 50, 71], ["resistance patterns", "PROBLEM", 76, 95], ["S. marcescens strains", "PROBLEM", 100, 121], ["all penicillins", "TREATMENT", 149, 164], ["all carbapenems", "TREATMENT", 184, 199], ["a recent study", "TEST", 201, 215], ["all tested antibiotics", "TREATMENT", 249, 271], ["large", "OBSERVATION_MODIFIER", 11, 16], ["body", "OBSERVATION_MODIFIER", 17, 21]]], ["However, not much is known on the antimicrobial patterns of environmental Serratia members, and this study addresses this gap.", [["Serratia members", "ORGANISM", 74, 90], ["this study", "TEST", 96, 106]]], ["More recently, pangenome-based analysis of 49 S. marcescens strains from nosocomial and environmental origins as well as different countries, revealed consistently presence of high number of ARGs (Abreo and Altier, 2019), likely due to stress imposed by environmental contaminants, as also suggested in this study on strain SRS-8-S-2018.", [["S. marcescens strains", "ORGANISM", 46, 67], ["S. marcescens", "SPECIES", 46, 59], ["S. marcescens", "SPECIES", 46, 59], ["pangenome", "TEST", 15, 24], ["S. marcescens strains", "PROBLEM", 46, 67], ["nosocomial", "PROBLEM", 73, 83], ["high number of ARGs", "PROBLEM", 176, 195], ["stress", "PROBLEM", 236, 242], ["environmental contaminants", "PROBLEM", 254, 280], ["this study", "TEST", 303, 313], ["strain SRS", "TEST", 317, 327], ["nosocomial", "OBSERVATION", 73, 83], ["high", "OBSERVATION_MODIFIER", 176, 180], ["number", "OBSERVATION_MODIFIER", 181, 187], ["likely due to", "UNCERTAINTY", 222, 235], ["stress", "OBSERVATION", 236, 242], ["environmental contaminants", "OBSERVATION", 254, 280]]], ["To obtain a better understanding on the relationship between the environmentally relevant S. marcescens strain SRS-8-S-2018 with some other medical/clinically relevant isolates, comparative whole genome analysis was run using the Integrated Microbial Genomes (IMG) system, and results are shown in Figure 9.", [["S. marcescens", "ORGANISM", 90, 103], ["S. marcescens", "SPECIES", 90, 103], ["S. marcescens", "SPECIES", 90, 103], ["comparative whole genome analysis", "TEST", 178, 211]]], ["Specifically, we selected the closest taxonomic relatives of strain SRS-8-S-2018 identified in previous analysis, such as S. marcescens WW4, S. marcescens EGD-HP20, along with several strains isolated from bacteremia or clinical settings, such as S. marcescens UMH12, S. marcescens 332; a total of 32 S. marcescens strains were included in this analysis.", [["bacteremia", "DISEASE", 206, 216], ["SRS-8-S-2018", "CELL", 68, 80], ["S. marcescens WW4", "ORGANISM", 122, 139], ["S. marcescens", "ORGANISM", 141, 154], ["EGD-HP20", "ORGANISM", 155, 163], ["S. marcescens UMH12", "ORGANISM", 247, 266], ["S. marcescens 332", "ORGANISM", 268, 285], ["S. marcescens", "ORGANISM", 301, 314], ["strains", "ORGANISM", 315, 322], ["S. marcescens", "SPECIES", 122, 135], ["S. marcescens", "SPECIES", 141, 154], ["S. marcescens", "SPECIES", 247, 260], ["S. marcescens", "SPECIES", 268, 281], ["S. marcescens", "SPECIES", 301, 314], ["S. marcescens", "SPECIES", 122, 135], ["S. marcescens EGD-HP20", "SPECIES", 141, 163], ["S. marcescens", "SPECIES", 247, 260], ["S. marcescens", "SPECIES", 268, 281], ["S. marcescens", "SPECIES", 301, 314], ["strain SRS", "TEST", 61, 71], ["previous analysis", "TEST", 95, 112], ["S. marcescens", "TEST", 122, 135], ["S. marcescens EGD", "TEST", 141, 158], ["HP20", "PROBLEM", 159, 163], ["several strains", "PROBLEM", 176, 191], ["bacteremia", "PROBLEM", 206, 216], ["S. marcescens", "TEST", 247, 260], ["S. marcescens", "TEST", 268, 281], ["S. marcescens strains", "PROBLEM", 301, 322], ["this analysis", "TEST", 340, 353], ["bacteremia", "OBSERVATION", 206, 216]]], ["Remarkably, strain SRS-8-S-2018 clustered closest to the strains UMH 6 and UMH 12 in a PCA drawn on COG profiles for the selected genomes (Figure 9A).", [["UMH 6", "CELL", 65, 70], ["UMH 12", "CELL", 75, 81], ["strains UMH 6", "DNA", 57, 70], ["UMH 12", "DNA", 75, 81], ["strain SRS", "TEST", 12, 22], ["UMH", "TEST", 75, 78], ["a PCA", "TEST", 85, 90], ["COG profiles", "TEST", 100, 112]]], ["Conversely, strains WW4 and EGD-HP20- the closest taxonomic relatives of strain SRS-8-S-2018, clustered away from the cohort with which strain SRS-8-S-2018 clustered, which were all medically relevant strains.", [["EGD-HP20", "ORGANISM", 28, 36], ["SRS-8-S-2018", "CELL", 80, 92], ["S-2018", "CELL", 149, 155], ["strains", "PROBLEM", 12, 19], ["EGD", "TEST", 28, 31], ["HP20", "TEST", 32, 36], ["strain SRS", "TEST", 73, 83], ["strain SRS", "TEST", 136, 146]]], ["As stated before, COGs represent families of orthologous protein-coding genes and is a reliable assessment of comparing protein phylogeny from microbial genomes (Galperin et al., 2019), and hence, is a functional assessment of a bacteria of interest.", [["orthologous protein-coding genes", "DNA", 45, 77], ["orthologous protein", "PROBLEM", 45, 64], ["a reliable assessment", "TEST", 85, 106], ["a functional assessment", "TEST", 200, 223], ["a bacteria of interest", "PROBLEM", 227, 249]]], ["This observation was again confirmed when PCA clustering was based on the presence of KEGG pathway (EC) profiles (Figure 9B), which is based on the enzymatically catalyzed network of metabolic pathways and reactions, constructed upon the entirety of all available biochemical information and is not organism-specific.", [["EC", "ANATOMY", 100, 102], ["EC", "CELL", 100, 102], ["This observation", "TEST", 0, 16], ["PCA clustering", "PROBLEM", 42, 56]]], ["Similar to the COG-based analysis, the closest association of strain SRS-8-S-2018 was with strains UMH7 and 332- many of these strains were active in bacteremia (Anderson et al., 2017).", [["bacteremia", "DISEASE", 150, 160], ["strain SRS", "TEST", 62, 72], ["strains UMH7", "TEST", 91, 103], ["these strains", "PROBLEM", 121, 134], ["bacteremia", "PROBLEM", 150, 160], ["active", "OBSERVATION_MODIFIER", 140, 146], ["bacteremia", "OBSERVATION", 150, 160]]], ["Overall, this is strong evidence that strain SRS-8-S-2018, isolated from a metalliferous contaminated soil environment, is functionally more similar to medically relevant isolates.", [["SRS-8-S-2018", "CHEMICAL", 45, 57], ["strain SRS", "TEST", 38, 48], ["a metalliferous contaminated soil environment", "PROBLEM", 73, 118]]], ["Overall, this is succinct evidence that the environment is potentially serving as a niche for the development, recruitment and proliferation of pathogenic traits within Serratia species, which needs to be evaluated to obtain mitigation strategies and avoidance of possible future pathogenic outbreaks emanating from ecological systems; as is indicative for the origin of the COVID-19 viral pathogen from bats, which is likely the main reservoir for this pathogen (Banerjee et al., 2019; Andersen et al., 2020).Data Availability StatementThe datasets presented in this study can be found in online repositories.", [["Serratia species", "ORGANISM", 169, 185], ["COVID-19 viral", "ORGANISM", 375, 389], ["pathogenic traits within Serratia species", "PROBLEM", 144, 185], ["mitigation strategies", "TREATMENT", 225, 246], ["future pathogenic outbreaks", "PROBLEM", 273, 300], ["the COVID", "TEST", 371, 380], ["viral pathogen", "PROBLEM", 384, 398], ["this study", "TEST", 563, 573], ["indicative for", "UNCERTAINTY", 342, 356], ["viral pathogen", "OBSERVATION", 384, 398]]], ["SG, AP, and AC performed the genomic analysis.", [["SG, AP, and AC", "TEST", 0, 14], ["the genomic analysis", "TEST", 25, 45]]], ["SG, MA, and RR performed the BIOLOG and phenomic tests and analyzed the results.", [["RR", "TEST", 12, 14], ["the BIOLOG and phenomic tests", "TEST", 25, 54]]], ["AC, SG, AP, MA, RR, and RJ drafted the manuscript.", [["RR", "TEST", 16, 18]]]], "c356824bf71180c7e6f11a2829f380557a80f6f8": [["In this issue of Travel Medicine and Infectious Disease, Hon urges health authorities to provide consistant terminology for respiratory syndromes and illustrates the importance of travel in the dissemination of such disease [1] .", [["respiratory", "ANATOMY", 124, 135], ["Infectious Disease", "DISEASE", 37, 55], ["respiratory syndromes", "DISEASE", 124, 145], ["respiratory syndromes", "PROBLEM", 124, 145]]], ["The latest respiratory syndrome to cause waves in the infectious disease world is the Middle East Respiratory Syndrome (MERS).", [["respiratory syndrome", "DISEASE", 11, 31], ["infectious disease", "DISEASE", 54, 72], ["Middle East Respiratory Syndrome", "DISEASE", 86, 118], ["MERS", "DISEASE", 120, 124], ["The latest respiratory syndrome", "PROBLEM", 0, 31], ["the infectious disease", "PROBLEM", 50, 72], ["the Middle East Respiratory Syndrome", "PROBLEM", 82, 118], ["respiratory syndrome", "OBSERVATION", 11, 31], ["infectious", "OBSERVATION", 54, 64], ["Middle", "ANATOMY_MODIFIER", 86, 92], ["Respiratory Syndrome", "OBSERVATION", 98, 118]]], ["This is a new human disease that was first reported from Saudi Arabia after identification of a novel coronavirus (CoV) from a Saudi Arabian patient who died from severe respiratory illness in June, 2012 [2] .", [["respiratory", "ANATOMY", 170, 181], ["respiratory illness", "DISEASE", 170, 189], ["human", "ORGANISM", 14, 19], ["coronavirus", "ORGANISM", 102, 113], ["CoV", "ORGANISM", 115, 118], ["patient", "ORGANISM", 141, 148], ["human", "SPECIES", 14, 19], ["coronavirus", "SPECIES", 102, 113], ["patient", "SPECIES", 141, 148], ["human", "SPECIES", 14, 19], ["CoV", "SPECIES", 115, 118], ["a new human disease", "PROBLEM", 8, 27], ["a novel coronavirus", "PROBLEM", 94, 113], ["severe respiratory illness", "PROBLEM", 163, 189], ["new", "OBSERVATION_MODIFIER", 10, 13], ["human", "OBSERVATION_MODIFIER", 14, 19], ["disease", "OBSERVATION", 20, 27], ["severe", "OBSERVATION_MODIFIER", 163, 169], ["respiratory", "ANATOMY", 170, 181], ["illness", "OBSERVATION", 182, 189]]]], "PMC7110242": [["1 INTRODUCTIONA crucial aspect in protein functioning is correct localization within the cell, and a variety of mechanisms, often based on special targeting sequences, exist to ensure proper delivery of proteins.", [["cell", "ANATOMY", 89, 93], ["cell", "CELL", 89, 93], ["special targeting sequences", "TEST", 139, 166], ["proper delivery of proteins", "TREATMENT", 184, 211], ["protein functioning", "OBSERVATION", 34, 53], ["cell", "OBSERVATION", 89, 93]]], ["The initial development of predictors such as PSORT I (Nakai and Kanehisa, 1991) has resulted in a wide array of methods to predict protein sub-cellular compartment localization on the basis of sequence information (Emanuelsson, 2002; Gardy and Brinkman, 2006; Schneider and Fechner, 2004).", [["cellular compartment", "ANATOMY", 144, 164], ["PSORT I", "PROTEIN", 46, 53]]], ["Although the usefulness of general localization predictors is without doubt, fine-grained models of cellular processes require insight into sub-compartmental localization of proteins, e.g. in plasma membrane microdomains (Buist et al., 2006) or sub-nuclear compartments (Lei and Dai, 2005).1 INTRODUCTIONThe biologically important secretory pathway consists of among others ER and Golgi, the latter of which is compartmentalized into cis-, medial- and trans-Golgi and Trans Golgi Network (TGN).", [["cellular", "ANATOMY", 100, 108], ["plasma membrane microdomains", "ANATOMY", 192, 220], ["nuclear compartments", "ANATOMY", 249, 269], ["ER", "ANATOMY", 374, 376], ["Golgi", "ANATOMY", 381, 386], ["Golgi", "ANATOMY", 458, 463], ["TGN", "ANATOMY", 489, 492], ["cellular", "CELL", 100, 108], ["plasma", "CELLULAR_COMPONENT", 192, 198], ["membrane microdomains", "CELLULAR_COMPONENT", 199, 220], ["ER", "GENE_OR_GENE_PRODUCT", 374, 376], ["Golgi", "CELLULAR_COMPONENT", 381, 386], ["Golgi", "CELLULAR_COMPONENT", 458, 463], ["Trans Golgi", "CELLULAR_COMPONENT", 468, 479], ["TGN", "CELLULAR_COMPONENT", 489, 492], ["ER", "PROTEIN", 374, 376], ["Golgi", "PROTEIN", 381, 386], ["TGN", "PROTEIN", 489, 492], ["cellular processes", "PROBLEM", 100, 118], ["cellular processes", "OBSERVATION", 100, 118]]], ["Sub-Golgi localization is important for various processes.", [["Golgi", "ANATOMY", 4, 9], ["Golgi", "CELLULAR_COMPONENT", 4, 9], ["various processes", "PROBLEM", 40, 57], ["Golgi localization", "OBSERVATION", 4, 22]]], ["In particular, N-glycans influence protein conformation, stability and biological activity (Lehle et al., 2006) and the sequence of additions and trimmings of N-glycans to and from glycoproteins is governed by the sub-Golgi location of glycosyltransferases and glycosidases (Colley, 1997).", [["Golgi", "ANATOMY", 218, 223], ["N", "CHEMICAL", 15, 16], ["N", "CHEMICAL", 159, 160], ["N-glycans", "GENE_OR_GENE_PRODUCT", 15, 24], ["N-glycans", "GENE_OR_GENE_PRODUCT", 159, 168], ["Golgi", "CELLULAR_COMPONENT", 218, 223], ["glycosidases", "GENE_OR_GENE_PRODUCT", 261, 273], ["glycoproteins", "PROTEIN", 181, 194], ["glycosyltransferases", "PROTEIN", 236, 256], ["glycosidases", "PROTEIN", 261, 273], ["trimmings of N-glycans", "TREATMENT", 146, 168], ["glycoproteins", "TREATMENT", 181, 194], ["stability", "OBSERVATION_MODIFIER", 57, 66]]], ["Most of these enzymes are type II transmembrane proteins, which contain a single pass transmembrane domain (TMD); in addition, they consist of a cytoplasmic N-terminus and a luminal stem domain which links the TMD to the luminal C-terminal catalytic domain (Breton et al., 2006).", [["cytoplasmic", "ANATOMY", 145, 156], ["luminal stem", "ANATOMY", 174, 186], ["luminal", "ANATOMY", 221, 228], ["luminal", "CHEMICAL", 174, 181], ["luminal", "CHEMICAL", 221, 228], ["N", "CHEMICAL", 157, 158], ["C", "CHEMICAL", 229, 230], ["type II transmembrane", "GENE_OR_GENE_PRODUCT", 26, 47], ["cytoplasmic", "ORGANISM_SUBSTANCE", 145, 156], ["enzymes", "PROTEIN", 14, 21], ["type II transmembrane proteins", "PROTEIN", 26, 56], ["transmembrane domain", "PROTEIN", 86, 106], ["TMD", "PROTEIN", 108, 111], ["cytoplasmic N-terminus", "PROTEIN", 145, 167], ["luminal stem domain", "PROTEIN", 174, 193], ["TMD", "PROTEIN", 210, 213], ["luminal C-terminal catalytic domain", "PROTEIN", 221, 256], ["these enzymes", "TEST", 8, 21], ["type II transmembrane proteins", "PROBLEM", 26, 56], ["a single pass transmembrane domain", "PROBLEM", 72, 106], ["a cytoplasmic N-terminus", "TREATMENT", 143, 167], ["a luminal stem domain", "PROBLEM", 172, 193], ["luminal stem", "ANATOMY", 174, 186], ["luminal", "ANATOMY_MODIFIER", 221, 228], ["terminal", "ANATOMY_MODIFIER", 231, 239]]], ["Various regions have been implicated specifically as localization signal sequence, depending on the enzyme being investigated: the length of the TMD (Saint-Jore-Dupas et al., 2006), the cytoplasmic N-terminal domain (Zerfaoui et al., 2002), and the combined cytoplasmic, transmembrane and stem (CTS) regions (Grabenhorst and Conradt, 1999).", [["cytoplasmic", "ANATOMY", 186, 197], ["cytoplasmic", "ANATOMY", 258, 269], ["transmembrane", "ANATOMY", 271, 284], ["N", "CHEMICAL", 198, 199], ["cytoplasmic", "ORGANISM_SUBSTANCE", 186, 197], ["cytoplasmic", "ORGANISM_SUBSTANCE", 258, 269], ["transmembrane", "CELLULAR_COMPONENT", 271, 284], ["cytoplasmic N-terminal domain", "PROTEIN", 186, 215], ["cytoplasmic, transmembrane and stem (CTS) regions", "PROTEIN", 258, 307], ["localization signal sequence", "TEST", 53, 81], ["the enzyme", "TEST", 96, 106], ["the cytoplasmic N", "TEST", 182, 199], ["the combined cytoplasmic, transmembrane and stem (CTS) regions", "PROBLEM", 245, 307], ["stem", "ANATOMY", 289, 293]]], ["Experimental exchange of the CTS domains has been shown to result in altered enzyme locations with which the glycosidase assembly line could be redesigned for the production of specific glycan structures (Czlapinski and Bertozzi, 2006).1 INTRODUCTIONA second type of biologically important type II proteins for which sub-Golgi localization is highly relevant are Golgi SNAREs, which are involved in vesicle trafficking; the localization of t-SNAREs determines which vesicles (containing corresponding v-SNAREs) can dock (Puthenveedu and Linstedt, 2005).", [["Golgi", "ANATOMY", 321, 326], ["Golgi SNAREs", "ANATOMY", 363, 375], ["vesicle", "ANATOMY", 399, 406], ["vesicles", "ANATOMY", 466, 474], ["CTS", "DISEASE", 29, 32], ["glycosidase", "GENE_OR_GENE_PRODUCT", 109, 120], ["type II proteins", "GENE_OR_GENE_PRODUCT", 290, 306], ["Golgi", "CELLULAR_COMPONENT", 321, 326], ["Golgi SNAREs", "CELLULAR_COMPONENT", 363, 375], ["vesicle", "CELLULAR_COMPONENT", 399, 406], ["t-SNAREs", "GENE_OR_GENE_PRODUCT", 440, 448], ["vesicles", "CELLULAR_COMPONENT", 466, 474], ["CTS domains", "PROTEIN", 29, 40], ["type II proteins", "PROTEIN", 290, 306], ["Golgi SNAREs", "PROTEIN", 363, 375], ["t-SNAREs", "PROTEIN", 440, 448], ["v-SNAREs", "PROTEIN", 501, 509], ["the CTS domains", "TEST", 25, 40], ["altered enzyme locations", "PROBLEM", 69, 93], ["the glycosidase assembly line", "PROBLEM", 105, 134], ["t-SNAREs", "TREATMENT", 440, 448], ["Golgi SNAREs", "OBSERVATION", 363, 375]]], ["Experimental localization of these and other proteins in the Golgi is relatively easy but sub-Golgi localization requires complicated experimental approaches and consequently, many proteins are annotated as Golgi-localized without known sub-Golgi localization.1 INTRODUCTIONDifferent mechanisms have been proposed for Golgi and post-Golgi localization: (1) the TMD length can play a role according to the bilayer thickness model for Golgi retention, which proposes that the shorter TMD of Golgi proteins prevents them from entering cholesterol-rich transport vesicles destined for the plasma membrane (Webb et al., 1998); (2) alternatively, the formation of oligomers within the Golgi may prevent protein movement into transport vesicles (Colley, 1997).", [["Golgi", "ANATOMY", 61, 66], ["Golgi", "ANATOMY", 94, 99], ["Golgi", "ANATOMY", 241, 246], ["Golgi", "ANATOMY", 318, 323], ["Golgi", "ANATOMY", 333, 338], ["Golgi", "ANATOMY", 433, 438], ["Golgi", "ANATOMY", 489, 494], ["vesicles", "ANATOMY", 559, 567], ["plasma membrane", "ANATOMY", 585, 600], ["Golgi", "ANATOMY", 679, 684], ["transport vesicles", "ANATOMY", 719, 737], ["cholesterol", "CHEMICAL", 532, 543], ["cholesterol", "CHEMICAL", 532, 543], ["Golgi", "CELLULAR_COMPONENT", 61, 66], ["Golgi", "CELLULAR_COMPONENT", 94, 99], ["Golgi-", "GENE_OR_GENE_PRODUCT", 207, 213], ["Golgi", "CELLULAR_COMPONENT", 241, 246], ["Golgi", "CELLULAR_COMPONENT", 318, 323], ["Golgi", "CELLULAR_COMPONENT", 333, 338], ["Golgi", "CELLULAR_COMPONENT", 433, 438], ["Golgi", "CELLULAR_COMPONENT", 489, 494], ["cholesterol", "SIMPLE_CHEMICAL", 532, 543], ["transport vesicles", "CELLULAR_COMPONENT", 549, 567], ["plasma membrane", "CELLULAR_COMPONENT", 585, 600], ["Golgi", "CELLULAR_COMPONENT", 679, 684], ["vesicles", "CELLULAR_COMPONENT", 729, 737], ["Golgi-", "PROTEIN", 207, 213], ["Golgi proteins", "PROTEIN", 489, 503], ["the bilayer thickness model", "TREATMENT", 401, 428], ["Golgi retention", "PROBLEM", 433, 448], ["the shorter TMD of Golgi proteins", "PROBLEM", 470, 503], ["the plasma membrane", "TEST", 581, 600], ["the formation of oligomers", "PROBLEM", 641, 667], ["Golgi localization", "OBSERVATION", 241, 259], ["Golgi retention", "OBSERVATION", 433, 448], ["protein movement", "OBSERVATION", 697, 713]]], ["A predictor has been previously developed for Golgi versus post-Golgi localization, based on hydrophobicity and frequency of different residues within the TMD of type II membrane proteins (Yuan and Teasdale, 2002).", [["Golgi", "ANATOMY", 46, 51], ["Golgi", "ANATOMY", 64, 69], ["membrane", "ANATOMY", 170, 178], ["Golgi", "CELLULAR_COMPONENT", 46, 51], ["Golgi", "CELLULAR_COMPONENT", 64, 69], ["type II membrane proteins", "GENE_OR_GENE_PRODUCT", 162, 187], ["type II membrane proteins", "PROTEIN", 162, 187], ["hydrophobicity", "PROBLEM", 93, 107], ["different residues", "PROBLEM", 125, 143], ["different residues", "OBSERVATION", 125, 143]]], ["Here we develop a predictor specifically for the sub-compartments within the Golgi part of the secretion pathway: cis-, medial- and trans-Golgi and the TGN.", [["sub-compartments", "ANATOMY", 49, 65], ["Golgi", "ANATOMY", 77, 82], ["Golgi", "ANATOMY", 138, 143], ["TGN", "ANATOMY", 152, 155], ["Golgi", "CELLULAR_COMPONENT", 77, 82], ["Golgi", "CELLULAR_COMPONENT", 138, 143], ["TGN", "CELLULAR_COMPONENT", 152, 155], ["cis-, medial- and trans-Golgi", "PROTEIN", 114, 143], ["TGN", "PROTEIN", 152, 155], ["cis-", "TEST", 114, 118], ["medial", "OBSERVATION_MODIFIER", 120, 126]]], ["It is known that the composition of ER, Golgi and plasma-membranes differs (Mitra et al., 2004; van Meer et al., 2008) and likewise the membrane composition of the different sub-Golgi compartments may vary; we therefore reasoned that the TMD of type II membrane proteins may contain signatures that help identify their preferred location, even though these TMD characteristics themselves may not be the single driving force that targets these proteins to their location.1 INTRODUCTIONOur approach takes the following steps: (1) assembly of an exhaustive dataset of experimentally determined sub-Golgi localization for type II transmembrane proteins; (2) development of a predictor based on this dataset; we specifically assess whether the TMD contains enough information to develop such a predictor; and (3) application of the predictor to several glycosylation-related enzymes and SNAREs.", [["ER", "ANATOMY", 36, 38], ["Golgi", "ANATOMY", 40, 45], ["plasma-membranes", "ANATOMY", 50, 66], ["membrane", "ANATOMY", 136, 144], ["sub-Golgi compartments", "ANATOMY", 174, 196], ["membrane", "ANATOMY", 253, 261], ["Golgi", "ANATOMY", 595, 600], ["ER", "GENE_OR_GENE_PRODUCT", 36, 38], ["Golgi", "CELLULAR_COMPONENT", 40, 45], ["plasma-membranes", "CELLULAR_COMPONENT", 50, 66], ["membrane", "CELLULAR_COMPONENT", 136, 144], ["type II membrane proteins", "GENE_OR_GENE_PRODUCT", 245, 270], ["Golgi", "CELLULAR_COMPONENT", 595, 600], ["type II transmembrane", "GENE_OR_GENE_PRODUCT", 618, 639], ["SNAREs", "GENE_OR_GENE_PRODUCT", 882, 888], ["ER", "PROTEIN", 36, 38], ["type II membrane proteins", "PROTEIN", 245, 270], ["type II transmembrane proteins", "PROTEIN", 618, 648], ["glycosylation-related enzymes", "PROTEIN", 848, 877], ["SNAREs", "PROTEIN", 882, 888], ["the TMD of type II membrane proteins", "PROBLEM", 234, 270], ["type II transmembrane proteins", "PROBLEM", 618, 648], ["the TMD", "PROBLEM", 735, 742]]], ["Because the available amount of type II transmembrane proteins with known sub-Golgi localization is small, we followed an innovative approach where we use additional homologous sequences in the training set of our predictor.", [["Golgi", "ANATOMY", 78, 83], ["type II transmembrane", "GENE_OR_GENE_PRODUCT", 32, 53], ["Golgi", "CELLULAR_COMPONENT", 78, 83], ["type II transmembrane proteins", "PROTEIN", 32, 62], ["type II transmembrane proteins", "PROBLEM", 32, 62], ["additional homologous sequences", "TREATMENT", 155, 186], ["small", "OBSERVATION_MODIFIER", 100, 105]]], ["As prediction algorithm we chose the support vector machine (SVM) algorithm which can incorporate sequence information via the kernel function.", [["prediction algorithm", "TEST", 3, 23]]], ["A variety of string-based kernel functions exist, ranging from bag-of-words kernels (mainly useful for document classification) to dedicated kernels for protein sequence analysis, most notably substring spectrum kernels (which count the occurrence of substrings) and variations e.g. including gaps (Lodhi et al., 2002).", [["protein sequence analysis", "TEST", 153, 178], ["variety", "OBSERVATION_MODIFIER", 2, 9]]], ["We tailor the definition of the kernel such that it fits the nature of our biological problem, i.e. prediction based on TMD sequence.", [["TMD sequence", "TEST", 120, 132]]], ["Since the TMD has a well-defined alpha-helical structure it is rational to take this into account when defining a kernel.", [["TMD", "DISEASE", 10, 13], ["alpha-helical structure", "PROTEIN", 33, 56], ["a well-defined alpha-helical structure", "PROBLEM", 18, 56], ["well-defined", "OBSERVATION_MODIFIER", 20, 32], ["alpha-helical structure", "OBSERVATION", 33, 56]]], ["This approach is an example of applying structure-based features in kernel functions, which to our knowledge has not previously been explored in depth.", [["kernel functions", "OBSERVATION", 68, 84]]], ["Our results show that this approach indeed can be used to predict sub-Golgi localization, and we provide several examples of valuable applications of our predictions.2.1 Localization dataset and prediction of type II membrane proteins ::: 2 METHODSBased on literature search and on entries in the general localization database Locate (http://locate.imb.uq.edu.au/cgi-bin/display.cgi) (Aturaliya et al., 2006; Sprenger et al., 2008) a dataset of protein sequences with known sub-Golgi localization was assembled.", [["Golgi", "ANATOMY", 70, 75], ["membrane", "ANATOMY", 217, 225], ["Golgi", "ANATOMY", 478, 483], ["Golgi", "CELLULAR_COMPONENT", 70, 75], ["type II membrane proteins", "GENE_OR_GENE_PRODUCT", 209, 234], ["Golgi", "CELLULAR_COMPONENT", 478, 483], ["type II membrane proteins", "PROTEIN", 209, 234], ["this approach", "TREATMENT", 22, 35], ["Localization dataset", "TEST", 170, 190], ["type II membrane proteins", "PROBLEM", 209, 234], ["literature search", "TEST", 257, 274], ["protein sequences", "TEST", 445, 462]]], ["Because our main interest for sub-Golgi localization prediction is related to type II transmembrane proteins, a first filtering step was to apply transmembrane (TM) helix prediction to these sequences using TMHMM (Krogh et al., 2001).", [["Golgi", "ANATOMY", 34, 39], ["transmembrane", "ANATOMY", 146, 159], ["Golgi", "CELLULAR_COMPONENT", 34, 39], ["type II transmembrane", "GENE_OR_GENE_PRODUCT", 78, 99], ["transmembrane", "CELLULAR_COMPONENT", 146, 159], ["type II transmembrane proteins", "PROTEIN", 78, 108], ["transmembrane (TM) helix", "PROTEIN", 146, 170], ["type II transmembrane proteins", "PROBLEM", 78, 108], ["transmembrane (TM) helix prediction", "TREATMENT", 146, 181], ["these sequences", "TEST", 185, 200]]], ["Only sequences predicted to be of the type II transmembrane signature (i.e. with exactly one TM helix predicted and of \u2018N-term in / TM / C-term out\u2019 topology) were retained.", [["type II transmembrane signature", "PROTEIN", 38, 69], ["TM helix", "PROTEIN", 93, 101], ["TM", "PROTEIN", 132, 134], ["C", "PROTEIN", 137, 138], ["the type II transmembrane signature", "PROBLEM", 34, 69]]], ["Since the number of type II transmembrane proteins with experimentally verified sub-Golgi localization information is rather small, no distinction was made between different species.", [["Golgi", "ANATOMY", 84, 89], ["type II transmembrane", "GENE_OR_GENE_PRODUCT", 20, 41], ["Golgi", "CELLULAR_COMPONENT", 84, 89], ["type II transmembrane proteins", "PROTEIN", 20, 50], ["type II transmembrane proteins", "PROBLEM", 20, 50], ["different species", "PROBLEM", 164, 181], ["small", "OBSERVATION_MODIFIER", 125, 130]]], ["Subsequently, these sequences were aligned with Muscle (Edgar, 2004) and clustered based on sequence identity, in order to prepare a non-redundant dataset for training and testing.", [["Muscle", "ANATOMY", 48, 54], ["Muscle", "TISSUE", 48, 54], ["these sequences", "TEST", 14, 29], ["testing", "TEST", 172, 179], ["Muscle", "ANATOMY", 48, 54]]], ["Clustering was performed using the minimum variance method implemented in the R function hclust (Murtagh, 1983).", [["the minimum variance method", "TREATMENT", 31, 58]]], ["The number of clusters was selected by assessing the inter-cluster sequence identity, which was found to rise sharply above 31 clusters.2.1 Localization dataset and prediction of type II membrane proteins ::: 2 METHODSFor each cluster, additional sequences were obtained based on ENSEMBL families (Flicek et al., 2008) if available, and otherwise via BLAST.", [["type II membrane", "GENE_OR_GENE_PRODUCT", 179, 195], ["type II membrane proteins", "PROTEIN", 179, 204], ["the inter-cluster sequence identity", "TEST", 49, 84], ["Localization dataset", "TEST", 140, 160], ["type II membrane proteins", "TEST", 179, 204], ["additional sequences", "TEST", 236, 256], ["clusters", "OBSERVATION_MODIFIER", 14, 22]]], ["In both cases, matching over the full-length amino-acid sequence was required, as well as a minimum sequence identity of 70%.", [["amino-acid", "CHEMICAL", 45, 55], ["amino-acid", "CHEMICAL", 45, 55], ["amino-acid", "AMINO_ACID", 45, 55], ["the full-length amino-acid sequence", "TREATMENT", 29, 64], ["a minimum sequence identity", "TEST", 90, 117]]], ["On these additional sequences, the same TM-prediction-based filter as described above was applied, but these predicted TMD sequences were only used for training, not for testing or validation.2.2 Amino acid grouping ::: 2 METHODSDifferent groupings of amino acids were tested in the definition of kernel features: (1) amino acids with similar dipole and volumes of side chains were clustered following (Shen et al., 2007) into the following 7 groups: AGV, ILFP, YMTS, HNQW, RK, DE and C; (2) we also tested using all 20 amino acids separately; and (3) a grouping of most similar amino acids based on a transmembrane substitution matrix (Ng et al., 2000), resulting in the groups VIM, YF, DE, TS with all other amino acids separately.", [["transmembrane", "ANATOMY", 602, 615], ["Amino acid", "CHEMICAL", 196, 206], ["amino acids", "CHEMICAL", 252, 263], ["amino acids", "CHEMICAL", 318, 329], ["amino acids", "CHEMICAL", 520, 531], ["amino acids", "CHEMICAL", 579, 590], ["amino acids", "CHEMICAL", 710, 721], ["Amino acid", "CHEMICAL", 196, 206], ["amino acids", "CHEMICAL", 252, 263], ["amino acids", "CHEMICAL", 318, 329], ["amino acids", "CHEMICAL", 520, 531], ["amino acids", "CHEMICAL", 579, 590], ["amino acids", "CHEMICAL", 710, 721], ["amino acids", "AMINO_ACID", 252, 263], ["amino acids", "AMINO_ACID", 318, 329], ["amino acids", "AMINO_ACID", 520, 531], ["amino acids", "AMINO_ACID", 579, 590], ["matrix", "CELLULAR_COMPONENT", 629, 635], ["VIM", "GENE_OR_GENE_PRODUCT", 679, 682], ["amino acids", "AMINO_ACID", 710, 721], ["TM-prediction-based filter", "DNA", 40, 66], ["TMD sequences", "DNA", 119, 132], ["VIM", "PROTEIN", 679, 682], ["these additional sequences", "TEST", 3, 29], ["the same TM-prediction-based filter", "TREATMENT", 31, 66], ["testing", "TEST", 170, 177], ["validation", "TEST", 181, 191], ["Amino acid grouping", "TEST", 196, 215], ["amino acids", "TREATMENT", 252, 263], ["amino acids", "TEST", 318, 329], ["similar dipole and volumes of side chains", "TREATMENT", 335, 376], ["AGV", "PROBLEM", 451, 454], ["all 20 amino acids", "TREATMENT", 513, 531], ["similar amino acids", "TREATMENT", 571, 590], ["a transmembrane substitution matrix", "TREATMENT", 600, 635], ["all other amino acids", "TEST", 700, 721], ["filter", "OBSERVATION", 60, 66]]], ["Because the grouping based on dipole and volume resulted in the best predictor performance, only SVM results using this approach are presented here.2.3 Kernel function and Support Vector Machine (SVM) ::: 2 METHODS", [["this approach", "TREATMENT", 115, 128], ["Support Vector Machine", "TREATMENT", 172, 194]]]], "PMC4773045": [], "9cb1931bec1bc6fd8eeb4888fc7cf3a33fb26438": [["T he novel coronavirus disease emerged in December 2019 and, in less than 3 months, evolved to a worldwide pandemic.", [["coronavirus disease", "DISEASE", 11, 30], ["coronavirus", "ORGANISM", 11, 22], ["coronavirus", "SPECIES", 11, 22], ["novel coronavirus disease", "PROBLEM", 5, 30], ["coronavirus disease", "OBSERVATION", 11, 30]]], ["[1] [2] [3] This virus has spread rapidly, leading to an unprecedented global crisis that shows no signs of abating in the near future.", [["This virus", "PROBLEM", 12, 22], ["an unprecedented global crisis", "PROBLEM", 54, 84], ["signs of abating", "PROBLEM", 99, 115], ["crisis", "OBSERVATION", 78, 84], ["no signs of", "UNCERTAINTY", 96, 107]]], ["As of Wednesday, April 1, 2020, there were more than 911 308 cases and more than 45 000 deaths reported globally.", [["deaths", "DISEASE", 88, 94]]], ["4 Confirmed cases in the United States were at 206 207 with more than 4542 deaths.", [["deaths", "DISEASE", 75, 81]]], ["5 The impact of COVID-19 on our daily lives, work, families, and overall operations is unprecedented in modern times, and the situation continues to change on a day-to-day basis.", [["COVID", "TREATMENT", 16, 21]]], ["In addition to constantly evolving information, there are misconceptions among the public about the pathology, etiology, transmission, treatment, and risks associated with COVID-19.", [["COVID-19", "CHEMICAL", 172, 180], ["treatment", "TREATMENT", 135, 144], ["COVID", "TEST", 172, 177]]]], "PMC5761721": [["IntroductionMicrotubule severing enzymes are a family of AAA-ATPase proteins that participate in fundamental cellular processes such as mitosis, ciliary biogenesis and growth cone motility.", [["Microtubule", "ANATOMY", 12, 23], ["cellular", "ANATOMY", 109, 117], ["ciliary", "ANATOMY", 145, 152], ["Microtubule", "CELLULAR_COMPONENT", 12, 23], ["AAA-ATPase", "GENE_OR_GENE_PRODUCT", 57, 67], ["cellular", "CELL", 109, 117], ["ciliary", "MULTI-TISSUE_STRUCTURE", 145, 152], ["Microtubule severing enzymes", "PROTEIN", 12, 40], ["AAA-ATPase proteins", "PROTEIN", 57, 76], ["Microtubule severing enzymes", "TEST", 12, 40], ["AAA", "PROBLEM", 57, 60], ["ATPase proteins", "PROBLEM", 61, 76], ["fundamental cellular processes", "PROBLEM", 97, 127], ["mitosis", "PROBLEM", 136, 143], ["ciliary biogenesis", "PROBLEM", 145, 163], ["growth cone motility", "PROBLEM", 168, 188], ["fundamental cellular processes", "OBSERVATION", 97, 127], ["ciliary biogenesis", "OBSERVATION", 145, 163]]], ["In neurons this family is known to control such processes as axonal elongation1 and synaptic development.2 In addition, mutations in microtubule severing enzyme genes SPG4, KATNB1 and KATNAL2 are associated with hereditary spastic paraplegia, cerebral malformations and autism, respectively,3, 4, 5, 6 and mutations in Fign cause a range of phenotypes in mice.7 Currently the microtubule severing enzyme KATNAL1 is poorly characterised and it is not yet understood how the enzyme functions in the nervous system.", [["neurons", "ANATOMY", 3, 10], ["axonal", "ANATOMY", 61, 67], ["synaptic", "ANATOMY", 84, 92], ["microtubule", "ANATOMY", 133, 144], ["cerebral", "ANATOMY", 243, 251], ["microtubule", "ANATOMY", 376, 387], ["nervous system", "ANATOMY", 497, 511], ["hereditary spastic paraplegia", "DISEASE", 212, 241], ["cerebral malformations", "DISEASE", 243, 265], ["autism", "DISEASE", 270, 276], ["neurons", "CELL", 3, 10], ["axonal elongation1", "CELLULAR_COMPONENT", 61, 79], ["synaptic", "CELLULAR_COMPONENT", 84, 92], ["microtubule severing enzyme", "GENE_OR_GENE_PRODUCT", 133, 160], ["SPG4", "GENE_OR_GENE_PRODUCT", 167, 171], ["KATNB1", "GENE_OR_GENE_PRODUCT", 173, 179], ["KATNAL2", "GENE_OR_GENE_PRODUCT", 184, 191], ["cerebral malformations", "PATHOLOGICAL_FORMATION", 243, 265], ["Fign", "GENE_OR_GENE_PRODUCT", 319, 323], ["mice", "ORGANISM", 355, 359], ["microtubule", "CELLULAR_COMPONENT", 376, 387], ["KATNAL1", "GENE_OR_GENE_PRODUCT", 404, 411], ["nervous system", "ANATOMICAL_SYSTEM", 497, 511], ["microtubule severing enzyme genes", "DNA", 133, 166], ["SPG4", "DNA", 167, 171], ["KATNB1", "DNA", 173, 179], ["KATNAL2", "DNA", 184, 191], ["Fign", "DNA", 319, 323], ["microtubule severing enzyme", "PROTEIN", 376, 403], ["KATNAL1", "PROTEIN", 404, 411], ["mice", "SPECIES", 355, 359], ["mice", "SPECIES", 355, 359], ["axonal elongation1", "PROBLEM", 61, 79], ["mutations", "PROBLEM", 120, 129], ["SPG4", "TEST", 167, 171], ["KATNB1", "TEST", 173, 179], ["KATNAL2", "TREATMENT", 184, 191], ["hereditary spastic paraplegia", "PROBLEM", 212, 241], ["cerebral malformations", "PROBLEM", 243, 265], ["autism", "PROBLEM", 270, 276], ["the microtubule severing enzyme KATNAL1", "TEST", 372, 411], ["hereditary", "OBSERVATION_MODIFIER", 212, 222], ["spastic", "OBSERVATION_MODIFIER", 223, 230], ["paraplegia", "OBSERVATION", 231, 241], ["cerebral", "ANATOMY", 243, 251], ["malformations", "OBSERVATION", 252, 265], ["poorly characterised", "OBSERVATION_MODIFIER", 415, 435], ["nervous system", "ANATOMY", 497, 511]]], ["Recent evidence from genetic characterisation of human patients suggests that haploinsufficiency of KATNAL1 is linked with a number of symptoms including intellectual disability (ID) and craniofacial dysmorphologies.8, 9 It is also notable that a very rare KATNAL1 mutation has been associated with schizophrenia10 (http://atgu.mgh.harvard.edu/~spurcell/genebook/genebook.cgi?user=guest&cmd=verb-gene&tbox=KATNAL1) and that Peters syndrome and autism have both been associated with the chromosomal region containing the KATNAL1 locus.11, 12 Although such association studies strongly suggest that KATNAL1 plays a fundamental role in the central nervous system (CNS), additional studies using cellular or animals models are required to understand how the gene may be causative for disease.", [["craniofacial", "ANATOMY", 187, 199], ["chromosomal", "ANATOMY", 486, 497], ["central nervous system", "ANATOMY", 637, 659], ["CNS", "ANATOMY", 661, 664], ["cellular", "ANATOMY", 692, 700], ["KATNAL1", "DISEASE", 100, 107], ["intellectual disability", "DISEASE", 154, 177], ["ID", "DISEASE", 179, 181], ["craniofacial dysmorphologies", "DISEASE", 187, 215], ["Peters syndrome", "DISEASE", 424, 439], ["autism", "DISEASE", 444, 450], ["KATNAL1", "CHEMICAL", 597, 604], ["human", "ORGANISM", 49, 54], ["patients", "ORGANISM", 55, 63], ["KATNAL1", "GENE_OR_GENE_PRODUCT", 100, 107], ["KATNAL1", "GENE_OR_GENE_PRODUCT", 257, 264], ["chromosomal", "CELLULAR_COMPONENT", 486, 497], ["KATNAL1", "GENE_OR_GENE_PRODUCT", 520, 527], ["KATNAL1", "GENE_OR_GENE_PRODUCT", 597, 604], ["central nervous system", "ANATOMICAL_SYSTEM", 637, 659], ["CNS", "ANATOMICAL_SYSTEM", 661, 664], ["cellular", "CELL", 692, 700], ["KATNAL1", "PROTEIN", 100, 107], ["KATNAL1", "DNA", 257, 264], ["KATNAL1 locus", "DNA", 520, 533], ["KATNAL1", "PROTEIN", 597, 604], ["human", "SPECIES", 49, 54], ["patients", "SPECIES", 55, 63], ["human", "SPECIES", 49, 54], ["haploinsufficiency of KATNAL1", "PROBLEM", 78, 107], ["symptoms", "PROBLEM", 135, 143], ["intellectual disability", "PROBLEM", 154, 177], ["craniofacial dysmorphologies", "PROBLEM", 187, 215], ["a very rare KATNAL1 mutation", "PROBLEM", 245, 273], ["schizophrenia10", "PROBLEM", 299, 314], ["Peters syndrome", "PROBLEM", 424, 439], ["autism", "PROBLEM", 444, 450], ["such association studies", "TEST", 550, 574], ["additional studies", "TEST", 667, 685], ["disease", "PROBLEM", 780, 787], ["haploinsufficiency", "OBSERVATION", 78, 96], ["craniofacial", "ANATOMY", 187, 199], ["dysmorphologies", "OBSERVATION", 200, 215], ["Peters syndrome", "OBSERVATION", 424, 439], ["KATNAL1 locus", "OBSERVATION", 520, 533], ["central", "ANATOMY_MODIFIER", 637, 644], ["nervous system", "ANATOMY", 645, 659]]], ["Here we present the first study describing neural and behavioural deficits associated with a loss of function allele of Katnal1 in the mouse.", [["neural", "ANATOMY", 43, 49], ["neural and behavioural deficits", "DISEASE", 43, 74], ["Katnal1", "GENE_OR_GENE_PRODUCT", 120, 127], ["mouse", "ORGANISM", 135, 140], ["allele", "DNA", 110, 116], ["Katnal1", "DNA", 120, 127], ["mouse", "SPECIES", 135, 140], ["mouse", "SPECIES", 135, 140], ["the first study", "TEST", 16, 31], ["neural and behavioural deficits", "PROBLEM", 43, 74]]], ["This mutant mouse line was independently identified in two parallel phenotyping screens, which demonstrated that mutant mice showed both male sterility and circadian phenotypes.", [["mouse", "ORGANISM", 12, 17], ["mice", "ORGANISM", 120, 124], ["mutant mouse line", "CELL_LINE", 5, 22], ["mouse", "SPECIES", 12, 17], ["mice", "SPECIES", 120, 124], ["mouse", "SPECIES", 12, 17], ["mice", "SPECIES", 120, 124], ["two parallel phenotyping screens", "TEST", 55, 87], ["circadian phenotypes", "PROBLEM", 156, 176], ["mouse line", "OBSERVATION", 12, 22], ["circadian phenotypes", "OBSERVATION", 156, 176]]], ["Subsequent behavioural investigations demonstrated that this mutation is associated with anxiety and memory deficits.", [["anxiety", "DISEASE", 89, 96], ["memory deficits", "DISEASE", 101, 116], ["Subsequent behavioural investigations", "TEST", 0, 37], ["this mutation", "PROBLEM", 56, 69], ["anxiety", "PROBLEM", 89, 96], ["memory deficits", "PROBLEM", 101, 116]]], ["Underlying these behavioural phenotypes, we identified histopathological abnormalities in the brains of Katnal11H/1H mutants, including disordered cellular layers in the hippocampus and cortex and substantially larger ventricles.", [["brains", "ANATOMY", 94, 100], ["cellular layers", "ANATOMY", 147, 162], ["hippocampus", "ANATOMY", 170, 181], ["cortex", "ANATOMY", 186, 192], ["ventricles", "ANATOMY", 218, 228], ["Katnal11H/1H", "ORGANISM", 104, 116], ["cellular layers", "TISSUE", 147, 162], ["hippocampus", "MULTI-TISSUE_STRUCTURE", 170, 181], ["cortex", "MULTI-TISSUE_STRUCTURE", 186, 192], ["ventricles", "MULTI-TISSUE_STRUCTURE", 218, 228], ["Underlying these behavioural phenotypes", "PROBLEM", 0, 39], ["histopathological abnormalities in the brains of Katnal11H/1H mutants", "PROBLEM", 55, 124], ["disordered cellular layers in the hippocampus and cortex", "PROBLEM", 136, 192], ["substantially larger ventricles", "PROBLEM", 197, 228], ["behavioural phenotypes", "OBSERVATION", 17, 39], ["cellular layers", "OBSERVATION", 147, 162], ["hippocampus", "ANATOMY", 170, 181], ["cortex", "ANATOMY_MODIFIER", 186, 192], ["substantially", "OBSERVATION_MODIFIER", 197, 210], ["larger", "OBSERVATION_MODIFIER", 211, 217], ["ventricles", "ANATOMY", 218, 228]]], ["Further investigations demonstrated that Katnal11H/1H mice show neuronal migration and ciliary function deficits suggesting KATNAL1 plays an essential role in these processes.", [["neuronal", "ANATOMY", 64, 72], ["ciliary", "ANATOMY", 87, 94], ["Katnal11H/1H mice", "ORGANISM", 41, 58], ["neuronal", "CELL", 64, 72], ["ciliary", "MULTI-TISSUE_STRUCTURE", 87, 94], ["KATNAL1", "GENE_OR_GENE_PRODUCT", 124, 131], ["KATNAL1", "PROTEIN", 124, 131], ["mice", "SPECIES", 54, 58], ["Further investigations", "TEST", 0, 22], ["Katnal11H", "TEST", 41, 50], ["neuronal migration", "PROBLEM", 64, 82], ["ciliary function deficits", "PROBLEM", 87, 112], ["neuronal migration", "OBSERVATION", 64, 82], ["essential", "OBSERVATION_MODIFIER", 141, 150]]], ["These findings are the first to our knowledge to conclusively show that mutations in Katnal1 lead to behavioural and neuronal disturbances and provide insight regarding the clinical associations that have been linked to the gene.Animals ::: Materials and methodsAnimal studies were performed under guidance from the Medical Research Council in Responsibility in the Use of Animals for Medical Research (July 1993) and Home Office Project Licences 30/2686 and 80/2310 (UK) and project licence 106/2009-B (Italy).", [["neuronal", "ANATOMY", 117, 125], ["neuronal disturbances", "DISEASE", 117, 138], ["Katnal1", "GENE_OR_GENE_PRODUCT", 85, 92], ["neuronal", "CELL", 117, 125], ["Katnal1", "PROTEIN", 85, 92], ["mutations in Katnal1", "PROBLEM", 72, 92], ["behavioural and neuronal disturbances", "PROBLEM", 101, 138], ["Animal studies", "TEST", 262, 276]]], ["ENU mutagenesis and animal breeding regimes were performed as previously described.13 Phenotyping was performed on mouse cohorts that were partially or completely congenic on the C57BL/6 J background.Circadian wheel running ::: Materials and methodsCircadian wheel running was performed as previously described.14Sleep assessment by electroencephalography and electromyography ::: Materials and methodsElectroencephalography and electromyography was performed as previously described.15Spontaneous alternation ::: Behavioural phenotyping ::: Materials and methodsMice were placed in a walled T-maze (black polyvinyl chloride, lined with sawdust; stem=88 \u00d7 13 cm; arms=32 \u00d7 13 cm) and allowed to enter a goal arm of their choice.", [["ENU", "CHEMICAL", 0, 3], ["polyvinyl chloride", "CHEMICAL", 606, 624], ["ENU", "CHEMICAL", 0, 3], ["polyvinyl chloride", "CHEMICAL", 606, 624], ["mouse", "ORGANISM", 115, 120], ["C57BL/6 J background", "ORGANISM", 179, 199], ["Mice", "ORGANISM", 563, 567], ["polyvinyl chloride", "SIMPLE_CHEMICAL", 606, 624], ["mouse", "SPECIES", 115, 120], ["Mice", "SPECIES", 563, 567], ["mouse", "SPECIES", 115, 120], ["ENU mutagenesis", "TREATMENT", 0, 15], ["animal breeding regimes", "TREATMENT", 20, 43], ["Phenotyping", "TEST", 86, 97], ["Sleep assessment", "TEST", 313, 329], ["electroencephalography", "TEST", 333, 355], ["electromyography", "TEST", 360, 376], ["methodsElectroencephalography", "TEST", 395, 424], ["electromyography", "TEST", 429, 445], ["methodsMice", "TREATMENT", 556, 567], ["a walled T-maze (black polyvinyl chloride", "TREATMENT", 583, 624], ["stem", "TEST", 646, 650], ["arms", "TEST", 663, 667]]], ["The mouse was confined in the goal arm for 30 s, before being allowed a second free choice of goal arm.", [["mouse", "ORGANISM", 4, 9], ["mouse", "SPECIES", 4, 9], ["mouse", "SPECIES", 4, 9], ["a second free choice of goal arm", "TREATMENT", 70, 102]]], ["One trial was performed per day for 10 days.Open field behaviour ::: Behavioural phenotyping ::: Materials and methodsMice were placed into a walled arena (grey polyvinyl chloride; 45 \u00d7 45 cm) and allowed to explore for 20 min.", [["polyvinyl chloride", "CHEMICAL", 161, 179], ["polyvinyl chloride", "CHEMICAL", 161, 179], ["Mice", "ORGANISM", 118, 122], ["polyvinyl chloride", "SIMPLE_CHEMICAL", 161, 179], ["Mice", "SPECIES", 118, 122], ["methodsMice", "TREATMENT", 111, 122], ["a walled arena (grey polyvinyl chloride", "TREATMENT", 140, 179]]], ["Animals were monitored by EthoVision XT analysis software (Noldus, Wageningen, Netherlands).Video tracking in the home cage ::: Behavioural phenotyping ::: Materials and methodsActivity in the home cage was recorded by video tracking as previously described.16Morris water maze and ultrasonic vocalisation ::: Behavioural phenotyping ::: Materials and methodsThese tests were performed as previously described.17Brain histology and immunofluorescence ::: Materials and methodsBrains were mounted in OCT (VWR) and 12 \u03bcm coronal sections taken.", [["Brain", "ANATOMY", 412, 417], ["Brains", "ANATOMY", 476, 482], ["sections", "ANATOMY", 527, 535], ["Animals", "ORGANISM", 0, 7], ["These tests", "TEST", 359, 370], ["OCT (VWR", "TEST", 499, 507], ["12 \u03bcm coronal sections", "TEST", 513, 535]]], ["Sections were stained with hematoxylin and eosin, or immunolabelled following standard protocols.Neuronal migration assessment ::: Materials and methodsIn vivo neuronal migration assessment was performed as previously described18 using embryos at either E13 or E15 (three mothers per age group) and pups at P9.", [["Neuronal", "ANATOMY", 97, 105], ["neuronal", "ANATOMY", 160, 168], ["embryos", "ANATOMY", 236, 243], ["hematoxylin", "CHEMICAL", 27, 38], ["eosin", "CHEMICAL", 43, 48], ["hematoxylin", "SIMPLE_CHEMICAL", 27, 38], ["eosin", "SIMPLE_CHEMICAL", 43, 48], ["Neuronal", "CELL", 97, 105], ["neuronal", "CELL", 160, 168], ["embryos", "DEVELOPING_ANATOMICAL_STRUCTURE", 236, 243], ["pups", "ORGANISM_SUBDIVISION", 299, 303], ["hematoxylin", "TREATMENT", 27, 38], ["eosin", "TREATMENT", 43, 48], ["Neuronal migration assessment", "TEST", 97, 126], ["vivo neuronal migration assessment", "TEST", 155, 189], ["neuronal migration", "OBSERVATION", 160, 178]]], ["Cell counts were performed using ImageJ (NIH, Bethesda, MD, USA).Neuronal migration assessment ::: Materials and methodsIn vitro neuronal migration assessment was performed using a Boyden chamber migration protocol as previously described.19Micro-computed tomography scanning ::: Materials and methodsMicro-computed tomography was performed using a Skyscan 1172 at 90 kV, 112 \u03bcA using an aluminium and copper filter, a rotation step of 0.250 degrees and a pixel size of 4.96 \u03bcm.Micro-computed tomography scanning ::: Materials and methodsSegmentation, volume calculation and 3D modelling was performed using ITK-SNAP version 3.0.0 (ref.", [["Cell", "ANATOMY", 0, 4], ["Neuronal", "ANATOMY", 65, 73], ["neuronal", "ANATOMY", 129, 137], ["aluminium", "CHEMICAL", 388, 397], ["copper", "CHEMICAL", 402, 408], ["aluminium", "CHEMICAL", 388, 397], ["copper", "CHEMICAL", 402, 408], ["Cell", "CELL", 0, 4], ["Neuronal", "CELL", 65, 73], ["neuronal", "CELL", 129, 137], ["aluminium", "SIMPLE_CHEMICAL", 388, 397], ["Cell counts", "TEST", 0, 11], ["Neuronal migration assessment", "TEST", 65, 94], ["vitro neuronal migration assessment", "TEST", 123, 158], ["a Boyden chamber migration protocol", "TREATMENT", 179, 214], ["computed tomography scanning", "TEST", 247, 275], ["computed tomography", "TEST", 307, 326], ["a Skyscan", "TEST", 347, 356], ["an aluminium and copper filter", "TREATMENT", 385, 415], ["a rotation step", "TEST", 417, 432], ["a pixel size", "TEST", 454, 466], ["Micro-computed tomography scanning", "TEST", 478, 512], ["methodsSegmentation", "TEST", 531, 550], ["volume calculation", "TEST", 552, 570], ["3D modelling", "TEST", 575, 587], ["SNAP version", "TEST", 612, 624], ["size", "OBSERVATION_MODIFIER", 462, 466], ["4.96 \u03bcm", "OBSERVATION_MODIFIER", 470, 477]]], ["20) and 3DSlicer.21Golgi-Cox staining of neurons ::: Materials and methodsGolgi-Cox neuronal staining was performed using the FD Rapid GolgiStain Kit (FD NeuroTechnologies, Columbia, MD, USA).", [["Golgi", "ANATOMY", 19, 24], ["neurons", "ANATOMY", 41, 48], ["Golgi", "ANATOMY", 74, 79], ["neuronal", "ANATOMY", 84, 92], ["Golgi", "CELLULAR_COMPONENT", 19, 24], ["neurons", "CELL", 41, 48], ["Golgi", "CELLULAR_COMPONENT", 74, 79], ["neuronal", "CELL", 84, 92], ["Cox neuronal staining", "TEST", 80, 101]]], ["Neurons were analysed using ImageJ.Motile cilia analysis ::: Materials and methodsBrains from P2 mice were dissected, and the dorsal cerebral half was sectioned (250 \u03bcm) through the floor of the lateral and 3rd ventricle using a vibratome.", [["Neurons", "ANATOMY", 0, 7], ["cilia", "ANATOMY", 42, 47], ["Brains", "ANATOMY", 82, 88], ["dorsal cerebral", "ANATOMY", 126, 141], ["lateral", "ANATOMY", 195, 202], ["3rd ventricle", "ANATOMY", 207, 220], ["Neurons", "CELL", 0, 7], ["mice", "ORGANISM", 97, 101], ["dorsal cerebral half", "MULTI-TISSUE_STRUCTURE", 126, 146], ["lateral", "MULTI-TISSUE_STRUCTURE", 195, 202], ["ventricle", "MULTI-TISSUE_STRUCTURE", 211, 220], ["mice", "SPECIES", 97, 101], ["mice", "SPECIES", 97, 101], ["ImageJ", "TEST", 28, 34], ["Motile cilia analysis", "TEST", 35, 56], ["P2 mice", "TREATMENT", 94, 101], ["dorsal cerebral", "ANATOMY", 126, 141], ["floor", "ANATOMY_MODIFIER", 182, 187], ["lateral", "ANATOMY_MODIFIER", 195, 202], ["3rd ventricle", "ANATOMY", 207, 220]]], ["Ciliary beat frequency and pattern was analysed as previously described.22Electron microscopy ::: Materials and methodsFor Scanning Electron Microscopy the ependymal lining of the lateral ventricle was fixed in 2.5% glutaraldehyde, 2% paraformaldehyde in 0.1 m phosphate buffer, incubated in 2% osmium tetroxide, and dehydrated through ethanol solutions.", [["Ciliary", "ANATOMY", 0, 7], ["ependymal lining", "ANATOMY", 156, 172], ["lateral ventricle", "ANATOMY", 180, 197], ["glutaraldehyde", "CHEMICAL", 216, 230], ["phosphate", "CHEMICAL", 261, 270], ["osmium tetroxide", "CHEMICAL", 295, 311], ["ethanol", "CHEMICAL", 336, 343], ["glutaraldehyde", "CHEMICAL", 216, 230], ["paraformaldehyde", "CHEMICAL", 235, 251], ["phosphate", "CHEMICAL", 261, 270], ["osmium tetroxide", "CHEMICAL", 295, 311], ["ethanol", "CHEMICAL", 336, 343], ["ependymal lining", "TISSUE", 156, 172], ["lateral ventricle", "MULTI-TISSUE_STRUCTURE", 180, 197], ["glutaraldehyde", "SIMPLE_CHEMICAL", 216, 230], ["paraformaldehyde", "SIMPLE_CHEMICAL", 235, 251], ["osmium tetroxide", "SIMPLE_CHEMICAL", 295, 311], ["ethanol", "SIMPLE_CHEMICAL", 336, 343], ["Ciliary beat frequency", "TEST", 0, 22], ["Scanning Electron Microscopy", "TEST", 123, 151], ["2% paraformaldehyde in 0.1 m phosphate buffer", "TREATMENT", 232, 277], ["2% osmium tetroxide", "TREATMENT", 292, 311], ["ethanol solutions", "TREATMENT", 336, 353], ["ependymal", "ANATOMY_MODIFIER", 156, 165], ["lining", "ANATOMY_MODIFIER", 166, 172], ["lateral ventricle", "ANATOMY", 180, 197]]], ["Samples were critical point dried using an Emitech K850 (Quorum Technologies, East Sussex, UK), coated with platinum using a Quorom Q150R S sputter coater (Quorum Technologies). and visualised using a JEOL LSM-6010 scanning electron microscope (Jeol, Herts, UK).Electron microscopy ::: Materials and methodsTransmission electron microscopy was performed as previously described.22Statistical analysis ::: Materials and methodsData was analysed using two-tailed students T test or AVOVA using SPSS (IBM) or GraphPad Prism 5.0 (GraphPad Software, La Jolla, CA, USA).", [["Samples", "ANATOMY", 0, 7], ["platinum", "CHEMICAL", 108, 116], ["platinum", "CHEMICAL", 108, 116], ["S", "CHEMICAL", 138, 139], ["platinum", "SIMPLE_CHEMICAL", 108, 116], ["Samples", "TEST", 0, 7], ["an Emitech K850", "TREATMENT", 40, 55], ["platinum", "TREATMENT", 108, 116], ["a Quorom Q150R S sputter coater", "TREATMENT", 123, 154], ["a JEOL LSM", "TREATMENT", 199, 209], ["Electron microscopy", "TEST", 262, 281], ["methodsTransmission electron microscopy", "TEST", 300, 339], ["methodsData", "TEST", 419, 430], ["SPSS (IBM", "TEST", 492, 501], ["GraphPad", "TEST", 506, 514], ["Prism", "TEST", 515, 520], ["GraphPad", "TEST", 526, 534], ["Software", "TEST", 535, 543]]], ["Significance level for all analysis was set at P<0.05.", [["Significance level", "TEST", 0, 18], ["all analysis", "TEST", 23, 35]]], ["All graphs are presented showing mean\u00b1s.e.m.Statistical analysis ::: Materials and methodsAdditional and more detailed methods can be found in supplementary information.Identification and cloning of the Katnal11Hmutation ::: ResultsTo identify novel gene mutations affecting circadian behaviour we undertook a circadian running wheel screen of pedigrees of N-ethyl-N-nitrosourea mutagenised mice.13 In one pedigree 17.65% of animals showed a short circadian period in constant darkness (<23 h observed in 12 out of 68 animals screened).", [["N-ethyl-N-nitrosourea", "CHEMICAL", 357, 378], ["N-ethyl-N-nitrosourea", "CHEMICAL", 357, 378], ["N-ethyl-N-nitrosourea", "SIMPLE_CHEMICAL", 357, 378], ["mice", "ORGANISM", 391, 395], ["Katnal11Hmutation", "DNA", 203, 220], ["mice", "SPECIES", 391, 395], ["All graphs", "TEST", 0, 10], ["novel gene mutations affecting circadian behaviour", "PROBLEM", 244, 294], ["N-ethyl", "TREATMENT", 357, 364], ["N-nitrosourea mutagenised mice", "TREATMENT", 365, 395], ["a short circadian period", "PROBLEM", 440, 464], ["constant darkness", "PROBLEM", 468, 485]]], ["An outcross using an affected female produced no affected animals (33 animals screened).", [["female", "ORGANISM", 30, 36], ["affected animals", "PROBLEM", 49, 65]]], ["In subsequent intercross screens 15.5% of animals were affected (53 out of 342 animals screened), suggesting that the pedigree carries a mutation causing a recessive circadian phenotype which is 60% penetrant.", [["animals", "ORGANISM", 42, 49], ["subsequent intercross screens", "TEST", 3, 32], ["a mutation", "PROBLEM", 135, 145], ["a recessive circadian phenotype", "PROBLEM", 154, 185]]], ["We found no gender bias in affected animals (proportion of affected animals: male=47.2% female=52.8%).Identification and cloning of the Katnal11Hmutation ::: ResultsConcurrently a male sterility phenotype was identified within the same pedigree.23 Genome-wide SNP linkage analysis mapped the circadian and sterility phenotypes to the same region on chromosome 5 and subsequent sequencing identified the causative mutation as a T to G single point mutation within exon seven of the Katnal1 gene.", [["chromosome 5", "ANATOMY", 349, 361], ["SNP", "CHEMICAL", 260, 263], ["chromosome 5", "CELLULAR_COMPONENT", 349, 361], ["Katnal1", "GENE_OR_GENE_PRODUCT", 481, 488], ["Katnal11Hmutation", "DNA", 136, 153], ["chromosome 5", "DNA", 349, 361], ["Katnal1 gene", "DNA", 481, 493], ["gender bias in affected animals", "PROBLEM", 12, 43], ["a male sterility phenotype", "PROBLEM", 178, 204], ["wide SNP linkage analysis", "PROBLEM", 255, 280], ["sterility phenotypes", "PROBLEM", 306, 326], ["the causative mutation", "PROBLEM", 399, 421], ["no", "UNCERTAINTY", 9, 11], ["sterility phenotypes", "OBSERVATION", 306, 326]]], ["For full details of mapping and identification of the mutation see reference 23.", [["the mutation", "TEST", 50, 62]]], ["This mutant allele was designated Katnal11H, and results in a leucine to valine substitution at residue 286 of the protein.", [["leucine", "CHEMICAL", 62, 69], ["valine", "CHEMICAL", 73, 79], ["leucine", "CHEMICAL", 62, 69], ["valine", "CHEMICAL", 73, 79], ["leucine", "AMINO_ACID", 62, 69], ["valine", "AMINO_ACID", 73, 79], ["residue 286", "AMINO_ACID", 96, 107], ["mutant allele", "DNA", 5, 18], ["Katnal11H", "DNA", 34, 43], ["a leucine to valine substitution", "TREATMENT", 60, 92], ["the protein", "TEST", 111, 122]]], ["In vitro functional analysis demonstrated that the mutation is a recessive loss-of-function allele.23 3D modelling of the protein suggests that this loss of function is due to hydrophobic changes in the AAA domain of the enzyme (Supplementary Figure S1).", [["recessive loss-of-function allele", "DNA", 65, 98], ["AAA domain", "PROTEIN", 203, 213], ["enzyme", "PROTEIN", 221, 227], ["Supplementary Figure S1", "PROTEIN", 229, 252], ["vitro functional analysis", "TEST", 3, 28], ["the mutation", "PROBLEM", 47, 59], ["a recessive loss", "PROBLEM", 63, 79], ["the protein", "TEST", 118, 129], ["this loss of function", "PROBLEM", 144, 165], ["hydrophobic changes", "PROBLEM", 176, 195], ["the enzyme", "TEST", 217, 227], ["AAA", "OBSERVATION", 203, 206]]], ["Genotyping confirmed that the mutation was homozygous in affected circadian animals and wild type or heterozygous in unaffected animals, confirming that Katnal11H was causative for the circadian phenotype.Circadian and sleep anomalies in Katnal11H/1Hmice ::: ResultsMore extensive circadian phenotyping conducted on Katnal1 homozygotes (Katnal11H/1H) and wild-type littermates (Katnal1+/+) confirmed that Katnal11H/1H mice had a shorter free-running circadian period (Figures 1a\u2013c) and furthermore revealed that Katnal11H/1H animals were more active in the light phase of the light/dark cycle (Figure 1d), showed increased anticipation of light to dark transitions and greater shift in activity onset when released from light/dark cycles to constant darkness (Figure 1e).", [["Circadian and sleep anomalies", "DISEASE", 205, 234], ["Katnal11H", "GENE_OR_GENE_PRODUCT", 153, 162], ["Katnal1", "GENE_OR_GENE_PRODUCT", 316, 323], ["Katnal11H/1H", "ORGANISM", 337, 349], ["wild-type littermates", "ORGANISM", 355, 376], ["Katnal1", "GENE_OR_GENE_PRODUCT", 378, 385], ["Katnal11H/1H mice", "ORGANISM", 405, 422], ["Katnal11H/1H animals", "ORGANISM", 512, 532], ["Katnal11H", "PROTEIN", 153, 162], ["Katnal1 homozygotes", "CELL_LINE", 316, 335], ["Katnal1", "PROTEIN", 378, 385], ["mice", "SPECIES", 418, 422], ["Genotyping", "TEST", 0, 10], ["the mutation", "PROBLEM", 26, 38], ["homozygous in affected circadian animals", "PROBLEM", 43, 83], ["heterozygous in unaffected animals", "PROBLEM", 101, 135], ["the circadian phenotype", "PROBLEM", 181, 204], ["sleep anomalies", "PROBLEM", 219, 234], ["circadian phenotyping", "TEST", 281, 302], ["Katnal1 homozygotes", "TEST", 316, 335], ["Katnal1", "TEST", 378, 385], ["Katnal11H/1H animals", "TEST", 512, 532], ["dark transitions", "PROBLEM", 648, 664], ["constant darkness", "PROBLEM", 741, 758], ["active", "OBSERVATION_MODIFIER", 543, 549], ["increased", "OBSERVATION_MODIFIER", 613, 622], ["greater shift", "OBSERVATION_MODIFIER", 669, 682]]], ["Bioluminescence recordings performed using PER2::LUCIFERASE reporter mice carrying the Katnal11H mutation revealed that these circadian changes were not due to changes to the core molecular clock of the suprachiasmatic nucleus (the site of the master circadian clock in the brain; Supplementary Figure S2).Circadian and sleep anomalies in Katnal11H/1Hmice ::: ResultsCircadian disruptions are often associated with deficits in sleep homeostasis.", [["suprachiasmatic nucleus", "ANATOMY", 203, 226], ["brain", "ANATOMY", 274, 279], ["Circadian and sleep anomalies", "DISEASE", 306, 335], ["PER2", "GENE_OR_GENE_PRODUCT", 43, 47], ["mice", "ORGANISM", 69, 73], ["Katnal11H", "GENE_OR_GENE_PRODUCT", 87, 96], ["suprachiasmatic nucleus", "MULTI-TISSUE_STRUCTURE", 203, 226], ["brain", "ORGAN", 274, 279], ["PER2", "DNA", 43, 47], ["Katnal11H", "DNA", 87, 96], ["mice", "SPECIES", 69, 73], ["mice", "SPECIES", 69, 73], ["Bioluminescence recordings", "TEST", 0, 26], ["the Katnal11H mutation", "TEST", 83, 105], ["these circadian changes", "PROBLEM", 120, 143], ["sleep anomalies", "PROBLEM", 320, 335], ["ResultsCircadian disruptions", "PROBLEM", 360, 388], ["deficits in sleep homeostasis", "PROBLEM", 415, 444], ["molecular clock", "OBSERVATION", 180, 195], ["suprachiasmatic nucleus", "ANATOMY", 203, 226], ["brain", "ANATOMY", 274, 279]]], ["Therefore to complement our circadian studies we conducted wireless electroencephalography recordings over a baseline period of 24 h and following a 6 h period of sleep deprivation.", [["circadian studies", "TEST", 28, 45], ["electroencephalography recordings", "TEST", 68, 101], ["sleep deprivation", "PROBLEM", 163, 180]]], ["A detailed summary of electroencephalography analysis is given in Supplementary Table S1.", [["electroencephalography analysis", "TEST", 22, 53]]], ["Compared to wild-type littermates, the non-REM delta power of Katnal11H/1H mice was higher in the dark phase of baseline sleep (mixed ANOVA, interaction factors \u2018genotype X time, F(1,88)=8.91, P=0.0175) (Figure 1f) and in both the light and dark phases of recovery sleep (mixed ANOVA, interaction factors \u2018genotype X time\u2019, F(1,136)=11.93, P=0.0086; Figure 1g).", [["wild-type littermates", "ORGANISM", 12, 33], ["Katnal11H/1H mice", "ORGANISM", 62, 79], ["interaction factors", "PROTEIN", 285, 304], ["mice", "SPECIES", 75, 79], ["the non-REM delta power", "TEST", 35, 58], ["Katnal11H", "TEST", 62, 71], ["baseline sleep", "PROBLEM", 112, 126], ["genotype X time", "TEST", 162, 177], ["P", "TEST", 193, 194], ["genotype X time\u2019", "TEST", 306, 322], ["P", "TEST", 340, 341], ["dark phase", "OBSERVATION_MODIFIER", 98, 108], ["dark phases", "OBSERVATION_MODIFIER", 241, 252]]], ["All other sleep parameters were unaffected in Katnal11H/1H animals.Katnal11H/1H mice display a spectrum of behavioural deficits ::: ResultsHuman patients carrying a heterozygous deletion incorporating the Katnal1 locus show a number of cognitive deficits including ID and a delay in language acquisition.8, 9 We therefore investigated whether these deficits were modelled in Katnal11H/1H mice by subjecting animal cohorts to a battery of behavioural tests.", [["behavioural deficits", "DISEASE", 107, 127], ["cognitive deficits", "DISEASE", 236, 254], ["ID", "DISEASE", 265, 267], ["1H", "CHEMICAL", 56, 58], ["Katnal11H/1H animals", "ORGANISM", 46, 66], ["Katnal11H/1H mice", "ORGANISM", 67, 84], ["patients", "ORGANISM", 145, 153], ["Katnal1", "GENE_OR_GENE_PRODUCT", 205, 212], ["Katnal11H/1H mice", "ORGANISM", 375, 392], ["Katnal1 locus", "DNA", 205, 218], ["mice", "SPECIES", 80, 84], ["patients", "SPECIES", 145, 153], ["mice", "SPECIES", 388, 392], ["behavioural deficits", "PROBLEM", 107, 127], ["a heterozygous deletion", "PROBLEM", 163, 186], ["cognitive deficits", "PROBLEM", 236, 254], ["language acquisition", "TEST", 283, 303], ["these deficits", "PROBLEM", 343, 357], ["behavioural tests", "TEST", 438, 455], ["deficits", "OBSERVATION", 349, 357]]], ["Data and cohort details are given in Supplementary Table S2.Katnal11H/1H mice display a spectrum of behavioural deficits ::: ResultsBoth working memory and spatial memory were significantly poorer in Katnal11H/1H mice, as evidenced by reduced spontaneous alternations in a T-maze (Figure 2a) and in the Morris water maze where mutants take longer to find the platform in acquisition trials (Figure 2b), show poorer improvements in the latency to find the platform (Figure 2c) and spend less time in the target quadrant than wild types (Figure 2d).", [["behavioural deficits", "DISEASE", 100, 120], ["Katnal11H/1H mice", "ORGANISM", 60, 77], ["Katnal11H/1H mice", "ORGANISM", 200, 217], ["mice", "SPECIES", 73, 77], ["mice", "SPECIES", 213, 217], ["behavioural deficits", "PROBLEM", 100, 120], ["reduced spontaneous alternations", "PROBLEM", 235, 267]]], ["Anxiety and locomotor activity was assessed by monitoring activity in an open field arena.", [["Anxiety", "DISEASE", 0, 7], ["Anxiety", "PROBLEM", 0, 7], ["locomotor activity", "PROBLEM", 12, 30]]], ["To differentiate between activity and anxiety changes in the open field arena we analysed activity in both the anxiogenic centre and the anxiolytic periphery of the arena.", [["anxiety", "DISEASE", 38, 45], ["anxiety changes", "PROBLEM", 38, 53], ["activity", "OBSERVATION_MODIFIER", 25, 33], ["anxiety", "OBSERVATION", 38, 45], ["anxiolytic", "ANATOMY", 137, 147], ["periphery", "ANATOMY_MODIFIER", 148, 157], ["arena", "ANATOMY", 165, 170]]], ["This analysis demonstrated that Katnal11H/1H animals showed increased activity in both regions of the open field (distance travelled in centre of open field: wild type=164\u00b112 m, Katnal11H/1H=243\u00b120 m, P=0.02; distance travelled in periphery of open field: wild type=4.3\u00b10.2 m, Katnal11H/1H=6\u00b10.3 m, P=0.004).", [["Katnal11H/1H animals", "ORGANISM", 32, 52], ["This analysis", "TEST", 0, 13], ["Katnal11H/1H animals", "TEST", 32, 52], ["increased activity", "PROBLEM", 60, 78], ["Katnal11H/1H", "TEST", 178, 190], ["P", "TEST", 201, 202], ["wild type", "TEST", 256, 265], ["Katnal11H/1H", "TEST", 277, 289], ["P", "TEST", 299, 300], ["increased", "OBSERVATION_MODIFIER", 60, 69], ["activity", "OBSERVATION_MODIFIER", 70, 78], ["both", "ANATOMY_MODIFIER", 82, 86], ["regions", "ANATOMY_MODIFIER", 87, 94]]], ["Conversely when mouse activity was recorded in the home cage, we found no difference between genotypes (distance travelled over 24 h: wild type=399\u00b177 m, Katnal11H/1H=418\u00b141 m, P=0.833) suggesting that the former activity differences were due to the novel environment of the open field rather than generalised hyperactivity in Katnal11H/1H animals.", [["hyperactivity", "DISEASE", 310, 323], ["1H", "CHEMICAL", 337, 339], ["mouse", "ORGANISM", 16, 21], ["Katnal11H/1H animals", "ORGANISM", 327, 347], ["mouse", "SPECIES", 16, 21], ["mouse", "SPECIES", 16, 21], ["P", "TEST", 177, 178], ["the former activity differences", "PROBLEM", 202, 233], ["generalised hyperactivity", "PROBLEM", 298, 323]]], ["Finally, in certain conditions (such as maternal separation) mice emit ultrasonic vocalisations (USVs).", [["mice", "ORGANISM", 61, 65], ["mice", "SPECIES", 61, 65]]], ["To test whether Katnal11H/1H animals vocalised differently to wild types, we separated pups at postnatal days 7\u20138 (the age at which mice show peak of USV emission24) and recorded their USVs.", [["1H", "CHEMICAL", 26, 28], ["Katnal11H/1H animals", "ORGANISM", 16, 36], ["pups", "ORGANISM_SUBDIVISION", 87, 91], ["mice", "ORGANISM", 132, 136], ["Katnal11H", "PROTEIN", 16, 25], ["mice", "SPECIES", 132, 136]]], ["In these tests, compared to wild types, Katnal11H/1H pups produced fewer (Figure 2g) and shorter (Figure 2h) vocalisations, containing fewer phrases (Figure 2i).Gross brain morphological abnormalities in Katnal11H/1Hmice ::: ResultsSince we observed a number of behavioural phenotypes in Katnal11H/1H mice, we performed histological analysis to ascertain whether differences in brain histology underlied these behaviours.", [["brain", "ANATOMY", 167, 172], ["brain", "ANATOMY", 378, 383], ["1H", "CHEMICAL", 50, 52], ["Katnal11H/1H pups", "ORGANISM", 40, 57], ["brain", "ORGAN", 167, 172], ["Katnal11H/1H mice", "ORGANISM", 288, 305], ["brain", "ORGAN", 378, 383], ["mice", "SPECIES", 301, 305], ["these tests", "TEST", 3, 14], ["Katnal11H", "TEST", 40, 49], ["Gross brain morphological abnormalities", "PROBLEM", 161, 200], ["behavioural phenotypes", "PROBLEM", 262, 284], ["histological analysis", "TEST", 320, 341], ["brain histology", "TEST", 378, 393], ["brain", "ANATOMY", 167, 172], ["morphological abnormalities", "OBSERVATION", 173, 200]]], ["Data and cohort details are given in Supplementary Table S3.Gross brain morphological abnormalities in Katnal11H/1Hmice ::: ResultsAnalysis of hematoxylin and eosin stained brain sections revealed that, compared to wildtype littermates, Katnal11H/1H animals had less tightly packed pyramidal cell layers in the hippocampus (Figures 3a and b) and a narrower cortical layer 1 and wider cortical layer 6 (Figures 3c\u2013e).", [["brain", "ANATOMY", 66, 71], ["brain sections", "ANATOMY", 173, 187], ["pyramidal cell layers", "ANATOMY", 282, 303], ["hippocampus", "ANATOMY", 311, 322], ["cortical layer", "ANATOMY", 357, 371], ["cortical layer", "ANATOMY", 384, 398], ["hematoxylin", "CHEMICAL", 143, 154], ["eosin", "CHEMICAL", 159, 164], ["brain", "ORGAN", 66, 71], ["hematoxylin", "SIMPLE_CHEMICAL", 143, 154], ["eosin", "GENE_OR_GENE_PRODUCT", 159, 164], ["brain sections", "MULTI-TISSUE_STRUCTURE", 173, 187], ["wildtype littermates", "ORGANISM", 215, 235], ["Katnal11H/1H animals", "ORGANISM", 237, 257], ["pyramidal cell layers", "TISSUE", 282, 303], ["hippocampus", "ORGAN", 311, 322], ["Gross brain morphological abnormalities", "PROBLEM", 60, 99], ["hematoxylin", "TEST", 143, 154], ["eosin stained brain sections", "TEST", 159, 187], ["wildtype littermates", "TEST", 215, 235], ["Katnal11H", "TEST", 237, 246], ["a narrower cortical layer", "PROBLEM", 346, 371], ["brain", "ANATOMY", 66, 71], ["morphological abnormalities", "OBSERVATION", 72, 99], ["less", "OBSERVATION_MODIFIER", 262, 266], ["tightly packed", "OBSERVATION_MODIFIER", 267, 281], ["pyramidal cell layers", "OBSERVATION", 282, 303], ["hippocampus", "ANATOMY", 311, 322], ["narrower", "OBSERVATION_MODIFIER", 348, 356], ["cortical", "OBSERVATION_MODIFIER", 357, 365], ["layer", "OBSERVATION_MODIFIER", 366, 371], ["wider", "OBSERVATION_MODIFIER", 378, 383], ["cortical", "OBSERVATION_MODIFIER", 384, 392], ["layer", "OBSERVATION_MODIFIER", 393, 398]]], ["To confirm these cortical layer differences, immunofluorescence was performed using the cortical layer markers calbindin (layers 2/3 and 5; Figures 3f and g), CUX1 (layers 2/3 and 4; Figures 3i and j), FOXP2 (layer 6a) and CTGF (layer 6b) (Figures 3l and m).", [["cortical layer", "ANATOMY", 17, 31], ["cortical layer", "ANATOMY", 88, 102], ["cortical layer", "MULTI-TISSUE_STRUCTURE", 17, 31], ["calbindin", "GENE_OR_GENE_PRODUCT", 111, 120], ["CUX1", "GENE_OR_GENE_PRODUCT", 159, 163], ["FOXP2 (layer 6a", "GENE_OR_GENE_PRODUCT", 202, 217], ["CTGF", "GENE_OR_GENE_PRODUCT", 223, 227], ["calbindin", "PROTEIN", 111, 120], ["layers 2/3 and 5; Figures 3f and g", "PROTEIN", 122, 156], ["CUX1", "PROTEIN", 159, 163], ["layers 2/3 and 4; Figures 3i and j", "PROTEIN", 165, 199], ["FOXP2", "PROTEIN", 202, 207], ["layer 6a", "PROTEIN", 209, 217], ["CTGF", "PROTEIN", 223, 227], ["layer 6b", "PROTEIN", 229, 237], ["these cortical layer differences", "PROBLEM", 11, 43], ["immunofluorescence", "TEST", 45, 63], ["Figures", "TEST", 140, 147], ["CUX1", "TEST", 159, 163], ["Figures", "TEST", 183, 190], ["FOXP2", "TEST", 202, 207], ["CTGF", "TEST", 223, 227], ["cortical", "OBSERVATION_MODIFIER", 17, 25], ["layer", "OBSERVATION_MODIFIER", 26, 31]]], ["Quantification of fluorescence intensity demonstrated that in Katnal11H/1H cortex both calbindin and CUX1 labelling was more intense closer to the cortical surface, which is consistent with the reduction in the size of layer 1 (two-way analysis of variance (ANOVA), interaction factors \u2018genotype X distance of fluorescence from cortical surface\u2019, calbindin: F(75,988)=16.8, P<0.0005; CUX1: F(93,372=2.17, P=0.001; Figures 3h and k).", [["Katnal11H/1H cortex", "ANATOMY", 62, 81], ["cortical surface", "ANATOMY", 147, 163], ["cortical surface", "ANATOMY", 328, 344], ["1H", "CHEMICAL", 72, 74], ["calbindin", "GENE_OR_GENE_PRODUCT", 87, 96], ["CUX1", "GENE_OR_GENE_PRODUCT", 101, 105], ["cortical surface", "CELLULAR_COMPONENT", 147, 163], ["calbindin", "GENE_OR_GENE_PRODUCT", 347, 356], ["Katnal11H", "PROTEIN", 62, 71], ["calbindin", "PROTEIN", 87, 96], ["CUX1", "PROTEIN", 101, 105], ["interaction factors", "PROTEIN", 266, 285], ["fluorescence intensity", "TEST", 18, 40], ["Katnal11H", "TEST", 62, 71], ["interaction factors", "PROBLEM", 266, 285], ["fluorescence", "TEST", 310, 322], ["cortical surface", "TEST", 328, 344], ["P", "TEST", 374, 375], ["CUX1", "TEST", 384, 388], ["P", "TEST", 405, 406], ["Figures", "TEST", 414, 421], ["k", "TEST", 429, 430], ["fluorescence intensity", "OBSERVATION", 18, 40], ["more", "OBSERVATION_MODIFIER", 120, 124], ["intense", "OBSERVATION_MODIFIER", 125, 132], ["cortical", "ANATOMY_MODIFIER", 147, 155], ["surface", "ANATOMY_MODIFIER", 156, 163], ["consistent with", "UNCERTAINTY", 174, 189], ["reduction", "OBSERVATION_MODIFIER", 194, 203], ["size", "OBSERVATION_MODIFIER", 211, 215], ["layer", "OBSERVATION_MODIFIER", 219, 224]]], ["Similar quantification revealed that FOXP2 labelling extended further from layer 6b (as labelled by CTGF) in the Katnal11H/1H cortex, which is consistent with an increase in the size of layer 6 (two-way ANOVA, interaction factors \u2018genotype X distance of fluorescence from CTGF labelling:\u2019 F(93,372)=1.32, P=0.038; Figure 3n).", [["Katnal11H/1H cortex", "ANATOMY", 113, 132], ["1H", "CHEMICAL", 123, 125], ["FOXP2", "GENE_OR_GENE_PRODUCT", 37, 42], ["layer 6b", "GENE_OR_GENE_PRODUCT", 75, 83], ["CTGF", "GENE_OR_GENE_PRODUCT", 100, 104], ["CTGF", "GENE_OR_GENE_PRODUCT", 272, 276], ["FOXP2", "DNA", 37, 42], ["CTGF", "PROTEIN", 100, 104], ["interaction factors", "PROTEIN", 210, 229], ["CTGF", "PROTEIN", 272, 276], ["Similar quantification", "TEST", 0, 22], ["FOXP2 labelling", "PROBLEM", 37, 52], ["CTGF labelling", "TEST", 272, 286], ["P", "TEST", 305, 306], ["FOXP2 labelling", "OBSERVATION", 37, 52], ["layer", "OBSERVATION_MODIFIER", 75, 80], ["1H cortex", "ANATOMY", 123, 132], ["consistent with", "UNCERTAINTY", 143, 158], ["increase", "OBSERVATION_MODIFIER", 162, 170], ["size", "OBSERVATION_MODIFIER", 178, 182], ["layer", "OBSERVATION_MODIFIER", 186, 191]]], ["Finally, three dimensional models of the ventricular system were constructed from brain micro-computed tomography scans (Figures 3o and p).", [["ventricular system", "ANATOMY", 41, 59], ["brain", "ANATOMY", 82, 87], ["ventricular system", "MULTI-TISSUE_STRUCTURE", 41, 59], ["brain", "ORGAN", 82, 87], ["brain micro-computed tomography scans", "TEST", 82, 119], ["Figures", "TEST", 121, 128], ["ventricular system", "ANATOMY", 41, 59]]], ["Volumetric analysis revealed that Katnal11H/1H mice had substantially larger ventricles than wild types (Figure 3q).Neuronal migration and morphology defects in Katnal11H/1Hbrains ::: ResultsThe histological phenotypes of Katnal11H/1H mouse brains described above are suggestive of neuronal migration defects.18 We therefore investigated whether Katnal11H/1H mice showed abnormal neuronal migration using BrdU labelling of E13 and E15 embryos and quantified labelled cells in the cortex of P9 pups (described in reference 18).", [["ventricles", "ANATOMY", 77, 87], ["Neuronal", "ANATOMY", 116, 124], ["brains", "ANATOMY", 241, 247], ["neuronal", "ANATOMY", 282, 290], ["neuronal", "ANATOMY", 380, 388], ["E13", "ANATOMY", 423, 426], ["E15 embryos", "ANATOMY", 431, 442], ["cells", "ANATOMY", 467, 472], ["cortex", "ANATOMY", 480, 486], ["pups", "ANATOMY", 493, 497], ["BrdU", "CHEMICAL", 405, 409], ["Katnal11H/1H mice", "ORGANISM", 34, 51], ["ventricles", "MULTI-TISSUE_STRUCTURE", 77, 87], ["Neuronal", "CELL", 116, 124], ["Katnal11H/1H mouse", "ORGANISM", 222, 240], ["brains", "ORGANISM", 241, 247], ["neuronal", "CELL", 282, 290], ["Katnal11H/1H mice", "ORGANISM", 346, 363], ["neuronal", "CELL", 380, 388], ["BrdU", "SIMPLE_CHEMICAL", 405, 409], ["E13", "CELL", 423, 426], ["E15 embryos", "TISSUE", 431, 442], ["cells", "CELL", 467, 472], ["cortex", "MULTI-TISSUE_STRUCTURE", 480, 486], ["pups", "ORGAN", 493, 497], ["mice", "SPECIES", 47, 51], ["mouse", "SPECIES", 235, 240], ["mice", "SPECIES", 359, 363], ["mouse", "SPECIES", 235, 240], ["Volumetric analysis", "TEST", 0, 19], ["Katnal11H", "TEST", 34, 43], ["substantially larger ventricles", "PROBLEM", 56, 87], ["Neuronal migration and morphology defects", "PROBLEM", 116, 157], ["The histological phenotypes", "TEST", 191, 218], ["neuronal migration defects", "PROBLEM", 282, 308], ["Katnal11H", "TEST", 346, 355], ["abnormal neuronal migration", "PROBLEM", 371, 398], ["quantified labelled cells", "PROBLEM", 447, 472], ["larger", "OBSERVATION_MODIFIER", 70, 76], ["ventricles", "ANATOMY", 77, 87], ["migration", "OBSERVATION_MODIFIER", 125, 134], ["morphology defects", "OBSERVATION", 139, 157], ["histological phenotypes", "OBSERVATION", 195, 218], ["suggestive of", "UNCERTAINTY", 268, 281], ["neuronal", "OBSERVATION", 282, 290], ["migration defects", "OBSERVATION", 291, 308], ["abnormal", "OBSERVATION_MODIFIER", 371, 379], ["neuronal migration", "OBSERVATION", 380, 398], ["labelled cells", "OBSERVATION", 458, 472], ["cortex", "ANATOMY_MODIFIER", 480, 486]]], ["At both ages Katnal11H/1H animals had greater numbers of labelled neurons in bins close to the cortical surface (two-way ANOVA, interaction factors \u2018genotype X bin\u2019: E13 brains; F(9,80)=2.361, P=0.02.", [["neurons", "ANATOMY", 66, 73], ["cortical surface", "ANATOMY", 95, 111], ["E13 brains", "ANATOMY", 166, 176], ["neurons", "CELL", 66, 73], ["cortical surface", "MULTI-TISSUE_STRUCTURE", 95, 111], ["labelled neurons", "CELL_TYPE", 57, 73], ["interaction factors", "PROTEIN", 128, 147], ["Katnal11H", "TEST", 13, 22], ["greater numbers of labelled neurons", "PROBLEM", 38, 73], ["genotype X bin\u2019", "TEST", 149, 164], ["P", "TEST", 193, 194], ["labelled neurons", "OBSERVATION", 57, 73], ["cortical", "ANATOMY_MODIFIER", 95, 103], ["surface", "ANATOMY_MODIFIER", 104, 111]]], ["E15 brains; F(9,70)=2.412, P=0.019; Figures 4a\u2013f).", [["E15 brains", "ANATOMY", 0, 10], ["P", "TEST", 27, 28], ["Figures", "TEST", 36, 43]]], ["These results demonstrate a defect in neuronal migration during development, with the final location of Katnal11H/1H neurons positioned closer to the cortical surface compared to wild type.", [["neuronal", "ANATOMY", 38, 46], ["Katnal11H/1H neurons", "ANATOMY", 104, 124], ["cortical surface", "ANATOMY", 150, 166], ["1H", "CHEMICAL", 114, 116], ["neuronal", "CELL", 38, 46], ["Katnal11H", "GENE_OR_GENE_PRODUCT", 104, 113], ["cortical surface", "CELLULAR_COMPONENT", 150, 166], ["Katnal11H", "PROTEIN", 104, 113], ["a defect in neuronal migration", "PROBLEM", 26, 56], ["Katnal11H/1H neurons", "TREATMENT", 104, 124], ["defect", "OBSERVATION", 28, 34], ["neuronal migration", "OBSERVATION", 38, 56], ["cortical", "ANATOMY_MODIFIER", 150, 158], ["surface", "OBSERVATION_MODIFIER", 159, 166], ["wild type", "OBSERVATION", 179, 188]]], ["To confirm these results we used a Boyden chamber19 and performed in vitro neuronal migration analysis in E13.5 primary cortical neuronal cultures.", [["neuronal", "ANATOMY", 75, 83], ["E13.5 primary cortical neuronal cultures", "ANATOMY", 106, 146], ["neuronal", "CELL", 75, 83], ["E13.5 primary cortical neuronal cultures", "CELL", 106, 146], ["Boyden chamber19", "CELL_LINE", 35, 51], ["E13.5 primary cortical neuronal cultures", "CELL_LINE", 106, 146], ["a Boyden chamber19", "TREATMENT", 33, 51], ["cortical neuronal cultures", "TEST", 120, 146]]], ["Here we found that a greater proportion of Katnal11H/1H cortical neurons migrated to the base of the cell culture insert compared to wildtype controls (Supplementary Figure S3).", [["cortical neurons", "ANATOMY", 56, 72], ["cell culture", "ANATOMY", 101, 113], ["Katnal11H", "GENE_OR_GENE_PRODUCT", 43, 52], ["cortical neurons", "CELL", 56, 72], ["cell", "CELL", 101, 105], ["Katnal11H/1H cortical neurons", "CELL_LINE", 43, 72], ["Katnal11H/1H cortical neurons", "PROBLEM", 43, 72], ["the cell culture insert", "TREATMENT", 97, 120], ["greater", "OBSERVATION_MODIFIER", 21, 28], ["base", "ANATOMY_MODIFIER", 89, 93], ["cell culture", "OBSERVATION", 101, 113]]], ["Since in both BrdU labelling and the Boyden assay neurons from Katnal11H/1H animals migrated further than those of wild-type littermates, these results suggest that Katnal11H/1H cortical neurons show defects in the termination of cortical neuronal migration.Neuronal migration and morphology defects in Katnal11H/1Hbrains ::: ResultsGiven its role in cytoskeletal organisation, we also hypothesised that neuronal morphology is modulated by Katnal1.", [["neurons", "ANATOMY", 50, 57], ["cortical neurons", "ANATOMY", 178, 194], ["cortical neuronal", "ANATOMY", 230, 247], ["Neuronal", "ANATOMY", 258, 266], ["cytoskeletal", "ANATOMY", 351, 363], ["neuronal", "ANATOMY", 404, 412], ["BrdU", "CHEMICAL", 14, 18], ["BrdU", "SIMPLE_CHEMICAL", 14, 18], ["neurons", "CELL", 50, 57], ["Katnal11H/1H animals", "ORGANISM", 63, 83], ["wild-type littermates", "ORGANISM", 115, 136], ["Katnal11H/1H cortical neurons", "ORGANISM", 165, 194], ["cortical neuronal", "CELL", 230, 247], ["Neuronal", "CELL", 258, 266], ["cytoskeletal", "CELLULAR_COMPONENT", 351, 363], ["neuronal", "CELL", 404, 412], ["Katnal1", "GENE_OR_GENE_PRODUCT", 440, 447], ["Boyden assay neurons", "CELL_LINE", 37, 57], ["Katnal11H/1H cortical neurons", "CELL_LINE", 165, 194], ["Katnal1", "PROTEIN", 440, 447], ["the Boyden assay", "TEST", 33, 49], ["Katnal11H/1H cortical neurons", "PROBLEM", 165, 194], ["defects", "PROBLEM", 200, 207], ["cortical neuronal migration", "PROBLEM", 230, 257], ["Neuronal migration and morphology defects", "PROBLEM", 258, 299], ["defects", "OBSERVATION", 200, 207], ["cortical neuronal migration", "OBSERVATION", 230, 257], ["migration", "OBSERVATION_MODIFIER", 267, 276], ["morphology defects", "OBSERVATION", 281, 299], ["cytoskeletal organisation", "OBSERVATION", 351, 376]]], ["Analysis of golgi stained neurons from layers 2\u20133 of the cortex (Figures 4g and i) demonstrated that, compared to wild-type littermates, Katnal11H/1H neurons had larger soma (Figure 4k), and shorter and thinner axons (Figures 4l and m) (data and cohort details are given in Supplementary Table S3).", [["neurons", "ANATOMY", 26, 33], ["layers 2\u20133", "ANATOMY", 39, 49], ["cortex", "ANATOMY", 57, 63], ["Katnal11H/1H neurons", "ANATOMY", 137, 157], ["soma", "ANATOMY", 169, 173], ["axons", "ANATOMY", 211, 216], ["golgi", "GENE_OR_GENE_PRODUCT", 12, 17], ["neurons", "CELL", 26, 33], ["cortex", "MULTI-TISSUE_STRUCTURE", 57, 63], ["wild-type littermates", "ORGANISM", 114, 135], ["Katnal11H/1H neurons", "CELL", 137, 157], ["axons", "MULTI-TISSUE_STRUCTURE", 211, 216], ["golgi stained neurons", "CELL_TYPE", 12, 33], ["Katnal11H/1H neurons", "CELL_LINE", 137, 157], ["golgi stained neurons", "PROBLEM", 12, 33], ["Katnal11H", "TEST", 137, 146], ["golgi stained", "OBSERVATION", 12, 25], ["cortex", "ANATOMY", 57, 63]]], ["Furthermore, analysis at higher magnification (Figures 4h and j), demonstrated that the number of synaptic spines on Katnal11H/1H neurons was significantly reduced compared to wild type (Figure 4n).Katnal11H/1Hassociated with defects in motile cilia ::: ResultsRecent studies have demonstrated that mutations in some microtubule severing enzymes can cause defects in cilia.5 Since such ciliary defects could underlie the phenotypes described above we studied the motile cilia of the ependymal lining of the lateral ventricle in sections of postnatal day 2 mouse brains from both Katnal11H/1H (n=4) and wild-type animals (n=3).", [["synaptic spines", "ANATOMY", 98, 113], ["Katnal11H/1H neurons", "ANATOMY", 117, 137], ["cilia", "ANATOMY", 244, 249], ["microtubule", "ANATOMY", 317, 328], ["cilia", "ANATOMY", 367, 372], ["ciliary", "ANATOMY", 386, 393], ["cilia", "ANATOMY", 470, 475], ["ependymal lining", "ANATOMY", 483, 499], ["lateral ventricle", "ANATOMY", 507, 524], ["sections", "ANATOMY", 528, 536], ["brains", "ANATOMY", 562, 568], ["ciliary defects", "DISEASE", 386, 401], ["1H", "CHEMICAL", 127, 129], ["synaptic spines", "CELLULAR_COMPONENT", 98, 113], ["Katnal11H", "GENE_OR_GENE_PRODUCT", 198, 207], ["microtubule", "CELLULAR_COMPONENT", 317, 328], ["cilia", "CELLULAR_COMPONENT", 367, 372], ["ciliary", "MULTI-TISSUE_STRUCTURE", 386, 393], ["cilia", "IMMATERIAL_ANATOMICAL_ENTITY", 470, 475], ["ependymal lining", "TISSUE", 483, 499], ["lateral ventricle", "MULTI-TISSUE_STRUCTURE", 507, 524], ["sections", "MULTI-TISSUE_STRUCTURE", 528, 536], ["mouse", "ORGANISM", 556, 561], ["brains", "DEVELOPING_ANATOMICAL_STRUCTURE", 562, 568], ["Katnal11H/1H neurons", "CELL_LINE", 117, 137], ["Katnal11H", "PROTEIN", 198, 207], ["microtubule severing enzymes", "PROTEIN", 317, 345], ["mouse", "SPECIES", 556, 561], ["mouse", "SPECIES", 556, 561], ["analysis", "TEST", 13, 21], ["Katnal11H", "TEST", 198, 207], ["ResultsRecent studies", "TEST", 254, 275], ["mutations in some microtubule severing enzymes", "PROBLEM", 299, 345], ["defects in cilia", "PROBLEM", 356, 372], ["such ciliary defects", "PROBLEM", 381, 401], ["the phenotypes", "PROBLEM", 417, 431], ["Katnal11H", "TEST", 579, 588], ["defects", "OBSERVATION", 226, 233], ["motile cilia", "OBSERVATION", 237, 249], ["defects", "OBSERVATION", 356, 363], ["cilia", "ANATOMY_MODIFIER", 367, 372], ["ciliary defects", "OBSERVATION", 386, 401], ["motile cilia", "OBSERVATION", 463, 475], ["ependymal", "ANATOMY_MODIFIER", 483, 492], ["lining", "ANATOMY_MODIFIER", 493, 499], ["lateral ventricle", "ANATOMY", 507, 524]]], ["We found that the ciliary beat frequency (CBF) of Katnal11H/1H animals was significantly attenuated compared to wild-type (CBF: wildtype=22.39\u00b10.94 Hz, Katnal11H/1H=14.25\u00b10.92 Hz, P=0.0001; Figure 5a, Supplementary Movies S1).", [["ciliary", "ANATOMY", 18, 25], ["CBF", "PROTEIN", 123, 126], ["the ciliary beat frequency", "TEST", 14, 40], ["CBF", "TEST", 42, 45], ["Katnal11H", "TEST", 50, 59], ["significantly attenuated", "PROBLEM", 75, 99], ["CBF", "TEST", 123, 126], ["wildtype", "TEST", 128, 136], ["Hz", "TEST", 148, 150], ["Katnal11H/1H", "TEST", 152, 164], ["Hz", "TEST", 176, 178], ["P", "TEST", 180, 181], ["Figure 5a", "TEST", 190, 199], ["ciliary beat", "OBSERVATION", 18, 30]]], ["This reduction in CBF in Katnal11H/1H animals was also associated with an increased proportion of cilia with an abnormal beat pattern (ciliary dyskinesia) (proportion of dyskinetic cilia: wild type=17%, Katnal11H/1H=75%) (Figure 5b and Supplementary Movies S1).", [["cilia", "ANATOMY", 98, 103], ["ciliary", "ANATOMY", 135, 142], ["cilia", "ANATOMY", 181, 186], ["ciliary dyskinesia", "DISEASE", 135, 153], ["Katnal11H/1H animals", "ORGANISM", 25, 45], ["cilia", "CELLULAR_COMPONENT", 98, 103], ["CBF", "PROTEIN", 18, 21], ["This reduction", "TREATMENT", 0, 14], ["CBF", "TEST", 18, 21], ["an increased proportion of cilia", "PROBLEM", 71, 103], ["an abnormal beat pattern", "PROBLEM", 109, 133], ["ciliary dyskinesia", "PROBLEM", 135, 153], ["dyskinetic cilia", "PROBLEM", 170, 186], ["wild type", "TEST", 188, 197], ["Katnal11H", "TEST", 203, 212], ["Figure", "TEST", 222, 228], ["reduction", "OBSERVATION_MODIFIER", 5, 14], ["increased", "OBSERVATION_MODIFIER", 74, 83], ["cilia", "ANATOMY_MODIFIER", 98, 103], ["abnormal beat pattern", "OBSERVATION", 112, 133], ["ciliary dyskinesia", "OBSERVATION", 135, 153], ["dyskinetic cilia", "OBSERVATION", 170, 186]]], ["Visual inspection of the cilia identified a number of ciliary abnormalities such as a swollen ciliary tip (Supplementary Movie S3) or extremely long cilia (Supplementary Movie S4) scattered throughout the field of cilia in Katnal11H/1H ventricles.", [["cilia", "ANATOMY", 25, 30], ["ciliary", "ANATOMY", 54, 61], ["ciliary tip", "ANATOMY", 94, 105], ["cilia", "ANATOMY", 149, 154], ["cilia", "ANATOMY", 214, 219], ["ventricles", "ANATOMY", 236, 246], ["1H", "CHEMICAL", 233, 235], ["cilia", "CELLULAR_COMPONENT", 25, 30], ["ciliary", "MULTI-TISSUE_STRUCTURE", 54, 61], ["long cilia", "CELLULAR_COMPONENT", 144, 154], ["cilia", "CELLULAR_COMPONENT", 214, 219], ["1H ventricles", "MULTI-TISSUE_STRUCTURE", 233, 246], ["Visual inspection", "TEST", 0, 17], ["ciliary abnormalities", "PROBLEM", 54, 75], ["a swollen ciliary tip", "PROBLEM", 84, 105], ["extremely long cilia", "PROBLEM", 134, 154], ["cilia", "ANATOMY", 25, 30], ["number", "OBSERVATION_MODIFIER", 44, 50], ["ciliary abnormalities", "OBSERVATION", 54, 75], ["swollen", "OBSERVATION_MODIFIER", 86, 93], ["ciliary", "OBSERVATION_MODIFIER", 94, 101], ["tip", "OBSERVATION_MODIFIER", 102, 105], ["long cilia", "OBSERVATION_MODIFIER", 144, 154], ["scattered", "OBSERVATION_MODIFIER", 180, 189], ["field", "ANATOMY_MODIFIER", 205, 210], ["cilia", "ANATOMY_MODIFIER", 214, 219], ["1H ventricles", "ANATOMY", 233, 246]]], ["These abnormalities were observed in approximately 25% of Katnal11H/1H brain slices.", [["brain slices", "ANATOMY", 71, 83], ["These abnormalities", "PROBLEM", 0, 19], ["abnormalities", "OBSERVATION", 6, 19], ["brain slices", "ANATOMY", 71, 83]]], ["The abnormal cilia always showed a dyskinetic beat pattern and lower beat frequency.", [["cilia", "ANATOMY", 13, 18], ["cilia", "ORGAN", 13, 18], ["The abnormal cilia always", "PROBLEM", 0, 25], ["a dyskinetic beat pattern", "PROBLEM", 33, 58], ["lower beat frequency", "PROBLEM", 63, 83], ["abnormal cilia", "OBSERVATION", 4, 18], ["dyskinetic beat", "OBSERVATION", 35, 50], ["lower", "OBSERVATION_MODIFIER", 63, 68], ["beat frequency", "OBSERVATION", 69, 83]]], ["To further investigate ciliary morphology we performed scanning electron microscopy upon the ependymal lining of the lateral ventricles of both Katnal11H/1H (n=3) and wild-type animals (n=3; Figures 5c and d).", [["ciliary", "ANATOMY", 23, 30], ["ependymal lining", "ANATOMY", 93, 109], ["lateral ventricles", "ANATOMY", 117, 135], ["ciliary", "MULTI-TISSUE_STRUCTURE", 23, 30], ["ependymal lining", "TISSUE", 93, 109], ["lateral ventricles", "MULTI-TISSUE_STRUCTURE", 117, 135], ["scanning electron microscopy", "TEST", 55, 83], ["ependymal", "ANATOMY_MODIFIER", 93, 102], ["lining", "ANATOMY_MODIFIER", 103, 109], ["lateral ventricles", "ANATOMY", 117, 135]]], ["Cilia measurements showed no significant differences in average cilia length between genotypes (average cilia length: wild type=6.22\u00b10.86 \u03bcm, Katnal11H/1H=6.54\u00b10.94 Hz, P=0.303).", [["Cilia", "ANATOMY", 0, 5], ["cilia", "ANATOMY", 64, 69], ["cilia", "ANATOMY", 104, 109], ["cilia", "IMMATERIAL_ANATOMICAL_ENTITY", 64, 69], ["Cilia measurements", "TEST", 0, 18], ["significant differences", "PROBLEM", 29, 52], ["genotypes", "TEST", 85, 94], ["cilia length", "TEST", 104, 116], ["wild type", "TEST", 118, 127], ["\u03bcm", "TEST", 138, 140], ["Katnal11H/1H", "TEST", 142, 154], ["Hz", "TEST", 165, 167], ["P", "TEST", 169, 170], ["no", "UNCERTAINTY", 26, 28], ["significant", "OBSERVATION_MODIFIER", 29, 40], ["differences", "OBSERVATION", 41, 52], ["average", "OBSERVATION_MODIFIER", 56, 63], ["cilia", "OBSERVATION_MODIFIER", 64, 69], ["length", "OBSERVATION_MODIFIER", 70, 76]]], ["However in Katnal11H/1H samples we noted the presence of both long and short cilia (Figures 5e and f; defined as two standard deviations longer or shorter than the average cilia length) that were not present in wild-type samples.", [["Katnal11H/1H samples", "ANATOMY", 11, 31], ["cilia", "ANATOMY", 77, 82], ["cilia", "ANATOMY", 172, 177], ["samples", "ANATOMY", 221, 228], ["1H", "CHEMICAL", 21, 23], ["Katnal11H", "PROTEIN", 11, 20], ["Katnal11H/1H samples", "TEST", 11, 31], ["both long and short cilia", "PROBLEM", 57, 82], ["short cilia", "OBSERVATION_MODIFIER", 71, 82]]], ["In addition, inspection of Katnal11H/1H cilia identified ciliary abnormalities including bifurcated cilia (Figure 5g), abnormal kinks and bends in the cilia (Figure 5h) and swellings along the length of the cilia (Figure 5i).", [["cilia", "ANATOMY", 40, 45], ["ciliary", "ANATOMY", 57, 64], ["cilia", "ANATOMY", 100, 105], ["cilia", "ANATOMY", 151, 156], ["cilia", "ANATOMY", 207, 212], ["ciliary abnormalities", "DISEASE", 57, 78], ["abnormal kinks", "DISEASE", 119, 133], ["ciliary", "MULTI-TISSUE_STRUCTURE", 57, 64], ["cilia", "CELLULAR_COMPONENT", 100, 105], ["cilia", "CELLULAR_COMPONENT", 151, 156], ["cilia", "CELLULAR_COMPONENT", 207, 212], ["Katnal11H", "PROTEIN", 27, 36], ["inspection of Katnal11H/1H cilia", "TEST", 13, 45], ["ciliary abnormalities", "PROBLEM", 57, 78], ["bifurcated cilia", "PROBLEM", 89, 105], ["abnormal kinks and bends in the cilia", "PROBLEM", 119, 156], ["swellings", "PROBLEM", 173, 182], ["ciliary abnormalities", "OBSERVATION", 57, 78], ["bifurcated", "OBSERVATION_MODIFIER", 89, 99], ["cilia", "ANATOMY_MODIFIER", 100, 105], ["abnormal", "OBSERVATION_MODIFIER", 119, 127], ["kinks", "OBSERVATION_MODIFIER", 128, 133], ["bends", "OBSERVATION_MODIFIER", 138, 143], ["cilia", "ANATOMY_MODIFIER", 151, 156], ["swellings", "OBSERVATION", 173, 182], ["length", "OBSERVATION_MODIFIER", 193, 199], ["cilia", "ANATOMY_MODIFIER", 207, 212]]], ["Transmission electron microscopy of ependymal cilia found that vesicular aggregates were present within the ciliary swellings described above (Figure 5j).", [["ependymal cilia", "ANATOMY", 36, 51], ["vesicular aggregates", "ANATOMY", 63, 83], ["ciliary swellings", "ANATOMY", 108, 125], ["ependymal cilia", "MULTI-TISSUE_STRUCTURE", 36, 51], ["vesicular aggregates", "CELLULAR_COMPONENT", 63, 83], ["ciliary swellings", "MULTI-TISSUE_STRUCTURE", 108, 125], ["Transmission electron microscopy", "TEST", 0, 32], ["ependymal cilia", "PROBLEM", 36, 51], ["vesicular aggregates", "PROBLEM", 63, 83], ["the ciliary swellings", "PROBLEM", 104, 125], ["ependymal cilia", "ANATOMY", 36, 51], ["vesicular aggregates", "OBSERVATION", 63, 83], ["ciliary", "ANATOMY_MODIFIER", 108, 115], ["swellings", "OBSERVATION", 116, 125]]], ["Although these abnormalities were present in only a small proportion (<1%) of Katnal11H/1H cilia, they were notably absent from wild-type cilia.DiscussionMicrotubule severing enzymes play diverse roles in the nervous system.1, 2 However, at present the microtubule severing enzyme Katnal1 is poorly defined in the context of CNS development and function.", [["cilia", "ANATOMY", 91, 96], ["cilia", "ANATOMY", 138, 143], ["Microtubule", "ANATOMY", 154, 165], ["nervous system", "ANATOMY", 209, 223], ["microtubule", "ANATOMY", 253, 264], ["CNS", "ANATOMY", 325, 328], ["Katnal11H", "GENE_OR_GENE_PRODUCT", 78, 87], ["cilia", "CELL", 138, 143], ["Microtubule", "CELLULAR_COMPONENT", 154, 165], ["nervous system", "ANATOMICAL_SYSTEM", 209, 223], ["microtubule", "CELLULAR_COMPONENT", 253, 264], ["Katnal1", "GENE_OR_GENE_PRODUCT", 281, 288], ["CNS", "ANATOMICAL_SYSTEM", 325, 328], ["Microtubule severing enzymes", "PROTEIN", 154, 182], ["microtubule severing enzyme", "PROTEIN", 253, 280], ["Katnal1", "PROTEIN", 281, 288], ["these abnormalities", "PROBLEM", 9, 28], ["Katnal11H/1H cilia", "TEST", 78, 96], ["Microtubule severing enzymes", "TEST", 154, 182], ["the microtubule severing enzyme Katnal1", "TEST", 249, 288], ["abnormalities", "OBSERVATION", 15, 28], ["small", "OBSERVATION_MODIFIER", 52, 57], ["proportion", "OBSERVATION_MODIFIER", 58, 68], ["type cilia", "OBSERVATION", 133, 143], ["diverse", "OBSERVATION_MODIFIER", 188, 195], ["nervous system", "ANATOMY", 209, 223], ["poorly defined", "OBSERVATION_MODIFIER", 292, 306], ["CNS development", "OBSERVATION", 325, 340]]], ["Here we present a detailed phenotypic analysis of Katnal11H and show that the mutation is associated with changes in circadian rhythms, sleep and behaviour.", [["Katnal11H", "GENE_OR_GENE_PRODUCT", 50, 59], ["Katnal11H", "PROTEIN", 50, 59], ["Katnal11H", "TEST", 50, 59], ["the mutation", "PROBLEM", 74, 86], ["changes in circadian rhythms", "PROBLEM", 106, 134]]], ["Furthermore we demonstrate that defects in brain histopathology, neuronal migration and neuronal morphology underlie these phenotypes.", [["brain", "ANATOMY", 43, 48], ["neuronal", "ANATOMY", 65, 73], ["neuronal", "ANATOMY", 88, 96], ["brain", "ORGAN", 43, 48], ["neuronal", "CELL", 65, 73], ["neuronal", "CELL", 88, 96], ["defects in brain histopathology", "PROBLEM", 32, 63], ["neuronal migration", "PROBLEM", 65, 83], ["these phenotypes", "PROBLEM", 117, 133], ["defects", "OBSERVATION", 32, 39], ["brain", "ANATOMY", 43, 48], ["histopathology", "OBSERVATION", 49, 63], ["neuronal migration", "OBSERVATION", 65, 83]]], ["Finally we also demonstrate that Katnal11H causes a range of defects in the motile cilia of ventricular ependymal cells.", [["cilia", "ANATOMY", 83, 88], ["ventricular ependymal cells", "ANATOMY", 92, 119], ["Katnal11H", "CHEMICAL", 33, 42], ["Katnal11H", "GENE_OR_GENE_PRODUCT", 33, 42], ["cilia", "CELLULAR_COMPONENT", 83, 88], ["ventricular ependymal cells", "CELL", 92, 119], ["Katnal11H", "PROTEIN", 33, 42], ["ventricular ependymal cells", "CELL_TYPE", 92, 119], ["Katnal11H", "TEST", 33, 42], ["a range of defects", "PROBLEM", 50, 68], ["range", "OBSERVATION_MODIFIER", 52, 57], ["defects", "OBSERVATION", 61, 68], ["motile cilia", "ANATOMY_MODIFIER", 76, 88], ["ventricular", "ANATOMY", 92, 103], ["ependymal cells", "OBSERVATION", 104, 119]]], ["The data we present here are the first to associate KATNAL1 with such dysfunctions with important implications for clinical association studies.DiscussionThe Katnal11H mutation was initially identified with a circadian deficit including a short free-running period and advanced activity onset.", [["circadian deficit", "DISEASE", 209, 226], ["KATNAL1", "GENE_OR_GENE_PRODUCT", 52, 59], ["Katnal11H", "GENE_OR_GENE_PRODUCT", 158, 167], ["KATNAL1", "PROTEIN", 52, 59], ["Katnal11H", "DNA", 158, 167], ["such dysfunctions", "PROBLEM", 65, 82], ["clinical association studies", "TEST", 115, 143], ["The Katnal11H mutation", "TEST", 154, 176], ["a circadian deficit", "PROBLEM", 207, 226], ["advanced activity onset", "PROBLEM", 269, 292]]], ["However subsequent ex vivo experiments using SCN slices of animals carrying the PER2::LUC reporter gene demonstrated no defects in SCN cellular rhythms, suggesting that the core circadian clock was unperturbed by the mutation.", [["SCN slices", "ANATOMY", 45, 55], ["cellular", "ANATOMY", 135, 143], ["SCN slices", "MULTI-TISSUE_STRUCTURE", 45, 55], ["animals", "ORGANISM", 59, 66], ["PER2", "GENE_OR_GENE_PRODUCT", 80, 84], ["LUC", "GENE_OR_GENE_PRODUCT", 86, 89], ["SCN cellular", "CELL", 131, 143], ["PER2::LUC reporter gene", "DNA", 80, 103], ["LUC reporter gene", "TEST", 86, 103], ["defects in SCN cellular rhythms", "PROBLEM", 120, 151], ["the core circadian clock", "PROBLEM", 169, 193], ["no", "UNCERTAINTY", 117, 119], ["defects", "OBSERVATION", 120, 127]]], ["Phenotypes in circadian running wheel rhythms that are not associated with changes to the core clock mechanism have also been reported in mouse models of schizophrenia.25 Here it has been suggested that the wheel running changes observed are the result in defects in output pathways from the SCN circadian clock.", [["schizophrenia", "DISEASE", 154, 167], ["mouse", "ORGANISM", 138, 143], ["mouse", "SPECIES", 138, 143], ["mouse", "SPECIES", 138, 143], ["Phenotypes", "PROBLEM", 0, 10], ["schizophrenia", "PROBLEM", 154, 167], ["defects in output pathways", "PROBLEM", 256, 282], ["schizophrenia", "OBSERVATION", 154, 167], ["defects", "OBSERVATION", 256, 263]]], ["Similarly, in Katnal11H/1H mice we hypothesise that the defects we demonstrate in neuronal anatomy and neuronal morphology may disrupt output signals from the SCN.", [["neuronal", "ANATOMY", 82, 90], ["neuronal", "ANATOMY", 103, 111], ["Katnal11H/1H mice", "ORGANISM", 14, 31], ["neuronal", "CELL", 82, 90], ["neuronal", "CELL", 103, 111], ["mice", "SPECIES", 27, 31], ["the defects", "PROBLEM", 52, 63], ["defects", "OBSERVATION", 56, 63], ["neuronal anatomy", "OBSERVATION", 82, 98], ["SCN", "ANATOMY", 159, 162]]], ["Alternatively given that various neuropeptides such as oxytocin are secreted in a circadian manner from ependymal cells lining the third ventricle of the brain,26 altered ventricular morphology and ciliary function in Katnal11H/1H mice may disrupt the circulation of factors secreted by the ciliated ventricular ependymal cells and contribute to the disruption of the behavioural rhythms observed.DiscussionThe behavioural consequences of microtubule severing enzyme dysfunction in mouse models have been poorly characterised.", [["ependymal cells", "ANATOMY", 104, 119], ["third ventricle", "ANATOMY", 131, 146], ["brain", "ANATOMY", 154, 159], ["ventricular", "ANATOMY", 171, 182], ["ciliary", "ANATOMY", 198, 205], ["ventricular ependymal cells", "ANATOMY", 300, 327], ["microtubule", "ANATOMY", 439, 450], ["oxytocin", "CHEMICAL", 55, 63], ["oxytocin", "CHEMICAL", 55, 63], ["oxytocin", "GENE_OR_GENE_PRODUCT", 55, 63], ["ependymal cells", "CELL", 104, 119], ["third ventricle", "MULTI-TISSUE_STRUCTURE", 131, 146], ["brain", "ORGAN", 154, 159], ["ventricular", "MULTI-TISSUE_STRUCTURE", 171, 182], ["ciliary", "MULTI-TISSUE_STRUCTURE", 198, 205], ["Katnal11H/1H mice", "ORGANISM", 218, 235], ["ciliated ventricular ependymal cells", "CELL", 291, 327], ["microtubule", "CELLULAR_COMPONENT", 439, 450], ["mouse", "ORGANISM", 482, 487], ["ependymal cells", "CELL_TYPE", 104, 119], ["ciliated ventricular ependymal cells", "CELL_TYPE", 291, 327], ["microtubule", "PROTEIN", 439, 450], ["mice", "SPECIES", 231, 235], ["mouse", "SPECIES", 482, 487], ["mouse", "SPECIES", 482, 487], ["various neuropeptides", "PROBLEM", 25, 46], ["oxytocin", "TREATMENT", 55, 63], ["ciliary function", "TEST", 198, 214], ["Katnal11H/1H mice", "TREATMENT", 218, 235], ["the ciliated ventricular ependymal cells", "PROBLEM", 287, 327], ["the disruption of the behavioural rhythms", "PROBLEM", 346, 387], ["microtubule severing enzyme dysfunction in mouse models", "PROBLEM", 439, 494], ["ependymal cells", "OBSERVATION", 104, 119], ["third ventricle", "ANATOMY", 131, 146], ["brain", "ANATOMY", 154, 159], ["ventricular", "ANATOMY", 171, 182], ["morphology", "OBSERVATION_MODIFIER", 183, 193], ["ciliary function", "OBSERVATION", 198, 214], ["ciliated", "ANATOMY_MODIFIER", 291, 299], ["ventricular", "ANATOMY", 300, 311], ["ependymal cells", "OBSERVATION", 312, 327], ["microtubule severing", "OBSERVATION", 439, 459], ["enzyme dysfunction", "OBSERVATION", 460, 478], ["mouse models", "OBSERVATION", 482, 494], ["poorly characterised", "OBSERVATION_MODIFIER", 505, 525]]], ["Currently the phenotypes described are limited to motor dysfunction in mice lacking the Spg4 gene27 and head shaking and circling in the Fign mutant.7, 28, 29 In contrast, here we demonstrate that loss of function of Katnal1 is associated with a range of behavioural phenotypes, including changes in circadian activity, poor learning and memory, hyperactivity in a novel environment (the open field) and deficits in USVs.", [["head", "ANATOMY", 104, 108], ["motor dysfunction", "DISEASE", 50, 67], ["hyperactivity", "DISEASE", 346, 359], ["mice", "ORGANISM", 71, 75], ["Spg4", "GENE_OR_GENE_PRODUCT", 88, 92], ["head", "ORGANISM_SUBDIVISION", 104, 108], ["Fign", "GENE_OR_GENE_PRODUCT", 137, 141], ["Katnal1", "GENE_OR_GENE_PRODUCT", 217, 224], ["Spg4 gene27", "PROTEIN", 88, 99], ["Fign mutant", "PROTEIN", 137, 148], ["Katnal1", "PROTEIN", 217, 224], ["mice", "SPECIES", 71, 75], ["mice", "SPECIES", 71, 75], ["the phenotypes", "PROBLEM", 10, 24], ["motor dysfunction", "PROBLEM", 50, 67], ["head shaking", "PROBLEM", 104, 116], ["circling", "PROBLEM", 121, 129], ["loss of function of Katnal1", "PROBLEM", 197, 224], ["behavioural phenotypes", "PROBLEM", 255, 277], ["changes in circadian activity", "PROBLEM", 289, 318], ["hyperactivity", "PROBLEM", 346, 359], ["deficits in USVs", "PROBLEM", 404, 420], ["head", "ANATOMY", 104, 108], ["circadian activity", "OBSERVATION", 300, 318]]], ["Notably the learning and memory, anxiety and vocalisation phenotypes reprise the clinical symptoms of ID, increased anxiety in novel situations and delays in language acquisition reported in human patients who carry microdeletions incorporating haploinsufficiency of KATNAL1.8, 9 While it is also worth noting that mutant mice spend more time the centre of the open field than wild types (implying that Katnal11H/1H animals show reduced anxiety), we suggest that this result is confounded by the hyperactivity in novel environments phenotype we also describe in mutant mice.", [["anxiety", "DISEASE", 33, 40], ["ID", "DISEASE", 102, 104], ["anxiety", "DISEASE", 116, 123], ["microdeletions", "DISEASE", 216, 230], ["anxiety", "DISEASE", 437, 444], ["hyperactivity", "DISEASE", 496, 509], ["human", "ORGANISM", 191, 196], ["patients", "ORGANISM", 197, 205], ["mice", "ORGANISM", 322, 326], ["Katnal11H/1H animals", "ORGANISM", 403, 423], ["mice", "ORGANISM", 569, 573], ["human", "SPECIES", 191, 196], ["patients", "SPECIES", 197, 205], ["mice", "SPECIES", 322, 326], ["mice", "SPECIES", 569, 573], ["human", "SPECIES", 191, 196], ["mice", "SPECIES", 322, 326], ["mice", "SPECIES", 569, 573], ["anxiety", "PROBLEM", 33, 40], ["vocalisation phenotypes", "PROBLEM", 45, 68], ["the clinical symptoms", "PROBLEM", 77, 98], ["increased anxiety in novel situations", "PROBLEM", 106, 143], ["microdeletions incorporating haploinsufficiency", "PROBLEM", 216, 263], ["reduced anxiety", "PROBLEM", 429, 444], ["the hyperactivity in novel environments phenotype", "PROBLEM", 492, 541], ["hyperactivity", "OBSERVATION", 496, 509]]], ["This observation is backed up by the fact that mutant animals showed increased activity in all regions of the open field rather than just the anxiolytic periphery.", [["mutant animals", "PROBLEM", 47, 61], ["increased activity", "PROBLEM", 69, 87], ["increased", "OBSERVATION_MODIFIER", 69, 78], ["activity", "OBSERVATION_MODIFIER", 79, 87], ["anxiolytic periphery", "OBSERVATION", 142, 162]]], ["Here we also highlight defects in Katnal11H/1H mice such as compromised neuronal migration and morphology which may underpin such phenotypes.", [["neuronal", "ANATOMY", 72, 80], ["Katnal11H/1H mice", "ORGANISM", 34, 51], ["neuronal", "CELL", 72, 80], ["mice", "SPECIES", 47, 51], ["highlight defects", "PROBLEM", 13, 30], ["Katnal11H/1H mice", "TREATMENT", 34, 51], ["compromised neuronal migration", "PROBLEM", 60, 90], ["defects", "OBSERVATION", 23, 30], ["neuronal migration", "OBSERVATION", 72, 90]]], ["In Drosophila, the homologue of Katnal1 (kat-60L1) has been demonstrated to play a critical role in neuronal morphology during development,30 however the data that we present here is the first to demonstrate a similar phenotype in mammals and furthermore suggests how subtle perturbations to KATNAL1 function may contribute to specific neural and behavioural conditions.", [["neuronal", "ANATOMY", 100, 108], ["neural", "ANATOMY", 336, 342], ["Katnal1", "GENE_OR_GENE_PRODUCT", 32, 39], ["kat-60L1", "GENE_OR_GENE_PRODUCT", 41, 49], ["neuronal", "CELL", 100, 108], ["KATNAL1", "GENE_OR_GENE_PRODUCT", 292, 299], ["Katnal1", "PROTEIN", 32, 39], ["kat", "PROTEIN", 41, 44], ["60L1", "PROTEIN", 45, 49], ["KATNAL1", "PROTEIN", 292, 299], ["Drosophila", "SPECIES", 3, 13], ["Drosophila", "SPECIES", 3, 13], ["subtle perturbations to KATNAL1 function", "PROBLEM", 268, 308], ["specific neural and behavioural conditions", "PROBLEM", 327, 369], ["neuronal morphology", "OBSERVATION_MODIFIER", 100, 119]]], ["For example, defects in neuronal migration, synaptic spines and neuronal morphology such as those we have demonstrated here, have been suggested to underpin ID in conditions such as lissencephaly,18 Down\u2019s syndrome31 and Rett syndrome.32 While we are not suggesting that Katnal1 is causative for these conditions, similarities in symptoms and neuronal phenotypes between these conditions and those linked to Katnal1 dysfunction should be appreciated.", [["neuronal", "ANATOMY", 24, 32], ["synaptic spines", "ANATOMY", 44, 59], ["neuronal", "ANATOMY", 64, 72], ["neuronal", "ANATOMY", 343, 351], ["lissencephaly", "DISEASE", 182, 195], ["Down\u2019s syndrome31", "DISEASE", 199, 216], ["Rett syndrome", "DISEASE", 221, 234], ["neuronal", "CELL", 24, 32], ["synaptic spines", "CELLULAR_COMPONENT", 44, 59], ["neuronal", "CELL", 64, 72], ["Katnal1", "GENE_OR_GENE_PRODUCT", 271, 278], ["neuronal", "CELL", 343, 351], ["Katnal1", "GENE_OR_GENE_PRODUCT", 408, 415], ["Katnal1", "PROTEIN", 271, 278], ["defects in neuronal migration", "PROBLEM", 13, 42], ["lissencephaly", "PROBLEM", 182, 195], ["Rett syndrome", "PROBLEM", 221, 234], ["Katnal1", "TREATMENT", 271, 278], ["these conditions", "PROBLEM", 296, 312], ["symptoms", "PROBLEM", 330, 338], ["neuronal phenotypes", "PROBLEM", 343, 362], ["Katnal1 dysfunction", "PROBLEM", 408, 427], ["defects", "OBSERVATION", 13, 20], ["neuronal migration", "OBSERVATION", 24, 42], ["synaptic spines", "OBSERVATION", 44, 59], ["neuronal morphology", "OBSERVATION", 64, 83], ["Rett syndrome", "OBSERVATION", 221, 234], ["not suggesting", "UNCERTAINTY", 251, 265]]], ["Furthermore a rare mutation in KATNAL1 has been associated with schizophrenia10 (http://atgu.mgh.harvard.edu/~spurcell/genebook/genebook.cgi?user=guest&cmd=verb-gene&tbox=KATNAL1) and KATNAL1 has been shown to interact with the schizophrenia associated gene DISC1.33 In line with these observations we note that increases in ventricular volume and reductions in synaptic spines have been reported in schizophrenic patients34, 35 and our data demonstrates the same phenotypes in Katnal11H/1H mice.", [["ventricular", "ANATOMY", 325, 336], ["synaptic spines", "ANATOMY", 362, 377], ["schizophrenia", "DISEASE", 228, 241], ["schizophrenic", "DISEASE", 400, 413], ["KATNAL1", "GENE_OR_GENE_PRODUCT", 31, 38], ["KATNAL1", "GENE_OR_GENE_PRODUCT", 184, 191], ["ventricular", "MULTI-TISSUE_STRUCTURE", 325, 336], ["synaptic spines", "MULTI-TISSUE_STRUCTURE", 362, 377], ["patients", "ORGANISM", 414, 422], ["Katnal11H/1H mice", "ORGANISM", 478, 495], ["KATNAL1", "DNA", 31, 38], ["schizophrenia10", "DNA", 64, 79], ["KATNAL1", "PROTEIN", 184, 191], ["schizophrenia associated gene", "DNA", 228, 257], ["DISC1.33", "DNA", 258, 266], ["patients", "SPECIES", 414, 422], ["mice", "SPECIES", 491, 495], ["a rare mutation in KATNAL1", "PROBLEM", 12, 38], ["schizophrenia10", "PROBLEM", 64, 79], ["KATNAL1", "TREATMENT", 184, 191], ["increases in ventricular volume", "PROBLEM", 312, 343], ["our data", "TEST", 433, 441], ["rare", "OBSERVATION_MODIFIER", 14, 18], ["mutation", "OBSERVATION", 19, 27], ["increases", "OBSERVATION_MODIFIER", 312, 321], ["ventricular", "ANATOMY", 325, 336], ["volume", "OBSERVATION", 337, 343], ["reductions", "OBSERVATION_MODIFIER", 348, 358], ["synaptic spines", "OBSERVATION", 362, 377]]], ["Thus the range of phenotypes associated with defects in the function of Katnal1 strongly suggests that the gene should be considered in the pathology of disorders such as ID and schizophrenia.DiscussionWe do note one key genetic difference between the human patients and Katnal11H/1H animals.", [["ID", "DISEASE", 171, 173], ["schizophrenia", "DISEASE", 178, 191], ["Katnal1", "GENE_OR_GENE_PRODUCT", 72, 79], ["human", "ORGANISM", 252, 257], ["patients", "ORGANISM", 258, 266], ["Katnal11H/1H animals", "ORGANISM", 271, 291], ["Katnal1", "PROTEIN", 72, 79], ["human", "SPECIES", 252, 257], ["patients", "SPECIES", 258, 266], ["human", "SPECIES", 252, 257], ["phenotypes", "PROBLEM", 18, 28], ["defects", "PROBLEM", 45, 52], ["disorders", "PROBLEM", 153, 162], ["schizophrenia", "PROBLEM", 178, 191], ["defects", "OBSERVATION", 45, 52]]], ["While the human patients were all heterozygous for the Katnal1 deletion, we found no phenotype in heterozygous mutant mice (data not shown) suggesting that while haploinsufficiency is causative for phenotypes in humans, mice require complete loss of KATNAL1 function to show similar effects.", [["human", "ORGANISM", 10, 15], ["patients", "ORGANISM", 16, 24], ["Katnal1", "GENE_OR_GENE_PRODUCT", 55, 62], ["mutant mice", "ORGANISM", 111, 122], ["humans", "ORGANISM", 212, 218], ["mice", "ORGANISM", 220, 224], ["KATNAL1", "GENE_OR_GENE_PRODUCT", 250, 257], ["Katnal1 deletion", "DNA", 55, 71], ["KATNAL1", "PROTEIN", 250, 257], ["human", "SPECIES", 10, 15], ["patients", "SPECIES", 16, 24], ["mice", "SPECIES", 118, 122], ["humans", "SPECIES", 212, 218], ["mice", "SPECIES", 220, 224], ["human", "SPECIES", 10, 15], ["mice", "SPECIES", 118, 122], ["humans", "SPECIES", 212, 218], ["mice", "SPECIES", 220, 224], ["all heterozygous", "PROBLEM", 30, 46], ["the Katnal1 deletion", "PROBLEM", 51, 71], ["phenotype in heterozygous mutant mice", "PROBLEM", 85, 122], ["phenotypes in humans", "PROBLEM", 198, 218], ["KATNAL1 function", "TREATMENT", 250, 266], ["no", "UNCERTAINTY", 82, 84]]], ["A similar discrepancy between humans and mice has also been noted for the intellectual disability candidate gene CTNNB1.17 While heterozygous loss of function mutations in CTNNB1 are causative for intellectual disability in humans, conditional knock outs for CTNNB1 have no reported behavioural or craniofacial phenotypes.36, 37 These differences demonstrate that while mouse models of intellectual disability are of great use in our understanding of the causative mechanisms which underlie the condition, there are still genetic and neurodevelopmental differences between species which also must be taken into account.", [["craniofacial", "ANATOMY", 298, 310], ["intellectual disability", "DISEASE", 74, 97], ["loss of function", "DISEASE", 142, 158], ["intellectual disability", "DISEASE", 197, 220], ["intellectual disability", "DISEASE", 386, 409], ["humans", "ORGANISM", 30, 36], ["mice", "ORGANISM", 41, 45], ["CTNNB1", "GENE_OR_GENE_PRODUCT", 113, 119], ["CTNNB1", "GENE_OR_GENE_PRODUCT", 172, 178], ["humans", "ORGANISM", 224, 230], ["CTNNB1", "GENE_OR_GENE_PRODUCT", 259, 265], ["mouse", "ORGANISM", 370, 375], ["intellectual disability candidate gene", "DNA", 74, 112], ["CTNNB1", "DNA", 113, 119], ["CTNNB1", "DNA", 172, 178], ["CTNNB1", "PROTEIN", 259, 265], ["humans", "SPECIES", 30, 36], ["mice", "SPECIES", 41, 45], ["humans", "SPECIES", 224, 230], ["mouse", "SPECIES", 370, 375], ["humans", "SPECIES", 30, 36], ["mice", "SPECIES", 41, 45], ["humans", "SPECIES", 224, 230], ["mouse", "SPECIES", 370, 375], ["heterozygous loss of function mutations in CTNNB1", "PROBLEM", 129, 178], ["intellectual disability in humans", "PROBLEM", 197, 230], ["CTNNB1", "PROBLEM", 259, 265], ["craniofacial phenotypes", "PROBLEM", 298, 321], ["intellectual disability", "PROBLEM", 386, 409], ["still genetic and neurodevelopmental differences between species", "PROBLEM", 516, 580], ["similar", "OBSERVATION_MODIFIER", 2, 9], ["discrepancy", "OBSERVATION", 10, 21], ["craniofacial", "ANATOMY", 298, 310], ["phenotypes", "OBSERVATION", 311, 321], ["great", "OBSERVATION_MODIFIER", 417, 422]]], ["We also note that while the Katnal11H mutation shows a loss of catalytic function in both HEK293 cells and Sertoli cells,23 this loss of function has not been verified in neuronal cells.", [["HEK293 cells", "ANATOMY", 90, 102], ["Sertoli cells", "ANATOMY", 107, 120], ["neuronal cells", "ANATOMY", 171, 185], ["Katnal11H", "GENE_OR_GENE_PRODUCT", 28, 37], ["HEK293 cells", "CELL", 90, 102], ["Sertoli cells", "CELL", 107, 120], ["neuronal cells", "CELL", 171, 185], ["Katnal11H", "PROTEIN", 28, 37], ["HEK293 cells", "CELL_LINE", 90, 102], ["Sertoli cells", "CELL_LINE", 107, 120], ["neuronal cells", "CELL_TYPE", 171, 185], ["the Katnal11H mutation", "TEST", 24, 46], ["a loss of catalytic function", "PROBLEM", 53, 81], ["Sertoli cells", "TEST", 107, 120], ["this loss of function", "PROBLEM", 124, 145], ["catalytic function", "OBSERVATION", 63, 81], ["HEK293 cells", "OBSERVATION", 90, 102], ["Sertoli cells", "OBSERVATION", 107, 120], ["neuronal cells", "OBSERVATION", 171, 185]]], ["However, given that our data demonstrates that the Katnal11H mutation lies in an essential catalytic domain and that we show neuronal phenotypes in Katnal11H/1H mice, we would expect to see the same loss of catalytic function in neurons.DiscussionThe data we present here also demonstrate defects in motile cilia in Katnal11H/1H mice.", [["neuronal", "ANATOMY", 125, 133], ["neurons", "ANATOMY", 229, 236], ["cilia", "ANATOMY", 307, 312], ["Katnal11H", "GENE_OR_GENE_PRODUCT", 51, 60], ["neuronal", "CELL", 125, 133], ["Katnal11H/1H mice", "ORGANISM", 148, 165], ["neurons", "CELL", 229, 236], ["cilia", "CELLULAR_COMPONENT", 307, 312], ["Katnal11H/1H mice", "ORGANISM", 316, 333], ["Katnal11H", "PROTEIN", 51, 60], ["catalytic domain", "PROTEIN", 91, 107], ["neurons", "CELL_TYPE", 229, 236], ["mice", "SPECIES", 161, 165], ["mice", "SPECIES", 329, 333], ["our data", "TEST", 20, 28], ["the Katnal11H mutation", "PROBLEM", 47, 69], ["neuronal phenotypes", "PROBLEM", 125, 144], ["catalytic function in neurons", "PROBLEM", 207, 236], ["The data", "TEST", 247, 255], ["defects in motile cilia", "PROBLEM", 289, 312], ["neuronal phenotypes", "OBSERVATION", 125, 144], ["catalytic function", "OBSERVATION", 207, 225], ["defects", "OBSERVATION", 289, 296], ["motile cilia", "OBSERVATION", 300, 312]]], ["Ciliary disruptions in humans (ciliopathies) include Bardet-Biedl and Joubert syndrome.38 While there is currently limited data available regarding the behavioural phenotypes of mouse models of ciliopathies, we note that ciliary dysfunction in mice has been linked with learning and memory39 and vocalisation phenotypes,40 both of which were disturbed in the Katnal11H/1H mice described here.", [["Ciliary", "ANATOMY", 0, 7], ["ciliary", "ANATOMY", 221, 228], ["Ciliary disruptions", "DISEASE", 0, 19], ["ciliopathies", "DISEASE", 31, 43], ["Bardet-Biedl and Joubert syndrome", "DISEASE", 53, 86], ["ciliopathies", "DISEASE", 194, 206], ["ciliary dysfunction", "DISEASE", 221, 240], ["Ciliary", "MULTI-TISSUE_STRUCTURE", 0, 7], ["humans", "ORGANISM", 23, 29], ["ciliopathies", "CANCER", 31, 43], ["mouse", "ORGANISM", 178, 183], ["ciliopathies", "CANCER", 194, 206], ["ciliary", "MULTI-TISSUE_STRUCTURE", 221, 228], ["mice", "ORGANISM", 244, 248], ["Katnal11H/1H mice", "ORGANISM", 359, 376], ["humans", "SPECIES", 23, 29], ["mouse", "SPECIES", 178, 183], ["mice", "SPECIES", 244, 248], ["mice", "SPECIES", 372, 376], ["humans", "SPECIES", 23, 29], ["mouse", "SPECIES", 178, 183], ["mice", "SPECIES", 244, 248], ["mice", "SPECIES", 372, 376], ["Ciliary disruptions in humans (ciliopathies)", "PROBLEM", 0, 44], ["Joubert syndrome", "PROBLEM", 70, 86], ["ciliopathies", "PROBLEM", 194, 206], ["ciliary dysfunction", "PROBLEM", 221, 240], ["vocalisation phenotypes", "PROBLEM", 296, 319], ["disruptions", "OBSERVATION", 8, 19], ["Joubert syndrome", "OBSERVATION", 70, 86], ["ciliary dysfunction", "OBSERVATION", 221, 240]]], ["It is also notable that the neuronal migration and enlarged ventricle phenotypes that we describe in Katnal11H/1H mice recapitulate features associated with known ciliopathy gene mutations.41, 42, 43, 44 Furthermore in Bardet-Biedl syndrome mouse models ciliary defects such as reduced CBF45 and structural defects such as abnormal lengthening and swellings along their length41 have been described, that are similar to those we describe in Katnal11H/1H mice.", [["neuronal", "ANATOMY", 28, 36], ["ventricle", "ANATOMY", 60, 69], ["ciliary", "ANATOMY", 254, 261], ["Bardet-Biedl syndrome", "DISEASE", 219, 240], ["ciliary defects", "DISEASE", 254, 269], ["neuronal", "CELL", 28, 36], ["ventricle", "MULTI-TISSUE_STRUCTURE", 60, 69], ["Katnal11H/1H mice", "ORGANISM", 101, 118], ["ciliopathy", "GENE_OR_GENE_PRODUCT", 163, 173], ["Bardet-Biedl", "ORGANISM", 219, 231], ["mouse", "ORGANISM", 241, 246], ["ciliary", "MULTI-TISSUE_STRUCTURE", 254, 261], ["CBF45", "GENE_OR_GENE_PRODUCT", 286, 291], ["length41", "GENE_OR_GENE_PRODUCT", 370, 378], ["Katnal11H/1H mice", "ORGANISM", 441, 458], ["ciliopathy gene mutations", "DNA", 163, 188], ["CBF45", "PROTEIN", 286, 291], ["length41", "PROTEIN", 370, 378], ["mice", "SPECIES", 114, 118], ["mouse", "SPECIES", 241, 246], ["mice", "SPECIES", 454, 458], ["Bardet-Biedl syndrome mouse", "SPECIES", 219, 246], ["the neuronal migration", "PROBLEM", 24, 46], ["enlarged ventricle phenotypes", "PROBLEM", 51, 80], ["known ciliopathy gene mutations", "PROBLEM", 157, 188], ["Bardet", "TEST", 219, 225], ["Biedl syndrome", "PROBLEM", 226, 240], ["ciliary defects", "PROBLEM", 254, 269], ["reduced CBF45", "PROBLEM", 278, 291], ["structural defects", "PROBLEM", 296, 314], ["abnormal lengthening and swellings", "PROBLEM", 323, 357], ["neuronal migration", "OBSERVATION", 28, 46], ["enlarged", "OBSERVATION_MODIFIER", 51, 59], ["ventricle", "ANATOMY", 60, 69], ["ciliopathy", "OBSERVATION", 163, 173], ["gene mutations", "OBSERVATION", 174, 188], ["ciliary defects", "OBSERVATION", 254, 269], ["reduced", "OBSERVATION_MODIFIER", 278, 285], ["structural defects", "OBSERVATION", 296, 314], ["abnormal", "OBSERVATION_MODIFIER", 323, 331], ["lengthening", "OBSERVATION_MODIFIER", 332, 343]]], ["There is strong evidence that ciliopathy associated genes play a number of roles in neuronal development by affecting processes such as progenitor proliferation or maintenance of the radial glia scaffold.43 However it is also clear that defects in microtubule organisation also affect synaptic structure.2 At present it is difficult to disentangle the relative contributions of defects in microtubule severing and ciliary abnormalities to the overall phenotypes we observe in Katnal11H/1H mice.", [["neuronal", "ANATOMY", 84, 92], ["progenitor", "ANATOMY", 136, 146], ["radial glia", "ANATOMY", 183, 194], ["microtubule", "ANATOMY", 248, 259], ["synaptic", "ANATOMY", 285, 293], ["microtubule", "ANATOMY", 389, 400], ["ciliary", "ANATOMY", 414, 421], ["ciliopathy", "DISEASE", 30, 40], ["neuronal", "CELL", 84, 92], ["progenitor", "CELL", 136, 146], ["radial glia scaffold", "CELLULAR_COMPONENT", 183, 203], ["microtubule", "CELLULAR_COMPONENT", 248, 259], ["microtubule", "CELLULAR_COMPONENT", 389, 400], ["ciliary", "MULTI-TISSUE_STRUCTURE", 414, 421], ["Katnal11H/1H mice", "ORGANISM", 476, 493], ["ciliopathy associated genes", "DNA", 30, 57], ["microtubule", "PROTEIN", 248, 259], ["microtubule", "PROTEIN", 389, 400], ["mice", "SPECIES", 489, 493], ["ciliopathy", "PROBLEM", 30, 40], ["progenitor proliferation", "PROBLEM", 136, 160], ["the radial glia scaffold", "TREATMENT", 179, 203], ["defects in microtubule organisation", "PROBLEM", 237, 272], ["defects in microtubule severing", "PROBLEM", 378, 409], ["ciliary abnormalities", "PROBLEM", 414, 435], ["ciliopathy", "OBSERVATION", 30, 40], ["progenitor proliferation", "OBSERVATION", 136, 160], ["radial glia", "ANATOMY", 183, 194], ["defects", "OBSERVATION", 237, 244], ["microtubule organisation", "OBSERVATION", 248, 272], ["synaptic structure", "OBSERVATION", 285, 303], ["defects", "OBSERVATION", 378, 385], ["microtubule severing", "OBSERVATION", 389, 409], ["ciliary abnormalities", "OBSERVATION", 414, 435]]], ["Further investigations are required to clarify the impacts of these two processes.", [["Further investigations", "TEST", 0, 22]]], ["However it is notable that while defects in cilia structure may contribute to the phenotypes we describe in Katnal11H/1H mice, they are far less prominent in Katnal11H/1H mice than in other mouse ciliopathy models,41 suggesting that the ciliary component of KATNAL1 dysfunction may be mild compared to other ciliopathies.", [["cilia", "ANATOMY", 44, 49], ["ciliary", "ANATOMY", 237, 244], ["KATNAL1 dysfunction", "DISEASE", 258, 277], ["ciliopathies", "DISEASE", 308, 320], ["cilia", "CELLULAR_COMPONENT", 44, 49], ["Katnal11H/1H mice", "ORGANISM", 108, 125], ["Katnal11H/1H mice", "ORGANISM", 158, 175], ["mouse", "ORGANISM", 190, 195], ["ciliary", "MULTI-TISSUE_STRUCTURE", 237, 244], ["KATNAL1", "GENE_OR_GENE_PRODUCT", 258, 265], ["ciliopathies", "CANCER", 308, 320], ["mice", "SPECIES", 121, 125], ["mice", "SPECIES", 171, 175], ["mouse", "SPECIES", 190, 195], ["mouse", "SPECIES", 190, 195], ["defects in cilia structure", "PROBLEM", 33, 59], ["the phenotypes", "PROBLEM", 78, 92], ["KATNAL1 dysfunction", "PROBLEM", 258, 277], ["other ciliopathies", "PROBLEM", 302, 320], ["defects", "OBSERVATION", 33, 40], ["cilia structure", "OBSERVATION", 44, 59], ["less prominent", "OBSERVATION_MODIFIER", 140, 154], ["ciliopathy", "OBSERVATION", 196, 206], ["ciliary", "OBSERVATION_MODIFIER", 237, 244], ["KATNAL1 dysfunction", "OBSERVATION", 258, 277], ["may be", "UNCERTAINTY", 278, 284], ["mild", "OBSERVATION_MODIFIER", 285, 289]]], ["Similarly while hydrocephalus has been suggested to be a component of some ciliopathy mouse models,46Katnal11H/1H mice showed only increased ventricle size rather than an increased incidence of hydrocephalus, further suggesting the ciliary defects in these animals are mild compared to other ciliopathies.DiscussionIn summary the data presented here clearly demonstrate that KATNAL1 plays an important role in a variety of neuronal processes including neuronal migration, neuronal morphology and ependymal ciliary function.", [["ventricle", "ANATOMY", 141, 150], ["ciliary", "ANATOMY", 232, 239], ["neuronal", "ANATOMY", 423, 431], ["neuronal", "ANATOMY", 452, 460], ["neuronal", "ANATOMY", 472, 480], ["ependymal ciliary", "ANATOMY", 496, 513], ["hydrocephalus", "DISEASE", 16, 29], ["ciliopathy", "DISEASE", 75, 85], ["hydrocephalus", "DISEASE", 194, 207], ["ciliary defects", "DISEASE", 232, 247], ["ciliopathies", "DISEASE", 292, 304], ["KATNAL1", "CHEMICAL", 375, 382], ["mouse", "ORGANISM", 86, 91], ["46Katnal11H/1H mice", "ORGANISM", 99, 118], ["ventricle", "MULTI-TISSUE_STRUCTURE", 141, 150], ["ciliary", "MULTI-TISSUE_STRUCTURE", 232, 239], ["ciliopathies", "CANCER", 292, 304], ["KATNAL1", "GENE_OR_GENE_PRODUCT", 375, 382], ["neuronal", "CELL", 423, 431], ["neuronal", "CELL", 452, 460], ["neuronal", "CELL", 472, 480], ["ependymal ciliary", "MULTI-TISSUE_STRUCTURE", 496, 513], ["KATNAL1", "PROTEIN", 375, 382], ["mouse", "SPECIES", 86, 91], ["mice", "SPECIES", 114, 118], ["mouse", "SPECIES", 86, 91], ["hydrocephalus", "PROBLEM", 16, 29], ["some ciliopathy mouse models", "PROBLEM", 70, 98], ["increased ventricle size", "PROBLEM", 131, 155], ["hydrocephalus", "PROBLEM", 194, 207], ["the ciliary defects", "PROBLEM", 228, 247], ["other ciliopathies", "PROBLEM", 286, 304], ["neuronal migration", "TREATMENT", 452, 470], ["hydrocephalus", "OBSERVATION", 16, 29], ["ciliopathy mouse models", "OBSERVATION", 75, 98], ["increased", "OBSERVATION_MODIFIER", 131, 140], ["ventricle", "OBSERVATION", 141, 150], ["size", "OBSERVATION_MODIFIER", 151, 155], ["increased", "OBSERVATION_MODIFIER", 171, 180], ["incidence", "OBSERVATION_MODIFIER", 181, 190], ["hydrocephalus", "OBSERVATION", 194, 207], ["ciliary defects", "OBSERVATION", 232, 247], ["mild", "OBSERVATION_MODIFIER", 269, 273], ["ciliopathies", "OBSERVATION", 292, 304], ["neuronal migration", "OBSERVATION", 452, 470], ["ependymal ciliary function", "OBSERVATION", 496, 522]]], ["The downstream effect of these defects leads in turn to a number of behavioural changes including in learning and memory, reaction to anxiogenic situations and circadian rhythms.", [["these defects", "PROBLEM", 25, 38], ["behavioural changes", "PROBLEM", 68, 87], ["anxiogenic situations", "PROBLEM", 134, 155], ["circadian rhythms", "TEST", 160, 177], ["downstream", "OBSERVATION_MODIFIER", 4, 14], ["effect", "OBSERVATION_MODIFIER", 15, 21], ["defects", "OBSERVATION", 31, 38]]], ["These data therefore highlight how perturbations in KATNAL1 may play a role in neuronal dysfunction and demonstrates that the enzyme is a novel candidate in the study of behavioural and neurodevelopmental disorders.", [["neuronal", "ANATOMY", 79, 87], ["neuronal dysfunction", "DISEASE", 79, 99], ["neurodevelopmental disorders", "DISEASE", 186, 214], ["KATNAL1", "GENE_OR_GENE_PRODUCT", 52, 59], ["neuronal", "CELL", 79, 87], ["KATNAL1", "PROTEIN", 52, 59], ["neuronal dysfunction", "PROBLEM", 79, 99], ["the enzyme", "TEST", 122, 132], ["the study", "TEST", 157, 166], ["neurodevelopmental disorders", "PROBLEM", 186, 214]]]], "PMC7498891": [["Comparison of Data Sources ::: Data Sources for Public Health Syndromic SurveillanceA quantitative compilation of our research results shows that most of the syndromic surveillance systems monitor a combination of data sources from multiple sites instead of relying on a single data indicator.", [["the syndromic surveillance systems", "PROBLEM", 154, 188], ["multiple sites", "PROBLEM", 232, 246]]], ["Out of the 56 systems numerated in Tables 10.1007/978-1-4419-1278-7_2#Tab2 through 10.1007/978-1-4419-1278-7_2#Tab5, wherein the details are known, 80% use ED chief complaints (both free text and ICD-9 coded chief complaints) as a timely public health indicator.", [["10.1007/978-1-4419-1278-7_2#Tab5", "DNA", 83, 115], ["ICD", "TREATMENT", 196, 199]]], ["However, absenteeism or drugs sales are never used alone.", [["absenteeism", "PROBLEM", 9, 20], ["drugs sales", "TREATMENT", 24, 35]]], ["Fourteen systems also connect to poison centers or laboratories for test orders, or monitor 911 calls.", [["test orders", "TEST", 68, 79]]], ["Additionally, most ED visits chief complaints are in free text (90%), which suggests the importance of free text processing or natural language processing techniques for medical information processing in this area.Comparison of Data Sources ::: Data Sources for Public Health Syndromic SurveillanceISDS (International Society for Disease Surveillance) also conducted a survey of state syndromic surveillance use including 46 respondents in 2008.", [["natural language processing techniques", "TREATMENT", 127, 165]]], ["The numbers largely align with our quantitative findings above.Comparison of Data Sources ::: Data Sources for Public Health Syndromic SurveillanceA major concern regarding the data used in the surveillance activities is about the effectiveness and validity of their usage for illness pattern detection.", [["illness", "DISEASE", 277, 284], ["illness pattern detection", "PROBLEM", 277, 302]]], ["To be valid in the context of syndromic surveillance, evidence is needed that a data source may have value in identifying an outbreak or biological attack.", [["syndromic surveillance", "TEST", 30, 52], ["an outbreak or biological attack", "PROBLEM", 122, 154]]], ["A number of studies have examined to some degree whether and how effective the data sources are, as well as a possible time lead compared with diagnosis.", [["studies", "TEST", 12, 19]]], ["Magruder's study (Magruder, 2003) about using OTC data/sales as a possible early warning indicator of human diseases revealed about a 90% correlation between flu-remedy sales and physician diagnoses of acute respiratory conditions together with a 3-day lead time reported.", [["respiratory", "ANATOMY", 208, 219], ["human", "ORGANISM", 102, 107], ["human", "SPECIES", 102, 107], ["human", "SPECIES", 102, 107], ["Magruder's study", "TEST", 0, 16], ["human diseases", "PROBLEM", 102, 116], ["acute respiratory conditions", "PROBLEM", 202, 230], ["acute", "OBSERVATION_MODIFIER", 202, 207], ["respiratory conditions", "OBSERVATION", 208, 230]]], ["Another study (Doroshenko et al., 2005) shows that nurse-led helpline calls can also be used for early event detection.", [["Another study", "TEST", 0, 13]]], ["One limitation of using chief complaints as syndromic data is that they provide different predictive values from discharge diagnoses, as reported by (Begier et al., 2003).", [["syndromic data", "PROBLEM", 44, 58]]], ["Generally, chief complaints best capture illnesses mainly characterized by nonspecific symptoms like fever, while discharge diagnoses appear better at tracking illnesses requiring brief ED clinical evaluation and testing, such as sepsis and possibly meningitis (Begier et al., 2003).Comparison of Data Sources ::: Data Sources for Public Health Syndromic SurveillanceAlthough most of the syndromic surveillance systems use multiple data sources, further examination about whether the different data are telling the same story, i.e., flagging the possible outbreaks for certain illness with consistency, is necessary.", [["fever", "DISEASE", 101, 106], ["sepsis", "DISEASE", 230, 236], ["meningitis", "DISEASE", 250, 260], ["illness", "DISEASE", 577, 584], ["best capture illnesses", "PROBLEM", 28, 50], ["nonspecific symptoms", "PROBLEM", 75, 95], ["fever", "PROBLEM", 101, 106], ["brief ED clinical evaluation", "TEST", 180, 208], ["testing", "TEST", 213, 220], ["sepsis", "PROBLEM", 230, 236], ["meningitis", "PROBLEM", 250, 260], ["the syndromic surveillance systems", "PROBLEM", 384, 418], ["further examination", "TEST", 446, 465], ["nonspecific", "OBSERVATION_MODIFIER", 75, 86], ["sepsis", "OBSERVATION", 230, 236], ["possibly", "UNCERTAINTY", 241, 249], ["meningitis", "OBSERVATION", 250, 260]]], ["Edge et al. (2004) reported correlations between OTC antinausea and antidiarrhea medication sales and ED admissions.", [["OTC antinausea", "TREATMENT", 49, 63], ["antidiarrhea medication", "TREATMENT", 68, 91]]], ["However, in a study conducted by the Infectious Disease Surveillance Center, Japan (Ohkusa et al., 2005a), they found no evidence that sales of OTC medications used to treat the common cold correlated with influenza activities.", [["Infectious Disease", "DISEASE", 37, 55], ["OTC", "SIMPLE_CHEMICAL", 144, 147], ["a study", "TEST", 12, 19], ["OTC medications", "TREATMENT", 144, 159], ["the common cold", "PROBLEM", 174, 189], ["influenza activities", "PROBLEM", 206, 226], ["Infectious", "OBSERVATION", 37, 47], ["no evidence", "UNCERTAINTY", 118, 129]]], ["It has been observed that as individuals may seek care in a variety of settings resulting in multiple reports for the same individual case in different data sources, combining these data sources properly presents major technical challenges due to dependencies existing among these data sources (Costa et al., 2007).Comparison of Data Sources ::: Data Sources for Public Health Syndromic SurveillancePreliminary investigations have evaluated the effectiveness of different data sources in syndromic surveillance and studied the differences among them in terms of information timeliness and characterization ability for outbreak detection, as they represent various aspects of patient healthcare-seeking behavior (Ma et al., 2005).", [["patient", "ORGANISM", 675, 682], ["patient", "SPECIES", 675, 682], ["SurveillancePreliminary investigations", "TEST", 387, 425], ["syndromic surveillance", "TEST", 488, 510], ["outbreak detection", "TEST", 618, 636]]], ["Table 3-1 provides a classification of different data sources used for syndromic surveillance organized by their timeliness and capability to characterize epidemic events.Existing Data Standards Used in Syndromic Surveillance ::: Standardized VocabulariesHere we provide a brief summary of each coding system to illustrate their scope and target medical domain.Existing Data Standards Used in Syndromic Surveillance ::: Standardized VocabulariesUMLS: The Unified Medical Language System (UMLS) (Fung et al., 2006) provides a cross reference ontology among a number of different biomedical coding systems and standards, and a semantic structure defining relationships among different clinical entities.", [["syndromic surveillance", "TEST", 71, 93], ["epidemic events", "PROBLEM", 155, 170]]], ["Its Semantic Network and Metathesaurus help facilitate system developers in building or enhancing electronic information systems that integrate and/or aggregate biomedical and health data and knowledge.Existing Data Standards Used in Syndromic Surveillance ::: Standardized VocabulariesLOINC: LOINC codes are universal identifiers for laboratory and other clinical observations.", [["VocabulariesLOINC", "DNA", 274, 291]]], ["Distinct LOINC codes are assigned based on specimen types (e.g., \u201cser\u201d = serum) and methods of the test (e.g., immune fluorescence), with specific description for different conditions.", [["specimen", "ANATOMY", 43, 51], ["serum", "ANATOMY", 73, 78], ["serum", "ORGANISM_SUBSTANCE", 73, 78], ["LOINC codes", "DNA", 9, 20], ["specimen types", "TEST", 43, 57], ["the test", "TEST", 95, 103], ["LOINC codes", "OBSERVATION", 9, 20]]], ["As LOINC codes were originally developed for billing purposes, they do not convey information about the purpose or results of the test (Wurtz, 2004).", [["LOINC codes", "DNA", 3, 14], ["the test", "TEST", 126, 134]]], ["The CDC has developed \u201cNationally Notifiable Conditions Mapping Tables\u201d (http://www.cdc.gov/PHIN/data_modelsa href=\"http://www.cdc.gov/PHIN/data_models\"www.cdc.gov/PHIN/data_models), which provide mappings from LOINC codes to nationally-notifiable (and some state notifiable) diseases or conditions.Existing Data Standards Used in Syndromic Surveillance ::: Standardized VocabulariesSNOMED: SNOMED is a nomenclature classification scheme for indexing medical vocabulary, including signs, symptoms, diagnoses, and procedures.", [["VocabulariesSNOMED", "DNA", 371, 389], ["diseases", "PROBLEM", 276, 284], ["symptoms", "PROBLEM", 488, 496], ["procedures", "TREATMENT", 513, 523]]], ["It can identify procedures and possible answers to clinical questions that are coded through LOINC.Existing Data Standards Used in Syndromic Surveillance ::: Standardized VocabulariesICD-9-CM: ICD-9-CM was developed to allow assignment of codes to diagnoses and procedures associated with hospital utilization in the United States and are often used for third-party insurance reimbursement purposes.", [["VocabulariesICD-9", "CHEMICAL", 171, 188], ["CM", "DISEASE", 189, 191], ["CM", "DISEASE", 199, 201], ["Standardized VocabulariesICD", "TEST", 158, 186], ["ICD", "TREATMENT", 193, 196], ["procedures", "TREATMENT", 262, 272], ["9-CM", "OBSERVATION_MODIFIER", 187, 191], ["ICD", "OBSERVATION", 193, 196], ["9-CM", "OBSERVATION_MODIFIER", 197, 201]]], ["Table 3-2 shows a partial code set used by ESSENCE for fever.Existing Data Standards Used in Syndromic Surveillance ::: Standardized VocabulariesAn updated release of ICD-10-CM was made available in 2007 for public viewing.", [["fever", "DISEASE", 55, 60], ["CM", "DISEASE", 174, 176], ["fever", "PROBLEM", 55, 60], ["ICD", "TREATMENT", 167, 170]]], ["The codes of ICD-10-CM are now under testing and not currently valid for any purpose or use.", [["CM", "DISEASE", 20, 22], ["ICD", "TREATMENT", 13, 16], ["testing", "TEST", 37, 44], ["ICD", "OBSERVATION", 13, 16], ["10-CM", "OBSERVATION_MODIFIER", 17, 22]]], ["A research study has been conducted to examine the usefulness of the ICD-10-CM system in capturing public health diseases, when compared with ICD-9-CM.", [["CM", "DISEASE", 148, 150], ["A research study", "TEST", 0, 16], ["the ICD", "TREATMENT", 65, 72], ["public health diseases", "PROBLEM", 99, 121], ["ICD", "TEST", 142, 145], ["ICD", "OBSERVATION", 69, 72], ["9-CM", "OBSERVATION_MODIFIER", 146, 150]]], ["The study also examined agreement levels of coders when coding public health diseases in both ICD-10-CM and ICD-9-CM.", [["CM", "DISEASE", 101, 103], ["CM", "DISEASE", 114, 116], ["The study", "TEST", 0, 9], ["coding public health diseases", "PROBLEM", 56, 85], ["both ICD", "TREATMENT", 89, 97], ["ICD", "TREATMENT", 108, 111], ["ICD", "OBSERVATION", 94, 97], ["10-CM", "OBSERVATION_MODIFIER", 98, 103], ["ICD", "OBSERVATION", 108, 111], ["9-CM", "OBSERVATION_MODIFIER", 112, 116]]], ["Overall results demonstrate that ICD-10-CM is more specific and fully captures more of the public health diseases examined than ICD-9-CM (Watzlaf et al., 2007).Existing Data Standards Used in Syndromic Surveillance ::: Standardized VocabulariesHL7: HL7 (HL7,2006; Hooda et al., 2004; Thomas and Mead,2005) is the ANSI-accredited healthcare standard messaging format, used for transmitting information across a variety of clinical and administrative healthcare information systems.", [["CM", "DISEASE", 40, 42], ["CM", "DISEASE", 134, 136], ["ICD", "TEST", 33, 36], ["ICD", "TEST", 128, 131], ["ICD", "OBSERVATION", 33, 36], ["10-CM", "OBSERVATION_MODIFIER", 37, 42]]], ["HL7 Version 2.3 provides a protocol that enables the flow of data between systems.", [["a protocol", "TREATMENT", 25, 35]]], ["HL7 Version 3.0 (Beeler, 1998) is being developed through the use of a formalized methodology involving the creation of a Reference Information Model to encompass the ability not only to move data, but also to use it once it has been moved.Existing Data Standards Used in Syndromic Surveillance ::: Standardized VocabulariesDevelopment and adaptation of coding standards and standardized messaging formats are essential for information exchange and sharing, a prerequisite for public health surveillance.", [["coding standards", "TREATMENT", 354, 370], ["public health surveillance", "TEST", 477, 503]]], ["Nonetheless, standards are being developed, improved, and adopted increasingly widely.Existing Data Standards Used in Syndromic Surveillance ::: Standardized VocabulariesIn addition to leveraging existing healthcare standards, some groups have proposed additional coding and messaging standards tailored specifically for syndromic surveillance.", [["syndromic surveillance", "TEST", 321, 343], ["improved", "OBSERVATION_MODIFIER", 44, 52]]], ["For example, the Frontlines group (Barthell et al., 2002, 2004) is focusing on the development of standard reporting and coding structures specific to syndromic data.", [["syndromic data", "TEST", 151, 165]]], ["They defined the data elements in triage surveillance reports and a set of codified values for chief complaints.", [["triage surveillance", "TEST", 34, 53], ["chief complaints", "PROBLEM", 95, 111]]], ["In the National VA Health Data Repository (HDR), \u201cUnique enterprise identifiers are assigned to each standard term, and a rich network of semantic relationships makes the resulting data not only recognizable, but also highly computable and reusable in a variety of applications, including decision support and data sharing with partners such as the Department of Defense (DoD)\u201d (Bouhaddou, Lincoln et al., 2006).Existing Data Standards Used in Syndromic Surveillance ::: Standardized VocabulariesIn addition to technical considerations, regulatory and compliance issues also need to be examined carefully to address data standardization challenges.", [["regulatory and compliance issues", "PROBLEM", 537, 569]]], ["Hunscher et al. (2006) described work in progress and lessons learned in translating complex natural-language concepts on case report forms into machine-readable format using the HL7 CDA, LOINC, and SNOMED-CT standards.Data Entry Approaches ::: Data Entry and Data TransmissionData entry approaches for syndromic surveillance fall into four categories: paper-based forms, Web-based interface, local data input software application, and hand-held devices (Zelicoff et al., 2001).", [["syndromic surveillance fall", "PROBLEM", 303, 330], ["hand-held devices", "TREATMENT", 436, 453]]], ["Many systems support multiple data entry approaches as they involve multiple sites with possibly different IT infrastructure support (Espino et al., 2004; Lombardo et al., 2003).", [["multiple sites", "PROBLEM", 68, 82]]], ["Automated transmission refers to transferring of data over a communication media where human intervention (e.g., to initiate each transmission transaction) is not required.", [["human", "ORGANISM", 87, 92], ["human", "SPECIES", 87, 92], ["human", "SPECIES", 87, 92], ["a communication media", "TREATMENT", 59, 80], ["human intervention", "TREATMENT", 87, 105]]], ["Manual transmission entails significant human intervention.", [["human", "ORGANISM", 40, 45], ["human", "SPECIES", 40, 45], ["human", "SPECIES", 40, 45], ["Manual transmission entails", "TREATMENT", 0, 27], ["significant human intervention", "TREATMENT", 28, 58], ["significant", "OBSERVATION_MODIFIER", 28, 39]]], ["About 33% of the 50 systems surveyed rely primarily on automated data transmission, whereas the remaining 67% rely on human intervention in both data requesting and receiving.", [["human", "ORGANISM", 118, 123], ["human", "SPECIES", 118, 123], ["human", "SPECIES", 118, 123], ["human intervention", "TREATMENT", 118, 136]]], ["For example, the RODS system and the BioPortal system use HL7 messaging protocols for automatic syndromic data transmission.", [["the RODS system", "TEST", 13, 28], ["HL7 messaging protocols", "TREATMENT", 58, 81], ["automatic syndromic data transmission", "PROBLEM", 86, 123], ["RODS", "OBSERVATION_MODIFIER", 17, 21]]], ["In RODS, an HL7 listener implemented as Enterprise JavaBean (EJB) beans is used to receive HL7 messages from each underlying health system.", [["an HL7 listener", "TREATMENT", 9, 24], ["Enterprise JavaBean (EJB) beans", "TREATMENT", 40, 71], ["HL7 messages", "TREATMENT", 91, 103]]], ["BioPortal also replies on an HL7-based approach to transmit data as HL7-compliant XML messages.", [["transmit data", "TEST", 51, 64]]], ["This approach allows for dynamic changes in the message structure (Hu et al., 2005; Zeng et al., 2004b).Secure Data Transmission ::: Data Entry and Data TransmissionCompared with other approaches that mainly support file-based transmissions in a batch mode, HL7-based approaches are more efficient and effective.", [["a batch mode", "TEST", 244, 256]]], ["According to a RODS study (Tsui et al.,2005), they could reduce reporting latency by 20 hours.", [["a RODS study", "TEST", 13, 25]]], ["Secure networking techniques such as VPNs (Virtual Private Networks), SSL (secure socket layer), HTTPS, and SFTP (secure file transfer protocol) are now being increasingly utilized (Rhodes and Kailar,2005).Secure Data Transmission ::: Data Entry and Data TransmissionIs there a best approach to transmit data from data providers to syndromic surveillance systems and the involved public health agencies?", [["Secure networking techniques", "TREATMENT", 0, 28], ["VPNs (Virtual Private Networks)", "TREATMENT", 37, 68], ["SSL (secure socket layer", "TREATMENT", 70, 94], ["SFTP (secure file transfer protocol", "TREATMENT", 108, 143], ["syndromic surveillance systems", "TEST", 332, 362]]], ["There is no simple answer to this question.", [["no", "UNCERTAINTY", 9, 11], ["simple", "OBSERVATION_MODIFIER", 12, 18]]], ["Typically the IT infrastructure of the data providers (e.g., hospitals) needs to be upgraded to enable timely, reliable, and secure data collection.Secure Data Transmission ::: Data Entry and Data TransmissionMany practical challenges hindering the data collection effort also need to be addressed, including: (1) providing and transmitting data either requires staff intervention or dedicated network infrastructure, which often require extra costs; (2) data sharing and transmission must comply with HIPAA and other privacy regulations; (3) reducing data acquisition latency has important implications to syndromic surveillance yet is difficult and can be costly; (4) data quality concerns (e.g., incompleteness and duplications) often pose additional challenges.", [["secure data collection", "TEST", 125, 147], ["staff intervention", "TREATMENT", 362, 380], ["syndromic surveillance", "TEST", 607, 629]]], ["When infectious disease data sets are shared across jurisdictions, important access control and security issues should be resolved in advance between the involved data providers and users (Hu et al., 2005).", [["important access control", "TREATMENT", 67, 91]]]], "32d7bc240bc5e8490bb891b341c58cd7935062f4": [["IntroductionThe growth of the inbound tourism market (tourism growth hereafter) is expected to have a strong effect on the hotel industry.", [["growth", "OBSERVATION_MODIFIER", 16, 22]]], ["Chen (2010) and Chen and Kim (2010) found that tourism growth proxied by the growth rate of total foreign tourist arrivals (GTA) in Taiwan has a significant influence on hotel sales and profitability.", [["significant", "OBSERVATION_MODIFIER", 145, 156]]], ["Kim et al. (2006) revealed that tourism growth can cause significant economic growth in Taiwan.", [["significant economic growth in Taiwan", "PROBLEM", 57, 94], ["significant", "OBSERVATION_MODIFIER", 57, 68], ["economic", "OBSERVATION_MODIFIER", 69, 77], ["growth", "OBSERVATION_MODIFIER", 78, 84]]], ["Accordingly, tourism growth, on the other hand, can significantly promote economic growth and improve business conditions, which in turn can have an indirect effect on the hotel industry.IntroductionAs hotel sales/profitability increase due to tourism growth in Taiwan, one interesting question arises: How well do hotel firms perform?", [["tourism", "OBSERVATION_MODIFIER", 13, 20], ["growth", "OBSERVATION_MODIFIER", 21, 27]]], ["Hence, given an improved hotel earnings due to tourism growth, a better equity performance of hotel companies is anticipated.IntroductionWhile the financial performance of hotel firms is expected to be closely related to tourism growth, previous hospitality studies found no significant link between tourism growth and hotel equity return (HER).", [["HER", "PROTEIN", 340, 343], ["previous hospitality studies", "TEST", 237, 265]]], ["Chen (2007a) investigated the effect of some selected economic variables and GTA on HER in Taiwan.", [["HER", "CHEMICAL", 84, 87], ["HER", "GENE_OR_GENE_PRODUCT", 84, 87], ["HER", "PROTEIN", 84, 87]]], ["The monthly tourism growth had a positive effect on the monthly HER, but the influence was not statistically significant.", [["HER", "CHEMICAL", 64, 67], ["HER", "GENE_OR_GENE_PRODUCT", 64, 67], ["HER", "PROTEIN", 64, 67], ["positive effect", "OBSERVATION_MODIFIER", 33, 48]]], ["Similarly, Chen (2010) found that the quarterly tourism growth rate could not significantly explain the quarterly HER.", [["HER", "CHEMICAL", 114, 117], ["HER", "GENE_OR_GENE_PRODUCT", 114, 117], ["HER", "PROTEIN", 114, 117]]], ["Chen (2011) offered an explanation for the absence of a significant relationship between tourism growth and HER.", [["HER", "CHEMICAL", 108, 111], ["HER", "GENE_OR_GENE_PRODUCT", 108, 111], ["HER", "PROTEIN", 108, 111]]], ["As mentioned, based on equity valuation model, variations in equity price reflect not only the future earnings stream, but also the perceived riskiness of equity cash flows.", [["equity valuation model", "TEST", 23, 45], ["cash flows", "OBSERVATION", 162, 172]]], ["He detected that tourism growth has a strong effect on growth rate of hotel sales (GS), but not on the perceived riskiness of equity cash flows.IntroductionChen (2011) Note: The number of available observations is 2513.", [["strong", "OBSERVATION_MODIFIER", 38, 44], ["effect", "OBSERVATION_MODIFIER", 45, 51]]], ["The standard errors for skewness and kurtosis are (6/T) 1/2 and (24/T) 1/2 , respectively.", [["kurtosis", "TEST", 37, 45]]], ["LM statistic is the Lagrange Multiplier normality test statistic, which is defined as [(T/6)b 2 1 + (T/24)(b2 \u2212 3) 2 ]\u223cx 2 2 , where b1 is the coefficient of skewness, and b2 is the coefficient of kurtosis (Jarque and Bera, 1980) .", [["T", "TEST", 101, 102], ["b2", "TEST", 107, 109], ["skewness", "OBSERVATION", 158, 166]]], ["The critical value at the 1% significance level is 9.21. contraction is statistically different from that in business cycle expansion.", [["The critical value", "TEST", 0, 18], ["statistically", "OBSERVATION_MODIFIER", 72, 85], ["different", "OBSERVATION_MODIFIER", 86, 95], ["expansion", "OBSERVATION_MODIFIER", 124, 133]]], ["Moreover, while the influence of GTA on HER is still irrelevant during expansion periods, tourism growth can significantly enhance HER during contraction periods.IntroductionThis study, motivated by abovementioned previous studies, used the quantile regression method to examine the effect of GTA on different quantiles of sales growth and financial performance of hotel firms.", [["GTA", "CHEMICAL", 33, 36], ["HER", "CHEMICAL", 40, 43], ["HER", "CHEMICAL", 131, 134], ["GTA", "SIMPLE_CHEMICAL", 33, 36], ["HER", "GENE_OR_GENE_PRODUCT", 40, 43], ["HER", "GENE_OR_GENE_PRODUCT", 131, 134], ["HER", "PROTEIN", 40, 43], ["HER", "PROTEIN", 131, 134], ["This study", "TEST", 174, 184], ["previous studies", "TEST", 214, 230], ["the quantile regression method", "TREATMENT", 237, 267], ["GTA", "PROBLEM", 293, 296]]], ["Consequently, the OLS regression test results can be distorted since events or news in the form of extreme outliers in financial markets can significantly influence tail values of a data distribution.IntroductionIn particular, the earthquake of September 21, 1999, the terrorist attacks of September 11, 2001, in the US, and the outbreak of Severe Acute Respiratory Syndrome on April 22, 2003, significantly harmed GS and HER in Taiwan, causing a large negative fluctuation in hotel sales and equity prices during the period from 1983 to 2013 (Chen, 2010 (Chen, , 2011 .", [["Acute Respiratory Syndrome", "DISEASE", 348, 374], ["HER", "CHEMICAL", 422, 425], ["tail", "ORGANISM_SUBDIVISION", 165, 169], ["HER", "GENE_OR_GENE_PRODUCT", 422, 425], ["HER", "PROTEIN", 422, 425], ["the OLS regression test", "TEST", 14, 37], ["extreme outliers in financial markets", "PROBLEM", 99, 136], ["the US", "TEST", 313, 319], ["Severe Acute Respiratory Syndrome", "PROBLEM", 341, 374], ["Severe", "OBSERVATION_MODIFIER", 341, 347], ["Acute", "OBSERVATION_MODIFIER", 348, 353], ["Respiratory Syndrome", "OBSERVATION", 354, 374], ["large", "OBSERVATION_MODIFIER", 447, 452], ["negative", "OBSERVATION", 453, 461], ["fluctuation", "OBSERVATION_MODIFIER", 462, 473]]], ["In fact, the summary statistics of GS and HER presented in the next section show that HER has fat tails during the sample period.IntroductionThus, by using the quantile regression approach, the study not only addresses the tail information of GS and HER, but also illustrates how tourism growth affects different quantiles of GS and HER.", [["fat", "ANATOMY", 94, 97], ["HER", "CHEMICAL", 42, 45], ["HER", "CHEMICAL", 86, 89], ["HER", "CHEMICAL", 250, 253], ["HER", "CHEMICAL", 333, 336], ["HER", "GENE_OR_GENE_PRODUCT", 42, 45], ["HER", "GENE_OR_GENE_PRODUCT", 86, 89], ["fat", "TISSUE", 94, 97], ["HER", "GENE_OR_GENE_PRODUCT", 250, 253], ["HER", "GENE_OR_GENE_PRODUCT", 333, 336], ["HER", "PROTEIN", 42, 45], ["HER", "PROTEIN", 86, 89], ["HER", "PROTEIN", 250, 253], ["HER", "PROTEIN", 333, 336], ["the study", "TEST", 190, 199]]], ["Test results contribute to the hospitality literature by showing a new and interesting finding regarding the relationship between tourism growth and HER.", [["HER", "CHEMICAL", 149, 152], ["HER", "GENE_OR_GENE_PRODUCT", 149, 152], ["HER", "PROTEIN", 149, 152]]], ["Specifically, the effect of tourism growth on GS and HER is asymmetric and state-dependent, i.e. the influences of tourism growth on GS and HER vary in different quantiles.IntroductionThe rest of the paper is organized as follows.", [["HER", "CHEMICAL", 53, 56], ["HER", "CHEMICAL", 140, 143], ["HER", "GENE_OR_GENE_PRODUCT", 53, 56], ["HER", "GENE_OR_GENE_PRODUCT", 140, 143], ["HER", "PROTEIN", 53, 56], ["HER", "PROTEIN", 140, 143], ["GS", "TEST", 46, 48], ["GS", "TEST", 133, 135], ["tourism", "OBSERVATION_MODIFIER", 28, 35], ["growth", "OBSERVATION_MODIFIER", 36, 42], ["asymmetric", "OBSERVATION_MODIFIER", 60, 70]]], ["Quantile regression test results are reported in Section 4.", [["Quantile regression test", "TEST", 0, 24]]], ["Section 5 concludes the paper with a discussion of major findings.Tourism growth and hotel dataThe growth rate of the number of total foreign tourist arrivals (GTA) was used as a proxy for tourism growth (Chen, 2010; Kim et al., 2006) :Tourism growth and hotel datawhere TA is the number of total foreign tourist arrivals during the month t.", [["growth", "OBSERVATION_MODIFIER", 99, 105]]], ["The TA data were taken from the database of the Taiwan Economic Journal (TEJ).", [["The TA data", "TEST", 0, 11]]], ["The growth rate of hotel sales is calculated as:Tourism growth and hotel datawhere S is the sales of each hotel firm at the end of the month t.Tourism growth and hotel dataThe study included equities of seven publicly traded hotel companies-Ambassador Hotel, First Hotel, Grand Formosa Regent Taipei, Hotel Holiday Garden, Leofoo Hotel, Landis Taipei, and Chihpen Royal.", [["The study", "TEST", 172, 181], ["growth", "OBSERVATION_MODIFIER", 4, 10]]], ["Hotel equity return is computed asTourism growth and hotel datawhere P t is the closing price of each hotel equity at the end of month t.Tourism growth and hotel dataTo capture the effect of the broad equity market movements on hotel sales growth and equity returns, the variable of the overall equity market return was incorporated into regression tests.", [["regression tests", "TEST", 338, 354], ["broad", "OBSERVATION_MODIFIER", 195, 200]]], ["An increase in stock prices, indicating that investors expect the economy to grow rapidly, is hence expected to affect hotel equity returns and sales growth.", [["An increase in stock prices", "TREATMENT", 0, 27], ["increase", "OBSERVATION_MODIFIER", 3, 11], ["stock prices", "OBSERVATION", 15, 27]]], ["The equity market return (MR) was computed as: MR t = ln TWI t /TWI t\u22121 , where TWI t is the Taiwan weighted index at the end of the month t.", [["MR", "PROTEIN", 26, 28], ["MR", "PROTEIN", 47, 49], ["TWI t", "DNA", 80, 85], ["MR", "TEST", 47, 49], ["ln TWI t /TWI t\u22121", "PROBLEM", 54, 71], ["TWI", "PROBLEM", 80, 83]]], ["All equity data were also taken from the TEJ database.", [["the TEJ database", "TEST", 37, 53]]], ["Table 1 presents the summary statistics of GTA, GS, HER, and MR over the entire sample period.", [["HER", "PROTEIN", 52, 55], ["MR", "PROTEIN", 61, 63], ["MR", "TEST", 61, 63]]], ["The results of statistical tests of the null hypothesis of normality (the Lagrange Multiplier test) are also reported in Table 1 .", [["statistical tests", "TEST", 15, 32], ["the Lagrange Multiplier test", "TEST", 70, 98]]], ["The skewness test measures the asymmetry of the data distribution about the mean, while kurtosis in excess of (Koenker and Machado, 1999) . * Significant at the 10% level. ** Significant at the 5% level. *** Significant at the 1% level.", [["The skewness test", "TEST", 0, 17], ["asymmetry", "OBSERVATION_MODIFIER", 31, 40], ["Significant", "OBSERVATION_MODIFIER", 142, 153], ["Significant", "OBSERVATION_MODIFIER", 175, 186]]], ["(Koenker and Machado, 1999) . * Significant at the 10% level. ** Significant at the 5% level. *** Significant at the 1% level.Tourism growth and hotel datathree implies that it is fat tailed.", [["fat", "ANATOMY", 180, 183], ["fat", "TISSUE", 180, 183], ["Significant", "OBSERVATION_MODIFIER", 32, 43], ["Significant", "OBSERVATION_MODIFIER", 65, 76]]], ["The third (skewness) and fourth (kurtosis) moments showed that the distributions of GS (HER) are negatively (positively) skewed and have fat tails.", [["fat tails", "ANATOMY", 137, 146], ["HER", "CHEMICAL", 88, 91], ["HER", "GENE_OR_GENE_PRODUCT", 88, 91], ["fat", "TISSUE", 137, 140], ["HER", "PROTEIN", 88, 91]]], ["The Lagrange Multiplier (LM) test rejected the normality hypothesis, suggesting that GS and HER do not follow the normal distribution.A quantile regression methodThe study performed a panel regression test based on Eq.", [["HER", "CHEMICAL", 92, 95], ["HER", "GENE_OR_GENE_PRODUCT", 92, 95], ["HER", "PROTEIN", 92, 95], ["The Lagrange Multiplier (LM) test", "TEST", 0, 33], ["GS", "TEST", 85, 87], ["A quantile regression method", "TREATMENT", 134, 162], ["The study", "TEST", 162, 171], ["a panel regression test", "TEST", 182, 205], ["normal", "OBSERVATION", 114, 120]]], ["(4b) is used to test the relationship between GTA and HERs:A quantile regression methodIf GTA can significantly (positively) affect GS (HER), the coefficient b 11 (b 21 ) is expected to be significantly positive and different from zero, since a high GTA would benefit GS (HER).", [["HER", "PROTEIN", 136, 139], ["HER", "PROTEIN", 272, 275], ["the coefficient b", "TEST", 142, 159], ["significantly positive", "PROBLEM", 189, 211], ["positive", "OBSERVATION", 203, 211]]], ["The panel regression tests given in Eqs.", [["The panel regression tests", "TEST", 0, 26]]], ["(4a) and (4b) can be estimated based on the OLS estimation.A quantile regression methodThe study also used a quantile regression method for panel data to analyze whether the relationship between GTA and GS/HER is sensitive to different quantiles of HER dispersions.", [["HER", "CHEMICAL", 206, 209], ["HER", "CHEMICAL", 249, 252], ["HER", "GENE_OR_GENE_PRODUCT", 206, 209], ["HER", "GENE_OR_GENE_PRODUCT", 249, 252], ["HER", "PROTEIN", 206, 209], ["HER", "PROTEIN", 249, 252], ["the OLS estimation", "TEST", 40, 58], ["A quantile regression method", "TREATMENT", 59, 87], ["The study", "TEST", 87, 96], ["panel data", "TEST", 140, 150]]], ["The quantile regression is more robust and generates more efficient estimates compared to the OLS regression because the quantile regression allows us to estimate the relationship between a dependent variable and its explanatory variables at any specific quantile.A quantile regression methodThe quantile regression to estimate the effect of GTA on GS/HER for quantiles is given as (Koenker, 2005) :A quantile regression methodwhere y is a dependent variable, x is a vector of independent variables and \u02c7 is a vector of coefficients.", [["HER", "GENE_OR_GENE_PRODUCT", 352, 355], ["HER", "PROTEIN", 352, 355], ["The quantile regression", "PROBLEM", 0, 23], ["a dependent variable", "PROBLEM", 188, 208], ["A quantile regression method", "TREATMENT", 264, 292], ["The quantile regression", "PROBLEM", 292, 315], ["GTA on GS", "TREATMENT", 342, 351], ["a dependent variable", "PROBLEM", 438, 458], ["more robust", "OBSERVATION_MODIFIER", 27, 38], ["dependent", "OBSERVATION_MODIFIER", 440, 449], ["variable", "OBSERVATION_MODIFIER", 450, 458]]], ["(5a) are obtained by minimizing weighted deviations from the conditional quantile:A quantile regression methodwhere the conditional distribution of the dependent variable y (GS/HER) is characterized by different values of the th quantile given x (GTA and MR), \u2208 (0, 1) and is a weighting factor called a check function defined as:A quantile regression methodwhere u t = y t \u2212 x t\u02c7.", [["HER", "PROTEIN", 177, 180], ["MR", "PROTEIN", 255, 257], ["MR", "TEST", 255, 257]]], ["The quantile regression coefficient\u02c6 determines the dependence relationship between GTA and the th conditional quantile of GS/HER, which offers a broader picture, showing the link between GTA and GS/HER.Quantile regression test resultsThe OLS and quantile regression estimation results reported in Table 2 indicate that GTA has a significant effect on GS, even at the different quantiles of GS.", [["GTA", "CHEMICAL", 320, 323], ["HER", "CHEMICAL", 126, 129], ["HER", "CHEMICAL", 199, 202], ["HER", "GENE_OR_GENE_PRODUCT", 126, 129], ["HER", "GENE_OR_GENE_PRODUCT", 199, 202], ["GTA", "SIMPLE_CHEMICAL", 320, 323], ["GS", "PROTEIN", 123, 125], ["HER", "PROTEIN", 126, 129], ["HER", "PROTEIN", 199, 202], ["Quantile regression test", "TEST", 203, 227], ["quantile regression estimation", "TEST", 247, 277], ["GTA", "PROBLEM", 320, 323], ["a significant effect on GS", "PROBLEM", 328, 354], ["significant", "OBSERVATION_MODIFIER", 330, 341], ["effect", "OBSERVATION_MODIFIER", 342, 348]]], ["Table 2 and Fig. 1 illustrate that the value of the estimated coefficients is positive and stable in magnitude as the quantile increases from .1 to .9, suggesting that the significant effect of GTA on GS is consistent.", [["GTA", "CHEMICAL", 194, 197], ["GTA", "SIMPLE_CHEMICAL", 194, 197], ["the value", "TEST", 35, 44], ["the estimated coefficients", "TEST", 48, 74], ["GTA on GS", "TREATMENT", 194, 203], ["positive", "OBSERVATION", 78, 86], ["stable", "OBSERVATION_MODIFIER", 91, 97], ["significant", "OBSERVATION_MODIFIER", 172, 183]]], ["While MR positively and significantly influences GS based on the OLS regression estimation result, the significant influence exists only at certain quantiles of GS.Quantile regression test resultsAccording to the OLS regression estimation results in Table 3 , the effect of GTA on HER is found be positive, but this influence is not statistically significant at the 10% level, suggesting that the relationship between GTA and HER during the period from January 1983 to December 2013 is non-significant.", [["HER", "CHEMICAL", 281, 284], ["HER", "CHEMICAL", 426, 429], ["GTA", "SIMPLE_CHEMICAL", 274, 277], ["HER", "GENE_OR_GENE_PRODUCT", 281, 284], ["HER", "GENE_OR_GENE_PRODUCT", 426, 429], ["MR", "PROTEIN", 6, 8], ["HER", "PROTEIN", 281, 284], ["HER", "PROTEIN", 426, 429], ["MR", "TEST", 6, 8], ["significantly influences GS", "PROBLEM", 24, 51], ["the OLS regression estimation", "TEST", 61, 90], ["Quantile regression test", "TEST", 164, 188], ["significant", "OBSERVATION_MODIFIER", 103, 114], ["positive", "OBSERVATION", 297, 305]]], ["However, this study yielded some interesting results by looking at the quantile regression tests.Quantile regression test resultsQuantile regression estimation results in Table 3 revealed that the estimated coefficients of GTA on HER have an expected positive sign and are found to be statistically significant only at the low quantiles but not at the median and high quantiles.", [["HER", "CHEMICAL", 230, 233], ["HER", "GENE_OR_GENE_PRODUCT", 230, 233], ["HER", "PROTEIN", 230, 233], ["this study", "TEST", 9, 19], ["the quantile regression tests", "TEST", 67, 96], ["Quantile regression test", "TEST", 97, 121], ["Quantile regression estimation", "TEST", 129, 159], ["significant", "OBSERVATION", 299, 310], ["low quantiles", "OBSERVATION_MODIFIER", 323, 336]]], ["As shown in Fig. 2 , the quantile regression results also show evidence of asymmetries.", [["the quantile regression", "TEST", 21, 44], ["asymmetries", "PROBLEM", 75, 86], ["evidence of", "UNCERTAINTY", 63, 74], ["asymmetries", "OBSERVATION", 75, 86]]], ["The estimated coefficients consistently increase in magnitude as the quantile increases from .1 to .6.", [["The estimated coefficients", "PROBLEM", 0, 26], ["coefficients", "OBSERVATION_MODIFIER", 14, 26], ["consistently", "OBSERVATION_MODIFIER", 27, 39], ["increase", "OBSERVATION_MODIFIER", 40, 48]]], ["In comparison, both the OLS and quantile regression estimation results in Table 3 show that MR has a significant impact on HER, even at the different quantiles of HER.Discussion and conclusionWhile tourism growth was expected to have a strong influence on hotel performance, several hospitality studies failed to find a significant relationship between tourism growth and HER.", [["HER", "CHEMICAL", 123, 126], ["HER", "CHEMICAL", 163, 166], ["HER", "CHEMICAL", 372, 375], ["HER", "GENE_OR_GENE_PRODUCT", 123, 126], ["HER", "GENE_OR_GENE_PRODUCT", 163, 166], ["HER", "GENE_OR_GENE_PRODUCT", 372, 375], ["MR", "PROTEIN", 92, 94], ["HER", "PROTEIN", 123, 126], ["HER", "PROTEIN", 163, 166], ["HER", "PROTEIN", 372, 375], ["significant", "OBSERVATION_MODIFIER", 101, 112], ["impact", "OBSERVATION_MODIFIER", 113, 119]]], ["Using the quantile regression method, this study took a closer look at how tourism growth affects different quantiles of GS and HER, and it offers a new finding regarding the link between tourism growth and HER.Discussion and conclusionBoth the OLS and quantile regression estimation results indicated a consistent and significant effect of GTA on GS.", [["GTA", "CHEMICAL", 341, 344], ["HER", "CHEMICAL", 207, 210], ["HER", "GENE_OR_GENE_PRODUCT", 128, 131], ["HER", "GENE_OR_GENE_PRODUCT", 207, 210], ["GTA", "SIMPLE_CHEMICAL", 341, 344], ["HER", "PROTEIN", 128, 131], ["HER", "PROTEIN", 207, 210], ["this study", "TEST", 38, 48], ["quantile regression estimation", "TEST", 253, 283], ["GTA on GS", "PROBLEM", 341, 350]]], ["The OLS estimation results showed that tourism growth has a positive effect on HER, but this positive influence is not statistically significant.", [["HER", "CHEMICAL", 79, 82], ["HER", "GENE_OR_GENE_PRODUCT", 79, 82], ["HER", "PROTEIN", 79, 82], ["The OLS estimation", "TEST", 0, 18], ["positive effect", "OBSERVATION_MODIFIER", 60, 75]]], ["However, the quantile regression test results revealed interesting outcomes.", [["the quantile regression test", "TEST", 9, 37]]], ["Specifically, it was found that the link between tourism growth and HER is statistically significant at the low quantiles of HER but not at the median and high quantiles of HER.", [["HER", "CHEMICAL", 68, 71], ["HER", "CHEMICAL", 125, 128], ["HER", "CHEMICAL", 173, 176], ["HER", "GENE_OR_GENE_PRODUCT", 68, 71], ["HER", "GENE_OR_GENE_PRODUCT", 125, 128], ["HER", "GENE_OR_GENE_PRODUCT", 173, 176], ["HER", "PROTEIN", 68, 71], ["HER", "PROTEIN", 125, 128], ["HER", "PROTEIN", 173, 176]]], ["In other words, the significant effect of tourism growth on HER exists only when HER is low, i.e. the association between tourism growth and HER is state-dependent.Discussion and conclusionEmpirical findings provide two important implications.", [["HER", "CHEMICAL", 60, 63], ["HER", "CHEMICAL", 81, 84], ["HER", "CHEMICAL", 141, 144], ["HER", "GENE_OR_GENE_PRODUCT", 60, 63], ["HER", "GENE_OR_GENE_PRODUCT", 81, 84], ["HER", "GENE_OR_GENE_PRODUCT", 141, 144], ["HER", "PROTEIN", 60, 63], ["HER", "PROTEIN", 81, 84], ["HER", "PROTEIN", 141, 144], ["significant", "OBSERVATION_MODIFIER", 20, 31]]], ["Tourism growth has a significant influence on HER when HER is low, and low HER may be due to the effect of business contraction.", [["HER", "CHEMICAL", 46, 49], ["HER", "CHEMICAL", 55, 58], ["HER", "CHEMICAL", 75, 78], ["HER", "GENE_OR_GENE_PRODUCT", 46, 49], ["HER", "GENE_OR_GENE_PRODUCT", 55, 58], ["HER", "GENE_OR_GENE_PRODUCT", 75, 78], ["HER", "PROTEIN", 46, 49], ["HER", "PROTEIN", 55, 58], ["HER", "PROTEIN", 75, 78], ["business contraction", "TREATMENT", 107, 127]]], ["Therefore, the findings in this study seem to support those found in Chen (2011) , suggesting that the effect of tourism growth on HER depends on the state of economy and that tourism growth can significantly enhance HER during contraction periods.Discussion and conclusionSecond, Chen et al. (2012) detected that the Taiwanese hotels with a larger size (market value) have higher equity returns.", [["HER", "CHEMICAL", 131, 134], ["HER", "CHEMICAL", 217, 220], ["HER", "GENE_OR_GENE_PRODUCT", 131, 134], ["HER", "GENE_OR_GENE_PRODUCT", 217, 220], ["HER", "PROTEIN", 131, 134], ["HER", "PROTEIN", 217, 220], ["this study", "TEST", 27, 37], ["tourism growth", "PROBLEM", 113, 127], ["larger", "OBSERVATION_MODIFIER", 342, 348], ["size", "OBSERVATION_MODIFIER", 349, 353], ["higher", "OBSERVATION_MODIFIER", 374, 380], ["equity", "OBSERVATION_MODIFIER", 381, 387]]], ["In other words, low HER may be associated with hotels with a small size.", [["HER", "CHEMICAL", 20, 23], ["HER", "GENE_OR_GENE_PRODUCT", 20, 23], ["HER", "PROTEIN", 20, 23], ["small", "OBSERVATION_MODIFIER", 61, 66], ["size", "OBSERVATION_MODIFIER", 67, 71]]], ["Accordingly, this study provides a new finding.", [["this study", "TEST", 13, 23]]], ["While previous studies find no significant relationship between tourism growth and HER, this paper shows that tourism growth has a significant influence on equity returns of small hotel firms.", [["HER", "CHEMICAL", 83, 86], ["HER", "GENE_OR_GENE_PRODUCT", 83, 86], ["HER", "PROTEIN", 83, 86], ["previous studies", "TEST", 6, 22], ["significant", "OBSERVATION_MODIFIER", 131, 142], ["small", "OBSERVATION_MODIFIER", 174, 179], ["hotel firms", "OBSERVATION", 180, 191]]]]}